Structure Search

List Search MOL Search Structure Search

 EN

English - EN Chinese - ZH

 Cart 0
Chemistry
Life Science
Catalysts Ligands
Materials Science
Catalysts Ligands
Achiral Nitrogen Ligands
Pyridine and Phenanthroline Ligands (162)
Other Achiral Nitrogen Ligands (53)
Achiral Oxygen Ligands
Achiral Oxygen Ligand (54)
Achiral Phosphine Ligands
Alkyl-phosphine Ligands (17)
Aryl-phosphine Ligands (86)
2-(Diphenylphosphaneyl)Benzaldehyde (5)[1,1'-Biphenyl]-2-Yldi-Tert-Butylphosphane (4)Triphenylphosphine Oxide (7)
Bis-phosphine Ligands (90)
Monophosphine Ligands (256)
Multi-phosphine Ligands (5)
Chiral Nitrogen Ligands
Chiral Bis-nitrogen Ligands (133)
Salen Ligands (7)
Other Chiral Nitrogen Ligands (64)
Chiral Oxazoline Ligands
BOX Ligands (510)
Chiral Mono Oxazoline Ligands (363)
Ferrocenyl-oxazoline Ligands (10)
PHOX Ligands (218)
SOX Ligands (34)
TOX Ligands (6)
Other Oxazoline Ligands (14)
Chiral Oxygen Ligands
BINOLs (46)
BIPHENs (2)
Chiral Diphenols (112)
Other Chiral Oxygen Ligands (24)
Chiral Phosphine Ligands
Atropisomeric Bisphosphine Ligands (137)
BIDIME and BIBOP Ligands (78)
BIDIME-BIBOP (7)
2,2',3,3'-Tetrahydro-4,4'-Bibenzo[D][1,3]Oxaphosphole (7)
Chiral Aminophosphine Ligands (50)
Chiral Ferrocenyl Phosphine Ligands (96)
Chiral Phosphoramidite Ligands (98)
Duphos and BPE Ligands (28)
PHOX Ligands (218)
Sadphos Ligands (110)
Other C-Chiral Ligands (76)
Other P-Chiral Ligands (10)
Main-Group Metals
Aluminum (11)
Tin (3)
Metalloids
Metalloid (5)
Photoredox Catalysts
Organic-dye Photoredox Catalysts (88)
Photoredox Acridinium Catalysts (22)
Photoredox Carbazole Catalysts (10)
Photoredox Iridiums Catalysts (100)
Photoredox Rutheniums Catalysts (36)
Other Photoredox Catalysts (13)
Transition Metals
Cadmium (1)
Cobalt (93)
Copper (108)
Gold (70)
Iridium (60)
Iron (101)
Manganese (45)
Molybdenum (11)
Nickel (95)
Osmium (2)
Palladium (240)
Platinum (75)
Rhenium (6)
Rhodium (165)
Ruthenium (199)
Silver (33)
Tantalum (1)
Titanium (10)
Tungsten (6)
Vanadium (6)
Zinc (48)
Other Cheap Metals (6)
Chemistry
Asymmetric Synthesis
Chiral Building Blocks (18769)
Boronic Acids/Esters
1,3,2-Dioxaborinane (394)
Boronic Acids (13203)
MIDA Boronates (363)
Pinacol Boronates (16139)
Pinanediol Boronates (96)
Potassium Organotrifluoroborate Salts (1077)
Other Boronates (132)
Fluorine Chemistry
Aliphatic Fluorinated Building Blocks (660)
Aromatic Fluorinated Building Blocks (9087)
Bis(trifluoromethane)sulfonimides (49)
Difluoromethoxylated Building Blocks (238)
Difluoromethylated Building Blocks (334)
Hexafluorophosphates (62)
Monofluoromethylated Building Blocks (65)
Polyfluoroalkanes (84)
SF5-Containing Building Blocks (72)
Sulfonyl Fluorides (67)
Tetrafluoroborates (139)
Triflates (85)
Trifluoroborates (212)
Trifluoromethoxylated Building Blocks (567)
Trifluoromethylated Building Blocks (4366)
Trifluoromethylthiolated Building Blocks (49)
Heterocyclic Building Blocks
Acridines (641)
1,2,3,4-Tetrahydroacridine (9)9,10-Diphenylacridin-10-Ium (6)Acridine (19)
Aliphatic Heterocycles (104)
(1R,5S)-3-Azabicyclo[3.1.0]Hexane (11)1,2-Dithiolane (6)1,4-Diazepan-2-One (5)1,4-Diazepan-5-One (9)1,4-Dioxane (17)1,4-Oxazepane (8)10,11-Dihydro-5H-Dibenzo[B,F]Azepine (9)11,12-Didehydro-5,6-Dihydrodibenz[B,F]Azocine (14)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Glycyl)-2,2-Dimethyloxazolidine-4-Carboxylic Acid (9)3H-Diazirine (11)4-Benzyl-1,4-Oxazepane (5)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)
Aromatic Heterocycles (30)
1,2,4,5-Tetrazine (7)3,4-Dihydronaphthalen-2(1H)-One (23)
Azetidines (2929)
1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Phenylsulfonyl)Azetidine (7)1-Benzhydrylazetidine (13)1-Benzylazetidine (6)1-Methylazetidine (6)1-Phenylazetidine (8)2,7-Diazaspiro[3.5]Nonane (7)2-Azaspiro[3.3]Heptane (11)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)3-Bromoazetidine (3)3-Methylazetidin-3-Ol (3)3-Methyleneazetidine (8)3-Phenylazetidine (3)4-(Azetidin-1-Yl)Piperidine (6)Azetidin-2-One (11)Azetidin-2-Ylmethanol (7)Azetidin-3-Amine (4)Azetidin-3-Ol (11)Azetidin-3-Yl Acetate (3)Azetidin-3-Ylmethanamine (3)Azetidine-2-Carboxylic Acid (6)Azetidine-3-Carboxylic Acid (5)Benzyl Azetidine-1-Carboxylate (9)Methyl Azetidine-2-Carboxylate (3)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)Tert-Butyl Azetidine-1-Carboxylate (64)
Benzimidazoles (4387)
(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)1,2-Diphenyl-1H-Benzo[D]Imidazole (7)1-Benzyl-1H-Benzo[D]Imidazole (6)1-Ethyl-1H-Benzo[D]Imidazole (4)1-Methyl-1H-Benzo[D]Imidazole (47)1-Phenyl-1H-Benzo[D]Imidazole (4)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-2-Thiol (10)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-Benzyl-1H-Benzo[D]Imidazole (7)2-Bromo-1H-Benzo[D]Imidazole (4)2-Chloro-1H-Benzo[D]Imidazole (17)2-Methyl-1H-Benzo[D]Imidazole (20)4-Bromo-1H-Benzo[D]Imidazole (14)4-Methyl-1H-Benzo[D]Imidazole (7)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5-Bromo-1H-Benzo[D]Imidazole (13)5-Chloro-1H-Benzo[D]Imidazole (14)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methyl-1H-Benzo[D]Imidazole (10)6-Chloro-1H-Benzo[D]Imidazole (25)Methyl (1H-Benzo[D]Imidazol-2-Yl)Carbamate (5)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (3)Benzimidazole-Carboxylic Acid (43)
Benzisoxazoles (508)
3-Chlorobenzo[D]Isoxazole (7)3-Methylbenzo[D]Isoxazole (8)6-Bromobenzo[D]Isoxazole (5)Benzo[C]Isoxazole (5)Benzo[D]Isoxazol-3-Amine (8)
Benzodioxans (694)
(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)6-Bromo-2,3-Dihydrobenzo[B][1,4]Dioxine (6)
Benzofurans (3708)
1-(Benzofuran-2-Yl)Ethan-1-One (3)2,2-Dimethyl-2,3-Dihydrobenzofuran (7)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,3-Dihydrobenzofuran-7-Amine (5)2-(Benzofuran-3-Yl)Acetic Acid (3)2-Bromodibenzo[B,D]Furan (6)2-Ethylbenzofuran (3)2-Methylbenzofuran (5)3-Methylbenzofuran (4)4-Bromobenzofuran (3)4-Phenyldibenzo[B,D]Furan (8)5,7,8-Trimethylchromane (3)5-Bromo-2,3-Dihydrobenzofuran (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Methoxyisobenzofuran-1(3H)-One (5)6-Bromo-2,3-Dihydrobenzofuran (7)6-Fluoro-2,3-Dihydrobenzofuran (6)6-Methoxybenzofuran (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromobenzofuran (6)7-Fluoro-2,3-Dihydrobenzofuran (6)Benzofuran-2(3H)-One (7)Benzofuran-2-Carbaldehyde (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-2-Ylboronic Acid (8)Benzofuran-3(2H)-One (15)Benzofuran-3-Carboxylic Acid (6)Benzofuran-3-Yl(Phenyl)Methanone (11)Methyl Benzofuran-2-Carboxylate (6)Benzofuran-Carboxylic Acid (67)Dimethoxyisobenzofuran (4)Epoxyisobenzofuran (1)Fluorobenzofuran (19)Fluoroisobenzofuran (5)Methoxyisobenzofuran (4)Methylbenzofuran (25)
Benzothiazoles (2424)
2-(Methylthio)Benzo[D]Thiazole (6)2-Bromobenzo[D]Thiazole (28)2-Chlorobenzo[D]Thiazole (21)2-Methylbenzo[D]Thiazole (26)4-Bromobenzo[D]Thiazole (9)4-Chlorobenzo[D]Thiazole (7)4-Fluorobenzo[D]Thiazole (6)4-Methylbenzo[D]Thiazole (10)5-Chlorobenzo[D]Thiazole (5)5-Nitrobenzo[D]Thiazole (3)6-Bromobenzo[D]Thiazole (7)6-Chlorobenzo[D]Thiazole (6)6-Fluorobenzo[D]Thiazole (5)6-Methoxybenzo[D]Thiazole (6)6-Methylbenzo[D]Thiazole (6)6-Nitrobenzo[D]Thiazole (3)7-Bromobenzo[D]Thiazole (8)7-Chlorobenzo[D]Thiazole (6)7-Fluorobenzo[D]Thiazole (9)Benzo[D]Thiazol-2-Amine (30)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzo[D]Thiazol-6-Ol (2)Benzo[D]Thiazole-2-Carbonitrile (11)Benzo[D]Thiazole-2-Thiol (11)Benzo[D]Thiazole-6-Carboxylic Acid (5)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Benzothiazole-Carboxylic Acid (27)Bromobenzothiazole (7)Dichlorobenzothiazole (10)Methoxybenzothiazole (4)Methylbenzothiazole (7)
Benzothiophenes (1117)
2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-Methylbenzo[B]Thiophene (4)3-Bromobenzo[B]Thiophene (5)3-Chlorobenzo[B]Thiophene (6)3-Methylbenzo[B]Thiophene (4)4,5,6,7-Tetrahydrobenzo[B]Thiophene (21)5-Bromobenzo[B]Thiophene (3)5-Chlorobenzo[B]Thiophene (4)6-Bromobenzo[B]Thiophene (4)7-Bromobenzo[B]Thiophene (5)Benzo[B]Thiophen-2-Amine (5)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[B]Thiophene-3-Carbaldehyde (6)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Benzothiophene-Carboxylic Acid (58)
Benzoxazoles (2805)
2-Chlorobenzo[D]Oxazole (11)2-Methylbenzo[D]Oxazole (26)2-Phenylbenzo[D]Oxazole (22)3-Phenylbenzo[D]Oxazol-3-Ium (8)5-Bromobenzo[D]Oxazole (3)5-Chlorobenzo[D]Oxazole (5)5-Methylbenzo[D]Oxazole (3)6-Chlorobenzo[D]Oxazole (4)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Oxazole-2-Thiol (6)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Benzoxazole-Carboxylic Acid (25)
Carbazole Series (482)
1-Methyl-9H-Carbazole (7)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2-Bromo-9H-Carbazole (4)3,9-Diphenyl-9H-Carbazole (7)3-(Tert-Butyl)-9H-Carbazole (3)3-Bromo-9-Phenyl-9H-Carbazole (16)3-Bromo-9H-Carbazole (4)3-Chloro-9H-Carbazole (3)3-Methyl-9H-Carbazole (3)7H-Benzo[C]Carbazole (5)9-([1,1'-Biphenyl]-4-Yl)-9H-Carbazole (9)9-(P-Tolyl)-9H-Carbazole (5)9-Benzyl-9H-Carbazole (7)9-Ethyl-9H-Carbazole (10)Carbazolyl-Phenyl-Boronic Acid/Ester (14)
Cinnolines (355)
Cinnoline (11)
Dioxolanes (1580)
(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)1,3-Dioxolan-2-One (11)2,2-Difluorobenzo[D][1,3]Dioxole (24)2,2-Dimethyl-1,3-Dioxolane (29)2,2-Dimethylbenzo[D][1,3]Dioxole (7)2-Phenyl-1,3-Dioxolane (18)4-Bromobenzo[D][1,3]Dioxole (6)4-Methyl-1,3-Dioxolane (5)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromobenzo[D][1,3]Dioxole (12)5-Chlorobenzo[D][1,3]Dioxole (5)5-Nitrobenzo[D][1,3]Dioxole (4)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)Benzo[D][1,3]Dioxol-5-Amine (3)
Dioxoles (13)
Epoxides (407)
7-Oxabicyclo[4.1.0]Heptane (7)Ethyl Oxirane-2-Carboxylate (4)Oxiran-2-Ylmethanol (3)Epoxy (7)Oxirane (64)
Furans (6963)
2,3-Dihydrofuran-3-One (9)2-(Bromomethyl)Furan (3)2-(Chloromethyl)Furan (3)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-Bromofuran (21)2-Chlorofuran (3)2-Methylfuran (38)2-Nitrofuran (9)3-Bromofuran (13)4-Methylisobenzofuran-1(3H)-One (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Phenylfuran-2-Carbaldehyde (9)5-Phenylfuran-2-Carboxylic Acid (6)6-Chloro-2,3-Dihydrobenzofuran (3)6-Fluoroisobenzofuran-1(3H)-One (3)7-Chloro-2,3-Dihydrobenzofuran (3)Ethyl Furan-2-Carboxylate (6)Furan-2,5-Dione (8)Furan-2-Carbaldehyde (22)Furan-2-Carbonitrile (8)Furan-2-Carboxylic Acid (32)Furan-2-Ylmethanol (8)Furan-3-Carboxylic Acid (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Methyl Furan-2-Carboxylate (20)N-(Furan-2-Ylmethyl)Aniline (5)Aminodihydrofuran (7)Bromofuran (32)Chlorofuran (2)Chlorofuro (11)Cyanofuran (53)Dibromofuran (5)Dihydrofuran (31)Dihydrofuro (15)Dihydroxydihydrofuran (8)Dimethylfuran (10)Formylfuran (10)Hexahydrofuro (6)Hydroxydihydrofuran (31)Methyldihydrofuran (11)Methylfuran (58)Nitrofuran (10)
Imidazoles (834)
Biimidazole (5)Bromoimidazo (102)Dibromoimidazo (8)Dichloroimidazo (9)Dihydroimidazo (25)Imidazol-Amine (1)Methoxyimidazo (13)Methylimidazo (121)Tetrahydroimidazo (40)1,1'-Diphenyl-4,4',5,5'-Tetrahydro-1H,1'H-2,2'-Biimidazole (11)1,2-Dimethyl-1H-Imidazole (6)1,3-Diphenyl-1H-Imidazol-3-Ium (14)1,3-Diphenyl-4,5-Dihydro-1H-Imidazol-3-Ium (5)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(Phenylsulfonyl)-1H-Imidazole (5)1-Benzyl-1H-Imidazole (20)1-Decyl-3-Methyl-1H-Imidazol-3-Ium (14)1-Ethyl-1H-Imidazole (3)1-Isopropyl-1H-Imidazole (5)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Trityl-1H-Imidazole (15)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Imidazol-2-Amine (6)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carbonitrile (2)1H-Imidazole-4-Carboxylic Acid (4)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-Bromo-1H-Imidazole (13)2-Bromoimidazo[1,2-A]Pyridine (5)2-Ethyl-1H-Imidazole (3)2-Methyl-1-Phenyl-1H-Imidazole (11)2-Methylimidazo[1,2-A]Pyridine (8)2-Phenyl-1H-Benzo[D]Imidazole (26)2-Phenyl-1H-Imidazole (26)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propyl-1H-Imidazole (5)3-Bromoimidazo[1,2-A]Pyrazine (6)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Iodoimidazo[1,2-A]Pyridine (10)3-Methylimidazo[1,2-A]Pyridine (3)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Methyl-1-Phenyl-1H-Imidazole (7)4-Methyl-1H-Imidazole (6)4-Phenyl-1H-Imidazole (8)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Benzyl-1H-Imidazole (1)5-Bromoimidazo[1,2-A]Pyridine (6)5-Chloro-1H-Imidazole (2)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Iodo-1H-Imidazole (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Phenyl-1H-Imidazole (6)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6-Bromoimidazo[1,2-A]Pyrazine (11)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloroimidazo[1,2-B]Pyridazine (30)7-Methylimidazo[1,2-A]Pyridine (3)8-Bromoimidazo[1,2-A]Pyrazine (7)8-Bromoimidazo[1,2-A]Pyridine (15)8-Chloroimidazo[1,2-A]Pyrazine (8)8-Chloroimidazo[1,2-A]Pyridine (7)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Methylimidazo[1,2-A]Pyridine (9)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Imidazo[1,2-A]Pyridin-8-Ol (3)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Imidazo[1,2-C]Pyrimidine (6)Imidazo[1,5-A]Pyrazine (9)Imidazo[2,1-B]Thiazole (14)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)
Imidazolidines (1145)
Methylimidazolidine (3)Oxoimidazolidine (8)Thioxoimidazolidin (9)(3Ar,6As)-Tetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One (18)1-Phenylimidazolidin-2-One (8)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylimidazolidine-2,4-Dione (4)Imidazolidin-2-One (16)Imidazolidine-2,4-Dione (17)
Imidazolines (695)
Indazoles (3060)
(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)1-Benzyl-1H-Indazole (5)1-Ethyl-1H-Indazole (6)1H-Indazol-3-Amine (23)1H-Indazol-3-Ol (10)1H-Indazol-4-Amine (12)1H-Indazol-4-Ol (4)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-6-Ol (6)1H-Indazol-7-Amine (6)1H-Indazole-3-Carbaldehyde (19)1H-Indazole-3-Carbonitrile (9)1H-Indazole-3-Carboxylic Acid (23)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)2,3-Dimethyl-2H-Indazole (4)2-Methyl-2H-Indazole (34)3-(Piperidin-4-Yl)-1H-Indazole (5)3-Chloro-1H-Indazole (13)4,5,6,7-Tetrahydro-1H-Indazole (12)4-Chloro-1H-Indazole (18)4-Fluoro-1H-Indazole (22)4-Methoxy-1H-Indazole (7)4-Methyl-1H-Indazole (12)4-Nitro-1H-Indazole (10)5-Bromo-1H-Indazole (14)5-Chloro-1H-Indazole (9)5-Methoxy-1H-Indazole (5)5-Nitro-1H-Indazole (5)6-(Trifluoromethyl)-1H-Indazole (6)6-Bromo-1H-Indazole (23)6-Chloro-1H-Indazole (14)6-Fluoro-1H-Indazole (15)6-Methoxy-1H-Indazole (14)6-Methyl-1H-Indazole (9)6-Nitro-1H-Indazole (9)7-Bromo-1H-Indazole (18)7-Chloro-1H-Indazole (7)7-Fluoro-1H-Indazole (12)7-Methoxy-1H-Indazole (5)7-Nitro-1H-Indazole (11)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Indazol-Amide (3)
Indoles (7643)
(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1H-Indol-2-Yl)Boronic Acid (3)(1H-Indol-2-Yl)Methanol (8)(3As,7As)-Octahydro-1H-Indole (5)(9H-Fluoren-9-Yl)Methyl (2-(1H-Indol-3-Yl)Ethyl)Carbamate (12)1,2,3,4-Tetrahydrocyclopenta[B]Indole (5)1,2-Dimethyl-1H-Indole (3)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(Phenylsulfonyl)-1H-Indole (26)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)1-Benzyl-1H-Indole (9)1-Ethyl-1H-Indole (7)1-Methyl-1H-Indole (82)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Methyl-1H-Pyrrolo[2,3-B]Pyridine (14)1-Phenyl-1H-Indole (5)1H-Indol-3-Ol (5)1H-Indol-3-Yl Acetate (4)1H-Indol-4-Amine (10)1H-Indol-4-Ol (7)1H-Indol-5-Ol (4)1H-Indol-6-Amine (21)1H-Indol-6-Ol (6)1H-Indol-7-Amine (10)1H-Indole-2-Carbaldehyde (20)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-3-Carboxylic Acid (28)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carbonitrile (5)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carbonitrile (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carbonitrile (6)1H-Indole-7-Carboxylic Acid (7)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (13)2,3-Dimethyl-1H-Indole (9)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(4-Fluorophenyl)-1H-Indole (4)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Methyl-1H-Pyrrolo[2,3-B]Pyridine (12)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(Piperidin-4-Yl)-1H-Indole (8)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Methyl-1H-Indole (41)3H-Indole (8)4-Bromo-1H-Indole (25)4-Chloro-1H-Indole (21)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoroindoline-2,3-Dione (3)4-Methoxy-1H-Indole (11)4-Methyl-1H-Indole (23)4-Nitro-1H-Indole (6)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(Benzyloxy)-1H-Indole (8)5-Bromo-1-Methyl-1H-Indole (3)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoroindolin-2-One (4)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methyl-1H-Indole (33)5-Nitro-1H-Indole (6)6-(Trifluoromethyl)-1H-Indole (5)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Fluoro-1H-Indole (17)6-Methoxy-1H-Indole (12)6-Methyl-1H-Indole (29)6-Methyl-1H-Pyrrolo[2,3-B]Pyridine (8)6-Nitro-1H-Indole (8)7-Bromo-1H-Indole (28)7-Bromoindoline-2,3-Dione (3)7-Chloro-1H-Indole (29)7-Fluoro-1H-Indole (24)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)7-Methoxy-1H-Indole (8)7-Methyl-1H-Indole (34)7-Nitro-1H-Indole (11)9H-Pyrido[3,4-B]Indole (5)Benzo[Cd]Indol-2(1H)-One (5)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 2-(1H-Indol-3-Yl)Acetate (3)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)Tryptophan (22)Azaindole (44)Benzyloxyindole (1)Biindolinylidene (1)Bromo-Indole-Carboxylic Acid (25)Cyanoindole (5)Dihydroindolo (14)Fluoroindole (5)Formylindole (44)Hydroxyindole (7)Hydroxyisoindoline (2)Indolecarboxylic (2)Isoindole (26)Methoxyindole (9)Nitroindole (6)
Indolines (4489)
(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1-(Indolin-1-Yl)Ethan-1-One (9)1-Benzylindoline-2,3-Dione (5)1-Methylindolin-2-One (14)1-Methylindoline (3)1-Methylindoline-2,3-Dione (8)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-Methylindoline (7)2-Methylisoindolin-1-One (7)3,3-Dimethylindolin-2-One (5)3,3-Dimethylindoline (7)4-Bromoindoline (4)4-Chloroindoline-2,3-Dione (6)4-Methylindoline (3)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-Bromoindolin-2-One (5)5-Bromoindoline (8)5-Bromoisoindoline-1,3-Dione (3)5-Chloroindolin-2-One (3)5-Fluoroindoline (3)5-Methoxyindoline (4)5-Methylindolin-2-One (3)5-Methylindoline (3)6-Bromoindolin-2-One (8)6-Bromoindoline-2,3-Dione (4)6-Chloroindolin-2-One (5)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Fluoroindolin-2-One (5)6-Fluoroindoline-2,3-Dione (3)7-Bromoindoline (3)7-Fluoroindolin-2-One (3)7-Fluoroindoline-2,3-Dione (6)7-Methylindoline-2,3-Dione (7)Indoline-2-Carboxylic Acid (3)Methyl Indoline-6-Carboxylate (3)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Tert-Butyl Indoline-1-Carboxylate (24)Aminoindoline (10)Bromoindoline (17)Bromoisoindolin (5)Bromoisoindoline (6)Chloroindolin (4)Chloroisoindoline (3)Dibromoindoline (12)Dichloroindoline (16)Difluoroindoline (1)Dimethylindoline (21)Dioxoindoline (8)Dioxoisoindolin (72)Fluoroindolin (9)Fluoroindoline (9)Fluoroisoindoline (10)Hydroxyindolin (5)Indoline-Carboxylate (1)Isoindoline (20)Methoxyindoline (12)Methoxyisoindoline (9)Methylindoline (46)Methylisoindoline (18)Nitroindolin (6)Nitroindoline (11)Nitroisoindoline (8)Oxoindoline (32)Oxoisoindoline (16)Spiro-Indoline-Piperidine (34)
Isoquinolines (2730)
1,3-Dichloroisoquinoline (14)1-Bromoisoquinoline (20)1-Chloroisoquinoline (20)1-Methylisoquinoline (9)1H-Benzo[De]Isoquinoline-1,3(2H)-Dione (14)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)3-Bromoisoquinoline (10)3-Chloroisoquinoline (20)3-Methylisoquinoline (8)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Chloroisoquinoline (11)4-Fluoroisoquinoline (6)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromoisoquinoline (17)5-Chloroisoquinoline (6)5-Methoxyisoquinoline (6)5-Nitroisoquinoline (7)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromoisoquinoline (9)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromoisoquinoline (6)7-Chloroisoquinoline (6)7-Fluoroisoquinoline (3)7-Methoxyisoquinoline (5)8-Bromoisoquinoline (17)8-Chloroisoquinoline (7)8-Fluoroisoquinolin-1(2H)-One (3)8-Fluoroisoquinoline (10)8-Methoxyisoquinoline (7)Isoquinolin-1-Amine (18)Isoquinolin-1-Ol (9)Isoquinolin-3-Amine (13)Isoquinolin-3-Ol (6)Isoquinolin-4-Amine (16)Isoquinolin-4-Ol (9)Isoquinolin-4-Ylboronic Acid (3)Isoquinolin-5-Amine (9)Isoquinolin-5-Ol (7)Isoquinolin-8-Amine (6)Isoquinoline-1-Carbonitrile (7)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-5-Sulfonyl Chloride (3)Isoquinoline-6-Carboxylic Acid (3)Methyl Isoquinoline-3-Carboxylate (3)Methyl Isoquinoline-4-Carboxylate (6)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Bromoisoquinoline (69)Chloroisoquinoline (101)Dibromoisoquinoline (9)Dichloroisoquinoline (14)Dihydroisoquinoline (107)Fluoroisoquinoline (78)Methoxyisoquinoline (59)Methylisoquinoline (59)Nitroisoquinoline (23)
Isothiazoles (343)
Benzo[D]Isothiazol-3(2H)-One 1,1-Dioxide (10)Benzo[D]Isothiazole (12)Isothiazole (24)Methylisothiazole (5)
Isoxazoles (3403)
(3-Phenylisoxazol-5-Yl)Methanol (7)3-Bromoisoxazole (7)3-Methyl-5-Phenylisoxazole (6)3-Methylisoxazole (30)3-Phenylisoxazol-5-Amine (8)5-(Thiophen-2-Yl)Isoxazole (5)5-Cyclopropylisoxazole (5)5-Methyl-3-Phenylisoxazole (4)5-Methylisoxazole (16)5-Phenylisoxazole-3-Carboxylic Acid (15)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Isoxazol-3-Amine (7)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Amine (15)Isoxazol-5-Ylmethanol (5)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl 5-Phenylisoxazole-3-Carboxylate (6)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)Aminoisoxazole (7)Bromoisoxazole (5)Dihydroisoxazol (2)Dimethylisoxazole (17)Phenylisoxazole (28)
Morpholines (4990)
(R)-3-Phenylmorpholine (7)(S)-3-Phenylmorpholine (10)2,2-Dimethylmorpholine (5)2,6-Dimethylmorpholine (5)2-(Methoxymethyl)Morpholine (4)2-(Morpholin-2-Yl)Acetic Acid (5)2-Ethylmorpholine (3)2-Isopropylmorpholine (4)2-Methylmorpholine (7)2-Phenylmorpholine (8)3-(4-Morpholinophenyl)Oxazolidin-2-One (5)3-(Methoxymethyl)Morpholine (4)3-Ethylmorpholine (4)3-Isopropylmorpholine (5)3-Methylmorpholine (13)3-Phenylmorpholine (8)4-(2-Fluorophenyl)Morpholine (8)4-(3-Phenoxypropyl)Morpholine (7)4-(O-Tolyl)Morpholine (6)4-(Pyrazin-2-Yl)Morpholine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-Benzylmorpholin-3-One (6)4-Morpholinoaniline (4)4-Morpholinobenzaldehyde (8)4-Morpholinobenzoic Acid (5)4-Phenylmorpholin-3-One (6)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)Benzyl Morpholine-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Morpholin-2-Ylmethanamine (8)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Morpholine-2-Carbonitrile (4)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Morpholino(Phenyl)Methanone (11)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl Morpholine-4-Carboxylate (23)Benzylmorpholine (25)Cyanomorpholine (6)Dimorpholine (3)Ethylmorpholine (9)Isopropylmorpholine (9)Methylmorpholine (68)Morpholinobenzaldehyde (11)Morpholinobenzo (13)Morpholinobenzoic (8)Morpholinoethanone (5)Morpholinoethoxy (1)Morpholinoethyl (5)Morpholinomethyl (16)Morpholinophenyl (14)Morpholinopropoxy (6)Morpholinopyrimidin (6)Morpholinosulfonyl (7)Oxomorpholine (6)
Naphthyridines (940)
1,5-Naphthyridine-3-Carboxylic Acid (6)1,6-Naphthyridine (22)1,7-Naphthyridine (23)2,7-Naphthyridine (5)3-Bromo-1,5-Naphthyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Chloro-1,5-Naphthyridine (6)5,6,7,8-Tetrahydro-1,6-Naphthyridine (22)5,6,7,8-Tetrahydro-1,7-Naphthyridine (6)
Oxadiazoles (3552)
1,2,4-Oxadiazole (19)1,2,5-Oxadiazole (12)1,3,4-Oxadiazole (25)2,5-Diphenyl-1,3,4-Oxadiazole (6)2-Phenyl-1,3,4-Oxadiazole (26)3-Phenyl-1,2,4-Oxadiazole (23)Benzo[C][1,2,5]Oxadiazole (17)
Oxazines (235)
2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromo-2H-Benzo[B][1,4]Oxazin-3(4H)-One (7)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-2H-Benzo[B][1,4]Oxazin-3(4H)-One (8)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)
Oxazoles (2026)
Bioxazole (12)2-Bromooxazole (7)2-Chlorooxazole (7)2-Methyloxazole (19)2-Phenyloxazole (16)3,4-Diphenylisoxazole (8)4,5-Diphenyloxazole (7)4-(Oxazol-5-Yl)Aniline (3)4-Methyloxazole (9)5-(4-Nitrophenyl)Oxazole (3)5-Methyloxazole (5)6-Bromobenzo[D]Oxazole (3)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Methyl Oxazole-4-Carboxylate (9)Oxazol-2-Amine (8)Oxazole-4-Carboxylic Acid (4)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)
Oxazolidines (1299)
(R)-4-Benzyloxazolidin-2-One (5)(S)-4-Benzyloxazolidin-2-One (11)3-(4-Morpholinophenyl)Oxazolidin-2-One (5)3-Phenyloxazolidin-2-One (4)4-Isopropyloxazolidine (6)Oxazolidine (21)Oxazolidine-2,5-Dione (9)Dimethyloxazolidin (6)Dioxooxazolidin (2)Oxazolidinone (5)Phenyloxazolidin (9)Propionyloxazolidin (5)
Oxazolines (1577)
(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,3-Bis(4,5-Dihydrooxazol-2-Yl)Benzene (8)2,2'-(1,3-Diphenylpropane-2,2-Diyl)Bis(4,5-Dihydrooxazole) (5)2,2'-(2-Phenylethane-1,1-Diyl)Bis(4,5-Dihydrooxazole) (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Phenyl-4,5-Dihydrooxazole (18)4,4',5,5'-Tetrahydro-2,2'-Bioxazole (10)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)Bis((3Ar,8As)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis((3As,8Ar)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis(4,5-Dihydrooxazol-2-Yl)Methane (22)
Oxetanes (772)
Methyloxetane (11)
Phthalazines (423)
Phthalazine (16)Dihydrophthalazine (15)
Piperazines (7430)
(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(R)-2-Benzylpiperazine (5)1,4-Diphenylpiperazine (7)1-(2-Chlorophenyl)Piperazine (4)1-(2-Fluorophenyl)Piperazine (8)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-(Methylsulfonyl)Piperazine (5)1-(Phenylsulfonyl)Piperazine (17)1-(Piperidin-4-Yl)Piperazine (6)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-Benzhydryl-4-Benzylpiperazine (1)1-Benzhydrylpiperazine (9)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1-Benzyl-4-Methylpiperazine (10)1-Ethyl-4-Phenylpiperazine (4)1-Ethylpiperazine (6)1-Isopropylpiperazine (4)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methyl-4-Phenylpiperazine (22)1-Methylpiperazin-2-One (6)1-Methylpiperazine (21)10-(3-(Piperazin-1-Yl)Propyl)-10H-Phenothiazine (2)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperazin-1-Yl)Pyrazine (9)2-(Piperazin-1-Yl)Pyrimidine (11)2-Phenylpiperazine (17)3-(Piperazin-1-Yl)Aniline (3)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Piperazin-1-Yl)Pyridazine (7)3-Methylpiperazin-2-One (7)4-(Piperazin-1-Yl)Benzaldehyde (5)4-(Piperazin-1-Yl)Pyrimidine (13)Benzyl 2-Methylpiperazine-1-Carboxylate (7)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl 3-Methylpiperazine-1-Carboxylate (5)Phenyl(Piperazin-1-Yl)Methanone (20)Piperazine-2,5-Dione (9)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl 4-Benzylpiperazine-1-Carboxylate (13)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl Piperazine-1-Carboxylate (30)Isobutylpiperazine (6)Propylpiperazine (10)
Piperidines (21787)
Bipiperidine (12)Chloropiperidine (6)Dimethylpiperidine (46)Ethynylpiperidine (5)Fluoropiperidine (33)Formylpiperidine (9)Isopropylpiperidine (11)Piperidine-Carboxylate (3)Piperidineacetic (5)Piperidinecarboxylic (6)Piperidinyl-Phenyl-Boronic Acid/Ester (32)Propylpiperidine (8)(9H-Fluoren-9-Yl)Methyl Piperidine-1-Carboxylate (16)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(R)-2-Phenylpiperidine (10)(R)-3-Aminopiperidin-2-One (3)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)(S)-2-Phenylpiperidine (11)(S)-N-Phenylpiperidine-2-Carboxamide (1)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4'-Bipiperidine (8)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)Piperidine (23)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Piperidin-4-Yl)Piperazine (6)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-3-One (5)1-Benzylpiperidin-4-Amine (8)1-Benzylpiperidin-4-One (8)1-Isopropylpiperidine (5)1-Methyl-4-Phenylpiperidine (4)1-Methylpiperidin-2-One (3)1-Oxa-8-Azaspiro[4.5]Decane (5)1-Phenylpiperidin-2-One (8)2,2-Dimethylpiperidin-4-One (6)2,2-Dimethylpiperidine (21)2,7-Diazaspiro[3.5]Nonane (7)2,8-Diazaspiro[4.5]Decan-3-One (6)2,8-Diazaspiro[4.5]Decane (5)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-(Piperidin-4-Yl)Pyridine (5)2-Methylpiperidin-4-One (6)2-Methylpiperidine (14)2-Phenylpiperidine (14)3,3-Difluoropiperidin-4-One (3)3,3-Difluoropiperidine (29)3,3-Dimethylpiperidin-4-One (3)3,3-Dimethylpiperidine (5)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)-1H-Indazole (5)3-(Piperidin-4-Yl)-1H-Indole (8)3-(Piperidin-4-Yl)Pyridine (5)3-Fluoropiperidin-4-One (3)3-Fluoropiperidine (26)3-Methoxypiperidine (7)3-Methylpiperidin-4-One (3)3-Methylpiperidine (10)3-Phenylpiperidine (2)4,4-Difluoropiperidine (5)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-(Azetidin-1-Yl)Piperidine (6)4-(Piperidin-1-Yl)Pyrimidine (9)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Benzylpiperidine (18)4-Hydrazineylpiperidine (5)4-Hydroxypiperidin-2-One (3)4-Methyl-1-Phenylpiperidine (6)4-Methylenepiperidine (14)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenylpiperidin-4-Ol (10)5-Hydroxypiperidin-2-One (3)6-Azaspiro[2.5]Octane (10)6-Oxopiperidine-2-Carboxylic Acid (3)7-Azaspiro[3.5]Nonane (7)Azepane (25)Benzyl 3-Hydroxypiperidine-1-Carboxylate (7)Benzyl 4-Oxopiperidine-1-Carboxylate (12)Benzyl Piperidin-4-Ylcarbamate (7)Benzyl Piperidine-1-Carboxylate (50)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Ethyl Piperidine-1-Carboxylate (5)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)N-Benzylpiperidin-4-Amine (3)N-Methylpiperidin-3-Amine (5)N-Phenylpiperidine-2-Carboxamide (2)Phenyl(Piperidin-1-Yl)Methanone (21)Phenyl(Piperidin-4-Yl)Methanone (21)Piperidin-2-Ylmethanamine (6)Piperidin-2-Ylmethanol (11)Piperidin-3-Amine (17)Piperidin-3-Ol (27)Piperidin-3-One (13)Piperidin-3-Ylmethanamine (5)Piperidin-3-Ylmethanol (15)Piperidin-4-Amine (14)Piperidin-4-Ol (44)Piperidin-4-Ylmethanamine (7)Piperidin-4-Ylmethanol (11)Piperidine-2,4-Dione (5)Piperidine-2,6-Dione (13)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxamide (5)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (12)Quinuclidine (5)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Spiro[Indoline-3,4'-Piperidine] (5)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl (Piperidin-3-Ylmethyl)Carbamate (5)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Piperidin-3-Ylcarbamate (9)
Purines (2026)
(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (28)2-Chloro-7H-Purine (3)2-Chloro-9H-Purine (5)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)9H-Purin-6-Amine (3)
Pyrans (1098)
(S)-2-Phenylchroman-4-One (17)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)2,2-Dimethylchromane (5)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2H-Chromene (16)3,4-Dihydro-2H-Pyran (11)3,6-Dihydro-2H-Pyran (8)3-Acetyl-2H-Chromen-2-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (22)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-Hydroxy-2H-Chromen-2-One (10)4-Methyl-2H-Chromen-2-One (27)5-Fluorochroman-4-One (3)5-Fluorochromane (6)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)6-Bromochroman-4-One (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Fluorochroman-4-One (5)6-Fluorochromane (6)6-Methoxychromane (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromochroman-4-One (4)7-Bromochromane (7)7-Chlorochromane (5)7-Fluorochroman-4-One (5)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxychroman-4-One (3)8-Bromochroman-4-One (4)8-Bromochromane (6)8-Chlorochromane (5)8-Fluorochromane (5)8-Methylchroman-4-One (4)8-Methylchromane (11)Chroman-2-One (5)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Chroman-4-Ol (4)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Isochromane (11)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Tetrahydro-2H-Pyran-2-One (15)Tetrahydro-2H-Thiopyran (10)Tetrahydro-4H-Pyran-4-One (12)Thiochroman-4-One (10)Chromene-Carboxylic Acid (1)Thioglucopyranoside (4)
Pyrazines (3359)
Dibromopyrazine (7)Dichloropyrazine (21)Dihydropyrazine (6)Dimethylpyrazine (30)Ethoxypyrazine (5)Ethylpyrazine (7)Fluoropyrazine (6)Hydroxypyrazine (4)Iodopyrazine (17)Methoxypyrazine (36)Phenylpyrazin (5)Pyrazino (5)Pyrazino-Nitrile (50)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1-(Pyrazin-2-Yl)Ethan-1-One (5)1H-Pyrazolo[3,4-B]Pyrazine (5)2,3-Diphenylpyrazine (5)2,5-Dibromopyrazine (4)2,5-Dichloropyrazine (4)2,6-Dibromopyrazine (9)2,6-Dichloropyrazine (14)2-(Piperazin-1-Yl)Pyrazine (9)2-(Trifluoromethyl)Pyrazine (6)2-Bromo-3-Methoxypyrazine (5)2-Bromo-3-Methylpyrazine (5)2-Bromo-5-Chloropyrazine (6)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Methylpyrazine (5)2-Bromopyrazine (15)2-Chloro-3-Methylpyrazine (7)2-Chloro-6-Methylpyrazine (12)2-Chloropyrazine (24)2-Ethoxypyrazine (3)2-Ethylpyrazine (9)2-Fluoropyrazine (7)2-Iodopyrazine (25)2-Methoxypyrazine (45)2-Methylpyrazine (16)2-Phenylpyrazine (12)3-Chloropyrazin-2-Amine (6)3-Chloropyrazine-2-Carbonitrile (6)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4-(Pyrazin-2-Yl)Morpholine (5)5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine (11)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Bromopyrazin-2-Amine (13)5-Bromopyrazin-2-Ol (5)5-Chloropyrazin-2-Amine (9)5H-Pyrrolo[2,3-B]Pyrazine (14)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[4,3-A]Pyrazine (11)Ethyl Pyrazine-2-Carboxylate (10)Imidazo[1,5-A]Pyrazine (9)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl Pyrazine-2-Carboxylate (19)Pyrazin-2-Amine (22)Pyrazin-2-Ol (7)Pyrazin-2-Ylmethanamine (12)Pyrazine-2-Carbaldehyde (17)Pyrazine-2-Carbohydrazide (3)Pyrazine-2-Carbonitrile (15)Pyrazine-2-Carboxamide (10)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrazine (5)Pyrido[2,3-B]Pyrazine (12)Pyrido[3,4-B]Pyrazine (11)Tert-Butyl Pyrazin-2-Ylcarbamate (8)
Pyrazoles (16151)
(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)1,3-Dimethyl-1H-Pyrazole (28)1,3-Diphenyl-1H-Pyrazole (6)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1,5-Diphenyl-1H-Pyrazole (13)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Pyrazole (9)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Cyclopentyl-1H-Pyrazole (5)1-Cyclopropyl-1H-Pyrazole (9)1-Methyl-1H-Pyrazol-3-Amine (14)1-Methyl-3-Phenyl-1H-Pyrazole (21)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)1-Methyl-5-Phenyl-1H-Pyrazole (7)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)1-Trityl-1H-Pyrazole (5)1H-Pyrazol-4-Amine (6)1H-Pyrazol-4-Ol (3)1H-Pyrazol-5-Amine (19)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-4-Sulfonyl Chloride (8)1H-Pyrazole-5-Carboxamide (3)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrazolo[3,4-B]Pyrazine (5)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,4-Dihydro-3H-Pyrazol-3-One (10)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-Phenyl-2,4-Dihydro-3H-Pyrazol-3-One (24)3-(Tert-Butyl)-1-Phenyl-1H-Pyrazole (4)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Cyclopropyl-1H-Pyrazole (5)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Methyl-1-Phenyl-1H-Pyrazole (23)3-Phenyl-1H-Pyrazol-5-Amine (11)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyridine (6)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Iodo-1H-Pyrazole (9)4-Methyl-1-Phenyl-1H-Pyrazole (6)4-Methyl-1H-Pyrazole (11)4-Nitro-1H-Pyrazole (8)4-Phenyl-1H-Pyrazole (18)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)5-(Difluoromethyl)-1H-Pyrazole (6)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Cyclopropyl-1H-Pyrazole (6)5-Iodo-1H-Pyrazole (4)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine (13)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)7-Chloropyrazolo[1,5-A]Pyrimidine (8)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)Pyrazolo[1,5-A]Pyrazine (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Bipyrazole (5)Chloropyrazolo (33)Dichloropyrazolo (11)Dihydropyrazolo (28)Dimethylpyrazolo (6)Ethylpyrazole (7)Fluoropyrazolo (9)Hydroxypyrazolo (10)Methoxypyrazolo (16)Methyl-Pyrazole-Carboxylic Acid (147)Methyl-Pyrazolone (87)Methylpyrazolo (32)Pyrazolopyridine-Carboxylic Acid (48)Tetrahydropyrazolo (23)
Pyridazines (2753)
2-Methylpyridazin-3(2H)-One (7)3,6-Dichloropyridazine (20)3-(Piperazin-1-Yl)Pyridazine (7)3-(Trifluoromethyl)Pyridazine (3)3-Bromopyridazine (25)3-Chloro-4-Methylpyridazine (7)3-Chloropyridazine (44)3-Iodopyridazine (5)3-Methoxypyridazine (17)3-Methylpyridazine (6)3-Phenylpyridazine (8)4-Aminopyridazin-3(2H)-One (4)4-Bromopyridazin-3(2H)-One (3)4-Bromopyridazine (5)4-Chloropyridazin-3(2H)-One (4)4-Chloropyridazine (16)4-Methoxypyridazine (8)4-Methylpyridazine (3)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridazin-3-Amine (5)[1,2,4]Triazolo[4,3-B]Pyridazine (10)Ethyl Pyridazine-3-Carboxylate (6)Methyl Pyridazine-3-Carboxylate (7)Pyridazin-3-Amine (18)Pyridazin-3-Ol (3)Pyridazin-4-Amine (10)Pyridazine-3-Carboxylic Acid (7)Aminopyridazine (12)Dihydropyridazine (26)Dimethylpyridazine (9)Hexahydropyridazines (10)Pyridazinecarboxylic (1)
Pyridines (70358)
Acetylpyridin (5)Aminopicolinate (8)Benzyloxypyridine (36)Bipyridine (202)Bromopicolinate (19)Bromopicolinic (4)Bromopicolinic Acid (5)Bromopicolinonitrile (6)Bromopyrido (13)Butylpyridine (5)Chloroisonicotinic Acid (5)Chloronicotinaldehyde (23)Chloronicotinamide (11)Chloronicotinate (45)Chloronicotinic (41)Cyanopicolinate (7)Cyanopicolinic (6)Cyanopyridine (34)Cyclopropoxypyridine (6)Cyclopropylpyridine (30)Dibromopicolinate (4)Dibromopicolinic Acid (3)Dibromopyridine (36)Dichloropicolinate (9)Dichloropicolinonitrile (4)Dichloropyridine (120)Difluoropicolinic Acid (3)Difluoropyridine (58)Dihydropyrido (27)Diiodopyridine (13)Dimethoxypicolinic Acid (5)Dimethoxypyridine (33)Dimethylpyridine (143)Diphenylpyridine (6)Dipyridine (28)Ethoxypicolinic Acid (3)Ethoxypyridine (35)Ethylpyridine (36)Ethynylpicolinate (3)Fluoro-Pyridine--Boronate (79)Fluoropicolinaldehyde (8)Fluoropicolinamide (8)Fluoropicolinate (22)Fluoropyridine (287)Fluoropyrido (3)Formylpyridine (23)Hexahydropyrido (7)Hydrazinylpyridine (22)Hydroxymethylpyridine (27)Hydroxypicolinate (13)Hydroxypicolinic (9)Hydroxypicolinonitrile (7)Iodopicolinate (5)Iodopicolinic Acid (4)Iodopyridine (167)Isopropoxypyridine (20)Isopropylpyridine (32)Methoxyisonicotinaldehyde (10)Methoxynicotinaldehyde (18)Methoxypicolinaldehyde (13)Methoxypicolinamide (13)Methoxypicolinate (21)Methoxypicolinic (18)Methoxypicolinic Acid (16)Methoxypicolinimidamide (5)Methoxypicolinonitrile (13)Methoxypyridine (341)Methylisonicotinamide (8)Methylnicotinaldehyde (30)Methylnicotinamide (13)Methylpicolinaldehyde (16)Methylpicolinamide (15)Methylpicolinate (27)Methylpicolinic (23)Methylpicolinonitrile (28)Methylpyrido (13)Nitropyridine (393)Oxopyridin (2)Phenoxypyridin (1)Picolinate (42)Pyridinecarbonitrile (50)Pyridyl-Benzene-Boronic Acid/Ester (16)Pyridyl-Phenyl-Boronate (2)Pyridylmethyl (6)Terpyridine (32)Tetrachloropyridine (5)Tetrafluoropyridine (21)Tetrahydropyridine (49)Tetrahydropyrido (32)Tribromopyridine (9)Trichloropyridine (17)Trifluoropyridine (8)Trimethylpyridine (5)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3-Bromopyridin-2-Yl)Methanol (7)(3-Chloropyridin-2-Yl)Methanamine (6)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanol (10)(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(5-Chloropyridin-2-Yl)Methanamine (5)(6-Methylpyridin-2-Yl)Methanamine (6)(6-Methylpyridin-2-Yl)Methanol (5)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,1'-Diphenyl-[4,4'-Bipyridine]-1,1'-Diium (7)1,10-Phenanthrolin-4-Ol (3)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1,2,3,6-Tetrahydropyridine (22)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4-Di(Pyridin-4-Yl)Benzene (5)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-(Pyridin-4-Yl)Ethan-1-One (14)1-Benzyl-1,2,3,6-Tetrahydropyridine (9)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methylpyridin-1-Ium Iodide (5)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,2':6',2''-Terpyridine (15)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2,3'-Bipyridine (11)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (13)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dibromopyridine (21)2,3-Dichloropyridine (38)2,3-Difluoropyridine (13)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (6)2,3-Dihydro-[1,4]Dioxino[2,3-B]Pyridine (5)2,3-Dihydropyridin-2-One (5)2,3-Dimethoxypyridine (7)2,3-Dimethylpyridine (8)2,4,6-Trichloropyridine (5)2,4,6-Triphenylpyridine (7)2,4-Dibromopyridine (5)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloropyridine (50)2,4-Dimethylpyridine (5)2,5-Dibromopyridine (26)2,5-Dichloropyridine (32)2,5-Difluoropyridine (8)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Iodopyridine (4)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloronicotinonitrile (8)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2,6-Difluoropyridine (29)2,6-Dimethoxypyridine (11)2,6-Dimethylpyridin-4-Ol (4)2,6-Dimethylpyridine (26)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(2-Chlorophenyl)Pyridine (3)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-Fluorophenyl)Pyridine (11)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzyloxy)Pyridine (18)2-(Bromomethyl)Pyridine (27)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Difluoromethyl)Pyridine (21)2-(Methylsulfonyl)Pyridine (11)2-(Methylthio)Pyridine (5)2-(P-Tolyl)Pyridine (6)2-(Phenoxymethyl)Pyridine (5)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-4-Yl)Pyridine (5)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)Pyridine (6)2-Aminonicotinonitrile (6)2-Benzylpyridine (12)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Iodopyridine (6)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitropyridine (5)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Methylpyridine (6)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodopyridine (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Phenylpyridine (4)2-Bromonicotinic Acid (5)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Fluoropyridine (20)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Iodopyridine (19)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methylpyridine (31)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Iodopyridine (18)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodopyridine (9)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylpyridine (49)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Ethoxypyridine (20)2-Ethylpyridine (9)2-Ethynylpyridine (31)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Fluoro-3-Iodopyridine (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methoxypyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoropyridine (15)2-Hydrazineylpyridine (32)2-Iodo-6-Methylpyridine (5)2-Iodopyridine (27)2-Isopropoxypyridine (16)2-Isopropylpyridine (14)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Methoxy-5-Methylpyridine (5)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Methylpyridine (14)2-Methoxyisonicotinic Acid (13)2-Methoxypyridin-3-Amine (6)2-Methoxypyridine (435)2-Methyl-1,10-Phenanthroline (3)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-Nitropyridine (9)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)2-Methylimidazo[1,2-A]Pyridine (8)2-Methylpyridin-3-Ol (9)2-Methylpyridin-4-Amine (7)2-Methylpyridine 1-Oxide (9)2-Nitropyridine (40)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propoxypyridine (9)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,3'-Bipyridine (7)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)3,5-Dibromopyridine (12)3,5-Dichloropyridine (16)3,5-Difluoropyridine (12)3,5-Dimethoxypyridine (4)3,5-Dimethylpyridine (8)3,5-Diphenylpyridine (5)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-(Benzyloxy)Pyridine (19)3-(Bromomethyl)Pyridine (18)3-(Chloromethyl)Pyridine (22)3-(Cyclopropylmethyl)Pyridine (6)3-(Difluoromethyl)Pyridine (5)3-(Methylsulfonyl)Pyridine (5)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)Pyridine (5)3-(Pyrrolidin-2-Yl)Pyridine (6)3-(Tert-Butyl)Pyridine (5)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (51)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Methylpyridine (13)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylpyridine (4)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Cyclopropylpyridine (28)3-Ethoxypyridine (12)3-Ethylpyridine (11)3-Ethynylpyridine (22)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-2-Methylpyridine (15)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Fluoropicolinic Acid (6)3-Fluoropicolinonitrile (5)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Hydrazineylpyridine (8)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Methoxypyridin-2-Amine (5)3-Methoxypyridine (51)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Methyl-2-Phenylpyridine (3)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)3-Methyl-5-Nitropyridine (4)3-Methylimidazo[1,2-A]Pyridine (3)3-Methylpicolinic Acid (13)3-Methylpyridin-2-Amine (7)3-Methylpyridine (49)3-Methylpyridine 1-Oxide (7)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Phenoxypyridine (12)4'-Phenyl-2,2':6',2''-Terpyridine (13)4,4'-Bipyridine (10)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,7-Diphenyl-1,10-Phenanthroline (4)4-(2,4-Diphenyl-1H-Imidazol-5-Yl)Pyridine (5)4-(Benzyloxy)Pyridine (8)4-(Bromomethyl)Pyridine (8)4-(Pyridin-2-Yl)Morpholine (21)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-(Tert-Butyl)Pyridine (5)4-(Trifluoromethyl)Nicotinic Acid (3)4-(Trifluoromethyl)Pyridine (14)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-Methylpyridine (5)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Bromopyridine (31)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-3-Methylpyridine (7)4-Chloronicotinic Acid (4)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Cyclopropylpyridine (7)4-Ethoxypyridine (7)4-Ethynylpyridine (10)4-Iodopyridine (17)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Methoxypyridine (136)4-Methyl-2,2'-Bipyridine (8)4-Methyl-2-Phenylpyridine (3)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)4-Methyl-3-Nitropyridine (8)4-Methylnicotinic Acid (5)4-Methylpyridine (24)4-Nitropyridine (11)4-Phenoxypyridine (7)4-Phenyl-1,2,3,6-Tetrahydropyridine (7)4-Phenyl-1,4-Dihydropyridine (10)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5,6-Dichloropyridin-2-Amine (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Iodopyridine (5)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Fluoro-2-Methoxypyridine (15)5-Fluoro-2-Methylpyridine (8)5-Fluoropicolinonitrile (5)5-Fluoropyridin-2-Amine (15)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5-Methoxypyridin-3-Amine (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)5-Phenylpicolinic Acid (4)6,7-Dihydro-5H-Cyclopenta[B]Pyridine (18)6,7-Dihydro-5H-Cyclopenta[C]Pyridine (7)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromonicotinaldehyde (10)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chloro-5-Iodopyridin-2-Amine (3)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxynicotinaldehyde (4)6-Methoxypicolinic Acid (9)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylnicotinic Acid (6)6-Methylnicotinonitrile (7)6-Methylpicolinic Acid (12)6-Methylpicolinonitrile (10)6-Methylpyridin-2-Amine (46)6-Methylpyridin-2-Ol (23)6-Methylpyridin-3-Amine (5)6-Methylpyridin-3-Ol (7)6-Phenoxypyridin-3-Amine (5)6-Phenylnicotinic Acid (8)6-Phenylpicolinic Acid (3)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methylimidazo[1,2-A]Pyridine (3)9H-Pyrido[3,4-B]Indole (5)Bis(Pyridin-2-Ylmethyl)Amine (6)Dimethyl Pyridine-2,6-Dicarboxylate (7)Dimethyl(Pyridin-2-Yl)Phosphine Oxide (8)Dimethyl(Pyridin-3-Yl)Phosphine Oxide (7)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Methylnicotinate (6)Ethyl 4,6-Dichloronicotinate (4)Ethyl 6-Chloropicolinate (7)Ethyl Isonicotinate (12)Ethyl Nicotinate (25)Ethyl Picolinate (41)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Imidazo[1,2-A]Pyridin-2-Ylmethanol (4)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinaldehyde (68)Isonicotinamide (12)Isonicotinic Acid (23)Isonicotinohydrazide (6)Isonicotinonitrile (16)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Bromopicolinate (9)Methyl 3-Chloropicolinate (9)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)Methyl 5-Hydroxypicolinate (5)Methyl 6-Bromonicotinate (6)Methyl 6-Chloropicolinate (11)Methyl 6-Fluoronicotinate (4)Methyl 6-Methoxynicotinate (4)Methyl Isonicotinate (16)Methyl Nicotinate (52)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N-(Pyridin-2-Yl)Benzamide (9)N-Benzylpyridin-2-Amine (9)N-Methylpicolinamide (10)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpicolinamide (8)N-Phenylpyridin-2-Amine (9)Nicotinaldehyde (152)Nicotinamide (64)Nicotinic Acid (53)Nicotinonitrile (82)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)Phenyl(Pyridin-2-Yl)Methanone (10)Phenyl(Pyridin-3-Yl)Methanone (9)Picolinaldehyde (98)Picolinamide (26)Picolinic Acid (22)Picolinimidamide (11)Picolinohydrazide (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyridin-2-Amine (29)Pyridin-2-Ol (170)Pyridin-2-Ylboronic Acid (9)Pyridin-2-Ylmethanamine (38)Pyridin-2-Ylmethanol (65)Pyridin-3-Amine (21)Pyridin-3-Ol (13)Pyridin-3-Ylboronic Acid (49)Pyridin-3-Ylmethanamine (29)Pyridin-3-Ylmethanol (39)Pyridin-4-Amine (22)Pyridin-4-Ol (16)Pyridin-4-Ylboronic Acid (21)Pyridin-4-Ylmethanamine (12)Pyridin-4-Ylmethanol (16)Pyridine 1-Oxide (33)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyridine-2,6-Dicarboxylic Acid (9)Pyridine-2,6-Diol (6)Pyridine-2-Sulfonamide (6)Pyridine-2-Sulfonyl Chloride (9)Pyridine-2-Thiol (8)Pyridine-3-Sulfonic Acid (6)Pyridine-3-Sulfonyl Chloride (25)Pyrido[2,3-B]Pyrazine (12)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-B]Pyrazine (11)Pyrido[3,4-D]Pyrimidine (10)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl Pyridin-2-Ylcarbamate (37)Tert-Butyl Pyridin-3-Ylcarbamate (16)Tert-Butyl Pyridin-4-Ylcarbamate (6)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[3,2-B]Pyridine (18)Thieno[3,2-C]Pyridine (13)
Pyrimidines (14569)
Bipyrimidine (4)Dibromopyrimidine (15)Methoxypyrimidine (107)Pyrimidinone (3)Tetraoxatetradecan (10)Trichloropyrimidine (11)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)1,4,5,6-Tetrahydropyrimidine (4)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (10)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (31)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (50)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyrimidine (14)2,4,6-Triphenylpyrimidine (9)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichloropyrimidin-5-Amine (6)2,4-Dimethoxypyrimidine (13)2,4-Dimethylpyrimidine (7)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(Chloromethyl)Pyrimidine (5)2-(Methylsulfonyl)Pyrimidine (25)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Piperazin-1-Yl)Pyrimidine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Propylthio)Pyrimidine (5)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Trifluoromethyl)Pyrimidine (27)2-Aminopyrimidin-4(3H)-One (11)2-Bromopyrimidine (22)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloropyrimidin-4-Amine (22)2-Cyclopropylpyrimidine (10)2-Ethoxypyrimidine (7)2-Ethylpyrimidine (6)2-Fluoropyrimidine (9)2-Hydrazineylpyrimidine (6)2-Iodopyrimidine (8)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methylpyrimidin-4-Amine (22)2-Methylpyrimidin-4-Ol (11)2-Phenoxypyrimidine (8)2-Phenylpyrimidin-5-Amine (5)3-Methylpyrimidin-4(3H)-One (6)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyrimidin-2-Amine (9)4,6-Dichloropyrimidine (14)4,6-Diphenylpyrimidine (7)4-(Dimethoxymethyl)Pyrimidine (5)4-(Piperazin-1-Yl)Pyrimidine (13)4-(Piperidin-1-Yl)Pyrimidine (9)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-(Pyrimidin-4-Yl)Morpholine (13)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (22)4-Bromopyrimidine (24)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Chloro-5-Iodopyrimidine (6)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-6-Methoxypyrimidine (5)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Chloropyrimidine-5-Carbonitrile (6)4-Ethoxypyrimidine (6)4-Fluoropyrimidine (8)4-Iodopyrimidine (9)4-Methoxy-2-Methylpyrimidine (8)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Methyl-2-(Methylthio)Pyrimidine (7)4-Methylpyrimidin-2-Amine (9)4-Methylpyrimidine (22)4-Phenoxypyrimidine (5)4-Phenylpyrimidin-2-Amine (15)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(Benzyloxy)Pyrimidine (5)5-Benzylpyrimidine (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Bromo-2-(Methylthio)Pyrimidine (6)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Methylpyrimidine (5)5-Bromo-4-Chloropyrimidine (4)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine (8)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Ethylpyrimidine (5)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine (11)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyrimidine (5)5-Methylpyrimidine (3)5-Phenylpyrimidine (16)5H-Pyrrolo[3,2-D]Pyrimidine (16)6,7-Dihydro-5H-Cyclopenta[D]Pyrimidine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)6-Chloropyrimidin-4-Amine (8)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)[1,2,4]Triazolo[1,5-A]Pyrimidine (14)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Imidazo[1,2-C]Pyrimidine (6)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)N,N-Dimethylpyrimidin-2-Amine (10)N-(9-((2R,5S)-5-((Trityloxy)Methyl)Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)N-Benzyl-9H-Purin-6-Amine (6)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-D]Pyrimidine (10)Pyrimidin-2-Ol (21)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-2-Ylmethanol (5)Pyrimidin-4-Amine (29)Pyrimidin-4-Ol (25)Pyrimidin-5-Amine (6)Pyrimidin-5-Ol (5)Pyrimidin-5-Ylboronic Acid (9)Pyrimidine-2,4-Diamine (14)Pyrimidine-2-Carbonitrile (14)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-2-Thiol (6)Pyrimidine-4,6(1H,5H)-Dione (3)Pyrimidine-4-Carbonitrile (9)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carbaldehyde (38)Pyrimidine-5-Carbonitrile (6)Pyrimidine-5-Carboxylic Acid (7)Tetrahydropyrimidin-2(1H)-One (6)Thiazolo[5,4-D]Pyrimidine (5)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-D]Pyrimidine (24)
Pyrroles (4904)
(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(Phenylsulfonyl)-1H-Pyrrole (24)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-Benzylpyrrolidin-2-One (18)1-Methyl-1H-Pyrrole (43)1H-Pyrrol-1-Amine (7)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrole-3-Carbonitrile (9)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (6)2-Bromo-1H-Pyrrole (11)2-Methyl-1H-Pyrrole (49)2-Nitro-1H-Pyrrole (5)2-Phenyl-1H-Pyrrole (24)3,6-Di(Thiophen-2-Yl)-2,5-Dihydropyrrolo[3,4-C]Pyrrole-1,4-Dione (17)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Phenyl-1H-Pyrrole (5)3-Phenylpyrrolidine (7)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4H-Thieno[3,2-B]Pyrrole (6)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5H-Pyrrolo[2,3-B]Pyrazine (14)5H-Pyrrolo[3,2-D]Pyrimidine (16)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Pyrrolo[2,1-F][1,2,4]Triazine (14)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Bromopyrrolo (8)Chloropyrrolo (10)Dihydropyrrolo (15)Octahydropyrrolo (6)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)
Pyrrolidines (14604)
(3Ar,6As)-Octahydrocyclopenta[C]Pyrrole (5)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylpyrrolidine (4)(S)-3-Phenylpyrrolidine (4)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)(S)-N-(4-(Thiazol-5-Yl)Benzyl)Pyrrolidine-2-Carboxamide (7)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Phenylsulfonyl)Pyrrolidine (15)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzylpyrrolidin-2-One (18)1-Benzylpyrrolidine (26)1-Methylpyrrolidin-2-One (13)1-Phenylpyrrolidin-2-One (18)2,2-Dimethylpyrrolidine (4)2,5-Dioxopyrrolidin-1-Yl ((Benzyloxy)Carbonyl)Glycinate (8)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2,8-Diazaspiro[4.5]Decan-3-One (6)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(2-Chlorophenyl)Pyrrolidine (17)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Pyrrolidine (5)2-(Methoxymethyl)Pyrrolidine (6)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-1-Yl)Pyridine (11)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Azabicyclo[2.2.1]Heptane (6)2-Methyl-1-Phenyl-1H-Pyrrole (8)2-Methylpyrrolidine (21)3,3-Difluoropyrrolidine (29)3-(Pyrrolidin-2-Yl)Pyridine (6)3-Aminopyrrolidin-2-One (5)3-Bromopyrrolidine (6)3-Hydroxypyrrolidin-2-One (4)3-Phenoxypyrrolidine (5)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenylpyrrolidine (7)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Hydroxypyrrolidin-2-One (7)4-Phenylpyrrolidin-2-One (7)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Azaspiro[2.4]Heptane (13)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Azaspiro[3.4]Octane (4)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Hydroxypyrrolidine-1-Carboxylate (5)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Hexahydro-1H-Pyrrolizine (12)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl Prolinate (43)Methyl Pyrrolidine-3-Carboxylate (9)N,N-Dimethylpyrrolidin-3-Amine (7)N-Methylpyrrolidin-3-Amine (6)Octahydrocyclopenta[C]Pyrrole (6)Phenyl(Pyrrolidin-1-Yl)Methanone (12)Proline (13)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ol (59)Pyrrolidin-3-Ylmethanamine (6)Pyrrolidin-3-Ylmethanol (13)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-2-Carboxamide (12)Pyrrolidine-3-Carbonitrile (6)Pyrrolidine-3-Carboxylic Acid (14)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Hydroxypyrrolidine-1-Carboxylate (20)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl Pyrrolidin-3-Ylcarbamate (12)Tert-Butyl Pyrrolidine-1-Carboxylate (21)Acetylpyrrolidine (9)Benzylpyrrolidine (31)Bipyrrolidine (9)Bromopyrrolidine (7)Carbamoylpyrrolidine (5)Difluoropyrrolidine (16)Dimethylpyrrolidine (31)Dioxopyrrolidin (131)Ethylpyrrolidine (9)Fluoropyrrolidine (26)Formylpyrrolidine (10)Mercaptopyrrolidine (4)Methoxypyrrolidine (19)Methylenepyrrolidine (2)Methylpyrrolidine (128)Phenoxypyrrolidine (3)Pyrrolidine-Benzene-Boronic Acid/Ester (20)
Pyrrolines (1763)
1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1-Phenyl-1H-Pyrrole-2,5-Dione (12)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,5-Dihydro-1H-Pyrrol-2-One (5)2,5-Dihydro-1H-Pyrrole (13)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)3,4-Dihydro-2H-Pyrrole (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)
Quinazolines (3145)
2,4-Dichloroquinazoline (19)2-(Trifluoromethyl)Quinazoline (4)2-Bromoquinazoline (4)2-Chloroquinazolin-4(3H)-One (4)2-Cyclopropylquinazoline (5)2-Mercaptoquinazolin-4(3H)-One (3)2-Methylquinazoline (20)4-Chloroquinazoline (39)4-Methylquinazoline (4)5,6,7,8-Tetrahydroquinazoline (8)5-Chloroquinazoline (4)6-Bromoquinazoline (7)7-Bromoquinazolin-4(3H)-One (4)7-Fluoroquinazolin-4(3H)-One (4)7-Methoxy-N-Phenylquinazolin-4-Amine (12)8-Bromoquinazoline (8)8-Chloroquinazoline (5)8-Fluoroquinazoline (4)8-Methoxyquinazoline (3)8-Methylquinazoline (3)Ethyl Quinazoline-2-Carboxylate (4)N-(3-Chlorophenyl)Quinazolin-4-Amine (10)Quinazolin-2-Amine (13)Quinazolin-2-Ol (7)Quinazolin-4-Amine (8)Quinazolin-4-Ol (10)Dichloroquinazoline (14)Iodoquinazoline (10)Methylquinazoline (46)Nitroquinazoline (20)Trichloroquinazoline (5)
Quinolines (11911)
Iodoquinoline (32)1,2-Dihydroquinoline (5)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)2,2'-Biquinoline (3)2,3,6,7-Tetrahydro-1H,5H-Pyrido[3,2,1-Ij]Quinoline (7)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Hydroxyquinolin-4(1H)-One (3)2-Phenylquinoline (19)3,4-Dihydroisoquinoline (11)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Phenoxyquinoline (5)4-Phenylquinoline (9)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)7,8-Dihydroquinolin-5(6H)-One (5)7-(Benzyloxy)Quinoline (6)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)N-Phenylquinolin-4-Amine (11)
Quinoxalines (1412)
1,2,3,4-Tetrahydroquinoxaline (6)2-Chloroquinoxaline (39)2-Methylquinoxaline (5)2-Phenylquinoxaline (5)3,4-Dihydroquinoxalin-2(1H)-One (7)5-Bromoquinoxaline (6)6-Bromoquinoxaline (9)6-Chloroquinoxaline (3)6-Methoxyquinoxaline (6)Quinoxalin-2-Amine (3)Quinoxalin-2-Ol (4)Dichloroquinoxaline (8)Dihydroquinoxalin (7)
Quinuclidines (202)
Spiroes (4766)
1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4-Dioxaspiro[4.5]Decane (17)2,8-Diazaspiro[4.5]Decane (5)2-Oxa-8-Azaspiro[4.5]Decane (5)3-Phenyloxetane (11)6-Azaspiro[3.4]Octane (4)7-Azaspiro[3.5]Nonane (7)9,9'-Spirobi[Fluorene] (19)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidine] (5)Aminospiro (4)Azaspiro (246)Bromospiro (11)Diazaspiro (182)Dihydrospiro (18)Dioxaspiro (39)Fluorospiro (4)Oxospiro (22)Triazaspiro (13)
Tetrahydrofurans (2275)
(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(3Ar,6Ar)-Hexahydrofuro[3,2-B]Furan (5)(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-2-Yl)Methanol (6)(Tetrahydrofuran-3-Yl)Methanamine (3)1,3-Dihydrobenzo[C][1,2]Oxaborole (20)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (10)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (31)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (50)1-Oxa-8-Azaspiro[4.5]Decane (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (28)2-Oxa-8-Azaspiro[4.5]Decane (5)2-Oxabicyclo[2.1.1]Hexane (6)3-Aminodihydrofuran-2(3H)-One (4)3-Iodotetrahydrofuran (3)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (22)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Hydroxydihydrofuran-2(3H)-One (14)5-(Hydroxymethyl)Dihydrofuran-2(3H)-One (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (3)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)Dihydrofuran-3(2H)-One (8)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Amine (6)Tetrahydrofuran-3-Carboxylic Acid (4)Tetrahydrofuran-3-Ol (6)Hydroxytetrahydrofuran (16)Iodotetrahydrofuran (3)Methoxytetrahydrofuran (11)Oxotetrahydrofuran (26)
Tetrahydroisoquinolines (1291)
(9H-Fluoren-9-Yl)Methyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (7)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,4-Dihydroisoquinolin-3(2H)-One (5)1-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)2-Methyl-1,2,3,4-Tetrahydroisoquinoline (13)4,4-Dimethyl-1,2,3,4-Tetrahydroisoquinoline (3)5,6,7,8-Tetrahydroisoquinoline (5)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)Isoquinoline-1,3(2H,4H)-Dione (7)Tetrahydroisoquinoline-Carboxylic Acid (48)
Tetrahydropyrans (3363)
(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)4-Phenoxytetrahydro-2H-Pyran (5)9-Bromoanthracene (5)Chroman-Amine (1)Difluorochroman (16)
Tetrahydroquinolines (1464)
1-Ethyl-1,2,3,4-Tetrahydroquinoline (6)1-Methyl-1,2,3,4-Tetrahydroquinoline (6)2,3-Dihydroquinolin-4(1H)-One (19)2-Methyl-1,2,3,4-Tetrahydroquinoline (3)4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline (3)4-Methyl-1,2,3,4-Tetrahydroquinoline (2)5,6,7,8-Tetrahydroquinoline (17)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)Tert-Butyl 3,4-Dihydroquinoline-1(2H)-Carboxylate (11)Tetrahydroquinoline-Carboxylic Acid (18)
Tetrazoles (83)
1-Phenyl-1H-Tetrazole (6)5-Phenyl-1H-Tetrazole (23)5-Phenyl-2H-Tetrazole (9)
Thiadiazoles (2122)
1,2,3-Thiadiazole (8)1,2,4-Thiadiazole (16)1,2,5-Thiadiazole (6)1,3,4-Thiadiazol-2-Amine (9)2-Bromo-1,3,4-Thiadiazole (11)2-Methyl-1,3,4-Thiadiazole (12)2-Phenyl-1,3,4-Thiadiazole (19)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-Bromobenzo[C][1,2,5]Thiadiazole (14)Benzo[D][1,2,3]Thiadiazole (7)
Thiazines (62)
Thiazoles (6688)
1-(Thiazol-2-Yl)Ethan-1-One (9)2,4-Dibromothiazole (5)2,4-Dichlorothiazole (4)2,4-Dimethylthiazole (7)2,5-Dibromothiazole (5)2,5-Dimethylthiazole (4)2-(Chloromethyl)Thiazole (5)2-(Methylthio)Thiazole (5)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethyl)Thiazole (11)2-Bromo-4-Methylthiazole (7)2-Bromo-5-Methylthiazole (7)2-Chloro-4-Methylthiazole (5)2-Chloro-5-Methylthiazole (5)2-Chlorothiazole (32)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)2-Isopropylthiazole (11)2-Methyl-4-Phenylthiazole (6)2-Phenoxythiazole (5)2-Phenylbenzo[D]Thiazole (16)2-Phenylthiazole-4-Carbaldehyde (9)4,5,6,7-Tetrahydrobenzo[D]Thiazole (14)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5-Dihydrothiazole (8)4-(4-Fluorophenyl)Thiazole (9)4-(Trifluoromethyl)Thiazole (7)4-Bromothiazole (10)4-Cyclopropylthiazole (6)4-Methyl-2-Phenylthiazole (6)4-Methylthiazol-2-Amine (7)4-Methylthiazole (5)4-Phenylthiazol-2-Amine (37)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)5-Bromothiazol-2-Amine (6)5-Bromothiazole (8)5-Methyl-4-Phenylthiazole (5)5-Methylthiazol-2-Amine (6)5-Phenylthiazole (20)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Phenylthiazole-4-Carboxylate (12)Ethyl 2-Phenylthiazole-5-Carboxylate (9)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)N-(Thiazol-2-Yl)Acetamide (9)N-(Thiazol-2-Yl)Benzamide (9)N-Phenylthiazol-2-Amine (9)Tert-Butyl Thiazol-2-Ylcarbamate (22)Thiazol-2-Ylmethanamine (5)Thiazol-2-Ylmethanol (9)Thiazol-5-Amine (6)Thiazole-2-Carbaldehyde (9)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carbaldehyde (19)Thiazole-5-Carbonitrile (7)Thiazole-5-Carboxylic Acid (10)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thiazolo[5,4-D]Pyrimidine (5)Acetylthiazole (7)Bromothiazolo (9)Chlorothiazole (32)Chlorothiazolo (18)Cyanothiazole (7)Cyclopropylthiazole (11)Dibromothiazole (7)Dichlorothiazole (8)Dihydrothiazole (16)Dihydrothiazolo (14)Dimethylthiazole (22)Ethylthiazole (8)Formylthiazole (7)Methylthiazole (109)Nitrothiazol (8)Tetrahydrothiazolo (8)
Thiazolidines (1260)
(E)-5-Benzylidenethiazolidine-2,4-Dione (6)1,2,3-Oxathiazolidine 2,2-Dioxide (14)2-Thioxothiazolidin-4-One (6)Thiazolidine (16)Thioxothiazolidin (23)
Thiomorpholines (453)
Thiomorpholine (10)Thiomorpholine 1,1-Dioxide (6)
Thiophenes (956)
(9H-Fluoren-9-Yl)Methyl (2-(Thiophen-2-Yl)Ethyl)Carbamate (5)1-(Thiophen-2-Yl)Ethan-1-One (17)2,2'-Bithiophene (25)2,2':5',2''-Terthiophene (9)2,3-Dihydrothieno[3,4-B][1,4]Dioxine (9)2,5-Dibromothiophene (18)2,5-Diphenylthiophene (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethyl)Thiophene (10)2-Chlorothiophene (20)2-Ethynylthiophene (8)2-Iodothiophene (14)2-Methoxythiophene (7)2-Nitrothiophene (20)3-Bromothiophene (6)3-Chlorothiophene (17)3-Fluorothiophene (6)3-Methoxythiophene (9)3-Methylthiophene (14)3-Nitrothiophene (6)3-Phenylthiophene (13)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,7-Di(Thiophen-2-Yl)Benzo[C][1,2,5]Thiadiazole (9)4,8-Di(Thiophen-2-Yl)Benzo[1,2-B:4,5-B']Dithiophene (8)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-Cyclopenta[2,1-B:3,4-B']Dithiophene (9)4H-Thieno[3,2-B]Pyrrole (6)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5,6-Dihydro-4H-Cyclopenta[B]Thiophene (7)5-(Thiophen-2-Yl)Isoxazole (5)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Phenylthiophen-2-Amine (5)Benzo[1,2-B:4,5-B']Dithiophene (7)Dibenzo[B,D]Thiophene (22)Dihydrothiophen-3(2H)-One (4)Dithieno[3,2-B:2',3'-D]Thiophene (5)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Methyl Thiophene-3-Carboxylate (34)N,N-Diphenyl-4-(Thiophen-2-Yl)Aniline (5)Phenyl(Thiophen-2-Yl)Methanone (6)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-B]Pyridine (18)Thieno[3,2-B]Thiophene (19)Thieno[3,2-C]Pyridine (13)Thieno[3,2-D]Pyrimidine (24)Thieno[3,4-B]Thiophene (5)Thiophen-2-Ylboronic Acid (20)Thiophen-2-Ylmethanol (11)Thiophen-3-Amine (18)Thiophen-3-Ol (6)Thiophene-2-Carbaldehyde (43)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbaldehyde (17)Thiophene-3-Carbonitrile (13)Thiophene-3-Carboxamide (5)Thiophene-3-Carboxylic Acid (8)Acetylthiophene (5)Aminothiophene (23)Bromothieno (29)Chlorothieno (41)Chlorothiophene (61)Cyanothiophene (5)Dibromothieno (5)Dibromothiophene (17)Dichlorothieno (10)Dichlorothiophene (13)Dihydrothieno (24)Dihydrothiophene (1)Dihydroxythiophene (7)Dimethylthieno (10)Dimethylthiophene (21)Dithiophene (40)Fluorothiophene (18)Formylthiophene (16)Hydroxythiophene (7)Iodothieno (6)Iodothiophene (13)Methylthieno (27)Nitrothiophene (27)Terthiophene (10)Tetrahydrothieno (17)Thiophenecarboxaldehyde (10)Thiphen-Amine-Hydrochloride (54)Trithiophene (5)
Triazines (1388)
1,2,4-Triazine (10)1,3,5-Triazin-2-Amine (3)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4,6-Triphenyl-1,3,5-Triazine (24)2,4-Diphenyl-1,3,5-Triazine (6)2-Chloro-1,3,5-Triazine (10)2-Methoxy-1,3,5-Triazine (10)2-Phenyl-1,3,5-Triazine (6)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)Pyrrolo[2,1-F][1,2,4]Triazine (14)
Triazoles (7751)
(5As,10Br)-2-Phenyl-2,5A,6,10B-Tetrahydro-4H-Indeno[2,1-B][1,2,4]Triazolo[4,3-D][1,4]Oxazin-11-Ium (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-Benzyl-1H-1,2,3-Triazole (8)1-Benzyl-1H-1,2,4-Triazole (6)1-Methyl-1H-1,2,3-Triazole (9)1-Methyl-1H-1,2,4-Triazole (17)1-Methyl-1H-Benzo[D][1,2,3]Triazole (10)1-Phenethyl-1H-1,2,4-Triazole (6)1-Phenyl-1H-1,2,3-Triazole (7)1-Phenyl-1H-1,2,4-Triazole (20)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenyl-2H-Benzo[D][1,2,3]Triazole (8)2H-1,2,3-Triazole (7)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-Phenyl-4H-1,2,4-Triazole (6)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-1,2,4-Triazole (13)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)
Other Aliphatic Heterocycles (6209)
1,3-Dioxane (20)1,4-Diazepane (12)3-Azabicyclo[3.1.0]Hexane (14)
Other Aromatic Heterocycles (37758)
Indolizine (15)Phenazine (8)
NHCs
Achiral NHCs Catalysts (35)
Achiral NHCs Ligands (110)
Chiral NHCs Catalysts (138)
Chiral NHCs Ligands (84)
Organic Building Blocks
Acyl Chlorides (3021)
2-Chlorobenzoyl Chloride (13)2-Phenoxyacetyl Chloride (3)2-Phenylacetyl Chloride (9)
Alcohols (45626)
(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenylcyclopropyl)Methanol (3)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)(1H-Indol-2-Yl)Methanol (8)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromophenyl)Methanol (39)(2-Chlorophenyl)Methanol (40)(2-Fluorophenyl)Methanol (60)(2-Iodophenyl)Methanol (12)(2-Nitrophenyl)Methanol (29)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Methanol (22)(3-Chlorophenyl)Methanol (38)(3-Fluorophenyl)Methanol (58)(3-Iodophenyl)Methanol (13)(3-Methylpyridin-2-Yl)Methanol (10)(3-Nitrophenyl)Methanol (31)(3-Phenoxyphenyl)Methanol (3)(3-Phenylisoxazol-5-Yl)Methanol (7)(4-Fluorophenyl)Methanol (29)(4-Nitrophenyl)Methanol (17)(6-Methylpyridin-2-Yl)Methanol (5)(Tetrahydrofuran-2-Yl)Methanol (6)1,2-Diphenylethan-1-Ol (8)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenylethan-1-Ol (103)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Amino-2-Phenylethan-1-Ol (196)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxyethyl Benzoate (3)2-Phenoxyethan-1-Ol (14)2-Phenylethan-1-Ol (78)2-Phenylpropan-2-Ol (21)3-Phenylpropan-1-Ol (24)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Phenylpiperidin-4-Ol (10)Azetidin-2-Ylmethanol (7)Azetidin-3-Ol (11)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Cyclobutanol (46)Cyclobutylmethanol (15)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanol (51)Diphenylmethanol (20)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Ylmethanol (5)M-Tolylmethanol (34)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Naphthalen-1-Ylmethanol (8)O-Tolylmethanol (35)Oxiran-2-Ylmethanol (3)Piperidin-2-Ylmethanol (11)Piperidin-3-Ol (27)Piperidin-3-Ylmethanol (15)Piperidin-4-Ylmethanol (11)Pyridin-2-Ylmethanol (65)Pyridin-3-Ylmethanol (39)Pyridin-4-Ylmethanol (16)Pyrimidin-2-Ylmethanol (5)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ylmethanol (13)Quinazolin-2-Ol (7)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Thiazol-2-Ylmethanol (9)Thiophen-2-Ylmethanol (11)Triphenylmethanol (13)Amino-Propanol (6)Cyclopropylethanol (6)Diethanol (23)Diethanol (23)Dihydroxybenzylidene (4)Dihydroxynaphthalene (7)Dihydroxypropanoate (7)Dihydroxyterephthalic Acid (3)Hydroxyacetamide (1)Hydroxyacetimidamide (3)Hydroxyadamantan (4)Hydroxyadamantan (4)Hydroxyazetidine (7)Hydroxybenzyl (18)Hydroxybenzylidene (5)Hydroxybicyclo (7)Hydroxybutan (4)Hydroxybutan (4)Hydroxybutanoate (36)Hydroxybutanoic (33)Hydroxycarbamimidoyl (2)Hydroxycinnamic Acid (2)Hydroxycyclobutyl (3)Hydroxycyclohexyl (7)Hydroxycyclopentyl (1)Hydroxydiphenylmethyl (2)Hydroxyethoxy (22)Hydroxyethoxy (22)Hydroxyhexanoate (8)Hydroxyhexanoic (6)Hydroxyimino (11)Hydroxyisonicotinaldehyde (7)Hydroxyisonicotinate (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic Acid (4)Hydroxymethyl-Phenyl-Boronic-Acid (32)Hydroxynaphthalene (29)Hydroxynicotinaldehyde (7)Hydroxynicotinate (13)Hydroxynicotinonitrile (6)Hydroxyoctadec (1)Hydroxyoctadec (1)Hydroxyoctadecanoic (7)Hydroxypentanoate (6)Hydroxypropanoic (35)Pentahydroxyhexanal (9)Phenyl-Methanol (3)Propanediol (9)Propanediol (9)Tetrahydroxy (25)Tetrahydroxy (25)Tetrahydroxyhexanal (9)Tetrahydroxypentanal (5)Trihydroxy (246)Trihydroxy (246)
Aldehydes (18915)
1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Naphthaldehyde (23)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Indazole-3-Carbaldehyde (19)1H-Indole-2-Carbaldehyde (20)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3-Dichlorobenzaldehyde (7)2,3-Difluorobenzaldehyde (18)2,4-Dichlorobenzaldehyde (8)2,4-Difluorobenzaldehyde (19)2,6-Dibromobenzaldehyde (4)2,6-Difluorobenzaldehyde (25)2-(Benzyloxy)Benzaldehyde (13)2-(Phenylethynyl)Benzaldehyde (9)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethyl)Benzaldehyde (27)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-6-Fluorobenzaldehyde (15)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-4-Fluorobenzaldehyde (10)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluorobenzaldehyde (175)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodobenzaldehyde (17)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Naphthaldehyde (12)2-Nitrobenzaldehyde (53)2-Oxo-2-Phenylacetaldehyde (12)2-Phenylacetaldehyde (20)3-(Benzyloxy)Benzaldehyde (13)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethyl)Benzaldehyde (31)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Methoxybenzaldehyde (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-4-Methoxybenzaldehyde (7)3-Chlorobenzaldehyde (106)3-Fluorobenzaldehyde (137)3-Iodobenzaldehyde (28)3-Methoxy-2-Nitrobenzaldehyde (3)3-Nitrobenzaldehyde (49)3-Phenoxybenzaldehyde (7)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-(Benzyloxy)Benzaldehyde (23)4-(Piperazin-1-Yl)Benzaldehyde (5)4-Fluorobenzaldehyde (78)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Morpholinobenzaldehyde (8)4-Nitrobenzaldehyde (18)4-Phenoxybenzaldehyde (12)5-Phenylfuran-2-Carbaldehyde (9)6-Methoxynicotinaldehyde (4)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-4-Carbaldehyde (31)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-3-Carbaldehyde (6)Benzo[D][1,3]Dioxole-5-Carbaldehyde (6)Benzofuran-2-Carbaldehyde (5)Furan-2-Carbaldehyde (22)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Isonicotinaldehyde (68)Methyl 3-Formylbenzoate (23)Nicotinaldehyde (152)Picolinaldehyde (98)Pyrazine-2-Carbaldehyde (17)Pyrimidine-5-Carbaldehyde (38)Thiazole-2-Carbaldehyde (9)Thiazole-5-Carbaldehyde (19)Thiophene-2-Carbaldehyde (43)Thiophene-3-Carbaldehyde (17)Aminonicotinaldehyde (5)Aminonicotinaldehyde (5)Carboxyaldehyde (1094)Dicarbaldehyde (37)Dicarbaldehyde (37)Formylisonicotinate (7)Tetracarbaldehyde (8)Tetracarbaldehyde (8)Tricarbaldehyde (10)
Aliphatic Chain Hydrocarbons (12590)
Acetylthio (7)Acetylthio (7)Azanonadecan (7)Azanylylidene (1)Azapentadecan (10)Azapentadecan (10)Azatridecan (4)Butyloctyl (4)Butyloctyl (4)Carbonylbis (2)Carbonylbis (2)Diazirine (13)Diazirine (13)Didodecyl (7)Didodecyl (7)Diethyl (73)Diethyl (73)Dihydroxypropan (6)Diisobutyl (2)Diisopropyl (27)Diisopropyl (27)Dimethoxy (306)Dimethyladamantane (14)Dimethyladamantane (14)Dimethylalkanes (7)Dinonyl (1)Dinonyl (1)Dioctyl (1)Dioxide (451)Dioxide (451)Ethoxy (711)Ethoxyethoxy (5)Ethoxyethoxy (5)Ethoxyethyl (16)Ethoxyethyl (16)Ethoxymethyl (11)Ethoxymethylene (1)Ethoxymethylene (1)Isopropylidenebis (2)Isopropylsulfonyl (10)Isopropylsulfonyl (10)Methoxybut (2)Methoxybut (2)Methoxyethoxy (67)Methoxyethoxy (67)Methoxyethyl (68)Methoxyisonicotinic (11)Methoxyisonicotinic (11)Methoxymethoxy (23)Methoxymethoxy (23)Methoxymethyl (117)Methoxynicotinic (26)Methoxynicotinic (26)Methoxynicotinic Acid (20)Methoxypropan (24)Methoxypropan (24)Methoxypropoxy (8)Methoxypropoxy (8)Methoxypropyl (10)Methoxytetrahydro (14)Methoxytetrahydro (14)Methyladamantan (4)Methylisonicotinic (13)Oxoethoxy (1)Oxopropane (10)Oxopropyl (32)Oxopropyl (32)Pentyloxy (7)Tetramethoxy (6)Trimethoxy (15)Trimethoxy (15)Yldisulfanyl (7)
Aliphatic Cyclic Hydrocarbons (11026)
(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1-Phenylcyclopropyl)Methanol (3)(3Ar,E)-4-((Z)-2-(2-Methylenecyclohexylidene)Ethylidene)Octahydro-1H-Indene (7)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Pentylcyclohexyl)Benzene (5)(4-Propylcyclohexyl)Benzene (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Cyclopropylmethoxy)Benzene (18)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,1-Difluorocyclopentane (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-3-Cyclopropylbenzene (6)1-Chloro-2-Cyclopropylbenzene (7)1-Cyclohexyl-2-Fluorobenzene (4)1-Cyclopropyl-3-Methylbenzene (3)1-Methylcyclohex-1-Ene (26)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropan-1-Amine (26)1-Phenylcyclopropane-1-Carbonitrile (19)1-Phenylcyclopropane-1-Carboxylic Acid (23)2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-2-Phenylacetic Acid (5)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Cyclohexylacetic Acid (14)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Cyclopropylpyrimidine (10)2-Iodo-9H-Fluorene (8)2-Methylcyclohexan-1-One (3)2-Phenylcyclopropan-1-Amine (20)3,3-Dimethylcyclohexan-1-One (4)3-Cyclopropylpyridine (28)3-Methylcyclohexan-1-One (9)4-Cyclohexylbenzoic Acid (6)4-Cyclohexylbenzonitrile (10)4-Cyclohexylphenol (7)5-Azaspiro[2.4]Heptane (13)6-Azaspiro[2.5]Octane (10)9,9-Dimethyl-9H-Fluorene (16)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Bicyclo[2.2.1]Hept-2-Ene (18)Bicyclo[2.2.1]Heptane (15)Bromocyclohexane (7)Cyclobutanamine (90)Cyclobutanecarboxylic Acid (23)Cyclobutanol (46)Cyclobutylmethanol (15)Cycloheptane (12)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanamine (59)Cyclohexanecarboxylic Acid (83)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanamine (5)Cyclopentanecarboxylic Acid (26)Cyclopentanol (51)Cyclopropoxybenzene (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Isopropylcyclohexane (19)Methoxycyclohexane (7)Methyl 1-Phenylcyclopropane-1-Carboxylate (10)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)N-Methylcyclohexanamine (7)Naphthalene-1,4-Dione (23)Spiro[3.3]Heptane (11)Tert-Butyl (1-Phenylcyclopropyl)Carbamate (6)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclobutylcarbamate (17)Tert-Butyl Cyclohexylcarbamate (9)Tert-Butyl Cyclopentylcarbamate (28)Aminobicyclo (24)Aminocyclobutanol (5)Aminocyclobutyl (5)Aminocyclohexane (55)Aminocyclohexanol (21)Aminocyclopentanol (17)Aminocyclopentyl (6)Aminocyclopropyl (4)Azabicyclo (292)Azabicyclo (292)Azatricyclo (5)Azatricyclo (5)Azetidine (179)Azetidine (179)Benzylazetidin (9)Bicyclo (61)Bicyclohexyl (6)Bromobicyclo (9)Butylcyclohexyl (9)Butylsulfonyl (6)Chlorocyclopropyl (2)Cyanoazetidine (5)Cyanocyclopropyl (4)Cyclobutanecarbonitrile (2)Cyclobutylacetic (4)Cyclobutylmethyl (4)Cyclobutylmethyl (4)Cyclodextrin (1)Cyclodextrin (1)Cyclohexa (173)Cyclohexa (173)Cyclohexane (127)Cyclohexane (127)Cyclohexanecarboxylic (19)Cyclohexanediamine (8)Cyclohexanone (92)Cyclohexylacetic (2)Cyclohexylamino (9)Cyclohexylbutanoic (4)Cyclohexylcarbamoyl (5)Cyclohexylethanamine (11)Cyclohexylmethoxy (4)Cyclohexylmethoxy (4)Cyclohexylmethyl (7)Cyclohexylmethyl (7)Cyclohexyloxy (10)Cyclohexylpropan (92)Cyclohexylpropanoic (9)Cyclopentadienyl (2)Cyclopentane (169)Cyclopentane (169)Cyclopentanecarboxylic (7)Cyclopentyl (56)Cyclopentyl (56)Cyclopentylacetic (3)Cyclopentylamino (1)Cyclopentylmethyl (4)Cyclopentyloxy (16)Cyclopentyloxy (16)Cyclopentylpropanoic (1)Cyclopropanamine (32)Cyclopropanamine (32)Cyclopropanecarbonitrile (14)Cyclopropanecarbonyl (6)Cyclopropanecarbonyl (6)Cyclopropanecarboxamide (14)Cyclopropanol (4)Cyclopropoxyphenyl (7)Cyclopropyl (356)Cyclopropyl (356)Cyclopropylacetate (6)Cyclopropylacetic (3)Cyclopropylamino (24)Cyclopropylcarbamoyl (5)Cyclopropylethan (5)Cyclopropylethan (5)Cyclopropylethynyl (1)Cyclopropylmethoxy (32)Cyclopropylmethoxy (32)Cyclopropylmethyl (22)Cyclopropylmethyl (22)Cyclopropylpropanoic (5)Cyclopropylsulfonyl (6)Cyclopropylsulfonyl (6)Diazabicyclo (77)Diazabicyclo (77)Dicyclohexyl (6)Dicyclohexyl (6)Dicyclohexylphosphino (18)Dicyclohexylphosphino (18)Difluorocyclobutyl (6)Difluorocyclohexyl (6)Dihydroinden (8)Dihydroindeno (5)Dihydroindeno (5)Dihydropteridin (6)Dimethylbicyclo (5)Dimethylbicyclo (5)Dimethylcyclohex (5)Dimethylcyclohexane (16)Dimethylcyclohexanone (7)Dioxathiolane (1)Dioxathiolane (1)Dioxol (174)Dithiolan (1)Dithiolan (1)Ethylcyclohexyl (4)Ethylcyclohexyl (4)Ethylsulfonyl (42)Fluoroazetidine (1)Fluorobicyclo (4)Hexahydrocyclohepta (6)Hexahydrocyclohepta (6)Hexahydrocyclopenta (4)Hydroxycyclobutanecarboxylic (4)Hydroxycyclohexanecarboxylic (6)Methanesulfonyl (314)Methanesulfonyl (314)Methoxycyclohexanamine (6)Methylazetidine (30)Methylbicyclo (6)Methylbicyclo (6)Methylcyclobutanamine (5)Methylcyclobutanecarboxylic (5)Methylcyclohexanamine (11)Methylcyclohexane (8)Methylcyclohexane (8)Methylcyclohexanecarboxylic (5)Methylcyclohexanecarboxylic Acid (4)Methylcyclohexanol (21)Methylcyclohexanone (5)Methylcyclohexyl (33)Methylcyclopentane (2)Methylcyclopropanamine (4)Methylcyclopropanamine (4)Methylcyclopropane (16)Methylsulfinyl (24)Methylsulfonimidoyl (6)Methylsulfonimidoyl (6)Methylsulphonyl (10)Octahydrocyclopenta (14)Oxabicyclo (40)Oxabicyclo (40)Oxazepane (13)Oxetanes (228)Oxoazetidine (8)Oxoazetidine (8)Oxobicyclo (11)Oxobicyclo (11)Oxocyclobutyl (2)Oxocyclohex (3)Oxocyclohexane (4)Oxocyclohexane (4)Oxocyclohexanecarboxylic (6)Oxocyclohexyl (3)Oxocyclohexyl (3)Oxocyclopentane (2)Oxocyclopentyl (5)Pentamethylcyclopentadienyl (11)Pentylcyclohexyl (10)Pentylcyclohexyl (10)Phenylcyclopropanamine (8)Propylcyclohexyl (15)Propylcyclohexyl (15)Tetraazacyclododecane (13)Tetraazacyclododecane (13)Tetraazacyclotetradecane (7)Tetraazacyclotetradecane (7)Tetramethylcyclohexane (4)Tetraoxatridecan (3)Tetraoxatridecan (3)Thiazepine (2)Tricyclohexylphosphine (9)Trimethylbicyclo (21)Trimethylcyclohex (20)Trimethylcyclohexane (1)Trimethylcyclohexane (1)
Alkenyls (16089)
(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Nitrovinyl)Benzene (28)(Allyloxy)Benzene (19)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1,2-Diphenylethene (5)1,3,3-Trimethylcyclohex-1-Ene (12)1-Bromo-4-Styrylbenzene (5)1-Methylcyclohex-1-Ene (26)2-Benzalacetophenone (36)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methyleneazetidine (8)3-Phenylacrylaldehyde (29)3-Styrylphenol (11)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Prop-1-En-2-Yl)Cyclohex-1-Ene (5)5H-Dibenzo[B,F]Azepine (5)Allyl Benzoate (5)Cyclohex-1-En-1-Yl Trifluoromethanesulfonate (3)Cyclohex-1-En-1-Ylboronic Acid (4)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohexa-1,3-Diene (5)Cyclopent-2-En-1-Amine (4)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Methyl Cinnamate (37)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methylenecyclobutane (8)Methylenecyclohexane (8)N-Phenylacrylamide (7)Styrene (81)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Vinylcyclopropane (8)Acrylaldehyde (11)Acryloyl (9)Acryloyl (9)Annulene (2)Cyclohexene (88)Cyclooctene (9)Cyclopentene (3)Diacrylamide (6)Diallyl (5)Diazene (21)Divinyl (1)Divinyl (1)Enamide (6)Enamide (6)Enecarbaldehyde (2)Enoyl (9)Methacrylamide (3)Methacrylamide (3)Methoxycinnamaldehyde (3)Nitroethylene (37)Tetrahydrocyclopenta (19)
Alkyls (194)
Isopropyl-Phenyl-Boronic Acid/Ester (26)Methylpentan (11)
Alkynyls (2695)
(Bromoethynyl)Benzene (5)(Prop-2-Yn-1-Yloxy)Benzene (13)1,3,5-Tris(Phenylethynyl)Benzene (6)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-Ethynyl-2-Fluorobenzene (10)1-Methyl-4-(Phenylethynyl)Benzene (7)2-(Phenylethynyl)Benzaldehyde (9)2-Ethynylpyridine (31)2-Ethynylthiophene (8)3-Ethynylpyridine (22)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-(Phenylethynyl)Phenol (7)4-Ethynylpyridine (10)9,10-Bis(Phenylethynyl)Anthracene (5)Ethynylbenzene (145)Trimethyl(Phenylethynyl)Silane (23)
Amides (90268)
Acetamide (649)Acetamide (649)Acetamido (154)Carboxamide (929)Carboxamide (929)Diacetamide (3)Dicarboxamide (19)Diethylacetamide (4)Diethylacetamide (4)Dimethylacetamide (9)Dimethylnicotinamide (7)Dimethylnicotinamide (7)Formamidophenylboronic Acid/Ester (11)Isobutyramide (7)Oxobutanamide (10)Oxobutanamide (10)Pentanamide (18)Pentanamide (18)Propanamide (2)Propanamido (5)Propanamido (5)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)(S)-N-Phenylpiperidine-2-Carboxamide (1)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-Methylindoline-2,3-Dione (8)1-Phenylurea (11)1H-Pyrazole-5-Carboxamide (3)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Trifluoromethyl)Benzamide (6)2-Amino-3-Phenylpropanamide (8)2-Amino-N-Phenylbenzamide (21)2-Aminobenzamide (30)2-Bromo-N-Phenylacetamide (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylbenzamide (4)2-Chlorobenzamide (16)2-Fluoro-N-Methylbenzamide (12)2-Fluorobenzamide (32)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Iodobenzamide (4)2-Methoxybenzamide (9)3-Benzamidopropanoic Acid (3)3-Bromo-4-Fluorobenzamide (3)3-Fluorobenzamide (26)3-Nitrobenzamide (17)3-Oxo-N-Phenylbutanamide (10)4-Amino-N-Phenylbenzamide (7)4-Benzamidobenzoic Acid (3)4-Fluorobenzamide (19)4-Oxo-4-(Phenylamino)Butanoic Acid (7)Benzoylglycine (15)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Phenylcarbamate (15)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Isonicotinamide (12)N,N-Diethylbenzamide (17)N,N-Dimethylbenzamide (34)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)N-(2-Chlorophenyl)Acetamide (16)N-(2-Iodophenyl)Acetamide (8)N-(2-Nitrophenyl)Acetamide (11)N-(3-Fluorophenyl)Acetamide (14)N-(4-Aminophenyl)Benzamide (2)N-(4-Chlorophenyl)Acetamide (9)N-(4-Chlorophenyl)Benzamide (6)N-(4-Fluorophenyl)Benzamide (3)N-(4-Phenoxyphenyl)Acetamide (4)N-(O-Tolyl)Benzamide (9)N-(P-Tolyl)Benzamide (6)N-(Thiazol-2-Yl)Acetamide (9)N-Isopropylbenzamide (16)N-Methoxy-N-Methylbenzamide (24)N-Methylbenzamide (58)N-Methylpicolinamide (10)N-Phenylacrylamide (7)N-Phenylpivalamide (11)Nicotinamide (64)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Picolinamide (26)Piperidine-3-Carboxamide (5)Pyrazine-2-Carboxamide (10)Pyrrolidine-2-Carboxamide (12)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Thiophene-3-Carboxamide (5)
Amidines (1563)
Benzimidamide (50)N'-Hydroxybenzimidamide (13)Picolinimidamide (11)Carbamimidoyl (16)
Amines (139431)
Amino-Carboxylate (2)Amino-Propanol (6)Aminoacetamido (4)Aminoacetyl (2)Aminoadamantan (5)Aminoadamantan (5)Aminoazepane (10)Aminobutane (23)Aminobutane (23)Aminobutyl (15)Aminobutyl (15)Aminoethoxy (18)Aminoethoxy (18)Aminoethyl (157)Aminoethyl (157)Aminohexan (6)Aminohexyl (3)Aminohexyl (3)Aminoisonicotinic Acid (12)Aminomethyl (403)Aminomethyl (403)Aminooxy (6)Aminopentyl (10)Aminopentyl (10)Aminopropanamido (1)Aminopropane (20)Aminopropane (20)Aminopropoxy (2)Aminopropoxy (2)Aminotetrahydro (12)Aminotetrahydro (12)Benzylazetidine (4)Bromobenzylamine (6)Bromobenzylcarbamate (28)Butoxycarbonylamino (8)Butylcarbamoyl (5)Carbamothioyl (2)Carbamoyl (114)Chlorobenzylamine (4)Chroman-Amine (1)Diamino (90)Diamino (90)Diaminopteridin (3)Diaminopteridin (3)Dibutylamino (6)Dibutylamino (6)Dichlorobenzylamine (5)Diethylamino (91)Diethylamino (91)Diisopropylamino (1)Dimethyl-Ethylamine (2)Dimethylamino (489)Dimethylamino (489)Dimethylcarbamoyl (14)Dimethylmethanamine (16)Dipropylamino (1)Dipropylamino (1)Ethylamino (37)Ethylamino (37)Fluindamine (32)Hydroxyamino (3)Hydroxyamino (3)Imidazol-Amine (1)Methoxyethanamine (1)Methoxyethanamine (1)Methoxyimino (2)Methylamino (239)Methylamino (239)Methylcarbamoyl (19)Methylcarbamoyl (19)Propanediamine (6)Propylamino (5)Propylamino (5)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)Silanamine (3)Triamine (25)Triamine (25)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)Methanamine (12)(2-Chlorophenyl)Methanamine (28)(2-Fluorophenyl)Methanamine (49)(3-Chlorophenyl)Methanamine (19)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Fluorophenyl)Methanamine (27)(6-Methylpyridin-2-Yl)Methanamine (6)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-3-Yl)Methanamine (3)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2-Diphenylethan-1-Amine (13)1,3,4-Thiadiazol-2-Amine (9)1,3,5-Triazin-2-Amine (3)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-Aminoanthracene-9,10-Dione (8)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-4-Amine (8)1-Methyl-1H-Pyrazol-3-Amine (14)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclopropan-1-Amine (26)1-Phenylethan-1-Amine (436)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Imidazol-2-Amine (6)1H-Indazol-3-Amine (23)1H-Indazol-4-Amine (12)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-7-Amine (6)1H-Indol-4-Amine (10)1H-Indol-6-Amine (21)1H-Indol-7-Amine (10)1H-Pyrazol-4-Amine (6)1H-Pyrazol-5-Amine (19)1H-Pyrrol-1-Amine (7)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,3-Dichloroaniline (18)2,3-Difluoroaniline (34)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,4-Dibromoaniline (18)2,4-Dichloropyrimidin-5-Amine (6)2,4-Difluoroaniline (44)2,5-Difluoroaniline (34)2,6-Dibromoaniline (17)2,6-Dichloroaniline (27)2,6-Difluoroaniline (23)2,6-Diiodoaniline (8)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(Diethylamino)Ethyl Benzoate (3)2-(Methylsulfonyl)Aniline (3)2-(Phenylamino)Benzoic Acid (11)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethyl)Aniline (58)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-Phenylethan-1-Ol (196)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-Chlorophenol (4)2-Amino-3-Fluorobenzoic Acid (11)2-Amino-6-Bromophenol (3)2-Amino-6-Chlorobenzoic Acid (5)2-Amino-6-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Aminobenzamide (30)2-Aminobenzenesulfonic Acid (9)2-Aminophenol (107)2-Aminopyrimidin-4(3H)-One (11)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Methylaniline (6)2-Bromo-4-Methylaniline (14)2-Bromo-6-Methylaniline (11)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Chloro-3-Methylaniline (4)2-Chloro-4-Methylaniline (7)2-Chloro-6-Methylaniline (11)2-Chloro-N-Methylaniline (4)2-Chloro-N-Phenylaniline (8)2-Chloroaniline (214)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,4-Diamine (6)2-Chloropyrimidin-4-Amine (22)2-Fluoro-6-Iodoaniline (7)2-Fluoro-N-Phenylaniline (4)2-Fluoroaniline (262)2-Iodo-4-Methylaniline (5)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Methoxypyridin-3-Amine (6)2-Methyl-6-Nitroaniline (10)2-Methyl-N-Phenylaniline (7)2-Methylpyridin-4-Amine (7)2-Methylpyrimidin-4-Amine (22)2-Nitro-N-Phenylaniline (3)2-Phenoxyaniline (4)2-Phenylcyclopropan-1-Amine (20)2-Phenylpyrimidin-5-Amine (5)3,4-Dibromoaniline (4)3,4-Dichloroaniline (21)3,4-Difluoroaniline (44)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(Benzyloxy)Aniline (12)3-(Methylsulfonyl)Aniline (7)3-(Piperazin-1-Yl)Aniline (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethyl)Aniline (102)3-Aminobenzenesulfonic Acid (6)3-Aminodihydrofuran-2(3H)-One (4)3-Bromo-2-Fluoroaniline (15)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methylaniline (14)3-Bromoaniline (187)3-Bromobenzene-1,2-Diamine (11)3-Chloro-2-Iodoaniline (3)3-Chloro-2-Methylaniline (11)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Iodoaniline (3)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methylaniline (12)3-Chlorobenzene-1,2-Diamine (6)3-Chloropyrazin-2-Amine (6)3-Fluoro-2-Methylaniline (9)3-Fluoroaniline (289)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Methoxypyridin-2-Amine (5)3-Methyl-N-Phenylaniline (4)3-Methylpyridin-2-Amine (7)3-Nitroaniline (98)3-Phenoxyaniline (2)3-Phenyl-1H-Pyrazol-5-Amine (11)3-Phenylisoxazol-5-Amine (8)4,6-Dichloropyrimidin-2-Amine (9)4-(Benzyloxy)Aniline (8)4-(Oxazol-5-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Trifluoromethoxy)Aniline (26)4-Amino-2-Chlorobenzonitrile (8)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorobenzoic Acid (6)4-Amino-3-Chlorophenol (5)4-Amino-N-Phenylbenzenesulfonamide (3)4-Aminopyridazin-3(2H)-One (4)4-Benzylaniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Iodoaniline (3)4-Chloro-3-Methylaniline (11)4-Chloro-N-Phenylaniline (6)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Fluoro-N-Phenylaniline (4)4-Fluoroaniline (225)4-Iodo-N,N-Diphenylaniline (3)4-Methoxy-N-Phenylaniline (5)4-Methyl-3-Nitroaniline (8)4-Methylpyrimidin-2-Amine (9)4-Methylthiazol-2-Amine (7)4-Morpholinoaniline (4)4-Nitroaniline (65)4-Phenoxyaniline (6)4-Phenylpyrimidin-2-Amine (15)4-Phenylthiazol-2-Amine (37)5-Bromopyrazin-2-Amine (13)5-Bromothiazol-2-Amine (6)5-Chloropyrazin-2-Amine (9)5-Methoxypyridin-3-Amine (4)5-Methyl-2-Nitroaniline (6)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Methylthiazol-2-Amine (6)5-Phenylthiophen-2-Amine (5)5H-Dibenzo[B,F]Azepine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)6-Chloropyridazin-3-Amine (5)6-Chloropyrimidin-4-Amine (8)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylpyridin-2-Amine (46)6-Methylpyridin-3-Amine (5)6-Phenoxypyridin-3-Amine (5)7-Methoxy-N-Phenylquinazolin-4-Amine (12)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)9H-Purin-6-Amine (3)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-3-Amine (11)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Azetidin-3-Amine (4)Azetidin-3-Ylmethanamine (3)Aziridine (9)Benzo[B]Thiophen-2-Amine (5)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Thiazol-2-Amine (30)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Bis(Pyridin-2-Ylmethyl)Amine (6)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Cyclobutanamine (90)Cyclohexanamine (59)Cyclopent-2-En-1-Amine (4)Cyclopentanamine (5)Cyclopropyl(Phenyl)Methanamine (22)Diphenylmethanamine (26)Ethyl 2-Aminobenzoate (23)Ethyl 3-Aminobenzoate (19)Ethyl 4-Aminobenzoate (23)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Isoquinolin-1-Amine (18)Isoquinolin-3-Amine (13)Isoquinolin-4-Amine (16)Isoquinolin-5-Amine (9)Isoquinolin-8-Amine (6)Isoxazol-5-Amine (15)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 4-Aminobenzoate (71)Methyl L-Phenylalaninate (7)Morpholin-2-Ylmethanamine (8)N,N-Diethylaniline (18)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N,N-Dimethylaniline (117)N,N-Dimethylnaphthalen-1-Amine (4)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N,N-Dimethylpyrimidin-2-Amine (10)N,N-Dimethylpyrrolidin-3-Amine (7)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-(4-Aminophenyl)Benzamide (2)N-(Furan-2-Ylmethyl)Aniline (5)N-(Prop-2-Yn-1-Yl)-2,3-Dihydro-1H-Inden-1-Amine (3)N-Benzyl-1-Phenylethan-1-Amine (7)N-Benzylpiperidin-4-Amine (3)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-1,2-Diphenylethan-1-Amine (7)N-Methyl-1-Phenylmethanamine (65)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)N-Methylaniline (140)N-Methylcyclohexanamine (7)N-Methylpiperidin-3-Amine (5)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Methylpyrrolidin-3-Amine (6)N-Phenyl-3-(Trifluoromethyl)Aniline (3)N-Phenyl-4-(Trifluoromethyl)Aniline (3)N-Phenylnaphthalen-1-Amine (5)N-Phenylpyridin-2-Amine (9)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N1,N1-Diphenylbenzene-1,4-Diamine (2)N1-Phenylbenzene-1,4-Diamine (3)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Naphthalen-2-Amine (12)O-Benzylhydroxylamine (16)Oxazol-2-Amine (8)Phenylmethanamine (316)Piperidin-2-Ylmethanamine (6)Piperidin-3-Amine (17)Piperidin-3-Ylmethanamine (5)Piperidin-4-Amine (14)Piperidin-4-Ylmethanamine (7)Pyrazin-2-Amine (22)Pyrazin-2-Ylmethanamine (12)Pyridazin-3-Amine (18)Pyridazin-4-Amine (10)Pyridin-2-Amine (29)Pyridin-2-Ylmethanamine (38)Pyridin-3-Amine (21)Pyridin-3-Ylmethanamine (29)Pyridin-4-Amine (22)Pyridin-4-Ylmethanamine (12)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-4-Amine (29)Pyrimidin-5-Amine (6)Pyrimidine-2,4-Diamine (14)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-3-Ylmethanamine (6)Quinazolin-2-Amine (13)Quinazolin-4-Amine (8)Quinoxalin-2-Amine (3)Tetrahydrofuran-3-Amine (6)Thiazol-2-Ylmethanamine (5)Thiazol-5-Amine (6)Thiophen-3-Amine (18)Tri([1,1'-Biphenyl]-4-Yl)Amine (9)
Anhydrides (659)
1H,3H-Benzo[De]Isochromene-1,3-Dione (8)Furan-2,5-Dione (8)Dianhydride (3)
Aryls (187143)
(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(8S,9S,14R)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-3H-Cyclopenta[A]Phenanthren-3-One (1)(9H-Fluoren-9-Yl)Methyl (2-(Tritylthio)Ethyl)Carbamate (10)(9H-Fluoren-9-Yl)Methyl Cyclohexylcarbamate (8)(Benzylsulfonyl)Benzene (11)(Cyclopentyloxy)Benzene (12)1,1-Dimethylcyclopropane (5)1,3,4,5-Tetrahydro-2H-Benzo[B]Azepin-2-One (15)1,3-Diphenylurea (24)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-Benzyl-4-Chlorobenzene (6)1-Benzyl-4-Fluorobenzene (2)1-Bromonaphthalene (4)1-Chloronaphthalene (24)1-Fluoronaphthalene (23)1-Methoxynaphthalene (18)1-Methyl-4-(Phenylethynyl)Benzene (7)1-Methylnaphthalene (10)1-Naphthaldehyde (23)1-Naphthoic Acid (23)1-Nitronaphthalene (3)10H-Phenothiazine (20)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,5-Diphenylthiophene (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-Benzylaniline (5)2-Bromo-1,1'-Biphenyl (12)2-Bromonaphthalene (4)2-Chloro-1,1'-Biphenyl (8)2-Chloronaphthalene (6)2-Ethoxynaphthalene (4)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Iodonaphthalene (5)2-Methoxy-1,1'-Biphenyl (7)2-Methoxynaphthalene (22)2-Methoxytetrahydro-2H-Pyran (9)2-Methyl-1,1'-Biphenyl (26)2-Methylnaphthalene (13)2-Naphthaldehyde (12)2-Naphthoic Acid (14)2-Naphthonitrile (15)2-Nitronaphthalene (4)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)2-Phenylnaphthalene (12)3,3'-Diphenyl-5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (13)3,3-Diphenyl-3H-Benzo[C][1,2]Oxathiole 1,1-Dioxide (19)3-Bromo-1,1'-Biphenyl (12)3-Chloro-1,1'-Biphenyl (12)3-Fluoro-1,1'-Biphenyl (16)3-Methyl-1,1'-Biphenyl (10)3-Methyl-1,1':4',1''-Terphenyl (3)3-Phenethylphenol (5)3-Phenyl-1,2,4,5-Tetrazine (9)3-Styrylphenol (11)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Phenylsulfonyl)Morpholine (14)4-(Tert-Butyl)-1,1'-Biphenyl (5)4-Cyclohexylphenol (7)4-Iodo-1,1'-Biphenyl (9)4-Methoxy-1,1'-Biphenyl (4)9H-Xanthene (7)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-2-Ol (16)[1,1'-Biphenyl]-3-Amine (11)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-3-Carboxylic Acid (40)[1,1'-Biphenyl]-3-Ol (9)[1,1'-Biphenyl]-4-Carbaldehyde (31)[1,1'-Biphenyl]-4-Carbonitrile (27)[1,1'-Biphenyl]-4-Ol (29)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzyltriphenylphosphonium (14)Cyclopentylbenzene (28)Cyclopropanecarboxylic Acid (11)Cyclopropyl(Phenyl)Methanamine (22)Cyclopropyl(Phenyl)Methanone (13)Diphenyl Phosphonate (11)Diphenylphosphane (25)Diphenylphosphine Oxide (27)Ethane-1,1-Diyldibenzene (3)Ethene-1,1,2-Triyltribenzene (13)Ethyl Cyclopropanecarboxylate (8)Methyl 1-Naphthoate (7)Methyl 2-Naphthoate (11)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Cyclopropanecarboxylate (8)N,1-Diphenylmethanimine (15)N,N-Dimethylnaphthalen-1-Amine (4)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-2-Phenylacetamide (5)N-Benzylbenzamide (21)N-Benzylbenzenesulfonamide (18)N-Cyclopropylbenzamide (14)N-Cyclopropylbenzenesulfonamide (10)N-Phenethylbenzamide (9)N-Phenyl-2-Naphthamide (11)Naphthalen-1-Ol (28)Naphthalen-1-Ylboronic Acid (4)Naphthalen-1-Ylmethanol (8)Naphthalen-2-Amine (12)Naphthalen-2-Ol (25)Naphthalen-2-Ylboronic Acid (8)Naphthalene-1,4-Diol (3)Naphthalene-2-Sulfonic Acid (4)Propane-2,2-Diyldibenzene (17)Tert-Butyl Cyclopropylcarbamate (7)Tetrahydro-2H-Pyran-2-Ol (12)Tetrahydro-2H-Pyran-2-Yl Acetate (12)Tetraphenylmethane (16)Triphenylene (12)Vinylcyclopropane (8)Acetylbenzonitrile (3)Aminobenzyl (7)Benzylamine (21)Benzylamino (47)Benzylhydroxylamine (25)Benzylidene (16)Benzylidene (16)Benzyloxy (1061)Benzylthio (16)Benzylthio (16)Cyanobenzyl (12)Dibenzyl (15)Dibenzylamino (7)Dichlorobenzylidene (8)Difluorobenzyl (17)Dimethoxybenzyl (20)Dimethoxybenzyl (20)Dimethylbenzonitrile (25)Dimethylbenzyl (6)Dimethylbenzyl (6)Dimethylbenzylamine (6)Ethoxybenzyl (8)Ethoxybenzyl (8)Fluorobenzyl (131)Fluorobenzylidene (2)Formylbenzonitrile (35)Iodobenzyl (9)Isopropylbenzonitrile (4)Methoxybenzyl (175)Methoxybenzylamine (7)Methoxybenzylidene (6)Methylbenzonitrile (104)Methylbenzyl (73)Methylbenzyl (73)Methylbenzylamine (8)Methylbenzylidene (1)Methylbenzylidene (1)Nitrobenzyl (33)Nitrobenzylidene (2)Phenoxybenzonitrile (5)Trifluorobenzyl (2)
Azides (42)
Azoes (113)
(E)-1-(Naphthalen-1-Yl)-2-Phenyldiazene (7)1,2-Diphenyldiazene (7)3-(Phenyldiazenyl)Benzoic Acid (7)
Benzene Compounds (18901)
(((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Fluorophenyl)Propanoic Acid (3)(10Ar)-1,2,3,4,4A,9,10,10A-Octahydrophenanthrene (3)(1E,1'E)-N,N'-(Ethane-1,2-Diyl)Bis(1-Phenylmethanimine) (5)(1R,4R)-4-Phenyl-1,1'-Bi(Cyclohexane) (24)(9H-Fluoren-9-Yl)Methyl Benzylcarbamate (22)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(Cyclopentylmethyl)Benzene (5)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylmorpholine (7)(R)-4-Benzyloxazolidin-2-One (5)(R)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)(S)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)1,1':2',1''-Terphenyl (4)1,1':3',1''-Terphenyl (28)1,1':4',1'':4'',1'''-Quaterphenyl (7)1,1,2,2-Tetra([1,1'-Biphenyl]-4-Yl)Ethene (10)1,1-Dimethyl-1,2,3,4-Tetrahydronaphthalene (10)1,2,3,4-Tetrahydronaphthalen-1-Amine (36)1,2,3,4-Tetrahydronaphthalen-1-Ol (5)1,2,3,4-Tetrahydronaphthalene-1-Carboxylic Acid (3)1,2,3,5,6,7-Hexahydro-S-Indacene (23)1,2,4-Trimethylbenzene (41)1,2-Dihydroacenaphthylene (6)1,2-Dinitrobenzene (6)1,3,5-Tris(Phenylethynyl)Benzene (6)1,3,6,8-Tetraphenylpyrene (10)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dihydro-2H-Inden-2-One (6)1,3-Diphenoxypropane (6)1,3-Diphenyl-1H-Pyrazole (6)1,3-Diphenylpropane (6)1,3-Diphenylpropane-1,3-Dione (4)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-Benzylazetidine (6)1-Bromopyrene (4)1-Cyclohexyl-4-(Phenylethynyl)Benzene (10)1-Cyclopropylnaphthalene (6)1-Phenyl-1H-Tetrazole (6)1-Phenylnaphthalene (12)1-Trityl-1H-Pyrazole (5)1H-Indene (18)1H-Indene-1,3(2H)-Dione (5)2,2 ', 3,3' - Tetrahydro-1,1 '- Spiro [Indene] (5)2,3,4,5-Tetrahydro-1H-Benzo[C]Azepine (7)2,3-Dihydro-1H-Inden-1-Amine (52)2,3-Dihydro-1H-Inden-1-Ol (13)2,3-Dihydro-1H-Inden-4-Amine (6)2,3-Dihydro-1H-Inden-4-Ol (6)2,3-Dihydro-1H-Indene-1-Carboxylic Acid (5)2,3-Dihydro-1H-Indene-4-Carbonitrile (4)2,4-Diphenyl-1,3,5-Triazine (6)2,5-Diphenyl-1,3,4-Oxadiazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(2-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (24)2-(2-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (21)2-(2-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (29)2-(3-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (14)2-(3-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (19)2-(3-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (30)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (17)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (20)2-(4-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (15)2-(4-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Methyl-2,3-Dihydro-1H-Inden-1-One (9)2-Phenyl-1,3,5-Triazine (6)2-Phenyl-1,3-Dioxane (7)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenylisoindoline-1,3-Dione (7)2H-Benzo[B][1,4]Thiazin-3(4H)-One (6)3,3-Dimethyl-2,3-Dihydro-1H-Inden-1-One (5)3,4-Dihydro-2H-Benzo[B][1,4]Dioxepine (7)3,5,6,7-Tetrahydro-S-Indacen-1(2H)-One (5)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Chlorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-(Trifluoromethyl)Phenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Fluorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Methoxyphenyl)Propanoic Acid (4)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(O-Tolyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(P-Tolyl)Propanoic Acid (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (19)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoic Acid (12)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (13)3-Methyl-2,3-Dihydro-1H-Inden-1-One (4)3-Phenyl-1H-Pyrrole (5)3-Phenylazetidine (3)3-Phenyloxazolidin-2-One (4)3-Phenylpiperidine (2)4',5'-Diphenyl-1,1':2',1''-Terphenyl (7)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(3-Nitrophenyl)-1,3,2-Dioxaborolane (24)4,4,5,5-Tetramethyl-2-(M-Tolyl)-1,3,2-Dioxaborolane (21)4,4,5,5-Tetramethyl-2-(O-Tolyl)-1,3,2-Dioxaborolane (24)4,5-Diphenyloxazole (7)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-Bromo-2,3-Dihydro-1H-Inden-1-One (5)4-Bromo-2,3-Dihydro-1H-Indene (10)4-Chloro-2,3-Dihydro-1H-Inden-1-One (8)4-Chloro-2,3-Dihydro-1H-Indene (5)4-Cyclohexyl-1,1'-Biphenyl (18)4-Fluoro-2,3-Dihydro-1H-Inden-1-One (6)4-Fluoro-2,3-Dihydro-1H-Indene (14)4-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)4-Methyl-2,3-Dihydro-1H-Inden-1-One (8)4-Methyl-2,3-Dihydro-1H-Indene (3)4-Phenyl-1,1'-Bi(Cyclohexane) (8)4-Phenyl-4H-1,2,4-Triazole (6)5''-([1,1'-Biphenyl]-4-Yl)-1,1':4',1'':3'',1''':4''',1''''-Quinquephenyl (5)5',5''-Diphenyl-1,1':3',1'':3'',1'''-Quaterphenyl (8)5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (6)5,6,7,8-Tetrahydronaphthalen-2-Ol (5)5-Bromo-1,2,3,4-Tetrahydronaphthalene (6)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Methoxy-1,2,3,4-Tetrahydronaphthalene (3)5-Methoxy-2,3-Dihydro-1H-Indene (2)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Phenyl-1H-Imidazole (6)5-Phenylcyclohexane-1,3-Dione (6)6,7,8,9-Tetrahydro-5H-Benzo[7]Annulen-5-One (6)6-Bromo-1,2,3,4-Tetrahydronaphthalene (9)6-Bromo-2,3-Dihydro-1H-Inden-1-One (8)6-Bromo-3,4-Dihydronaphthalen-1(2H)-One (3)6-Chloro-1,2,3,4-Tetrahydronaphthalene (3)6-Chloro-2,3-Dihydro-1H-Inden-1-One (5)6-Fluoro-1,2,3,4-Tetrahydronaphthalene (6)6-Fluoro-2,3-Dihydro-1H-Inden-1-One (4)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methyl-1,2,3,4-Tetrahydronaphthalene (5)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)6-Methyl-3,4-Dihydronaphthalen-1(2H)-One (2)7-Bromo-2,3-Dihydro-1H-Inden-1-One (13)7-Chloro-2,3-Dihydro-1H-Inden-1-One (9)7-Fluoro-2,3-Dihydro-1H-Inden-1-One (8)7-Hydroxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methyl-2,3-Dihydro-1H-Inden-1-One (7)9,10-Bis(Phenylethynyl)Anthracene (5)9,10-Diphenylanthracene (16)9-Methylanthracene (4)9-Phenylxanthylium (7)9H-Fluoren-9-One (17)[1,1'-Binaphthalen]-2-Amine (3)[1,1':4',1''-Terphenyl]-4,4''-Dicarbaldehyde (9)Benzenesulfinic Acid (6)Benzil (17)Benzo-18-Crown-6 (7)Benzo[Lmn][3,8]Phenanthroline-1,3,6,8(2H,7H)-Tetraone (10)Benzyl ((Benzyloxy)Carbonyl)Glycinate (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Phenylpropanoate (8)Benzyl Piperidin-4-Ylcarbamate (7)Bicyclo[4.2.0]Octa-1,3,5-Triene (13)Cumene (182)Dibenzyl Phosphonate (6)Diphenylmethanimine (9)Ethane-1,1,2-Triyltribenzene (4)Ethylbenzene (198)Mesitylene (71)Methyl 2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (14)Methyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (11)N,2-Diphenylacetamide (7)N,N,N-Trimethyl-1-Phenylmethanaminium (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-Benzylcyclopropanamine (6)N-Phenylcinnamamide (16)N1,N1,N4,N4-Tetraphenylbenzene-1,4-Diamine (6)N4,N4,N4',N4'-Tetraphenyl-[1,1'-Biphenyl]-4,4'-Diamine (7)Phenanthrene (23)Phenanthrene-9,10-Dione (8)Phenethyldiphenylphosphane (6)Phenothiazin-5-Ium (6)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl 4-Cyclohexylbenzoate (8)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butylbenzene (252)Triphenyl Phosphate (6)Acetamidophenoxy (1)Acetamidophenyl (5)Acetylbenzoate (7)Acetylphenyl (13)Acetylphenyl (13)Acetylphenylboronic (3)Aminobenzoyl (4)Aminobiphenyl (4)Aminonaphthalene (14)Aminophenoxy (19)Aminophenyl (239)Anisole (4)Anthracenes (143)Benzaldehyde (1603)Benzamidophenyl (1)Benzenedimethanol (4)Benzenethiol (8)Benzhydrylazetidine (10)Benzhydrylazetidine (10)Benzhydryloxy (4)Benzhydryloxy (4)Benziodoxol (2)Benzodioxole (5)Benzoquinone (6)Benzoquinone (6)Benzoylbenzoate (4)Benzoylphenyl (4)Binaphthalene (123)Binaphthalene (123)Biphenyl (1393)Boronophenyl (1)Boronophenyl (1)Bromobenzo (104)Bromobenzoyl (6)Bromodibenzo (9)Bromophenoxy (34)Bromophenyl (975)Butoxyphenyl (8)Butylaniline (7)Butylbenzene (16)Butyldiphenylsilyl (7)Butylphenol (20)Butylphenyl (32)Butylphenyl (32)Carbamoylphenoxy (12)Carbamoylphenyl (8)Carboxyphenyl (17)Carboxyphenyl (17)Chlorobenzenesulfonyl (23)Chlorobenzoyl (9)Chlorodibenzo (18)Chloronaphthalene (36)Chlorophenethyl (7)Chlorophenoxy (44)Chlorophenylacetate (4)Chlorophenylacetate Acid (9)Chlorophenylboronic (5)Cyclopropylaniline (6)Cyclopropylbenzoate (5)Cyclopropylnaphthalen (10)Cyclopropylnaphthalen (10)Cyclopropylphenyl (12)Cyclopropylphenyl (12)Diaminobenzene (7)Dibenzaldehyde (19)Dibenzene (7)Dibenzimidamide (5)Dibenzo (108)Dibenzo (108)Dibenzoate (9)Dibenzonitrile (11)Dibromobenzene (45)Dibromobenzo (14)Dibromodibenzo (8)Dibromonaphthalene (15)Dibromophenanthrene (3)Dibromophenoxy (2)Dibromophenylboronic (3)Dichlorobenzene (38)Dichlorobenzoyl (4)Dichlorophenoxy (16)Dichlorophenyl (338)Dichlorophenylboronic (5)Didehydrodibenz (2)Didehydrodibenz (2)Diethoxyphenyl (10)Diethylaniline (6)Diethylbenzamide (7)Diethylbenzene (6)Diethylbenzene (6)Difluorobenzene (57)Difluorobenzo (12)Difluorobenzoyl (9)Difluorophenoxy (9)Difluorophenyl (399)Difluorophenylboronic (11)Dihydroanthracene (1)Dihydroanthracene (1)Dihydrobenzo (189)Dihydrobenzo (189)Dihydrodibenzo (7)Dihydronaphthalene (104)Dihydronaphthalene (104)Diiodobenzene (12)Diisopropylaniline (5)Diisopropylbenzamide (8)Diisopropylphenyl (40)Diisopropylphenyl (40)Dimesityl (12)Dimesityl (12)Dimethoxyacetophenone (5)Dimethoxyaniline (20)Dimethoxybenzaldehyde (40)Dimethoxybenzamide (6)Dimethoxybenzene (47)Dimethoxybenzo (4)Dimethoxybenzo (4)Dimethoxybenzoate (20)Dimethoxybenzohydrazide (3)Dimethoxybenzonitrile (11)Dimethoxybenzoyl (4)Dimethoxybiphenyl (3)Dimethoxybiphenyl (3)Dimethoxynaphthalene (10)Dimethoxynaphthalene (10)Dimethoxyphenol (22)Dimethoxyphenyl (255)Dimethoxyphenylboronic (17)Dimethoxyphenylboronic (17)Dimethoxystyryl (4)Dimethylaminophenyl (4)Dimethylanthracene (4)Dimethylbenzaldehyde (27)Dimethylbenzamide (37)Dimethylbenzene (334)Dimethylbenzene (334)Dimethylbenzenesulfonamide (16)Dimethylbenzo (21)Dimethylbenzo (21)Dimethylbenzoate (27)Dimethylbenzoyl (3)Dimethylbenzoyl (3)Dimethylnaphthalene (6)Dimethylphenol (36)Dimethylphenoxy (13)Dimethylphenoxy (13)Dimethylphenylboronic (6)Dimethylphenylboronic (6)Dimethylphenylhydrazine (3)Dimethylphenylisothiocyanate (4)Dinaphtho (5)Dinitrobenzene (20)Diphenol (32)Diphenylamino (27)Diphenylaniline (9)Diphenylethane (19)Diphenylethanone (5)Diphenylethene (6)Diphenylethyl (7)Diphenylethyl (7)Diphenylmethyl (8)Diphenylmethyl (8)Diphenylmethylene (6)Diphenylphosphine (204)Diphenylphosphine (204)Diphenylpropane (18)Diphenylsilane (2)Diphenylurea (4)Diphenylurea (4)Ethoxyaniline (10)Ethoxybenzaldehyde (9)Ethoxybenzoate (12)Ethoxybenzonitrile (6)Ethoxyphenoxy (7)Ethoxyphenoxy (7)Ethoxyphenyl (45)Ethoxyphenyl (45)Ethoxyphenylboronic (7)Ethylaniline (8)Ethylaniline (8)Ethylbenzenesulfonamide (337)Ethylbenzo (7)Ethylbenzo (7)Ethylbenzoate (9)Ethylphenol (12)Ethylphenyl (39)Ethylphenyl (39)Ethynylaniline (7)Ethynylbenzaldehyde (17)Ethynylphenyl (35)Fluorobenzeneboronic (24)Fluoronaphthalene (34)Fluorophenoxy (46)Formylbenzoate (39)Formylphenoxy (4)Formylphenoxy (4)Formylphenyl (43)Formylphenyl (43)Formylphenylboronic (9)Formylphenylboronic (9)Hexahydrobenzo (3)Hexahydrobenzo (3)Hexylphenyl (3)Hexylphenyl (3)Homophenylalanine (18)Hydroxybenzenesulfonate (5)Hydroxybenzimidamide (11)Hydroxyisophthalaldehyde (6)Hydroxyphenethyl (2)Hydroxyphenethyl (2)Hydroxyphenyl (461)Hydroxyphenyl (461)Iodobenzo (15)Iodobenzoic (54)Iodobenzoyl (7)Iodobiphenyl (24)Iododibenzo (7)Iodonaphthalene (9)Iodophenoxy (6)Isobutoxyphenyl (15)Isobutoxyphenyl (15)Isobutylbenzene (5)Isobutylbenzene (5)Isobutylphenyl (9)Isophthalate (8)Isophthalonitrile (4)Isopropoxyaniline (10)Isopropoxyaniline (10)Isopropoxybenzaldehyde (7)Isopropoxybenzoate (7)Isopropoxyphenyl (41)Isopropoxyphenyl (41)Isopropylaniline (18)Isopropylbenzaldehyde (6)Isopropylbenzamide (9)Isopropylbenzenesulfonamide (19)Isopropylbenzoate (8)Isopropylphenyl (58)Mercaptobenzo (21)Methanobenzo (15)Methanobenzo (15)Methoxyacetophenone (12)Methoxyaniline (74)Methoxybenzaldehyde (104)Methoxybenzene (1731)Methoxybenzene (1731)Methoxybenzenesulfonamide (6)Methoxybenzenesulfonic (3)Methoxybenzenesulfonyl (13)Methoxybenzenesulfonyl (13)Methoxybenzimidamide (5)Methoxybenzo (52)Methoxybenzo (52)Methoxybenzoate (116)Methoxybenzonitrile (67)Methoxybenzoyl (12)Methoxybenzoyl (12)Methoxycarbonylphenylboronic (5)Methoxynaphthalene (54)Methoxynaphthalene (54)Methoxyphenethyl (1)Methoxyphenethyl (1)Methoxyphenol (72)Methoxyphenoxy (41)Methoxyphenoxy (41)Methoxyphenylacetate (4)Methoxyphenylboronic (24)Methoxyphenylboronic (24)Methoxyphenylhydrazine (4)Methoxystyryl (13)Methylacetophenone (6)Methylaniline (183)Methylanisole (3)Methylanthracene (5)Methylbenzaldehyde (101)Methylbenzamide (90)Methylbenzamido (3)Methylbenzenesulfinamide (4)Methylbenzenesulfonamide (81)Methylbenzenesulfonic (9)Methylbenzenesulfonyl (4)Methylbenzenesulfonyl (4)Methylbenzimidamide (6)Methylbenzoate (193)Methylbenzohydrazide (7)Methylbenzothioamide (6)Methylbenzothioamide (6)Methylbenzotrifluoride (5)Methylbenzoyl (24)Methylbenzoyl (24)Methylnaphthalene (34)Methylnaphthalene (34)Methylphenol (107)Methylphenoxy (18)Methylphenoxy (18)Methylphenyl (527)Methylphenylacetonitrile (45)Methylphenylboronic (24)Methylphenylhydrazine (10)Methylpropiophenone (5)Methylpropiophenone (5)Naphthaldehyde (28)Naphthalene (459)Naphthalene (459)Naphthaleneboronic (15)Naphthalenesulfonic (7)Naphthamide (15)Naphthonitrile (18)Nitrobenzenesulfonyl (8)Nitrobenzo (54)Nitrobenzoyl (13)Nitronaphthalene (24)Nitrophenoxy (43)Nitrophenyl (723)Nitrophenylboronic (14)Nitrotoluene (27)Octylbenzene (11)Octylbenzene (11)Paracyclophane (2)Paracyclophane (2)Pentafluorobenzene (13)Pentylbenzene (5)Pentylbenzene (5)Pentylbenzoate (2)Pentylphenol (4)Pentylphenyl (5)Pentylphenyl (5)Perfluorophenoxy (5)Perfluorophenyl (31)Phenoxyacetate (5)Phenoxyaniline (8)Phenoxybenzaldehyde (5)Phenoxybenzoate (5)Phenoxyethyl (6)Phenoxyethyl (6)Phenoxymethyl (7)Phenoxymethyl (7)Phenoxyphenyl (61)Phenoxyphenyl (61)Phenoxypropan (4)Phenylacetamide (34)Phenylacetonitrile (8)Phenylacetyl (2)Phenylacetyl (2)Phenylacrylamide (3)Phenylalaninol (4)Phenylamino (31)Phenylaniline (19)Phenylanthracene (16)Phenylbenzamide (23)Phenylbenzenesulfonamide (3)Phenylbutanoate (12)Phenylbutoxy (2)Phenylbutoxy (2)Phenylcarbamoyl (5)Phenylcyclohexanone (6)Phenylcyclopropanecarboxylic (6)Phenylcyclopropyl (7)Phenylcyclopropyl (7)Phenyldiazenyl (4)Phenylene (169)Phenylene (169)Phenylenediamine (13)Phenylenedimethanamine (5)Phenylethanamine (12)Phenylethane (14)Phenylethane (14)Phenylethanol (9)Phenylethanone (20)Phenylethoxy (2)Phenylethyl (69)Phenylethyl (69)Phenylethylisocyanate (2)Phenylhex (3)Phenylimino (1)Phenylisocyanate (9)Phenylisoserine (4)Phenylmethanesulfonyl (2)Phenylmethanesulfonyl (2)Phenylmethanone (2)Phenylmethoxy (4)Phenylmethoxy (4)Phenylmethyl (8)Phenylmethyl (8)Phenylnaphthalene (6)Phenylpentan (11)Phenylpentan (11)Phenylpropanamide (15)Phenylpropyl (20)Phenylpyrazolo (8)Phenylsulfinyl (3)Phenylsulfinyl (3)Phenylsulfonyl (88)Phenylsulfonyl (88)Phenylthio (24)Phenylthio (24)Phenylthiophene (23)Phenylthiophene (23)Phenylthiourea (6)Phenylurea (3)Phenylurea (3)Phenylvinyl (9)Phthalate (23)Phthalimide (12)Phthalonitrile (9)Propoxybenzaldehyde (4)Propoxyphenyl (29)Propoxyphenyl (29)Propoxyphenylboronic (79)Propylphenyl (26)Propylphenyl (26)Pyrenes (52)Quaternaphthalene (6)Quaterphenyl (15)Quaterphenyl (15)Styryl (12)Sulfamoylphenyl (3)Sulfophenyl (4)Sulfophenyl (4)Terephthalaldehyde (11)Terephthalate (13)Terphenyl (239)Terphenyl (239)Tetraaniline (6)Tetrabenzaldehyde (7)Tetrafluorobenzene (17)Tetrahydrobenzo (70)Tetrahydrobenzo (70)Tetrahydronaphthalene (149)Tetrahydronaphthalene (149)Tetralone (12)Tetramethylbenzene (9)Tetramethylbenzene (9)Tetramethylbiphenyl (57)Tetramethylbiphenyl (57)Tetraphenyl (11)Tetraphenyl (11)Toluenesulfonyl (68)Tolyl (412)Tolyl (412)Tolylamino (3)Tolylazanediyl (4)Tolylazanediyl (4)Tolylethynyl (3)Tolyloxy (19)Tolyloxy (19)Tolylphosphine (8)Tolylphosphine (8)Tolylthio (3)Tolylthio (3)Trianiline (7)Tribenzaldehyde (5)Tribromobenzene (7)Trichlorobenzene (20)Trichlorophenoxy (3)Trichlorophenylboronic (6)Triethylbenzene (5)Trifluorophenyl (56)Trifluorophenylboronic (154)Triiodobenzene (5)Triisopropylbenzene (9)Triisopropylphenyl (6)Triisopropylphenyl (6)Trimethoxybenzene (43)Trimethoxystyryl (5)Trimethylaniline (18)Trimethylbenzene (28)Trimethylphenol (6)Trimethylphenyl (20)Trimethylphenyl (20)Trimethylpropiophenone (4)Triphenylphosphoranylidene (9)Triphenylphosphoranylidene (9)Triphenylvinyl (11)Trityl (19)Trityl (19)Tritylamino (2)Trityloxy (2)Tritylthio (3)Tritylthio (3)
Benzyl Bromides (1066)
1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Bromomethyl)-3-Methoxybenzene (19)1-Bromo-2-(Bromomethyl)Benzene (34)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-(Bromomethyl)Benzonitrile (15)Methyl 2-(Bromomethyl)Benzoate (33)
Benzyl Chlorides (646)
1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)Dichlorobenzyl (39)
Bromides (52779)
(1-Bromoethyl)Benzene (11)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromoethyl)Benzene (33)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Bromophenyl)Boronic Acid (39)(2-Bromophenyl)Hydrazine (8)(2-Bromophenyl)Methanamine (12)(2-Bromophenyl)Methanol (39)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Bromopropyl)Benzene (10)(3-Bromopyridin-2-Yl)Methanol (7)(4-Bromophenyl)(Phenyl)Methanone (9)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(Bromoethynyl)Benzene (5)(Dibromomethyl)Benzene (6)1,2,3-Tribromobenzene (5)1,2,4-Tribromobenzene (13)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-3-Methylbenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dibromobenzene (64)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2,4-Dimethylbenzene (3)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dibromo-2-Iodobenzene (4)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dibromo-2-Methylbenzene (14)1,3-Dibromo-2-Nitrobenzene (4)1,4-Dibromo-2-Iodobenzene (3)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Bromophenyl)Ethan-1-One (27)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-4-Bromobenzene (8)1-(Bromomethyl)-2-Iodobenzene (9)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-2-Methylbenzene (14)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Bromomethyl)-3-Methylbenzene (11)1-Benzyl-3-Bromobenzene (7)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2,3-Dimethylbenzene (23)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-(Bromomethyl)Benzene (34)1-Bromo-2-(Difluoromethyl)Benzene (5)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-2-(Tert-Butyl)Benzene (7)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Ethylbenzene (13)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-2-Iodobenzene (65)1-Bromo-2-Isopropylbenzene (10)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-3-Cyclopropylbenzene (6)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-3-Iodobenzene (70)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Bromo-4-Iodobenzene (67)1-Bromo-4-Phenoxybenzene (8)1-Bromo-4-Styrylbenzene (5)1-Bromobicyclo[1.1.1]Pentane (3)1-Bromoisoquinoline (20)1-Bromonaphthalene (4)2,3-Dibromopyridine (21)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dibromoaniline (18)2,4-Dibromophenol (16)2,4-Dibromopyridine (5)2,4-Dibromothiazole (5)2,5-Dibromopyrazine (4)2,5-Dibromopyridine (26)2,5-Dibromothiazole (5)2,5-Dibromothiophene (18)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromoaniline (17)2,6-Dibromobenzaldehyde (4)2,6-Dibromobenzonitrile (4)2,6-Dibromophenol (22)2,6-Dibromopyrazine (9)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Bromophenyl)Acetonitrile (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(Bromomethyl)Furan (3)2-(Bromomethyl)Pyridine (27)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Bromophenol (3)2-Amino-6-Bromophenol (3)2-Bromo-1,1'-Biphenyl (12)2-Bromo-1,3,4-Thiadiazole (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3,4-Trimethylbenzene (4)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,3-Dimethylbenzene (35)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1,4-Dimethylbenzene (22)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-1H-Benzo[D]Imidazole (4)2-Bromo-1H-Imidazole (13)2-Bromo-1H-Pyrrole (11)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylaniline (6)2-Bromo-3-Methylphenol (4)2-Bromo-3-Methylpyrazine (5)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-3-Nitropyridine (5)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-4-Methylaniline (14)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-4-Methylpyridine (6)2-Bromo-4-Methylthiazole (7)2-Bromo-4-Nitroaniline (12)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyrazine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Methylthiazole (7)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorobenzaldehyde (15)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Fluorobenzonitrile (7)2-Bromo-6-Fluorophenol (9)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylaniline (11)2-Bromo-6-Methylbenzoic Acid (5)2-Bromo-6-Methylphenol (7)2-Bromo-6-Methylpyrazine (5)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Bromo-6-Phenylpyridine (4)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Bromo-N-Phenylacetamide (5)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Bromobenzenesulfonyl Chloride (8)2-Bromobenzo[D]Thiazole (28)2-Bromodibenzo[B,D]Furan (6)2-Bromofuran (21)2-Bromoimidazo[1,2-A]Pyridine (5)2-Bromonaphthalene (4)2-Bromonicotinic Acid (5)2-Bromooxazole (7)2-Bromopyrazine (15)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Bromopyrimidine (22)2-Bromoquinazoline (4)3,4-Dibromoaniline (4)3,4-Dibromophenol (3)3,5-Dibromopyridine (12)3-(Bromomethyl)Pyridine (18)3-Bromo-1,1'-Biphenyl (12)3-Bromo-1,5-Naphthyridine (8)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoroaniline (15)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Fluorophenol (5)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Fluorobenzamide (3)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Fluorophenol (11)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methoxybenzaldehyde (9)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylaniline (14)3-Bromo-4-Methylbenzoic Acid (9)3-Bromo-4-Methylpyridine (13)3-Bromo-5'-Phenyl-1,1':3',1''-Terphenyl (4)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromoaniline (187)3-Bromoazetidine (3)3-Bromobenzene-1,2-Diamine (11)3-Bromobenzene-1,2-Diol (8)3-Bromobenzo[B]Thiophene (5)3-Bromobenzoic Acid (159)3-Bromobenzonitrile (110)3-Bromofuran (13)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Bromoisoquinoline (10)3-Bromoisoxazole (7)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Bromopyridazine (25)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Bromopyrrolidine (6)3-Bromothiophene (6)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Bromomethyl)Pyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Benzo[D]Imidazole (14)4-Bromo-1H-Indole (25)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Iodoaniline (8)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-(Trifluoromethyl)Aniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Methylpyridine (5)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Bromobenzo[C][1,2,5]Thiadiazole (14)4-Bromobenzo[D][1,3]Dioxole (6)4-Bromobenzo[D]Thiazole (9)4-Bromobenzofuran (3)4-Bromoindoline (4)4-Bromoisoindolin-1-One (3)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Bromopyridazine (5)4-Bromopyridine (31)4-Bromopyrimidine (24)4-Bromothiazole (10)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Bromo-1-Methyl-1H-Indole (3)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Bromo-1H-Benzo[D]Imidazole (13)5-Bromo-1H-Indazole (14)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Bromo-2,3-Dihydrobenzofuran (6)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Methylpyrimidine (5)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromobenzo[B]Thiophene (3)5-Bromobenzo[D][1,3]Dioxole (12)5-Bromobenzo[D]Oxazole (3)5-Bromoimidazo[1,2-A]Pyridine (6)5-Bromoindoline (8)5-Bromoisoindolin-1-One (8)5-Bromoisoquinoline (17)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyrazin-2-Ol (5)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Bromoquinoxaline (6)5-Bromothiazole (8)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indazole (23)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)6-Bromobenzo[B]Thiophene (4)6-Bromobenzo[D]Oxazole (3)6-Bromobenzo[D]Thiazole (7)6-Bromochroman-4-One (6)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Bromoindoline-2,3-Dione (4)6-Bromoisoindolin-1-One (4)6-Bromoisoquinoline (9)6-Bromonicotinaldehyde (10)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Bromoquinazoline (7)6-Bromoquinoxaline (9)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Bromo-1H-Indazole (18)7-Bromo-1H-Indole (28)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromobenzo[B]Thiophene (5)7-Bromobenzo[D]Thiazole (8)7-Bromobenzofuran (6)7-Bromochromane (7)7-Bromoindoline (3)7-Bromoisoquinoline (6)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)8-Bromochromane (6)8-Bromoimidazo[1,2-A]Pyridine (15)8-Bromoisoquinoline (17)8-Bromoquinazoline (8)9-Bromoanthracene (5)Bromocyclohexane (7)Ethyl 2-Bromo-2-Phenylacetate (6)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopicolinate (9)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 6-Bromonicotinate (6)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Bromoacetyl (14)Bromoaniline (2)Bromoanthracene (5)Bromoanthracene (5)Bromobenzaldehyde (15)Bromobenzamide (7)Bromobenzimidamide (6)Bromobenzyl (36)Bromobut (2)Bromobut (2)Bromobutoxy (4)Bromobutoxy (4)Bromobutyl (6)Bromobutyl (6)Bromochroman (26)Bromochroman (26)Bromocyclopropanecarboxylate (1)Bromoethoxy (22)Bromoethoxy (22)Bromoethyl (86)Bromoethyl (86)Bromoethynyl (6)Bromohexyl (11)Bromohexyl (11)Bromomethyl (759)Bromonicotinaldehyde (5)Bromonicotinamide (5)Bromooctyl (3)Bromopentyl (8)Bromopentyl (8)Bromopropane (10)Bromopropane (10)Bromopropoxy (6)Bromopropoxy (6)Bromopropyl (25)Bromopropyl (25)Bromothiochroman (4)Bromothiochroman (4)Bromovinyl (2)Dibromo (698)Dibromo (698)Dibromoanthracene (3)Dibromoanthracene (3)Dibromobenzaldehyde (8)Dibromobenzonitrile (8)Dibromomethyl (6)Dibromomethyl (6)Tetrabromo (10)Tetrabromo (10)Tribromo (9)Tribromo (9)
Carbamates (7952)
Carboxylic Acid Salts (668)
Carboxylic Acids (58150)
1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,5-Naphthyridine-3-Carboxylic Acid (6)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Naphthoic Acid (23)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropane-1-Carboxylic Acid (23)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carboxylic Acid (4)1H-Indazole-3-Carboxylic Acid (23)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)1H-Indole-3-Carboxylic Acid (28)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carboxylic Acid (7)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,3-Difluorobenzoic Acid (35)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)2,4-Difluorobenzoic Acid (29)2,5-Dichlorobenzoic Acid (13)2,5-Difluorobenzoic Acid (32)2,6-Dichlorobenzoic Acid (13)2,6-Difluorobenzoic Acid (33)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(2-Methoxyphenyl)Acetic Acid (16)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Hydroxyphenyl)Acetic Acid (8)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-Chlorophenoxy)Acetic Acid (3)2-(4-Fluorophenyl)Acetic Acid (30)2-(4-Methoxyphenyl)Acetic Acid (21)2-(4-Nitrophenyl)Acetic Acid (9)2-(Benzofuran-3-Yl)Acetic Acid (3)2-(M-Tolyl)Acetic Acid (16)2-(Morpholin-2-Yl)Acetic Acid (5)2-(O-Tolyl)Acetic Acid (17)2-(P-Tolyl)Acetic Acid (9)2-(Phenylamino)Benzoic Acid (11)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethyl)Benzoic Acid (33)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (17)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-6-Chlorobenzoic Acid (5)2-Benzoylbenzoic Acid (10)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Methylbenzoic Acid (5)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-6-Fluorobenzoic Acid (8)2-Chlorobenzoic Acid (130)2-Cyclohexylacetic Acid (14)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluorobenzoic Acid (220)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Iodobenzoic Acid (47)2-Methoxyisonicotinic Acid (13)2-Methyl-2-Phenylpropanoic Acid (20)2-Methyl-3-Nitrobenzoic Acid (7)2-Naphthoic Acid (14)2-Nitrobenzoic Acid (65)2-Oxo-2-Phenylacetic Acid (17)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2-Phenoxypropanoic Acid (13)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-(3-Chlorophenyl)Propanoic Acid (11)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Benzoic Acid (5)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Methylsulfonyl)Benzoic Acid (6)3-(Phenyldiazenyl)Benzoic Acid (7)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethyl)Benzoic Acid (52)3-Benzamidopropanoic Acid (3)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylbenzoic Acid (9)3-Bromobenzoic Acid (159)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Methoxybenzoic Acid (5)3-Chlorobenzoic Acid (144)3-Fluoro-4-Methoxybenzoic Acid (6)3-Fluorobenzoic Acid (206)3-Fluoropicolinic Acid (6)3-Iodobenzoic Acid (55)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methylpicolinic Acid (13)3-Nitrobenzoic Acid (109)3-Phenoxybenzoic Acid (6)3-Phenoxypropanoic Acid (14)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(Benzyloxy)Benzoic Acid (5)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Trifluoromethyl)Nicotinic Acid (3)4-Amino-3-Chlorobenzoic Acid (6)4-Benzamidobenzoic Acid (3)4-Cyclohexylbenzoic Acid (6)4-Fluoro-3-Iodobenzoic Acid (5)4-Fluorobenzoic Acid (114)4-Methylnicotinic Acid (5)4-Morpholinobenzoic Acid (5)4-Nitrobenzoic Acid (35)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Oxo-4-(Phenylamino)Butanoic Acid (7)4-Oxo-4-Phenylbutanoic Acid (16)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenoxybenzoic Acid (4)4-Phenylbutanoic Acid (19)5'-(4-Carboxyphenyl)-[1,1':3',1''-Terphenyl]-4,4''-Dicarboxylic Acid (7)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)5-Phenylfuran-2-Carboxylic Acid (6)5-Phenylisoxazole-3-Carboxylic Acid (15)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)6-Methoxypicolinic Acid (9)6-Methylnicotinic Acid (6)6-Methylpicolinic Acid (12)6-Oxopiperidine-2-Carboxylic Acid (3)6-Phenylpicolinic Acid (3)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-3-Carboxylic Acid (40)Azetidine-2-Carboxylic Acid (6)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[D]Thiazole-6-Carboxylic Acid (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-3-Carboxylic Acid (6)Benzoic Acid (3524)Benzoylglycine (15)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Cyclobutanecarboxylic Acid (23)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanecarboxylic Acid (83)Cyclopentanecarboxylic Acid (26)Cyclopropanecarboxylic Acid (11)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Furan-2-Carboxylic Acid (32)Furan-3-Carboxylic Acid (11)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Indoline-2-Carboxylic Acid (3)Isonicotinic Acid (23)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-6-Carboxylic Acid (3)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl Benzofuran-2-Carboxylate (6)Methyl Isoquinoline-3-Carboxylate (3)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Nicotinic Acid (53)Oxazole-4-Carboxylic Acid (4)Picolinic Acid (22)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (12)Proline (13)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Pyridazine-3-Carboxylic Acid (7)Pyridine-2,6-Dicarboxylic Acid (9)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carboxylic Acid (7)Pyrrolidine-3-Carboxylic Acid (14)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Carboxylic Acid (4)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carboxylic Acid (10)Thiophene-3-Carboxylic Acid (8)Tryptophan (22)Aceticacid (1248)Acetylbenzoic Acid (3)Acrylic (95)Aminobenzoic (7)Aminobutanoic (8)Aminoheptanoic (6)Aminohexanoic (10)Aminonicotinic Acid (4)Aminopentanoic (8)Aminophenylacetic Acid (22)Aminopropanoic (11)Aminoundecanoic Acid (4)Benzenedicarboxylic (6)Benzenedicarboxylic Acid (6)Benzylpropanoic Acid (75)Benzylsuccinic Acid (6)Boronobenzoic (4)Bromobutanoic (5)Bromododecanoate (3)Bromoisonicotinic Acid (4)Bromonicotinic (8)Bromonicotinic Acid (9)Bromophenylacetic Acid (15)Bromovalerate (4)Butanoic (124)Chlorobenzoic (35)Chloromandelic Acid (3)Chromene-Carboxylic Acid (1)Cyanonicotinic (5)Cyanonicotinic Acid (3)Diacetic (19)Diacetic (19)Diaminobenzoic (7)Diaminobutanoic (5)Diaminohexanoic (4)Dibenzoic (40)Dibromobenzoic (10)Dibromobenzoic Acid (10)Dibromonicotinic Acid (7)Dicarboxylic (183)Dicarboxylic (183)Dichlorobenzoic (21)Dichlorobenzoic Acid (22)Dichloroisonicotinic (6)Dichloroisonicotinic Acid (6)Dichlorophenylacetic Acid (4)Dienoate (14)Dienoic (10)Difluorobenzoic (54)Difluorobutanoic (3)Difluoroisonicotinic Acid (7)Difluorophenylacetic (7)Difluorophenylacetic Acid (7)Diiodobenzoic (5)Diisophthalic (17)Diisophthalic Acid (9)Diisopropylbenzoic Acid (4)Dimethoxybenzoic (33)Dimethoxyphenylacetic Acid (3)Dimethylbenzoic (32)Dimethylbutanoic (13)Dimethylbutanoic (13)Dimethylpropanoic (5)Diphenylpropanoic (8)Diyldimethanol (17)Enedioic (8)Enoic (127)Ethoxybenzoic (9)Ethylbenzoic (11)Ethylbenzoic Acid (12)Ethynylbenzoic (6)Ethynylbenzoic Acid (5)Fluoroisophthalic Acid (4)Fluorophenylacetic (10)Fluorophenylacetic Acid (11)Fluorophthalic (5)Fluorophthalic Acid (3)Fluoropicolinic (12)Formylbenzoic (22)Formylbenzoic Acid (19)Guanidinopentanoic (8)Heptanoic (6)Heptanoic (6)Hexacarboxylic Acid (5)Hexanoic (25)Hexanoic (25)Hydrazinylbenzoic (6)Hydrazinylbenzoic Acid (5)Hydroxynicotinic (15)Indolecarboxylic (2)Isophthalic (29)Isophthalic Acid (15)Isopropoxybenzoic (8)Isopropoxybenzoic Acid (7)Isopropylbenzoic (13)Isopropylnicotinic Acid (4)Malonate (39)Mercaptobenzoic (6)Mercaptobenzoic Acid (4)Mercaptopropanoic (11)Methoxybenzoic (142)Methoxybutanoic (4)Methoxybutanoic (4)Methoxyisophthalic Acid (5)Methoxyphenylacetic (10)Methoxyphenylacetic Acid (12)Methoxypropanoic (7)Methoxypropanoic (7)Methylbenzoic (174)Methylbutanoic (32)Methylbutanoic (32)Methylcinnamic Acid (9)Methylhexanoic (8)Methylhexanoic (8)Methylisophthalic Acid (17)Methylnicotinic (46)Methyloctanoic (6)Methylpentanoic (108)Methylpentanoic (108)Methylpropanoic (57)Naphthoic (64)Nitrobenzoic (161)Nitroisonicotinic Acid (5)Nitroisophthalic Acid (3)Nitronicotinic (10)Nitropicolinic (11)Octanoic (6)Octanoic (6)Oxoacetic (22)Oxobutanoic (57)Oxobutanoic (57)Oxodecanoic (5)Oxodecanoic (5)Oxododecanoic (9)Oxododecanoic (9)Oxoheptanoic (5)Oxoheptanoic (5)Oxoheptanoic Acid (4)Oxohexadecanoic (13)Oxohexadecanoic (13)Oxohexanoic (10)Oxohexanoic (10)Oxooctadecanoic (7)Oxooctadecanoic (7)Oxopentanoic (37)Oxopentanoic (37)Oxopropanoic (8)Pentanedioic (18)Pentanedioic (18)Pentanoic (27)Phenoxybenzoic (5)Phenylacetic (35)Phenylbutanoic (47)Phenylpentanoic (11)Phenylpropanoic (45)Propanoic (1168)Propenoic (6)Pyridazinecarboxylic (1)Succinic (13)Sulfamoylbenzoic (15)Sulfobenzoic (5)Terephthalic (7)Tetraacetic (5)Tetrabenzoic (13)Tetrabenzoic Acid (14)Tetracarboxylic (13)Tribenzoic (15)Tribenzoic Acid (14)Tricarboxylic (18)Trichlorobenzoic (5)Trichlorobenzoic Acid (4)Trifluorobenzoic (12)Trifluorobenzoic Acid (11)Trifluorobutanoic (3)Trifluoromethylbenzoic (5)Trifluoromethylbenzoic Acid (4)Trifluoropentanoic (4)Trifluorophenylacetic Acid (16)Trifluoropropanoic (4)Triiodobenzoic (4)Trimethylbenzoic Acid (4)
Chlorides (77742)
(2,3-Dichlorophenyl)Boronic Acid (11)(2,6-Dichlorophenyl)Boronic Acid (6)(2-Chloroethoxy)Benzene (5)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Chlorophenyl)Hydrazine (16)(2-Chlorophenyl)Methanamine (28)(2-Chlorophenyl)Methanol (40)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3,4-Dichlorophenyl)Boronic Acid (10)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Chlorophenyl)Boronic Acid (121)(3-Chlorophenyl)Hydrazine (12)(3-Chlorophenyl)Methanamine (19)(3-Chlorophenyl)Methanol (38)(3-Chloropyridin-2-Yl)Methanamine (6)(4-Chlorophenyl)(Phenyl)Methanone (11)(5-Chloropyridin-2-Yl)Methanamine (5)(Chloromethanetriyl)Tribenzene (7)(Chloromethylene)Dibenzene (5)1,2,3,4-Tetrachlorobenzene (8)1,2,4-Trichlorobenzene (26)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-3-Methylbenzene (8)1,2-Dichloro-4-Fluorobenzene (15)1,2-Dichloro-4-Methoxybenzene (11)1,2-Dichloro-4-Nitrobenzene (16)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dichloro-2-Fluorobenzene (23)1,3-Dichloro-2-Iodobenzene (5)1,3-Dichloro-2-Methoxybenzene (9)1,3-Dichloro-2-Nitrobenzene (5)1,3-Dichloroisoquinoline (14)1,4-Dichloro-2-Fluorobenzene (11)1,4-Dichloro-2-Methoxybenzene (8)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Chlorophenyl)Piperazine (4)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Chloromethyl)-2-Methylbenzene (7)1-Benzyl-2-Chlorobenzene (9)1-Benzyl-3-Chlorobenzene (3)1-Benzyl-4-Chlorobenzene (6)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-(Chloromethyl)Benzene (12)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-2-Cyclopropylbenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Iodobenzene (65)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3,5-Dimethylbenzene (8)1-Chloro-3-(Chloromethyl)Benzene (7)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Nitrobenzene (161)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Chloro-4-Iodobenzene (49)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Chloroanthracene-9,10-Dione (6)1-Chloroisoquinoline (20)1-Chloronaphthalene (24)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dichloroaniline (18)2,3-Dichlorobenzaldehyde (7)2,3-Dichlorophenol (9)2,3-Dichloropyridine (38)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyridine (5)2,4,6-Trichloropyrimidine (14)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dichloro-1-Fluorobenzene (27)2,4-Dichloro-1-Methoxybenzene (18)2,4-Dichloro-1-Nitrobenzene (19)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichlorobenzaldehyde (8)2,4-Dichlorobenzonitrile (4)2,4-Dichloropyridine (50)2,4-Dichloroquinazoline (19)2,4-Dichlorothiazole (4)2,5-Dichlorophenol (7)2,5-Dichloropyrazine (4)2,5-Dichloropyridine (32)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloroaniline (27)2,6-Dichlorobenzoic Acid (13)2,6-Dichlorobenzonitrile (8)2,6-Dichloronicotinonitrile (8)2,6-Dichlorophenol (16)2,6-Dichloropyrazine (14)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(2-Chlorophenyl)Pyridine (3)2-(2-Chlorophenyl)Pyrrolidine (17)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Chlorophenyl)Acetonitrile (16)2-(4-Chlorophenoxy)Acetic Acid (3)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Furan (3)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Chloromethyl)Pyrimidine (5)2-(Chloromethyl)Thiazole (5)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Chloro-1,1'-Biphenyl (8)2-Chloro-1,3,5-Triazine (10)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-1-Phenylethan-1-One (20)2-Chloro-1H-Benzo[D]Imidazole (17)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylaniline (4)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-3-Methylpyrazine (7)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Methylaniline (7)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-4-Methylpyridine (31)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Methylthiazole (5)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Methoxyaniline (8)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Methylthiazole (5)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorophenol (5)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodophenol (3)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylaniline (11)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylphenol (5)2-Chloro-6-Methylpyrazine (12)2-Chloro-6-Methylpyridine (49)2-Chloro-6-Nitroaniline (11)2-Chloro-7H-Purine (3)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloro-9H-Purine (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylaniline (8)2-Chloroaniline (214)2-Chlorobenzamide (16)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,3-Diol (4)2-Chlorobenzene-1,4-Diamine (6)2-Chlorobenzenesulfonyl Chloride (24)2-Chlorobenzenethiol (7)2-Chlorobenzo[D]Oxazole (11)2-Chlorobenzo[D]Thiazole (21)2-Chlorobenzoic Acid (130)2-Chlorobenzonitrile (99)2-Chlorobenzoyl Chloride (13)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chlorofuran (3)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronaphthalene (6)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chlorooxazole (7)2-Chlorophenol (163)2-Chloropyrazine (24)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Chloroquinoxaline (39)2-Chlorothiazole (32)2-Chlorothiophene (20)3,4-Dichloroaniline (21)3,5-Dichloropyridine (16)3,6-Dichloropyridazine (20)3-(3-Chlorophenyl)Propanoic Acid (11)3-(Chloromethyl)Pyridine (22)3-Chloro-1,1'-Biphenyl (12)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Chloro-1-Phenylpropan-1-One (10)3-Chloro-1H-Indazole (13)3-Chloro-2-Fluoroaniline (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Fluorobenzonitrile (7)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylaniline (11)3-Chloro-2-Methylpyridine (4)3-Chloro-2-Nitroaniline (5)3-Chloro-4-(Trifluoromethyl)Aniline (5)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chloro-4-Methylaniline (12)3-Chloro-4-Methylpyridazine (7)3-Chloro-4-Nitroaniline (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloro-9H-Carbazole (3)3-Chlorobenzaldehyde (106)3-Chlorobenzene-1,2-Diamine (6)3-Chlorobenzene-1,2-Diol (6)3-Chlorobenzenesulfonyl Chloride (21)3-Chlorobenzo[B]Thiophene (6)3-Chlorobenzoic Acid (144)3-Chlorobenzonitrile (100)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloroisoquinoline (20)3-Chlorophenol (113)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridazine (44)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Chlorothiophene (17)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,6-Dichloropyrimidine (14)4-Chloro-1,5-Naphthyridine (6)4-Chloro-1-Phenylbutan-1-One (8)4-Chloro-1H-Indazole (18)4-Chloro-1H-Indole (21)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Methylaniline (11)4-Chloro-3-Methylpyridine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-N-Phenylaniline (6)4-Chlorobenzene-1,3-Diol (6)4-Chlorobenzenesulfonic Acid (4)4-Chlorobenzenesulfonyl Chloride (12)4-Chlorobenzo[D]Thiazole (7)4-Chloroindoline-2,3-Dione (6)4-Chloroisoquinoline (11)4-Chloronicotinic Acid (4)4-Chloropyridazine (16)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Chloroquinazoline (39)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5,6-Dichloropyridin-2-Amine (4)5-Bromo-4-Chloropyrimidine (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Chloro-1H-Imidazole (2)5-Chloro-1H-Indazole (9)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chlorobenzo[B]Thiophene (4)5-Chlorobenzo[D]Oxazole (5)5-Chlorobenzo[D]Thiazole (5)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloroindolin-2-One (3)5-Chloroisoquinoline (6)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Chloropyrimidine (8)5-Chloroquinazoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Chloro-1H-Benzo[D]Imidazole (25)6-Chloro-1H-Indazole (14)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-2,3-Dihydrobenzofuran (3)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chlorobenzo[D]Oxazole (4)6-Chlorobenzo[D]Thiazole (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Chloroquinoxaline (3)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Chloro-1H-Indazole (7)7-Chloro-1H-Indole (29)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Chloro-2,3-Dihydrobenzofuran (3)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Chlorobenzo[D]Thiazole (6)7-Chlorochromane (5)7-Chloroisoquinoline (6)7-Chloropyrazolo[1,5-A]Pyrimidine (8)8-Chlorochromane (5)8-Chloroimidazo[1,2-A]Pyridine (7)8-Chloroisoquinoline (7)8-Chloroquinazoline (5)Ethyl 4,6-Dichloronicotinate (4)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloropicolinate (7)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 2,6-Dichlorobenzoate (7)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Chlorobenzoate (88)Methyl 3-Chloropicolinate (9)Methyl 6-Chloropicolinate (11)N-(2-Chlorophenyl)Acetamide (16)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(3-Chlorophenyl)Quinazolin-4-Amine (10)N-(4-Chlorophenyl)Acetamide (9)Phenyl Carbonochloridate (5)Pyridine-2-Sulfonyl Chloride (9)Pyridine-3-Sulfonyl Chloride (25)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Chloroacetamide (17)Chloroacetyl (12)Chloroaniline (18)Chlorobenzaldehyde (18)Chlorobenzamide (12)Chlorobutyl (6)Chlorobutyl (6)Chlorocarbonyl (7)Chloroethoxy (10)Chloroethoxy (10)Chloroethyl (89)Chloromethyl (478)Chloropicolinaldehyde (8)Chloropicolinamide (5)Chloropropane (18)Chloropropane (18)Chloropropoxy (2)Chloropropoxy (2)Chloropropyl (23)Dichloride (28)Dichloroaniline (9)Dichloroanthracene (3)Dichlorobenzaldehyde (13)Dichlorobenzamide (8)Dichloroisonicotinaldehyde (4)Dichloromethyl (3)Dichloromethyl (3)Dichloronicotinaldehyde (6)Dichloronicotinic (6)Dichloronicotinic (6)Dichloronicotinic Acid (5)Dichloropalladium (4)Dichloropalladium (4)Tetrachloro (2)Tetrachloro (2)Trichloro (36)Trichloro (36)Trichloroacetimidate (5)Trichloroaniline (6)Trichlorobenzaldehyde (4)Trichloromethyl (11)Trichloromethyl (11)
Diazoes (3)
Difluoromethyls (32559)
(Difluoromethyl)Benzene (63)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-(Difluoromethyl)-2-Fluorobenzene (13)1-Bromo-2-(Difluoromethyl)Benzene (5)2-(Difluoromethoxy)Phenol (5)2-(Difluoromethyl)Pyridine (21)3-(Difluoromethyl)Pyridine (5)4-(Difluoromethoxy)Aniline (6)5-(Difluoromethyl)-1H-Pyrazole (6)
Esters (51086)
(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1H-Indol-3-Yl Acetate (4)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Diethylamino)Ethyl Benzoate (3)2-Ethylhexyl Benzoate (13)2-Hydroxyethyl Benzoate (3)2-Phenoxyacetyl Chloride (3)4-Cyanophenyl Benzoate (11)Allyl Benzoate (5)Azetidin-3-Yl Acetate (3)Benzoic Anhydride (6)Benzyl Acetate (11)Benzyl Benzoate (12)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Morpholine-4-Carboxylate (5)Benzyl Phenylcarbamate (15)Benzyl Piperidine-1-Carboxylate (50)Butyl Benzoate (10)Dimethyl Isophthalate (32)Dimethyl Phthalate (14)Dimethyl Pyridine-2,6-Dicarboxylate (7)Ethane-1,2-Diyl Dibenzoate (11)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Aminobenzoate (23)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Bromo-2-Phenylacetate (6)Ethyl 2-Fluorobenzoate (37)Ethyl 2-Hydroxybenzoate (18)Ethyl 2-Iodobenzoate (4)Ethyl 2-Methylbenzoate (26)Ethyl 2-Methylnicotinate (6)Ethyl 2-Nitrobenzoate (9)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Ethyl 2-Phenoxyacetate (10)Ethyl 2-Phenylacetate (60)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Ethyl 3-Aminobenzoate (19)Ethyl 3-Fluorobenzoate (34)Ethyl 3-Hydroxybenzoate (12)Ethyl 3-Iodobenzoate (11)Ethyl 3-Nitrobenzoate (22)Ethyl 3-Oxo-3-Phenylpropanoate (41)Ethyl 3-Phenylpropanoate (17)Ethyl 4-Aminobenzoate (23)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Ethyl Cinnamate (26)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Ethyl Cyclopropanecarboxylate (8)Ethyl Furan-2-Carboxylate (6)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Ethyl Isonicotinate (12)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Ethyl Nicotinate (25)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Ethyl Oxirane-2-Carboxylate (4)Ethyl Picolinate (41)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Ethyl Pyrazine-2-Carboxylate (10)Ethyl Pyridazine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Ethyl Quinazoline-2-Carboxylate (4)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Hexyl Benzoate (5)Isobutyl Benzoate (10)Isopropyl Benzoate (10)Methyl 1-Naphthoate (7)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Methyl 2,6-Dichlorobenzoate (7)Methyl 2,6-Difluorobenzoate (17)Methyl 2-(1H-Indol-3-Yl)Acetate (3)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-(Bromomethyl)Benzoate (33)Methyl 2-(Chlorosulfonyl)Benzoate (7)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Cyanobenzoate (22)Methyl 2-Fluorobenzoate (132)Methyl 2-Hydroxybenzoate (74)Methyl 2-Iodobenzoate (28)Methyl 2-Methoxybenzoate (70)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Methyl 2-Methylbenzoate (101)Methyl 2-Naphthoate (11)Methyl 2-Nitrobenzoate (54)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 2-Phenylacetate (114)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-(Trifluoromethyl)Benzoate (22)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 3-Chlorobenzoate (88)Methyl 3-Cyanobenzoate (29)Methyl 3-Fluorobenzoate (136)Methyl 3-Formylbenzoate (23)Methyl 3-Hydroxybenzoate (58)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 3-Methoxybenzoate (72)Methyl 3-Methylbenzoate (75)Methyl 3-Nitrobenzoate (109)Methyl 3-Oxo-3-Phenylpropanoate (16)Methyl 3-Phenylpropanoate (28)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 4-Amino-3-Iodobenzoate (7)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Aminobenzoate (71)Methyl 4-Fluorobenzoate (75)Methyl 4-Nitrobenzoate (29)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl 4-Phenoxybenzoate (3)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 5-Hydroxypicolinate (5)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl 5-Phenylisoxazole-3-Carboxylate (6)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl 6-Methoxynicotinate (4)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Azetidine-2-Carboxylate (3)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cinnamate (37)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)Methyl Cyclopropanecarboxylate (8)Methyl Furan-2-Carboxylate (20)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Methyl Indoline-6-Carboxylate (3)Methyl Isonicotinate (16)Methyl Isoquinoline-4-Carboxylate (6)Methyl L-Phenylalaninate (7)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Methyl Nicotinate (52)Methyl Oxazole-4-Carboxylate (9)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)Methyl Prolinate (43)Methyl Pyrazine-2-Carboxylate (19)Methyl Pyridazine-3-Carboxylate (7)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)Methyl Pyrrolidine-3-Carboxylate (9)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)Methyl Thiophene-3-Carboxylate (34)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Propyl Benzoate (11)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Azetidine-1-Carboxylate (64)Tert-Butyl Benzoate (66)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclopentylcarbamate (28)Tert-Butyl Isoindoline-2-Carboxylate (13)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl Morpholine-4-Carboxylate (23)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl Piperazine-1-Carboxylate (30)Tert-Butyl Pyrrolidine-1-Carboxylate (21)Acetoxymethyl (85)Acetoxyphenyl (1)Acetyloxy (54)Acrylate (118)Acryloyloxy (3)Adipate (17)Adipate (17)Amino-Carboxylate (2)Aminobenzoate (18)Aminobenzylcarbamate (8)Aminobutanoate (14)Aminocyclobutanecarboxylic Acid (4)Aminocyclohexanecarboxylic (16)Aminocyclohexanecarboxylic Acid (10)Aminocyclopentanecarboxylic (13)Aminoheptanoate (9)Aminohexanoate (6)Aminoisonicotinate (4)Aminoisophthalate (5)Aminonicotinate (7)Aminopentanedioate (15)Aminopentanoate (7)Aminopropanoate (16)Benzoyloxy (14)Benzylcarbamate (8)Bromobenzoate (26)Bromobutanoate (9)Bromocyclopropanecarboxylate (1)Bromodecanoate (20)Bromoisonicotinate (8)Bromoisophthalate (3)Bromonicotinate (13)Bromopropanoate (9)Bromoundecanoate (3)Butoxycarbonyl (1675)Butoxycarbonyl (1675)Carbamate (1536)Chlorobenzoate (49)Chloroformate (4)Chloropicolinate (30)Chloropropanoate (5)Cyanoacrylate (6)Decanedioate (9)Decanedioate (9)Decanoate (7)Decanoate (7)Diacetate (56)Diacetoxy (1)Diacrylate (15)Diaminobenzoate (7)Dibromobenzoate (4)Dicarbamate (14)Dichlorobenzoate (24)Dichloroisonicotinate (9)Dimethacrylate (1)Dimethylbutanoate (14)Dimethylcarbamate (3)Dimethylnicotinate (10)Dimethylnicotinate (10)Dipropanoate (6)Dipropanoate (6)Diyldicarbamate (5)Dodecanoate (11)Enecarboxylate (9)Enoate (116)Ethoxycarbonyl (70)Ethylbutanoate (6)Ethynylbenzoate (7)Ethynylbenzylcarbamate (3)Glutarate (3)Glutarate (3)Hexanoate (14)Hexanoate (14)Indoline-Carboxylate (1)Iodoacrylate (6)Iodobutanoate (4)Iodopropanoate (1)Isobutyrate (18)Isobutyrate (18)Methacrylate (87)Methacryloyloxy (7)Methoxycarbonyl (169)Methoxycarbonyl (169)Methoxyisonicotinate (11)Methoxyisonicotinate (11)Methoxynicotinate (24)Methoxynicotinate (24)Methoxypropanoate (5)Methoxypropanoate (5)Methylacrylate (13)Methylbutanoate (38)Methylmalonate (6)Methylnicotinate (57)Methylpentanoate (17)Methylpropanoate (47)Nitropicolinate (13)Nonanedioate (4)Nonanedioate (4)Oxoacetate (21)Oxoacetate (21)Oxobutanoate (56)Oxobutanoate (56)Oxoheptanoate (8)Oxoheptanoate (8)Oxohexanoate (14)Oxohexanoate (14)Oxopentanoate (31)Oxopropanoate (39)Oxopropanoate (39)Pentanoate (13)Pentanoate (13)Phenylacrylate (5)Phenylpropanoate (31)Propanoate (276)Propylpentanoate (5)Propylpentanoate (5)Succinate (23)Succinate (23)Sulfamoylbenzoate (6)Tetraacetate (7)Tetraacetate (7)Tetradecanoate (10)Tetradecanoate (10)Thiophenecarboxylate (1)Tosylcarbamate (4)Tosyloxy (12)Triacetate (12)Triacetate (12)Vinylbenzoate (3)Vinylcyclopropanecarboxylic Acid (3)
Ethers (82403)
Butoxy-Phenyl-Boronic Acid/Ester (76)Diethoxy (14)Diethoxy (14)Diethoxyethyl (9)Diethoxyethyl (9)Diethoxymethyl (8)Diethoxymethyl (8)Dimethoxyethyl (8)Dimethoxypropane (11)Dimethoxypropane (11)Dioxane (153)Dioxepine (7)Dioxepine (7)Disulfide (38)Methoxyphenylboronic-Acid (32)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Benzyloxy)Phenyl)Boronic Acid (23)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloroethoxy)Benzene (5)(2-Methoxyethoxy)Benzene (32)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Phenoxyphenyl)Methanol (3)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-Methoxyphenyl)(Phenyl)Methanone (7)(9H-Fluoren-9-Yl)Methyl (2-(Benzyloxy)Ethyl)Carbamate (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Allyloxy)Benzene (19)(Ethoxymethyl)Benzene (7)(Hexyloxy)Benzene (7)(Methoxymethyl)Benzene (30)(Prop-2-Yn-1-Yloxy)Benzene (13)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)1,2-Bis(Benzyloxy)Benzene (11)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-4-Methoxybenzene (11)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-4-Methoxybenzene (19)1,2-Dimethoxybenzene (225)1,2-Diphenoxyethane (11)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dichloro-2-Methoxybenzene (9)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Dimethoxybenzene (239)1,3-Diphenoxybenzene (8)1,4-Dichloro-2-Methoxybenzene (8)1,4-Dimethoxybenzene (66)1-(2-Methoxyphenyl)Ethan-1-One (34)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-2-Methoxybenzene (19)1-(Benzyloxy)-2-Methylbenzene (12)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Benzyloxy)-3-Methylbenzene (8)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Benzyloxy)-4-Bromobenzene (8)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-3-Methoxybenzene (19)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-Benzyl-4-Methoxybenzene (8)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-Phenoxybenzene (8)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Phenoxybenzene (8)1-Iodo-2-Methoxybenzene (50)1-Iodo-3-Methoxybenzene (48)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-(Phenoxymethyl)Benzene (3)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methoxy-4-Nitrobenzene (90)1-Methoxynaphthalene (18)1-Methyl-3-Phenoxybenzene (9)1-Nitro-2-Phenoxybenzene (4)1-Nitro-4-Phenoxybenzene (5)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)2,3,5,6,8,9,11,12-Octahydrobenzo[B][1,4,7,10,13]Pentaoxacyclopentadecine (8)2,3-Dimethoxypyridine (7)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dichloro-1-Methoxybenzene (18)2,4-Difluoro-1-Methoxybenzene (25)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethoxypyrimidine (13)2,6-Dimethoxypyridine (11)2-(2-Methoxyphenyl)Acetic Acid (16)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(4-Methoxyphenyl)Acetic Acid (21)2-(Benzyloxy)Benzaldehyde (13)2-(Benzyloxy)Naphthalene (5)2-(Benzyloxy)Phenol (5)2-(Methoxymethyl)Morpholine (4)2-(Methoxymethyl)Pyrrolidine (6)2-(Phenoxymethyl)Oxirane (13)2-(Phenoxymethyl)Pyridine (5)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-3-Methoxypyrazine (5)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-5-Methoxyaniline (8)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Ethoxynaphthalene (4)2-Ethoxypyridine (20)2-Ethoxypyrimidine (7)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-6-Methoxypyridine (6)2-Isopropoxypyridine (16)2-Methoxy-1,1'-Biphenyl (7)2-Methoxy-1,3,5-Triazine (10)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-Methylpyridine (5)2-Methoxy-6-Methylpyridine (14)2-Methoxy-6-Nitrophenol (5)2-Methoxybenzamide (9)2-Methoxybenzenesulfonyl Chloride (15)2-Methoxynaphthalene (22)2-Methoxyphenol (201)2-Methoxypyrazine (45)2-Methoxypyridine (435)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methoxythiophene (7)2-Methyl-N-Phenylaniline (7)2-Phenoxyacetonitrile (11)2-Phenoxyaniline (4)2-Phenoxybenzonitrile (5)2-Phenoxyethan-1-Ol (14)2-Phenoxypropanoic Acid (13)2-Phenoxypyrimidine (8)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxythiazole (5)2-Propoxypyridine (9)3,5-Dimethoxypyridine (4)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Aniline (12)3-(Benzyloxy)Benzaldehyde (13)3-(Benzyloxy)Benzoic Acid (5)3-(Benzyloxy)Phenol (5)3-(Methoxymethyl)Morpholine (4)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methoxybenzaldehyde (7)3-Chloro-4-Methoxybenzoic Acid (5)3-Ethoxypyridine (12)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-4-Methoxybenzoic Acid (6)3-Methoxypiperidine (7)3-Methoxypyridazine (17)3-Methoxypyridine (51)3-Methoxythiophene (9)3-Phenoxyaniline (2)3-Phenoxybenzaldehyde (7)3-Phenoxybenzoic Acid (6)3-Phenoxybenzonitrile (5)3-Phenoxypropanoic Acid (14)3-Phenoxypyrrolidine (5)4-(3-Phenoxypropyl)Morpholine (7)4-(Benzyloxy)Aniline (8)4-(Benzyloxy)Benzaldehyde (23)4-(Benzyloxy)Benzoic Acid (5)4-(Benzyloxy)Phenol (2)4-(Difluoromethoxy)Aniline (6)4-(Dimethoxymethyl)Pyrimidine (5)4-(Phenylethynyl)Phenol (7)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-6-Methoxypyrimidine (5)4-Ethoxypyridine (7)4-Ethoxypyrimidine (6)4-Methoxy-1,1'-Biphenyl (4)4-Methoxy-1H-Indazole (7)4-Methoxy-1H-Indole (11)4-Methoxy-2-Methylpyrimidine (8)4-Methoxy-N-Phenylaniline (5)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methoxypyridazine (8)4-Methoxypyridine (136)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Phenoxyaniline (6)4-Phenoxybenzaldehyde (12)4-Phenoxybenzoic Acid (4)4-Phenoxypyridine (7)4-Phenoxypyrimidine (5)4-Phenoxyquinoline (5)4-Phenoxytetrahydro-2H-Pyran (5)5-(Benzyloxy)Pyrimidine (5)5-Fluoro-2-Methoxypyridine (15)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methoxy-1H-Indazole (5)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methoxy-2-Nitroaniline (7)5-Methoxyindoline (4)5-Methoxyisobenzofuran-1(3H)-One (5)5-Methoxyisoquinoline (6)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1H-Indazole (14)6-Methoxy-1H-Indole (12)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)6-Methoxybenzo[D]Thiazole (6)6-Methoxybenzofuran (4)6-Methoxychromane (5)6-Methoxyisoindolin-1-One (3)6-Methoxyquinoxaline (6)7-(Benzyloxy)Quinoline (6)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Methoxy-1H-Indazole (5)7-Methoxy-1H-Indole (8)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)7-Methoxyisoquinoline (5)8-Methoxyisoquinoline (7)8-Methoxyquinazoline (3)Butoxybenzene (51)Ethoxybenzene (285)Ethyl 2-Phenoxyacetate (10)Isobutoxybenzene (22)Isopropoxybenzene (85)Methoxycyclohexane (7)Methyl 2-Methoxybenzoate (70)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-Methoxybenzoate (72)Methyl 4-Phenoxybenzoate (3)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(4-Phenoxyphenyl)Acetamide (4)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)Phenethoxybenzene (23)Propoxybenzene (63)Tert-Butoxybenzene (17)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)
Fluorinated Building Blocks (98883)
(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Difluorophenyl)Boronic Acid (28)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Fluorophenyl)Boronic Acid (229)(2-Fluorophenyl)Hydrazine (22)(2-Fluorophenyl)Methanamine (49)(2-Fluorophenyl)Methanol (60)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Fluorophenyl)Boronic Acid (169)(3-Fluorophenyl)Methanol (58)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Fluorophenyl)Boronic Acid (93)(4-Fluorophenyl)Methanamine (27)(4-Fluorophenyl)Methanol (29)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,2,3,4,5-Pentafluorobenzene (51)1,2,3,4-Tetrafluorobenzene (74)1,2,3-Trifluorobenzene (157)1,2,4-Trifluorobenzene (211)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-4-Fluorobenzene (15)1,2-Difluoro-3-Iodobenzene (13)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-3-Methylbenzene (23)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Methoxybenzene (19)1,2-Difluoro-4-Nitrobenzene (43)1,2-Difluorobenzene (658)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dichloro-2-Fluorobenzene (23)1,3-Difluoro-2-Iodobenzene (12)1,3-Difluoro-2-Methylbenzene (18)1,3-Difluoro-2-Nitrobenzene (16)1,4-Dichloro-2-Fluorobenzene (11)1,4-Difluoro-2-Iodobenzene (8)1,4-Difluoro-2-Nitrobenzene (28)1,4-Difluorobenzene (362)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Fluorophenyl)Piperazine (8)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-Fluorophenyl)Ethan-1-One (63)1-(4-Fluorophenyl)Ethan-1-One (36)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)1-Benzyl-4-Fluorobenzene (2)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Cyclohexyl-2-Fluorobenzene (4)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethynyl-2-Fluorobenzene (10)1-Fluoro-2,3-Dimethylbenzene (8)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Methylbenzene (255)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3,5-Dimethylbenzene (12)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Methylbenzene (254)1-Fluoro-3-Nitrobenzene (216)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-Iodobenzene (65)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Methylbenzene (140)1-Fluoro-4-Phenoxybenzene (8)1-Fluorobicyclo[1.1.1]Pentane (4)1-Fluoronaphthalene (23)2'-Fluoro-1,1':4',1''-Terphenyl (6)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,3-Difluoroaniline (34)2,3-Difluorobenzaldehyde (18)2,3-Difluorobenzoic Acid (35)2,3-Difluorobenzonitrile (29)2,3-Difluorophenol (36)2,3-Difluoropyridine (13)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dichloro-1-Fluorobenzene (27)2,4-Difluoro-1-Iodobenzene (14)2,4-Difluoro-1-Methoxybenzene (25)2,4-Difluoro-1-Nitrobenzene (46)2,4-Difluoroaniline (44)2,4-Difluorobenzaldehyde (19)2,4-Difluorobenzoic Acid (29)2,4-Difluorobenzonitrile (21)2,4-Difluorophenol (21)2,5-Difluoroaniline (34)2,5-Difluorobenzoic Acid (32)2,5-Difluoropyridine (8)2,6-Difluoroaniline (23)2,6-Difluorobenzaldehyde (25)2,6-Difluorobenzoic Acid (33)2,6-Difluorobenzonitrile (28)2,6-Difluorophenol (24)2,6-Difluoropyridine (29)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Fluorophenyl)Acetonitrile (30)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Fluorophenyl)Pyrrolidine (5)2-(4-Fluorophenyl)-1H-Indole (4)2-(4-Fluorophenyl)Acetic Acid (30)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (17)2-Amino-3-Fluorobenzoic Acid (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorophenol (9)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-3-Fluoropyridine (20)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluorobenzaldehyde (10)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-4-Fluorophenol (9)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorobenzoic Acid (8)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-6-Fluorophenol (5)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1,3-Dimethylbenzene (14)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoro-N-Methylbenzamide (12)2-Fluoro-N-Phenylaniline (4)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluoroaniline (262)2-Fluorobenzaldehyde (175)2-Fluorobenzamide (32)2-Fluorobenzenesulfonamide (12)2-Fluorobenzenesulfonyl Chloride (31)2-Fluorobenzoic Acid (220)2-Fluoropyridine (15)2-Fluoropyrimidine (9)3,3-Difluoropiperidine (29)3,3-Difluoropyrrolidine (29)3,4-Difluoroaniline (44)3,4-Difluorophenol (19)3,5-Difluoropyridine (12)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-Chloro-2-Fluoroaniline (9)3-Fluoro-1,1'-Biphenyl (16)3-Fluoro-2-Iodoaniline (8)3-Fluoro-2-Methylaniline (9)3-Fluoro-2-Methylpyridine (15)3-Fluoro-4-Nitroaniline (7)3-Fluoroaniline (289)3-Fluorobenzaldehyde (137)3-Fluorobenzamide (26)3-Fluorobenzenesulfonyl Chloride (22)3-Fluorobenzoic Acid (206)3-Fluorophenol (180)3-Fluoropiperidine (26)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Fluorothiophene (6)4,4-Difluoropiperidine (5)4-(2-Fluorophenyl)Morpholine (8)4-(4-Fluorophenyl)Thiazole (9)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-1H-Indazole (22)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-2-Nitroaniline (14)4-Fluoroaniline (225)4-Fluorobenzaldehyde (78)4-Fluorobenzamide (19)4-Fluorobenzenesulfonyl Chloride (26)4-Fluorobenzo[D]Thiazole (6)4-Fluorobenzoic Acid (114)4-Fluorobenzonitrile (89)4-Fluoroisoquinoline (6)4-Fluorophenol (111)4-Fluoropyrimidine (8)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Fluoro-2-Methylpyridine (8)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochromane (6)5-Fluoroindoline (3)5-Fluoroisoindolin-1-One (3)5-Fluoropyridin-2-Amine (15)5-Fluoropyrimidine (11)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1H-Indazole (15)6-Fluoro-1H-Indole (17)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluorobenzo[D]Thiazole (5)6-Fluorochromane (6)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1H-Indazole (12)7-Fluoro-1H-Indole (24)7-Fluorobenzo[D]Thiazole (9)7-Fluoroindoline-2,3-Dione (6)7-Fluoroisoquinoline (3)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluorochromane (5)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Fluoroisoquinoline (10)8-Fluoroquinazoline (4)Benzenesulfonyl Fluoride (51)Ethyl 2-Fluorobenzoate (37)Ethyl 3-Fluorobenzoate (34)Fluorobenzene (9967)Methyl 2,6-Difluorobenzoate (17)Methyl 2-Fluorobenzoate (132)Methyl 3-Fluorobenzoate (136)Methyl 4-Fluorobenzoate (75)Methyl 6-Fluoronicotinate (4)N-(3-Fluorophenyl)Acetamide (14)N-(4-Fluorophenyl)Benzamide (3)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl Trifluoromethanesulfonate (27)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Trifluoro(Phenyl)Borate (80)Dichlorofluorobenzene (23)Difluoro (900)Difluoroaniline (37)Difluorobenzaldehyde (33)Difluorobenzamide (6)Difluorobenzenesulfonamide (5)Difluorobenzoate (59)Difluoroethyl (27)Difluoroethyl (27)Difluoromethoxy (198)Difluoromethoxy (198)Difluoropropan (7)Difluoropropan (7)Fluindamine (32)Fluoroacetanilide (5)Fluoroacetophenone (8)Fluoroaniline (65)Fluoroanisole (9)Fluorobenzaldehyde (69)Fluorobenzamide (28)Fluorobenzenesulfonamide (7)Fluorobenzenethiol (6)Fluorobenzylamine (10)Fluorobromobenzene (3)Fluorocinnamic (10)Fluorocinnamic (10)Fluorocinnamic Acid (9)Fluorocyclopropanecarboxylic (9)Fluoroethoxy (4)Fluoroethyl (8)Fluoroethyl (8)Fluoroindan (3)Fluoroindan (3)Fluoroisonicotinaldehyde (7)Fluoroisonicotinate (8)Fluoroisonicotinic (13)Fluoroisonicotinic Acid (13)Fluoromethyl (15)Fluoromethyl (15)Fluoronicotinaldehyde (20)Fluoronicotinamide (3)Fluoronicotinic (19)Fluoronicotinic (19)Fluoronicotinic Acid (14)Fluorophenylisocyanate (3)Fluoropropan (15)Fluoropropan (15)Fluorostyryl (7)Fluorosulfonyl (12)Fluorosulfonyl (12)Hexafluoro (9)Hexafluoro (9)Hexafluoropropan (4)Hexafluoropropan (4)Nonafluoro (2)Nonafluoro (2)Octafluoro (2)Octafluoro (2)Pentafluoro (4)Pentafluorobenzoate (4)Tetrafluoro (12)Tetrafluoro (12)Tetrafluoroaniline (7)Tetrafluoroethoxy (3)Tetrafluoroethoxy (3)Trifluoro (271)Trifluoro (271)Trifluoroacetamide (8)Trifluoroacetyl (13)Trifluoroaniline (11)Trifluorobenzaldehyde (9)Trifluorobenzoate (14)Trifluorobut (36)Trifluorobut (36)Trifluoroethan (2)Trifluoroethan (2)Trifluoroethanamine (23)Trifluoroethanol (6)Trifluoroethoxy (60)Trifluoroethoxy (60)Trifluoroethyl (63)Trifluoromethanesulfonamide (4)Trifluoromethanesulfonyl (22)Trifluoromethoxy (478)Trifluoromethoxy (478)Trifluoromethylthio (5)Trifluoromethylthio (5)Trifluoropropane (36)Trifluoropropanoate (5)Trifluoropropyl (9)
Guanidines (777)
Biguanide (2)Biguanide (2)
Hydrazides (3103)
Pyrazine-2-Carbohydrazide (3)Acetohydrazide (17)Acetohydrazide (17)Chlorobenzhydrazide (3)Dihydrazide (5)Dihydrazide (5)Fluorobenzohydrazide (6)
Hydrazines (6258)
(2-Bromophenyl)Hydrazine (8)(2-Chlorophenyl)Hydrazine (16)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)Hydrazine (22)(3-Chlorophenyl)Hydrazine (12)2-Hydrazineylpyridine (32)2-Hydrazineylpyrimidine (6)3-Hydrazineylpyridine (8)4-Hydrazineylpiperidine (5)Isonicotinohydrazide (6)Phenylhydrazine (153)Picolinohydrazide (5)Dichlorophenylhydrazine (3)Hydrazinecarbothioamide (2)Hydrazinecarboxamide (1)Hydrazinylbenzoate (6)
Hydrazones (2043)
1-Benzylidene-2-Phenylhydrazine (4)
Hydroxylamines (623)
N-Hydroxybenzamide (8)
Iodides (14074)
(2-Iodophenyl)(Phenyl)Methanone (4)(2-Iodophenyl)Methanol (12)(3-Iodophenyl)Boronic Acid (5)(3-Iodophenyl)Methanol (13)1,2-Benziodoxol-3-(1H)-One (6)1,2-Difluoro-3-Iodobenzene (13)1,2-Diiodobenzene (10)1,3-Dibromo-2-Iodobenzene (4)1,3-Dichloro-2-Iodobenzene (5)1,3-Difluoro-2-Iodobenzene (12)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Diiodobenzene (59)1,4-Dibromo-2-Iodobenzene (3)1,4-Difluoro-2-Iodobenzene (8)1-(2-Iodophenyl)Ethan-1-One (4)1-(3-Iodophenyl)Ethan-1-One (7)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Iodobenzene (9)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Bromo-2-Iodobenzene (65)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Iodobenzene (70)1-Bromo-4-Iodobenzene (67)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Iodobenzene (65)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-4-Iodobenzene (49)1-Ethyl-2-Iodobenzene (6)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-4-Iodobenzene (65)1-Iodo-2,3-Dimethylbenzene (8)1-Iodo-2,4-Dimethylbenzene (9)1-Iodo-2-(Trifluoromethoxy)Benzene (6)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-2-Isopropylbenzene (4)1-Iodo-2-Methoxybenzene (50)1-Iodo-2-Methylbenzene (91)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-(Trifluoromethoxy)Benzene (6)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Iodo-3-Methoxybenzene (48)1-Iodo-3-Methylbenzene (60)1-Iodo-3-Nitrobenzene (45)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)2,4-Difluoro-1-Iodobenzene (14)2,6-Dichloro-4-Iodopyridine (4)2,6-Diiodoaniline (8)2,6-Diiodophenol (16)2-Bromo-3-Iodopyridine (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Iodopyridine (5)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-4-Iodopyridine (19)2-Chloro-5-Iodopyridine (18)2-Chloro-6-Iodophenol (3)2-Chloro-6-Iodopyridine (9)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Iodopyridine (8)2-Fluoro-6-Iodoaniline (7)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodo-1,3-Dimethylbenzene (15)2-Iodo-1,4-Dimethylbenzene (5)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-4-Methylaniline (5)2-Iodo-6-Methylpyridine (5)2-Iodo-6-Nitroaniline (3)2-Iodo-9H-Fluorene (8)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Iodobenzaldehyde (17)2-Iodobenzamide (4)2-Iodobenzene-1,3-Diol (3)2-Iodobenzoic Acid (47)2-Iodobenzonitrile (26)2-Iodonaphthalene (5)2-Iodophenol (63)2-Iodopyrazine (25)2-Iodopyridine (27)2-Iodopyrimidine (8)2-Iodothiophene (14)3-Chloro-2-Iodoaniline (3)3-Chloro-4-Iodoaniline (3)3-Fluoro-2-Iodoaniline (8)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Iodobenzaldehyde (28)3-Iodobenzoic Acid (55)3-Iodobenzonitrile (27)3-Iodoimidazo[1,2-A]Pyridine (10)3-Iodophenol (21)3-Iodopyridazine (5)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Iodotetrahydrofuran (3)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Iodoaniline (8)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Iodoaniline (3)4-Chloro-5-Iodopyrimidine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-3-Iodobenzoic Acid (5)4-Iodo-1,1'-Biphenyl (9)4-Iodo-1H-Pyrazole (9)4-Iodo-N,N-Diphenylaniline (3)4-Iodopyridine (17)4-Iodopyrimidine (9)5-Bromo-2-Iodopyridine (5)5-Iodo-1H-Imidazole (4)5-Iodo-1H-Pyrazole (4)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Iodopyrimidine (5)6-Chloro-5-Iodopyridin-2-Amine (3)Ethyl 2-Iodobenzoate (4)Ethyl 3-Iodobenzoate (11)Methyl 2-Iodobenzoate (28)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 4-Amino-3-Iodobenzoate (7)N-(2-Iodophenyl)Acetamide (8)Phenyl(O-Tolyl)Iodonium (14)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Diiodo (19)Diiodobenzoate (5)Iodoaniline (60)Iodoanisole (5)Iodobenzaldehyde (38)Iodobenzamide (6)Iodobutane (1)Iodobutane (1)Iodoethoxy (6)Iodoethoxy (6)Iodoethyl (5)Iodoethyl (5)Iodomethyl (26)Iodomethyl (26)Iodonicotinaldehyde (6)Iodonicotinic (14)Iodonicotinic (14)Iodopropyl (4)Iodopropyl (4)
Isocyanates and Isothiocyanates (237)
(Isothiocyanatomethyl)Benzene (6)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)Isocyanatobenzene (47)Isothiocyanatobenzene (39)Isocyanate (4)Isocyanate (4)
Isocyanides (69)
Isocyanato (7)Isocyanide (1)Isothiocyanato (5)Isothiocyanato (5)
Ketones (39985)
(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Hydroxyphenyl)(Phenyl)Methanone (24)(2-Iodophenyl)(Phenyl)Methanone (4)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)(Phenyl)Methanone (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Bromophenyl)(Phenyl)Methanone (9)(4-Chlorophenyl)(Phenyl)Methanone (11)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Hydroxyphenyl)(Phenyl)Methanone (3)(4-Methoxyphenyl)(Phenyl)Methanone (7)(4-Nitrophenyl)(Phenyl)Methanone (3)(R)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-8-One (8)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1,3-Diphenylpropan-1-One (9)1,4-Diazepan-5-One (9)1,4-Dihydroisoquinolin-3(2H)-One (5)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-One (27)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-(2-Hydroxyphenyl)Ethan-1-One (74)1-(2-Iodophenyl)Ethan-1-One (4)1-(2-Methoxyphenyl)Ethan-1-One (34)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Fluorophenyl)Ethan-1-One (63)1-(3-Hydroxyphenyl)Ethan-1-One (20)1-(3-Iodophenyl)Ethan-1-One (7)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Fluorophenyl)Ethan-1-One (36)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Benzofuran-2-Yl)Ethan-1-One (3)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(M-Tolyl)Ethan-1-One (37)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-(O-Tolyl)Ethan-1-One (26)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Pyrazin-2-Yl)Ethan-1-One (5)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-4-Yl)Ethan-1-One (14)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-(Thiazol-2-Yl)Ethan-1-One (9)1-(Thiophen-2-Yl)Ethan-1-One (17)1-Aminoanthracene-9,10-Dione (8)1-Benzylindoline-2,3-Dione (5)1-Benzylpiperidin-3-One (5)1-Chloroanthracene-9,10-Dione (6)1-Hydroxyanthracene-9,10-Dione (12)1-Methylpiperazin-2-One (6)1-Methylpyrrolidin-2-One (13)1-Phenylbutan-1-One (13)1-Phenylpentan-1-One (12)1-Phenylpiperidin-2-One (8)1-Phenylpropan-2-One (36)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2,2-Dimethyl-1-Phenylpropan-1-One (8)2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2,3-Dihydrofuran-3-One (9)2,3-Dihydropyridin-2-One (5)2,5-Dichlorobenzoic Acid (13)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Benzalacetophenone (36)2-Benzoylbenzoic Acid (10)2-Chloro-1-Phenylethan-1-One (20)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chloroquinazolin-4(3H)-One (4)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Hydroxyquinolin-4(1H)-One (3)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methyl-1-Phenylpropan-1-One (20)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)2-Methylcyclohexan-1-One (3)2-Methylisoindolin-1-One (7)2-Methylisoindoline-1,3-Dione (5)2-Methylpyridazin-3(2H)-One (7)2-Oxo-2-Phenylacetaldehyde (12)2-Oxo-2-Phenylacetic Acid (17)3,3-Difluoropiperidin-4-One (3)3,3-Dimethylcyclohexan-1-One (4)3,3-Dimethylpiperidin-4-One (3)3,4-Dihydroquinoxalin-2(1H)-One (7)3-Acetyl-2H-Chromen-2-One (3)3-Aminopyrrolidin-2-One (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)3-Chloro-1-Phenylpropan-1-One (10)3-Fluoropiperidin-4-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (22)3-Hydroxypyrrolidin-2-One (4)3-Methylcyclohexan-1-One (9)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methylpiperazin-2-One (7)3-Methylpyrimidin-4(3H)-One (6)3-Oxo-3-Phenylpropanenitrile (21)3-Oxo-N-Phenylbutanamide (10)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylacrylaldehyde (29)3-Phenylimidazolidine-2,4-Dione (4)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-Benzylmorpholin-3-One (6)4-Bromoisoindolin-1-One (3)4-Bromopyridazin-3(2H)-One (3)4-Chloro-1-Phenylbutan-1-One (8)4-Chloropyridazin-3(2H)-One (4)4-Fluoroindoline-2,3-Dione (3)4-Hydroxy-2H-Chromen-2-One (10)4-Hydroxydihydrofuran-2(3H)-One (14)4-Hydroxypiperidin-2-One (3)4-Hydroxypyrrolidin-2-One (7)4-Methyl-2H-Chromen-2-One (27)4-Methylisobenzofuran-1(3H)-One (3)4-Oxo-4-Phenylbutanoic Acid (16)4-Phenylbutan-2-One (15)4-Phenylcyclohexan-1-One (11)4-Phenylmorpholin-3-One (6)4-Phenylpyrrolidin-2-One (7)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Bromoisoindolin-1-One (8)5-Bromoisoindoline-1,3-Dione (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloroisoindoline-1,3-Dione (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochroman-4-One (3)5-Fluoroindolin-2-One (4)5-Fluoroisoindolin-1-One (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Hydroxypiperidin-2-One (3)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Methylindolin-2-One (3)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Bromoisoindolin-1-One (4)6-Fluorochroman-4-One (5)6-Fluoroindoline-2,3-Dione (3)6-Fluoroisobenzofuran-1(3H)-One (3)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methoxyisoindolin-1-One (3)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)7,8-Dihydroquinolin-5(6H)-One (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromochroman-4-One (4)7-Bromoindoline-2,3-Dione (3)7-Bromoquinazolin-4(3H)-One (4)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Fluorochroman-4-One (5)7-Fluoroindolin-2-One (3)7-Fluoroquinazolin-4(3H)-One (4)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methoxychroman-4-One (3)7-Methylindoline-2,3-Dione (7)8-Bromochroman-4-One (4)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluoroisoquinolin-1(2H)-One (3)8-Methylchroman-4-One (4)Acetophenone (1123)Azepan-2-One (18)Benzo[Cd]Indol-2(1H)-One (5)Benzofuran-2(3H)-One (7)Chroman-2-One (5)Cyclobutanone (24)Cyclohex-2-En-1-One (27)Cyclohexane-1,3-Dione (12)Cyclopent-2-En-1-One (21)Cyclopentane-1,3-Dione (6)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Dihydrofuran-2,5-Dione (12)Dihydrofuran-3(2H)-One (8)Dihydrothiophen-3(2H)-One (4)Ethene-1,1-Diyldibenzene (10)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 3-Oxo-3-Phenylpropanoate (41)Furan-2(5H)-One (26)Isoquinolin-1-Ol (9)Methyl 3-Oxo-3-Phenylpropanoate (16)Morpholin-3-One (11)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(M-Tolyl)Methanone (3)Phenyl(P-Tolyl)Methanone (4)Phenyl(Pyridin-3-Yl)Methanone (9)Phenyl(Thiophen-2-Yl)Methanone (6)Piperidine-2,4-Dione (5)Propiophenone (59)Pyrimidine-4,6(1H,5H)-Dione (3)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tetrahydropyrimidin-2(1H)-One (6)Acetylacetonate (26)Bromoethanone (4)Butanedione (6)Butanedione (6)Butanone (10)Butanone (10)Carbonyl-Phenyl-Boronic Acid/Ester (184)Chloroethanone (2)Dicarbonyl (2)Dicarbonyl (2)Dichloroacetophenone (5)Dienone (2)Diethanone (5)Diethanone (5)Dione (1793)Dioxobutanoate (2)Enone (21)Ethanone (1019)Heptanedionato (7)Heptanedionato (7)Hydroxyethanone (3)Methyl-Pyrazolone (87)Oxoacetaldehyde (4)Oxoazepane (3)Oxoazepane (3)Oxochroman (5)Oxotetrahydro (11)Pyrimidinone (3)Tetraone (48)Tetraone (48)Trifluoroacetophenone (9)Trifluoroethanone (15)
Mercaptos (10)
Mercaptopropanoate (10)
Nitrates and Nitrites (1)
Nitriles (28530)
Acetonitrile (255)Acrylonitrile (8)Aminobutanenitrile (5)Aminocyclohexanecarbonitrile (6)Bromobenzonitrile (15)Bromonicotinonitrile (9)Bromophenylacetonitrile (2)Butanenitrile (2)Butanenitrile (2)Chlorobenzonitrile (27)Chloroisonicotinonitrile (4)Chloronicotinonitrile (40)Cyanide (434)Cyanide (434)Cyanoacetamide (4)Cyanoacetate (14)Cyanobenzaldehyde (4)Cyanobenzoate (27)Cyanobenzoic (20)Cyanoethyl (15)Cyanoethyl (15)Cyanoisonicotinate (4)Cyanomethyl (42)Cyanomethyl (42)Cyanonicotinate (8)Cyanophenoxy (8)Cyanophenyl (64)Cyanophenylboronic (5)Cyanopropan (4)Cyanopropan (4)Diacetonitrile (1)Diaminobenzonitrile (8)Dibromoisonicotinonitrile (3)Dicarbonitrile (45)Dicarbonitrile (45)Dichlorobenzonitrile (12)Dichloroisonicotinonitrile (4)Difluorobenzonitrile (41)Fluorobenzonitrile (85)Fluoroisonicotinonitrile (5)Fluoronicotinonitrile (14)Fluorophenylacetonitrile (8)Fluoropicolinonitrile (13)Formylnicotinonitrile (5)Formylnicotinonitrile (5)Hydrazinylbenzonitrile (6)Iodobenzonitrile (44)Iodonicotinonitrile (8)Malononitrile (43)Malononitrile (43)Methoxyisonicotinonitrile (7)Methoxyisonicotinonitrile (7)Methoxynicotinonitrile (18)Methoxynicotinonitrile (18)Methylnicotinonitrile (57)Methylnicotinonitrile (57)Methylpropanenitrile (9)Methylpropanenitrile (9)Nitropicolinonitrile (10)Oxopropanenitrile (8)Phenylacrylonitrile (21)Propanenitrile (41)Propanenitrile (41)Pyrazino-Nitrile (50)Tetrafluorobenzonitrile (5)Thiocyanatoaniline (3)Tricarbonitrile (5)Tricarbonitrile (5)Trifluorobenzonitrile (7)Trifluoromethylbenzonitrile (5)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclopropane-1-Carbonitrile (19)1H-Imidazole-4-Carbonitrile (2)1H-Indazole-3-Carbonitrile (9)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-5-Carbonitrile (5)1H-Indole-6-Carbonitrile (4)1H-Indole-7-Carbonitrile (6)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-3-Carbonitrile (9)2,3-Difluorobenzonitrile (29)2,4-Dichlorobenzonitrile (4)2,4-Difluorobenzonitrile (21)2,6-Dibromobenzonitrile (4)2,6-Dichlorobenzonitrile (8)2,6-Difluorobenzonitrile (28)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(2-Bromophenyl)Acetonitrile (10)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Fluorophenyl)Acetonitrile (30)2-(3-Chlorophenyl)Acetonitrile (16)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(Bromomethyl)Benzonitrile (15)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethyl)Benzonitrile (35)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorobenzonitrile (3)2-Aminonicotinonitrile (6)2-Bromo-6-Fluorobenzonitrile (7)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-N-Methylaniline (4)2-Chlorobenzonitrile (99)2-Hydroxybenzonitrile (45)2-Iodobenzonitrile (26)2-Naphthonitrile (15)2-Nitrobenzonitrile (37)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Phenoxyacetonitrile (11)2-Phenoxybenzonitrile (5)2-Phenylacetonitrile (172)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethyl)Benzonitrile (47)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromobenzonitrile (110)3-Chloro-2-Fluorobenzonitrile (7)3-Chlorobenzonitrile (100)3-Chloropyrazine-2-Carbonitrile (6)3-Fluoropicolinonitrile (5)3-Hydroxybenzonitrile (40)3-Iodobenzonitrile (27)3-Nitrobenzonitrile (59)3-Oxo-3-Phenylpropanenitrile (21)3-Phenoxybenzonitrile (5)4-Amino-2-Chlorobenzonitrile (8)4-Chloropyrimidine-5-Carbonitrile (6)4-Cyanophenyl Benzoate (11)4-Cyclohexylbenzonitrile (10)4-Fluorobenzonitrile (89)4-Nitrobenzonitrile (25)5-Fluoropicolinonitrile (5)6-Methylnicotinonitrile (7)6-Methylpicolinonitrile (10)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-4-Carbonitrile (27)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[D]Thiazole-2-Carbonitrile (11)Benzonitrile (1312)Furan-2-Carbonitrile (8)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinonitrile (16)Isoquinoline-1-Carbonitrile (7)Methyl 2-Cyanobenzoate (22)Methyl 3-Cyanobenzoate (29)Morpholine-2-Carbonitrile (4)Nicotinonitrile (82)Pyrazine-2-Carbonitrile (15)Pyrimidine-2-Carbonitrile (14)Pyrimidine-4-Carbonitrile (9)Pyrimidine-5-Carbonitrile (6)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-3-Carbonitrile (6)Thiazole-5-Carbonitrile (7)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbonitrile (13)
Nitroes (23699)
(2-Nitrophenyl)Boronic Acid (13)(2-Nitrophenyl)Methanol (29)(2-Nitrovinyl)Benzene (28)(3-Nitrophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)Boronic Acid (32)(3-Nitrophenyl)Methanol (31)(4-Nitrophenyl)(Phenyl)Methanone (3)(4-Nitrophenyl)Methanol (17)1,2-Dichloro-4-Nitrobenzene (16)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Nitrobenzene (43)1,2-Dimethyl-3-Nitrobenzene (6)1,2-Dinitrobenzene (6)1,3-Dibromo-2-Nitrobenzene (4)1,3-Dichloro-2-Nitrobenzene (5)1,3-Difluoro-2-Nitrobenzene (16)1,3-Dimethyl-2-Nitrobenzene (9)1,3-Dinitrobenzene (31)1,4-Difluoro-2-Nitrobenzene (28)1,4-Dimethyl-2-Nitrobenzene (10)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Tert-Butyl)-2-Nitrobenzene (4)1-(Tert-Butyl)-3-Nitrobenzene (7)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Nitrobenzene (161)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-3-Nitrobenzene (216)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-Nitrobenzene (45)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-Nitrobenzene (90)1-Methyl-2-Nitrobenzene (176)1-Methyl-3-Nitrobenzene (147)1-Methyl-4-Nitrobenzene (82)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-2-Phenoxybenzene (4)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Nitro-4-Phenoxybenzene (5)1-Nitronaphthalene (3)2,4-Dichloro-1-Nitrobenzene (19)2,4-Difluoro-1-Nitrobenzene (46)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethyl-1-Nitrobenzene (15)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(4-Nitrophenyl)Acetic Acid (9)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Nitroaniline (12)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Nitrophenol (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-6-Nitroaniline (11)2-Chloro-6-Nitrophenol (7)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-6-Nitroaniline (3)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Nitrophenol (5)2-Methyl-3-Nitrobenzoic Acid (7)2-Methyl-3-Nitropyridine (9)2-Methyl-6-Nitroaniline (10)2-Nitro-1H-Pyrrole (5)2-Nitro-N-Phenylaniline (3)2-Nitrobenzaldehyde (53)2-Nitrobenzoic Acid (65)2-Nitrobenzonitrile (37)2-Nitrofuran (9)2-Nitronaphthalene (4)2-Nitropyridine (40)2-Nitrothiophene (20)3-Chloro-2-Nitroaniline (5)3-Chloro-4-Nitroaniline (5)3-Fluoro-4-Nitroaniline (7)3-Methoxy-2-Nitrobenzaldehyde (3)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methyl-5-Nitropyridine (4)3-Nitroaniline (98)3-Nitrobenzaldehyde (49)3-Nitrobenzamide (17)3-Nitrobenzene-1,2-Diol (6)3-Nitrobenzenesulfonamide (8)3-Nitrobenzoic Acid (109)3-Nitrobenzonitrile (59)3-Nitrophenol (72)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Nitrothiophene (6)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-2-Nitroaniline (14)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Methyl-3-Nitroaniline (8)4-Methyl-3-Nitropyridine (8)4-Nitro-1H-Indazole (10)4-Nitro-1H-Indole (6)4-Nitro-1H-Pyrazole (8)4-Nitroaniline (65)4-Nitrobenzaldehyde (18)4-Nitrobenzene-1,3-Diol (5)4-Nitrobenzoic Acid (35)4-Nitrobenzonitrile (25)4-Nitrophenol (67)4-Nitropyridine (11)5-(4-Nitrophenyl)Oxazole (3)5-Methoxy-2-Nitroaniline (7)5-Methyl-2-Nitroaniline (6)5-Nitro-1H-Indazole (5)5-Nitro-1H-Indole (6)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Nitrobenzo[D][1,3]Dioxole (4)5-Nitrobenzo[D]Thiazole (3)5-Nitroisoquinoline (7)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1H-Indazole (9)6-Nitro-1H-Indole (8)6-Nitrobenzo[D]Thiazole (3)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Nitro-1H-Indazole (11)7-Nitro-1H-Indole (11)Ethyl 2-Nitrobenzoate (9)Ethyl 3-Nitrobenzoate (22)Ethyl Cinnamate (26)Methyl 2-Nitrobenzoate (54)Methyl 3-Nitrobenzoate (109)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Nitrobenzoate (29)N-(2-Nitrophenyl)Acetamide (11)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)Nitrobenzene (2303)Difluoronitrobenzene (9)Dinitro (7)Dinitroaniline (5)Nitroacetophenone (7)Nitroaniline (211)Nitrobenzaldehyde (100)Nitrobenzamide (35)Nitrobenzenesulfonamide (26)Nitrobenzonitrile (106)Nitrobenzotrifluoride (16)Nitroisophthalate (4)
Oximes (560)
Phenols (1790)
1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1-(2-Hydroxyphenyl)Ethan-1-One (74)1-(3-Hydroxyphenyl)Ethan-1-One (20)1-Hydroxyanthracene-9,10-Dione (12)2,3-Dichlorophenol (9)2,3-Difluorophenol (36)2,4-Dibromophenol (16)2,4-Difluorophenol (21)2,5-Dichlorophenol (7)2,6-Dibromophenol (22)2,6-Dichlorophenol (16)2,6-Difluorophenol (24)2,6-Diiodophenol (16)2,6-Dimethylphenol (19)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(3-Hydroxyphenyl)Acetic Acid (8)2-(Benzyloxy)Phenol (5)2-(Difluoromethoxy)Phenol (5)2-(Tert-Butyl)Phenol (56)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethyl)Phenol (23)2-Amino-3-Bromophenol (3)2-Amino-3-Chlorophenol (4)2-Aminophenol (107)2-Benzylphenol (8)2-Bromo-3-Methylphenol (4)2-Bromo-6-Methylphenol (7)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Chloro-4-Fluorophenol (9)2-Chloro-4-Nitrophenol (5)2-Chloro-6-Methylphenol (5)2-Chloro-6-Nitrophenol (7)2-Chlorobenzene-1,3-Diol (4)2-Chlorophenol (163)2-Ethylphenol (10)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Hydroxybenzonitrile (45)2-Iodobenzene-1,3-Diol (3)2-Iodophenol (63)2-Isopropylphenol (28)2-Methoxyphenol (201)3,4-Dibromophenol (3)3,4-Difluorophenol (19)3-(Benzyloxy)Phenol (5)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)Phenol (43)3-Bromo-2-Fluorophenol (5)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluorophenol (11)3-Bromobenzene-1,2-Diol (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chlorobenzene-1,2-Diol (6)3-Chlorophenol (113)3-Fluorophenol (180)3-Hydroxybenzonitrile (40)3-Iodophenol (21)3-Nitrobenzene-1,2-Diol (6)3-Nitrophenol (72)4-(Benzyloxy)Phenol (2)4-(Trifluoromethyl)Phenol (18)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorophenol (5)4-Benzylphenol (14)4-Chlorobenzene-1,3-Diol (6)4-Fluorophenol (111)4-Hydroxybenzenesulfonic Acid (5)4-Nitrobenzene-1,3-Diol (5)4-Nitrophenol (67)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)Ethyl 2-Hydroxybenzoate (18)Ethyl 3-Hydroxybenzoate (12)M-Cresol (147)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-Hydroxybenzoate (74)Methyl 3-Hydroxybenzoate (58)O-Cresol (164)P-Cresol (71)Pyrocatechol (134)Resorcinol (147)Aminophenol (9)Bromophenol (13)Chlorophenol (28)Dibromophenol (9)Dichlorophenol (17)Difluorophenol (36)Dihydroxybenzaldehyde (16)Dihydroxybenzamide (6)Dihydroxybenzoate (15)Dihydroxybenzoic (17)Dihydroxybenzonitrile (6)Dihydroxyphenyl (97)Dihydroxystyryl (4)Diiodophenol (7)Fluorophenol (73)Hydroxyacetophenone (16)Hydroxybenzaldehyde (88)Hydroxybenzamide (24)Hydroxybenzenesulfonic (4)Hydroxybenzenesulfonic Acid (3)Hydroxybenzoate (113)Hydroxybenzohydrazide (4)Hydroxybenzoic (89)Hydroxybenzonitrile (60)Hydroxybenzoyl (1)Hydroxyphenoxy (7)Hydroxyphenylacetic (7)Hydroxyphenylacetic Acid (7)Hydroxyphenylboronic (8)Hydroxypropiophenone (3)Iodophenol (41)Nitrophenol (134)Tetrafluorophenol (9)Trifluorophenol (5)Trihydroxybenzaldehyde (5)Trihydroxybenzoate (12)Trihydroxybenzoic (5)Trihydroxybenzoic Acid (4)Trihydroxyphenyl (10)
Phosphoruses (830)
1,1,1-Trifluoro-N-(4-Oxido-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin-4-Yl)Methanesulfonamide (16)Diethyl Benzylphosphonate (17)Dimethyl(Phenyl)Phosphine Oxide (20)Ethyltriphenylphosphonium (2)Methyltriphenylphosphonium (3)Phenyl Phosphate (3)Phenylphosphonic Acid (6)Diethoxyphosphoryl (5)Diisopropylphosphoramidite (4)Dimethoxyphosphoryl (4)Dimethoxyphosphoryl (4)Dimethylphosphine (28)Dioxaphosphepine (146)Diphosphonic (9)Phosphorothioate (1)
Polycyclic Aromatic Hydrocarbons (4)
Protective Groups (23)
Saturated Aliphatic Fused Rings (2)
(8Ar,12Br,14Br)-1,2,3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Icosahydropicene (2)
Silicon Compounds (450)
1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)Tert-Butyldimethyl(Phenoxy)Silane (17)Tetraphenylsilane (7)Trimethoxy(Phenyl)Silane (6)Trimethyl(Phenyl)Silane (22)Trimethyl(Phenylethynyl)Silane (23)Butyldimethylsilyl (94)Butyldimethylsilyl (94)Butyldimethylsilyloxy (8)Dimethylsilane (16)Dimethylsilane (16)Dimethylsilyl (4)Tetramethyldisiloxane (3)Tetramethyldisiloxane (3)Triethoxysilyl (13)Triethoxysilyl (13)Triisopropylsilyl (22)Triisopropylsilyl (22)Trimethoxysilane (19)Trimethoxysilane (19)Trimethylsilane (155)
Sulfamides (10219)
2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluorobenzenesulfonamide (12)2-Methylbenzenesulfonamide (8)3-Nitrobenzenesulfonamide (8)4-Amino-N-Phenylbenzenesulfonamide (3)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Chloro-N-Phenylbenzenesulfonamide (4)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methyl-N-Phenylbenzenesulfonamide (13)N,N-Diethylbenzenesulfonamide (8)N,N-Dimethylbenzenesulfonamide (23)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(O-Tolyl)Benzenesulfonamide (4)N-(Tert-Butyl)Benzenesulfonamide (14)N-Ethylbenzenesulfonamide (8)N-Isopropylbenzenesulfonamide (8)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylbenzenesulfonamide (15)N-Phenylbenzenesulfonamide (81)N-Phenylmethanesulfonamide (37)Phenylmethanesulfonamide (13)Pyridine-2-Sulfonamide (6)Dimethylsulfamoyl (5)Dimethylsulfamoyl (5)Methanesulfonamide (54)Methanesulfonamide (54)Methylmethanesulfonamide (3)Methylmethanesulfonamide (3)Methylsulfonamido (4)Methylsulfonamido (4)Sulfinamide (55)Sulfinamide (55)
Sulfides (10126)
(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)1,2-Diphenyldisulfane (19)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-(Methylthio)Pyridine (5)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Methylthio)Thiazole (5)2-(Propylthio)Pyrimidine (5)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Methyl-2-(Methylthio)Pyrimidine (7)5-Bromo-2-(Methylthio)Pyrimidine (6)Benzyl(Phenyl)Sulfane (5)Ethyl(Phenyl)Sulfane (8)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl(Trifluoromethyl)Sulfane (23)Methylthio (432)
Sulfonates (1162)
4-Methylbenzenesulfonate (9)
Sulfones (3928)
(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(Ethylsulfonyl)Benzene (8)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Methylsulfonyl)Piperazine (5)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-(Phenylsulfonyl)-1H-Imidazole (5)1-(Phenylsulfonyl)Azetidine (7)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Methyl-3-(Methylsulfonyl)Benzene (5)2-(Methylsulfonyl)Aniline (3)2-(Methylsulfonyl)Pyridine (11)2-(Methylsulfonyl)Pyrimidine (25)3-(Methylsulfonyl)Aniline (7)3-(Methylsulfonyl)Benzoic Acid (6)3-(Methylsulfonyl)Pyridine (5)Benzenesulfonyl Fluoride (51)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)Tetrahydrothiophene 1,1-Dioxide (13)
Sulfonic Acids (1262)
2-Aminobenzenesulfonic Acid (9)2-Methylbenzenesulfonic Acid (8)3-Aminobenzenesulfonic Acid (6)4-Chlorobenzenesulfonic Acid (4)4-Hydroxybenzenesulfonic Acid (5)Naphthalene-2-Sulfonic Acid (4)Pyridine-3-Sulfonic Acid (6)Aminobenzenesulfonic (4)Bromobenzenesulfonic Acid (4)Disulfonic (9)Disulfonic (9)Ethanesulfonic (3)Methanesulfonic (2)Methanesulfonic (2)Methylbenzenesulfonate (144)Propanesulfonic Acid (2)Trifluoromethanesulfonic (4)
Sulfonyl Chlorides (4028)
1H-Pyrazole-4-Sulfonyl Chloride (8)2-Bromobenzenesulfonyl Chloride (8)2-Chlorobenzenesulfonyl Chloride (24)2-Fluorobenzenesulfonyl Chloride (31)2-Methoxybenzenesulfonyl Chloride (15)2-Methylbenzenesulfonyl Chloride (22)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-Chlorobenzenesulfonyl Chloride (21)3-Fluorobenzenesulfonyl Chloride (22)4-Chlorobenzenesulfonyl Chloride (12)4-Fluorobenzenesulfonyl Chloride (26)Isoquinoline-5-Sulfonyl Chloride (3)Methyl 2-(Chlorosulfonyl)Benzoate (7)Phenylmethanesulfonyl Chloride (20)Fluorobenzenesulfonyl (12)
Sulfonyl Hydrazides (25)
Benzenesulfonohydrazide (12)
Sulfoxides (333)
(Methylsulfinyl)Benzene (7)
Thioesters (625)
Thiols (469)
1H-Benzo[D]Imidazole-2-Thiol (10)2-Chlorobenzenethiol (7)2-Mercaptoquinazolin-4(3H)-One (3)Benzo[D]Oxazole-2-Thiol (6)Benzo[D]Thiazole-2-Thiol (11)Phenylmethanethiol (16)Pyridine-2-Thiol (8)Pyrimidine-2-Thiol (6)Dithiole (9)Dithiole (9)Ethanethioate (9)Ethanethioate (9)Methanethiol (6)
Thiophenols (3045)
Thioureas (1128)
1,3-Diphenylthiourea (8)1-Phenylthiourea (33)Carbamimidothioate (4)
Trifluoromethyls (28892)
(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-(Trifluoromethyl)Phenyl)Methanol (22)(4-(Trifluoromethyl)Phenyl)Boronic Acid (23)(Perfluoropropane-2,2-Diyl)Dibenzene (7)(Trifluoromethyl)Benzene (1335)1,3-Bis(Trifluoromethyl)Benzene (70)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-(Trifluoromethyl)Benzene (126)1-Fluoro-3-(Trifluoromethyl)Benzene (98)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-(Trifluoromethyl)Benzene (53)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methyl-2-(Trifluoromethoxy)Benzene (5)1-Methyl-2-(Trifluoromethyl)Benzene (43)1-Methyl-3-(Trifluoromethyl)Benzene (22)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-(Trifluoromethyl)Aniline (58)2-(Trifluoromethyl)Benzaldehyde (27)2-(Trifluoromethyl)Benzamide (6)2-(Trifluoromethyl)Benzoic Acid (33)2-(Trifluoromethyl)Benzonitrile (35)2-(Trifluoromethyl)Phenol (23)2-(Trifluoromethyl)Pyrazine (6)2-(Trifluoromethyl)Pyridine (6)2-(Trifluoromethyl)Pyrimidine (27)2-(Trifluoromethyl)Quinazoline (4)2-(Trifluoromethyl)Thiazole (11)2-(Trifluoromethyl)Thiophene (10)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Aniline (102)3-(Trifluoromethyl)Benzaldehyde (31)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-(Trifluoromethyl)Benzoic Acid (52)3-(Trifluoromethyl)Benzonitrile (47)3-(Trifluoromethyl)Phenol (43)3-(Trifluoromethyl)Pyridazine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (51)3-Chloro-4-(Trifluoromethyl)Aniline (5)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4-(Trifluoromethoxy)Aniline (26)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-(Trifluoromethyl)Phenol (18)4-(Trifluoromethyl)Pyridine (14)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-(Trifluoromethyl)Thiazole (7)4-Bromo-3-(Trifluoromethyl)Aniline (7)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)6-(Trifluoromethyl)-1H-Indazole (6)6-(Trifluoromethyl)-1H-Indole (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 3-(Trifluoromethyl)Benzoate (22)N-Phenyl-4-(Trifluoromethyl)Aniline (3)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(Trifluoromethyl)Sulfane (23)Trifluoromethyl-Picolinamide (7)Trifluoromethylaniline (3)
Ureas (1841)
Other Function Groups (5)
Organocatalysts
Chiral Hydrogen-Bonding Organocatalysts (79)
Chiral Phosphoric Acids (161)
4-Hydroxy-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepine 4-Oxide (20)
Cinchona Alkaloids (32)
MacMillan Imidazolidinone Organocatalysts (15)
NHTf (59)
Proline-Based Organocatalysts (51)
Other Organocatalysts (45)
Organometallic Reagents
Organoborons (34731)
(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)(1H-Indol-2-Yl)Boronic Acid (3)(2,3-Dichlorophenyl)Boronic Acid (11)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Dichlorophenyl)Boronic Acid (6)(2,6-Difluorophenyl)Boronic Acid (28)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-Bromophenyl)Boronic Acid (39)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(2-Fluorophenyl)Boronic Acid (229)(2-Nitrophenyl)Boronic Acid (13)(3,4-Dichlorophenyl)Boronic Acid (10)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)Boronic Acid (121)(3-Fluorophenyl)Boronic Acid (169)(3-Iodophenyl)Boronic Acid (5)(3-Nitrophenyl)Boronic Acid (32)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(4-(Trifluoromethyl)Phenyl)Boronic Acid (23)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Fluorophenyl)Boronic Acid (93)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(E)-4,4,5,5-Tetramethyl-2-Styryl-1,3,2-Dioxaborolane (16)1,3,2-Dioxaborinane (6)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzyl)Piperazine (5)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Cyclopropylphenyl)-1,3,2-Dioxaborolane (5)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(4-Cyclopropylphenyl)-1,3,2-Dioxaborolane (8)2-(4-Fluorophenyl)-1,3,2-Dioxaborinane (5)2-([1,1'-Biphenyl]-4-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Cyclohex-1-En-1-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-(M-Tolyl)-1,3,2-Dioxaborinane (4)2-Benzyl-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (12)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(Naphthalen-1-Yl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(Naphthalen-2-Yl)-1,3,2-Dioxaborolane (12)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzofuran-2-Ylboronic Acid (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Cyclohex-1-En-1-Ylboronic Acid (4)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Isoquinolin-4-Ylboronic Acid (3)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)Naphthalen-1-Ylboronic Acid (4)Naphthalen-2-Ylboronic Acid (8)Phenylboronic Acid (1287)Pyridin-2-Ylboronic Acid (9)Pyridin-3-Ylboronic Acid (49)Pyridin-4-Ylboronic Acid (21)Pyrimidin-5-Ylboronic Acid (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Tetraphenylborate (8)Thiophen-2-Ylboronic Acid (20)Fluorene-Phenyl-Boronic Acid/Ester (4)Hydroxymethyl-Phenyl-Boronic-Acid (32)Methoxyphenylboronic-Acid (32)Phenyl-Naphthalene-Boronic Acid/Ester (9)
Organosilicons (73)
Organotins (5)
Other Organometallic Reagents (1)
Phase-Transfer Catalysts
Achiral Phase-Transfer Catalysts (61)
Chiral Phase-Transfer Catalysts (25)
Specialty Synthesis
Ionic Liquids (584)
Synthetic Reagents
C-C Bond Formation (62)
Condensation Agents (75)
Fluorination Reagents (20)
Halogenation Reagents (20)
Inorganic Salts (25228)
Phase Transfer Catalysts (33)
Other Synthetic Reagents (105)
Materials Science
Electronic Materials
Contact Printing & Self-Assembly Materials (73)
Liquid Crystal (LC) Materials (468)
Molecular Conductors (75)
Organic Field-Effect Transistor (OFET) Materials (103)
Thiophenes (1)
Organic Light-Emitting Diode (OLED) Materials (22)
4-(Diphenylamino)Benzaldehyde (8)4-Bromo-N,N-Bis(4-Methoxyphenyl)Aniline (3)4-Methoxy-N,N-Diphenylaniline (5)4-Methyl-N,N-Diphenylaniline (6)
Photoresist Materials (259)
Silane Coupling Agents (224)
Energy and Battery Materials
Battery Additives (75)
Battery Electrolytes Materials (16)
Battery Solvent Materials (24)
Electrode Active Materials (4)
Ionic Liquids (584)
Organic Redox Flow Battery Materials (26)
Solution & Vapor Deposition Precursors (31)
Material Building Blocks
Alkyl Chain Building Blocks (88)
Ligands for Functional Metal Complexes (220)
Liquid Crystal (LC) Building Blocks (347)
Phthalocyanine Building Blocks (37)
Small Molecule Semiconductor Building Blocks (1157)
Organic Frameworks and Supramolecular Materials
Covalent Organic Framework (COF) Linkers (1087)
Metal Organic Framework (MOF) Linkers (1692)
Metal Organic Frameworks (MOFs) (58)
Organic Framework Building Blocks (217)
Supramolecular Host Materials (122)
Polymer Additives
Antioxidants (85)
Crosslinking Agents (85)
Flame Retardants (44)
Light Stabilizers (67)
Plasticizers (81)
Polymerization Catalysts (155)
Polymerization Initiators (134)
Polymerization Reagents (229)
Surfactants (310)
Other Additives (36)
Polymer Reagents
Dendrimer Materials (57)
Ion Exchange Resins (5)
Monomers (1603)
Photopolymer Monomers (183)
Polybenzoxazole and Polyimide Raw Materials (239)
Polymer Semiconductor Monomers (270)
Polymers (804)
Quantum Dots and Micro/Nano Materials
Nanocarbon Materials (44)
Quantum Dot (QD) Capping Agents (172)
Quantum Dot (QD) Synthetic Reagents (12)
Solar Cells and Photonic Materials
Donor Intermediates & Acceptor Intermediates (1039)
Dye-Sensitized Solar Cell (DSSC) Materials (93)
Dyes and Pigments (391)
Organic Non-Linear Optical (NLO) Materials (20)
Organic Photo-Voltaics (OPVs) Materials (183)
Perovskite Solar Cell (PSC) Materials (238)
Visible Light Photoredox Catalysts (24)
Other Functional Materials
Aggregation-Induced Emission Materials (124)
Inorganic Compounds and Ceramic Materials (33)
Magnetic Materials (48)
Life Science
Inhibitors/Agonists
ADC (373)
ADC Linker (373)
Angiogenesis (1713)
ALK (86)Bcr-Abl (105)BTK (149)EGFR (404)FAK (56)FGFR (136)FLT3 (134)HER2 (31)HIF (111)JAK (245)PDGFR (127)Src (110)Syk (40)VDA (1)VEGFR (270)
Anti-Infection (4743)
3CLpro (41)Antibacterial (2089)Antifungal (523)Antiparasitic (639)Antiprotozoal (3)Antiviral (49)Arenavirus (5)BVDV (3)CMV (28)Dengue Virus (36)EBV (15)Enterovirus (34)FCoV (3)Filovirus (14)Flavivirus (64)GraR (1)HBV (150)HCV (222)HHV (1)HIV (444)HIV Integrase (38)HIV Protease (69)HPV (10)HRV (3)HSV (75)Influenza Virus (250)LpxC (2)M2 proton channel (2)MERS-CoV (1)Neuraminidase (4)NNRTI (12)NRTI (22)Orthopoxvirus (24)Penicillin-Binding Protein (7)PLP (13)Prion (1)Protein Synthesis (3)Reverse Transcriptase (98)RSV (43)SAMHD1 (1)SARS-CoV (296)SQLE (6)TMV (12)Viral MTase (3)Virus Protease (60)VSV (1)β-lactamase (51)
Antibody-Drug Conjugate/ADC Related (649)
ADC Linker (373)ADC Toxins (123)Payload-Linker Conjugate (165)
Apoptosis (2439)
Apoptosis (2139)Apoptosis Inducer (1403)Bcl-2 (195)Bcl-6 (6)BRK (3)c-Myc (47)c-RET (64)C/EBP (2)Caspase (170)DAPK (12)Ferroptosis (109)FKBP (15)GDNF Receptor (2)IAP (48)IDO (69)MDM2 (143)MRCK (2)Necroptosis (33)p32 (1)p53 (41)PERK (35)PKD (10)Pyroptosis (13)RIP Kinase (84)Survivin (12)Thymidylate Synthase (24)TNF (22)TNF Receptor (117)TNF-alpha (30)
Autophagy (732)
ATG4B (4)ATTECs (3)AUTACs (7)Autophagy (717)Beclin1 (1)FKBP (15)LC3 (1)LRRK2 (32)Lysosome (1)mitoNEET (1)Mitophagy (3)PPT (1)SPHK (27)TFEB (1)ULK (17)
Cell Cycle (4587)
Antifolate (31)APC (6)Aurora Kinase (86)BUB (3)Casein Kinase (101)CDK (475)Chk (46)CRISPR/Cas9 (7)CRM1 (16)DHFR (55)DNA polymerase θ (2)DNA/RNA Synthesis (619)DOCK (3)DYRK (60)E2F (2)eIF (43)Endonuclease (3)FOXM1 (3)G-quadruplex (6)Haspin Kinase (8)HDAC (334)HGF (1)HSF (4)HSP (160)IRE1 (28)Kinesin (35)Lats kinase (1)LIMK (17)Mad2 (1)Microtubule/Tubulin (305)MKLP (2)Mps1 (21)MTH2 (1)Nucleoside Antimetabolite/Analog (1439)p21 (1)PAK (29)PDI (1)PKMYT1 (2)PLK (50)PPAR (192)PTEN (5)RAD51 (17)Rho (14)RNA polymerase 2 (1)RNA polymerase 1 (2)ROCK (89)Separase (1)Sirtuin (130)SRPK (51)STK33 (2)TACC (3)Telomerase (20)TOPK (1)Topoisomerase (270)Wee1 (16)YB-1 (5)
Cytoskeleton (727)
Actin (1)Arp2/3 Complex (6)CYTH (1)Cytoplasmic dynein (1)Dynamin (14)FAK (56)Filamin-A (1)Gap Junction (11)Integrin (135)Kinesin (35)MARK (1)Microtubule/Tubulin (305)MLCK (5)Mps1 (21)Myosin (25)PAK (29)ROCK (89)Spastin (1)
DNA Damage (3017)
ADAR (1)AP endonuclease (1)ATAD5 (1)ATM/ATR (67)Aurora Kinase (86)Casein Kinase (101)ClpP (5)CRISPR/Cas9 (7)DNA Alkylator/Crosslinker (75)DNA-PK (39)DNA/RNA Synthesis (619)HDR (1)HSP (160)MRE11 (1)MTH1 (8)Nucleoside Antimetabolite/Analog (1439)OGG (3)p97 (15)PARP (175)RAD51 (17)RAD52 (3)Telomerase (20)Topoisomerase (270)WRN (5)YB-1 (5)
Endocrinology/Hormones (826)
5 Alpha Reductase (2)ACE (76)Adrenergic Receptor (183)Androgen Receptor (96)Aromatase (8)ERR (219)GHSR (21)Glucocorticoid Receptor (44)GNRH Receptor (19)Mineralocorticoid Receptor (12)Opioid Receptor (54)Progesterone Receptor (9)PTHR (1)Renin (18)Sepiapterin reductase (2)SSTR (28)Taste receptor (3)Thyroid Hormone Receptor (7)TPO (4)TRHR (1)TSH Receptor (17)TTR (7)
Endoplasmic Reticulum Stress (561)
Antioxidant (31)IRE1 (28)JNK (78)PDI (1)PERK (35)ROS (394)
Epigenetics (2361)
AMPK (107)Aurora Kinase (86)DNA Methyltransferase (42)Epigenetic Reader Domain (393)FTO (15)HDAC (334)HIF (111)Histone Acetyltransferase (92)Histone Demethylase (147)Histone Methyltransferase (294)JAK (245)MBD-containing protein (1)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (158)SF3B1 (3)Sirtuin (130)TET (8)
Ferroptosis Signaling Pathway (78)
ABC Transporter (2)ACC (22)GPx (24)GTPCH (1)SCD (18)SLC (6)VDAC (6)
GPCR/G Protein (3464)
5-HT Receptor (394)Adenosine Receptor (169)Adenylyl Cyclase (1)Adiponectin Receptor (2)Adrenergic Receptor (183)Amylin receptor (1)Angiotensin Receptor (73)Apelin Receptor (22)Bombesin Receptor (7)Bradykinin Receptor (17)cAMP (35)Cannabinoid Receptor (62)CaSR (23)CCR (89)CGRP Receptor (14)Chemerin Receptor (2)Cholecystokinin Receptor (32)CRF Receptor (19)CXCR (112)Dopamine Receptor (170)Endothelin Receptor (47)Epac (9)G protein (2)GHSR (21)GLP Receptor (25)Glucagon Receptor (51)GNRH Receptor (19)GPCR (200)GPCR19 (2)GPR109A (1)GPR119 (2)GPR139 (3)GPR24 (1)GPR35 (1)GPR40 (7)GPR52 (4)GPR6 (3)GPR68 (2)GPR84 (1)GPR88 (10)Guanylate Cyclase (30)HCAR (2)Histamine Receptor (236)ICMT (61)Kisspeptin Receptor (2)LHCGR (39)LPA Receptor (11)LPL Receptor (118)Melanocortin Receptor (25)mGluR (228)Motilin Receptor (1)MRGPR (13)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NMUR (2)NPFF receptor (3)Opioid Receptor (54)OXTR (10)P2Y Receptor (77)PACAP Receptor (3)PAFR (39)PAR (55)Prostaglandin Receptor (216)Ras (275)RGS (6)RXFP Receptor (14)Sigma Receptor (52)SOS (7)SRPK (51)SSTR (28)SUCNR1 (5)TAAR (8)TSH Receptor (17)Urotensin Receptor (7)Vasopressin Receptor (23)β-arrestin (17)
Hedgehog (Hh) (831)
BMI-1 (3)c-Myc (47)Casein Kinase (101)CDK (475)Cytoplasmic dynein (1)Gli (6)GSK-3 (125)PKA (59)Smo (36)ULK (17)
Hippo (80)
Lats kinase (1)MAP4K (47)MST (2)TEAD (10)YAP (28)
Immunology/Inflammation (2700)
AIM2 (5)AP-1 (15)Arginase (15)Calcineurin (8)CCR (89)CD19 (1)CD20 (2)CD22 (2)CD28 (2)CD28-B7 (1)CD3 (3)CD38 (10)CD47 (6)CD6 (1)CD73 (26)CD80 (1)cGAS (8)Complement System (45)COX (347)CRTH2 (9)CTLA-4 (2)CXCR (112)CYPA (1)FAP (17)FKBP (15)FLAP (17)FPR (17)Galectin (3)Glucocorticoid Receptor (44)Glycoprotein VI (3)GM-CSF (2)Histamine Receptor (236)HMGB (1)IFNAR (24)IL (173)IL Receptor (9)Immunology & Inflammation Related (76)IRAK (71)IRF3 (1)LAG-3 (1)LanC-like protein (1)Legumain (1)LTA4H (3)LTR (71)MALT1 (24)MIF (18)MyD88 (6)NADPH Oxidase (32)NFAT (11)NLR (73)NO Synthesis (6)NOS (185)NOT (1)Nrf2 (99)PD-1/PD-L1 (80)PG Synthase (31)PSMA (13)Pyroptosis (13)ROS (394)Ros1 (18)S100A9 (1)Scavenger receptor (1)SIK (15)SOD (4)SPHK (27)STING (99)TENT (1)Thrombopoietin Receptor (11)Tim3 (4)TLR (163)TSPO (2)VISTA (1)XBP1 (1)
JAK-STAT-Signaling (838)
EGFR (404)JAK (245)Pim (58)STAT (160)
MAPK/ERK Pathway (713)
AP-1 (15)ERK (166)HPK1 (2)JNK (78)KLF (5)MAP3K (24)MAP3K12 (1)MAP4K (47)MAP4K4 (5)MAP4K6 (1)MEK (100)MK2 (11)MLK (14)MNK (11)p38 MAPK (163)Raf (106)RSK (33)TAOK (1)
Membrane Transporter/Ion Channel (1706)
ABC Transporter (2)AKK1 (3)ANT (1)AQP (5)AQP3 (1)ARF (2)ATP synthase (19)ATPase (41)BCRP (23)Calcium Channel (270)CFTR (61)Chloride Channel (29)CRAC Channel (14)CRM1 (16)EAAT (3)Efflux pump (1)ENT (2)Ferroportin (2)GABA Receptor (186)GLUT (32)Glutamate transporter (21)Glycine transporter (22)HCN Channel (2)IBAT (10)ITPKA (2)MAT (24)MCT (17)Na+/Ca2+ Exchanger (15)Na+/K+ ATPase (15)Na/HCO3 cotransporter (1)NKCC (1)Oct (11)OCTN (1)Organic Anion Transporter (1)P-gp (53)P2X Receptor (79)Piezo (4)Potassium Channel (285)Proton Pump (55)SEO1 (1)SGLT (44)SLC (6)Sodium Channel (194)SV2 (2)TRP Channel (180)UCP (1)URAT1 (18)Urea Transporter (2)VDAC (6)VRAC (1)
Metabolic Enzyme (3494)
15-PGDH (2)2OG Oxygenase (1)3-PGDH (2)3MST (1)6PGD (3)ACAT (38)ACC (22)ACMSD (2)Aconitate hydratase (1)ACS (3)Adenosine Deaminase (12)Adenosylhomocysteinase (8)ADP-ribosyltransferase (1)AhR (50)AKR (15)ALDH (30)Aldose Reductase (54)Aminopeptidase (28)Antifolate (31)AO (2)ApoE (1)Arginase (15)Asparagine synthetase (1)ATF/CREB proteins (2)ATP Citrate Lyase (6)ATP synthase (19)BDK (1)Beta-glucuronidase (3)Carbonic Anhydrase (120)Carboxylesterase (23)Carboxypeptidase (7)Cardiolipin Peroxidase (1)Cathepsin (98)Ceramidase (4)CETP (15)Cholesterol Transporter (1)CPA (5)CPSI (2)Creatine kinase (1)Cryptochrome (5)CSE (2)CYP51 (1)D-amino acid oxidase (3)D6D (1)DAPA synthase (1)Decarboxylase (9)Dehydrogenase (157)DGAT (62)DGK (20)Dopamine β-hydroxylase (8)E-NTPDase (1)Elastase (33)Enolase (7)Enteropeptidase (5)ERAP (3)FABP (6)Factor Xa (45)Farnesyl Transferase (4)FAS (34)FBPase (4)Ferroptosis (109)FOXO (3)FPR (17)FTO (15)Fumarate hydratase (2)FVII (2)FXR (74)G0/G1 switch protein 2 (2)Galactosidases (5)GCN (1)GCS (3)GGTase (6)Glucokinase (26)Glucosidase (132)GLUT (32)Glutaminase C (2)Glutathione Reductase (1)Glyoxalase (14)GOAT (1)GPx (24)GSNOR (3)GST (16)Hexokinase (7)HMGCR (45)HPSE (2)Hydrolase (12)Hydroxylase (23)IDH (37)IDO (69)Ketohexokinase (5)LDL (11)LDLR (1)Lipase (93)Lipoxygenase (110)LOX (4)LRH-1 (4)LXR (27)MAGL (2)MASTL (1)MDH (3)MetAP (10)MGAT (7)Mineralocorticoid Receptor (12)Mitochondrial Electron Transport Chain (3)Mitochondrial Metabolism (97)MPC (3)NAMPT (33)Neprilysin (20)NNMT (8)NPP (2)NPR (15)NQO (2)OGT (2)OPA1 (1)P448 (1)P450 (261)PAI-1 (25)PARG (12)PDE (366)PDHK (12)PEPCK (2)PGAM1 (1)PGC-1α (4)PHGDH (5)Phospholipase (108)Phosphorylase (10)PI5P4K (11)PKM1 (2)PKM2 (6)Procollagen C Proteinase (1)Proprotein convertases (5)Pyruvate Kinase (28)QR (2)RAR/RXR (86)RBP (3)REV-ERB (4)ROR (67)SCD (18)sEH (33)SGK (15)SHMT (7)Sialyltransferase (1)Sphingosine acyltransferase (2)SQOR (2)Srx (1)Steroid Sulfatase (8)TDO (3)TGH (1)Thioredoxin (12)Thrombin (42)Thymidylate Synthase (24)Transferase (80)Transketolase (7)TrxR (11)Trypanothione reductase (1)UGT (3)VD/VDR (47)Xanthine Oxidase (50)αKGD (2)
Neuronal Signaling (3822)
5-HT Receptor (394)AAK1 (17)AChE (44)AChR (346)Adenosine Kinase (6)Adrenergic Receptor (183)AMPAR (54)Amylin receptor (1)Amyloid-β (170)Calcium Channel (270)CaMK (54)Cannabinoid Receptor (62)CGRP Receptor (14)Cholecystokinin Receptor (32)Cholinesterase (234)CHT (1)COMT (16)DAT (21)Dopamine Receptor (170)Endorphin (1)Enkephalinase (3)FAAH (45)GABA Receptor (186)Glucosylceramide Synthase (13)GluR (204)GPR119 (2)GPR139 (3)GPR24 (1)Histamine Receptor (236)Huntingtin (3)Imidazoline Receptor (14)Kainate receptor (5)MAO (192)Melanocortin Receptor (25)mGluR (228)MT Receptor (12)NET (3)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NGF (3)NK Receptor (57)NMDA (1)NMDAR (49)Notch (26)Nurr1 (7)OLIG2 (1)Opioid Receptor (54)OX Receptor (50)P2X Receptor (79)Proprotein convertases (5)QC (3)RAGE (3)REST (1)Ryanodine Receptor-1 (1)S100β (1)Secretase (112)SERT (27)Sigma Receptor (52)SMS (4)SSRIs (5)Substance P (2)TAAR (8)Tau Protein (28)TLX (1)Trk Receptor (80)TRP Channel (180)TTR (7)α-synuclein (1)
NF-κB Signaling Pathway (542)
IKK (75)MALT1 (24)NF-κB (420)Nrf2 (99)Pirin (3)RANKL (1)RANKL/RANK (3)RIP Kinase (84)TAK1 (3)
Notch Signaling Pathway (762)
ERK (166)Gli (6)MRCK (2)Notch (26)p53 (41)ROCK (89)TGF-beta/Smad (381)β-catenin (71)
PI3K/AKT/mTOR (1046)
Akt (208)AMPK (107)ATM/ATR (67)DNA-PK (39)FOXO (3)GSK-3 (125)MELK (9)mTOR (187)PDK (22)PDK-1 (3)PI3K (341)PI4K (28)PIKfyve (9)PIN1 (10)PTEN (5)RSK (33)
PPAR Signaling Pathway (2127)
ACS (3)Akt (208)AMPK (107)AQP (5)Bcl-6 (6)FABP (6)FATP (3)IL (173)LXR (27)MMP (176)NF-κB (420)NLR (73)OxPhos (4)PDK-1 (3)PEPCK (2)PPAR (192)RAR/RXR (86)RGS (6)ROS (394)SCD (18)SGK (15)Sirtuin (130)STAT (160)TNF-alpha (30)
Protease (696)
ADAMTS (5)Aspartic Protease (2)Cysteine Protease (25)Dipeptidase 1 (2)DP-IV (2)DPP1 (2)DPP2 (2)DPP4 (72)Glutaminase (26)MMP (176)NEP (4)PE (2)Proteasome (122)Ser/Thr Protease (164)SPP (1)Tyrosinase (101)
Protein Tyrosine Kinase/RTK (2741)
Ack1 (5)ALK (86)Bcr-Abl (105)BMX Kinase (3)BRK (3)BTK (149)c-FMS (60)c-Kit (87)c-Met/HGFR (131)c-RET (64)DDR1/DDR2 Receptor (22)DYRK (60)EGFR (404)Ephrin Receptor (16)ErbB (6)FAK (56)FGF (2)FGFR (136)FLT3 (134)GAK (624)HER2 (31)IGF-1R (28)Insulin Receptor (26)ITK (18)JAK (245)MRCK (2)PDGFR (127)PTK (7)Pyk2 (4)Ros1 (18)SHP2 (48)Src (110)Syk (40)TAM Receptor (50)Tie-2 (16)Trk Receptor (80)VEGFR (270)
Pyroptosis (994)
Caspase (170)Cathepsin (98)IL (173)MyD88 (6)NF-κB (420)TLR (163)
Stem Cells (1524)
BMI-1 (3)Casein Kinase (101)CREB (5)ERK (166)Frizzled (2)Gli (6)GSK-3 (125)Hedgehog (31)JAK (245)LIN28 (4)MST (2)Notch (26)Notum (2)PKA (59)PORCN (10)ROCK (89)sFRP-1 (1)Smo (36)SOD1 (2)STAT (160)TGF-beta/Smad (381)Wnt (104)YAP (28)β-catenin (71)
TGF-beta/Smad (457)
Bcr-Abl (105)PKC (158)ROCK (89)TGF-beta/Smad (381)
Toll-Like Receptor (TLR) (549)
CREB (5)IKK (75)IRAK (71)IRF3 (1)JNK (78)MyD88 (6)p38 MAPK (163)TAK1 (3)TLR (163)
Ubiquitin (370)
DUB (83)E1/E2/E3 Enzyme (142)FBXO (2)NAE (8)p97 (15)Proteasome (122)SUMO (4)
Vitamin D Related/Nuclear Receptor (586)
Androgen Receptor (96)Glucocorticoid Receptor (44)LXR (27)Mineralocorticoid Receptor (12)PPAR (192)Progesterone Receptor (9)RAR/RXR (86)REV-ERB (4)ROR (67)Thyroid Hormone Receptor (7)VD/VDR (47)
Wnt Signaling Pathway (2367)
AP-1 (15)APC (6)ATF/CREB proteins (2)c-Myc (47)Calcineurin (8)CaMK (54)Casein Kinase (101)CDK (475)CREB (5)Frizzled (2)GSK-3 (125)JNK (78)MMP (176)NF-κB (420)NFAT (11)p300/CBP/PROTAC (2)PDE (366)Phospholipase (108)PKC (158)PKG (10)Rho (14)ROCK (89)ROR (67)Wnt (104)β-catenin (71)
Other Inhibitors/Agonists (3183)
20-HETE (2)AIMP2-DX2 (2)Amino Acids and Amino Acid Derivatives (122)Aminoacyl-tRNA Synthetase (18)Anesthetic (3)Anti-inflammation (34)Anti-Thyroid Agent (1)Anti-tumor (7)Anti-ulcer (1)Antioxidant (31)Antispasmodic Agent (3)ASGPR (11)Bcat (11)c-RET (64)Cancer Stem Cells (2)CAR (5)Cardiac transcription factor (2)CBFβ-SMMHC (1)CD20 (2)CD52 (1)CD73 (26)CerK (1)Chelating Agent (16)Choleretic (1)Choline Kinase (3)CNT (1)CRTH2 (9)CSE (2)DCLK (1)DcpS (1)Decarboxylase (9)Dehydrogenase (157)Diabetes (2)Diuretic (1)Drug Metabolite (286)DUE-B (1)E2F (2)ECE (2)Endogenous Metabolite (1202)ERO1 (2)FAP (17)FATP (3)Fer/FerT (1)FPP synthase (1)Fucosyltransferase (4)Fungicide (61)G protein (2)Galectin (3)Galectin-3 (12)GBF1 (1)GCase (4)Glucocorticoid Receptor (44)GRK (21)GTPCH (1)Herbicide (17)HIPK2 (3)Histidine kinase (1)HNF4α (1)HPPD (3)HRGP (1)Hydroxylase (23)IgE (2)IMP1 (1)Importin β (1)Insecticide (27)ITPKA (2)LAT1 (3)LDL (11)Lipase (93)Lipocalin-2 (1)LYTACs (8)MALAT1 (1)MITF (1)MLKL (4)Molecular Glues (41)MPO (6)MTTP (8)Muscle Relaxant (1)MYOF (1)NAADP (1)Neuroprotection/neurogenic Agent (4)NMD (1)NT (2)Nur77 (8)O-GlcNAcase (9)O-glycosylation (1)OSBP (1)OSBPL (1)OSC (2)Osteoclasts/Bone/Osteogenesis (15)OxPhos (4)PAM complex (1)PANK (2)PAX2 (1)PBR (4)PCA1 (1)PCSK9 (7)PDX1 (1)PEPT (1)PFKFB3 (7)Phosphatase (250)Phosphorylase (10)Photosensitizer (6)PIN1 (10)PKG (10)Platelet (5)PME-1 (2)PMO/MNA (4)PNP (1)PREP (20)Protein Synthesis (3)PXR (3)Quorum Sensing (57)RasGAP (2)Rev-ErbA (3)RUNX (7)SAP (1)SMARC (6)SQS (4)SREBP (5)SRPK (51)Sweetener (3)Tgase (2)Thioredoxin (12)TIR1 (1)TNIK (8)TNK (4)TNNI3K (1)UGT1A1 (1)Urease (5)vanin (4)VDA (1)Vitamin (64)VPS (3)XOR (1)α-amylase (15)Others (2570)
Inhibitory Monoclonal Antibody
Human Inhibitory Monoclonal Antibody (62)
Amyloid-β/monoclonal antibody (2)CA Ⅸ/monoclonal antibody (1)CCR/monoclonal antibody (1)CD19/monoclonal antibody (1)CD20/monoclonal antibody (2)CD22/monoclonal antibody (1)CD25/monoclonal antibody (1)CD3/monoclonal antibody (1)CD38/monoclonal antibody (1)CD4/monoclonal antibody (1)CD40/monoclonal antibody (1)CD47/monoclonal antibody (1)CD52/monoclonal antibody (1)CD6/monoclonal antibody (1)CD62p/monoclonal antibody (1)CD73/monoclonal antibody (1)CGRP Receptor/monoclonal antibody (2)Complement System/monoclonal antibody (1)CTLA-4/monoclonal antibody (1)EGFR/monoclonal antibody (2)HER2/monoclonal antibody (2)IFNAR/monoclonal antibody (1)IgE/monoclonal antibody (2)IGF-1R/monoclonal antibody (1)IL-13/monoclonal antibody (1)IL-17a/monoclonal antibody (1)IL-1β/monoclonal antibody (1)IL-23/monoclonal antibody (2)IL-4Ra/monoclonal antibody (1)IL-5/monoclonal antibody (1)IL-5Rα/monoclonal antibody (1)IL-6/monoclonal antibody (3)Integrin/monoclonal antibody (1)KIR/monoclonal antibody (1)LAG-3/monoclonal antibody (1)PCSK9/monoclonal antibody (2)PD-1/PD-L1/monoclonal antibody (4)RANKL /monoclonal antibody (1)Sclerostin/monoclonal antibody (1)SLAMF7/monoclonal antibody (1)TIGIT/monoclonal antibody (1)Tim3/monoclonal antibody (1)TNF Receptor/monoclonal antibody (3)TNF-alpha/monoclonal antibody (2)TROP2/monoclonal antibody (1)VEGFR/monoclonal antibody (1)
Animal Modeling Reagents
Circulatory System Disease Models (11)
Cardiomyopathy Model (1)Heart Disease Correlation Model (2)Heart Failure Model (1)Hyperlipidemia Model (1)Hypertension Model (3)Thrombolysis Model (2)Vascular Inflammation Model (1)
Digestive System Disease Models (17)
Gallstone Model (1)Gastrointestinal Disease Model (8)Liver Disease Model (5)Pancreatic Disease Model (3)
Endocrine System Disease Models (12)
Aging Model (1)Diabetes Model (4)Hyperuricemia Model (8)
Immune and Inflammatory Disease Models (29)
Arthritis Model (1)Cystitis Model (1)Dermatitis Model (1)Ear Edema Model (1)Encephalomyelitis Model (2)Foot Edema Model (2)Gastrointestinal Inflammation and Ulcer Model (8)Gouty Arthritis Model (1)Liver Inflammation Model (2)Myocarditis Model (2)Nephritis Model (1)Pancreatitis Model (5)Psoriasis Model (3)Systemic Lupus Erythematosus Model (2)
Nervous System Disease Models (10)
Alzheimers Disease Model (3)Epilepsy Model (3)Neuropathic Pain Model (1)Parkinsons Disease Model (3)Schizophrenia Model (1)
Otorhinolaryngological Disease Models (4)
Cataract Model (1)Gingival Hyperplasia Model (2)Optic Neuropathy Model (1)Other Otorhinolaryngological Disease Model (1)
Respiratory System Disease Models (1)
Pulmonary Fibrosis Model (1)
Skin Disease Models (1)
Atopic Dermatitis Model (1)
Tumor Models (9)
Breast Tumor Model (2)Colon Tumor Model (1)Esophageal Tumor Model (1)Kidney Tumor Model (1)Liver Tumor Model (1)Lung Tumor Model (2)Skin Tumor Model (2)Uterine Fibroid Model (1)
Urinary System Disease Models (19)
Aging Model (1)Chronic Kidney Disease Model (2)Diabetes Model (4)Hyperuricemia Model (8)Kidney Stone Model (1)Nephrotoxicity Model (1)Renal Injury Model (5)Other Urinary System Disease Model (3)
Antibiotic and Antivirus
Function (144)
Anti-bacterial Antibiotic (2)Anti-fungal Antibiotic (7)Antivirus (66)Cell Culture Antibiotic (4)Insect Repellent (44)Plant Tissue Culture Antibiotic (7)Preservative and Disinfectant (20)
Structure (8731)
Amino Acid Derivative (3)Aminoglycoside (9)Ansamycin (3)Cephalosporin (7)Chloramphenicol (1)Imidazole (6044)Macrolide (8)Nucleoside (8)Penicillin (3)Pyridine / Pyrimidine (5)Quinolone (21)Sulfonamide (18)Tetracycline (6)β-Lactam (4)Other Antibiotics (37)Others (2570)
Biochemical Reagents
Amino Acids (809)
Amino Acid Amide (17)Biologically Modified Amino Acid (30)C-protective Amino Acid (191)N-protective Amino Acid (440)Non-protein Amino Acid (121)Protein Amino Acid (58)Side Chain Protected Amino Acid (25)
Biological Buffers (2603)
Good's Buffer (20)Other Buffers (13)Others (2570)
Cross-Linking Agents (34)
Amino-amino Crosslinker (8)Amino-sulfhydryl Crosslinker (15)Photoreactive Crosslinker (3)Sulfhydryl-carbonyl Crosslinker (1)Sulfhydryl-sulfhydryl Crosslinker (4)Other Reactive Crosslinkers (3)
Denaturants (2)
Surface Active Agent (2)
Detergents (18)
Amphoteric Surfactant (4)Anionic Surfactant (3)Cationic Surfactant (2)Nonionic Surfactant (6)Sulfonated Betaine (3)
Lipids (221)
Aliphatic Acyl (211)Glycerol Lipid (8)Sphingolipid (2)
Polypeptides (42)
Dipeptide and Tripeptide (39)Oligopeptide (3)
Steroids (2634)
Bile Acid (49)Cholestane (3)Estrogen (1)Plant Sterol (10)Steroidal Glycoside (3)Other Steroids (2)Others (2570)
Sugar and Derivatives (153)
Sugar (137)Sugar Alcohol (17)
Sweeteners (For Research Experiments) (19)
Artificial sweetener (7)Natural sweetener (12)
Cancer
Cancer Stem Cells (2471)
Cathepsin (98)CXCR (112)Hedgehog (31)IL (173)IL Receptor (9)Integrin (135)MIF (18)MMP (176)NF-κB (420)NOS (185)Notch (26)PDGFR (127)PPAR (192)STAT (160)TGF-beta/Smad (381)VEGFR (270)Wnt (104)YAP (28)
Tumor Development and Microenvironment Evolution (1827)
ALK (86)AP-1 (15)CAR (5)CCR (89)Complement System (45)COX (347)DDR1/DDR2 Receptor (22)ErbB (6)GABA Receptor (186)GSK-3 (125)IFNAR (24)IRAK (71)JAK (245)LAG-3 (1)NLR (73)Nrf2 (99)PD-1/PD-L1 (80)STING (99)Syk (40)TLR (163)TNF-alpha (30)TNK (4)
Tumor Epigenetics and Gene Regulation (2855)
Aminoacyl-tRNA Synthetase (18)ATM/ATR (67)DNA Methyltransferase (42)DNA/RNA Synthesis (619)Epigenetic Reader Domain (393)HDAC (334)HIF (111)Histone Acetyltransferase (92)Histone Demethylase (147)Histone Methyltransferase (294)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (158)RNA polymerase 1 (2)Sirtuin (130)TET (8)Topoisomerase (270)
Tumor Growth, Proliferation and Apoptosis (2213)
Akt (208)Aurora Kinase (86)Bcl-2 (195)c-Met/HGFR (131)c-Myc (47)EGFR (404)ERK (166)HER2 (31)MEK (100)MLKL (4)mTOR (187)p53 (41)PI3K (341)PTEN (5)Raf (106)Ras (275)ROR (67)Telomerase (20)
Tumor Metabolism (1272)
ACC (22)ALDH (30)AMPK (107)Arginase (15)ATP Citrate Lyase (6)Dehydrogenase (157)FBPase (4)FTO (15)GLUT (32)Glutaminase (26)Hexokinase (7)IDH (37)IDO (69)MCT (17)MDH (3)NADPH Oxidase (32)OGT (2)P450 (261)PDHK (12)PHGDH (5)PKM2 (6)ROS (394)SHMT (7)SLC (6)SOD (4)SREBP (5)
Cell Biology
Cell Analysis (2)
Cell Proliferation and Cytotoxicity (2)
Cell Apoptosis/Death Detection (1415)
Apoptosis Inducer (1403)Apoptosis Inhibitor (2)Iron death Inhibitor (10)
Cell Culture (329)
Additive and Auxiliary Reagent (134)Cell Assay Reagents (9)Cell Staining (3)Organoid Culture Additive (91)Stem Cell Induction (115)
Enzymology
Enzyme Inhibitors (215)
Acetaldehyde Dehydrogenase Inhibitor (2)Acyltransferase Inhibitor (4)Alkaline Phosphatase Inhibitor (2)Angiotensin Converting Enzyme Inhibitor (4)ATP Enzyme Inhibitor (7)Calcineurin Inhibitor (1)Carbonic Acid Dehydratase Inhibitor (2)Caspase Inhibitor (2)Cyclooxygenase (COX) Inhibitor (53)DNA Topoisomerase II Inhibitor (11)Hypoxia Inducible Factor (HIF) Inhibitor (3)Inosine Monophosphate (IMP) Dehydrogenase Inhibitor (10)Leukotriene A4 Hydrolase Inhibitor (3)Lipoxygenase Inhibitor (11)Monoamine Oxidase Inhibitor (4)NADH Peroxidase Inhibitor (2)Pancreatic Lipase Inhibitor (2)Phosphodiesterase Inhibitor (21)Protease Inhibitor (20)Reverse Transcriptase Inhibitor (16)Starch Glucosidase Inhibitor (3)Thromboxane Synthase Inhibitor (3)Topoisomerase I Inhibitor (8)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)
Enzyme Preparation (69)
Cyclooxygenase (COX) (52)E3 Ubiquitin Ligase (2)Hydrolase (12)Nitric Oxide Metabolism (3)
Enzyme Substrates (4)
Peroxidase Substrate (2)β-Glucuronidase Substrate (2)
Fluorescent Probe / Staining
Cell Biology Fluorescent Dyes (78)
Apoptosis Dyes (6)BODIPY (21)Cytoplasm Dyes (5)Cytotoxicity Analysis Dyes (12)Endocytosis and pinocytosis Dyes (5)Endoplasmic Reticulum Dyes (1)Exosome Dyes (4)Lipid Droplet Dyes (3)Lysosome Dyes (4)Membrane Dyes (5)Mitochondrial Dyes (5)NOS Dyes (8)Nucleic Acid Dyes (1)Nucleus Dyes (10)PH Indicators (19)ROS Dyes (27)
Fluorescence Labeling Reagents (2810)
Anthocyanine (1)Boron Dipyrrole Methylene  (2)Coumarin (8)Danacyl (2)Fluoressin (8)Nitrobenzoxadiazole (NBD) (2)Pyrene (6)Other Fluorescence Labeling Reagents (215)Others (2570)
Fluorescent Dyes (2743)
Acridine Dye (9)Cancer Analysis Dyes (8)Coumarine Dye (58)Cyanine Dye (24)Neuroscience Analysis Dyes (33)Protein (3)Other Fluorescent Dyes (7)Others (2570)
Molecular Biology
Extraction and Analysis Of Nucleic Acid (6)
Hybridization Reagent (4)Probe (2)
Gene Cloning (21)
Buffer (21)
Nucleic Acid Electrophoresis (5)
Electrophoretic Buffer (3)Gelatin (2)
Natural Products
Acanthaceae (20)
Adhatoda (4)Andrographis (9)Justicia (4)Phlogacanthus (2)Strobilanthes (1)
Aceraceae (2)
Acer (2)
Adiantaceae (2)
Adiantum (2)
Alariaceae (76)
Acanthopanax (5)Aralia (8)Diplopanax (3)Eleutherococcus (3)Hedera (4)Oplopanax (1)Panax (52)
Alismataceae (2)
Alisma (2)
Amaranthaceae (5)
Achyranthes (3)Celosia (1)Cyathula (1)
Amaryllidaceae (23)
Agave (4)Allium (5)Curculigo (10)Lycoris (3)Narcissus (1)
Anacardiaceae (15)
Lannea (1)lodes (1)Mangifera (6)Rhus (4)Toxicodendron (3)
Annonaceae (19)
Annona (2)Fissistigma (6)Goniothalamus (4)Guatteria (1)Miliusa (1)Orophea (2)Polyalthia (2)Uvaria (1)
Apocynaceae (45)
Alstonia (3)Apocynum (1)Aspidosperma (1)Catharanthus (5)Cerbera (5)Kopsia (1)Nerium (10)Plumeria (2)Rauvolfia (9)Thevetia (3)Trachelospermum (4)Voacanga (1)
Aquifoliaceae (3)
Ilex (3)
Araceae (14)
Acorus (10)Eminium (2)Pinellia (2)
Aristolochiaceae (16)
Aristolochia (12)Asarum (3)Holostylis (1)
Asclepiadaceae (20)
Cryptolepis (3)Cynanchum (7)Marsdenia (5)Periploca (5)
Asparagaceae (11)
Eucomis (2)Muscari (1)Scilla (8)
Asteraceae (227)
Achillea (3)Ageratum (1)Ambrosia (2)Arctium (2)Arnica (1)Artemisia (24)Aster (2)Atractylodes (9)Aucklandia (5)Bellis (1)Blumea (4)Cacalia (1)Carpesium (1)Carthamus (7)Centaurea (5)Centipeda (4)Chrysactinia (4)Chrysanthemum (6)Cichorium (2)Cirsium (2)Conyza (1)Coreopsis (1)Cosmos (1)Crepis (3)Cynara (1)Dahlia (2)Dittrichia (1)Doronicum (1)Echinacea (2)Eclipta (6)Elephantopus (1)Erigeron (3)Eupatorium (20)Gnaphalium (1)Gynura (2)Helianthus (4)Heterotheca (1)Inula (8)Kalimeris (1)Laggera (13)Laurentia (1)Ligularia (4)Matricaria (2)Petasites (2)Pulicaria (4)Saussurea (3)Scorzonera (2)Senecio (9)Siegesbeckia (2)Silybum (5)Smallanthus (1)Stevia (10)Tagetes (4)Telekia (1)Tessaria (1)Tussilago (2)Verbesina (1)Vernonia (5)Wedelia (2)Xanthium (6)Zinnia (1)
Athyriaceae (1)
Cystopteris (1)
Balsaminaceae (5)
Impatiens (5)
Berberidaceae (37)
Berberis (3)Bongardia (1)Caulophyllum (2)Dysosma (3)Epimedium (26)Sinopodophyllum (2)
Betulaceae (11)
Alnus (6)Betula (1)Carpinus (1)Corylus (3)
Bignoniaceae (16)
Catalpa (8)Crescentia (2)Incarvillea (1)Kigelia (1)Macfadyena (1)Markhamia (1)Oroxylum (2)
Blechnaceae (1)
Woodwardia (1)
Boraginaceae (18)
Arnebia (2)Echium (1)Ehretia (1)Lithospermum (13)Tournefortia (1)
Burseraceae (12)
Boswellia (4)Canarium (5)Commiphora (3)
Buxaceae (3)
Buxus (3)
By Structure (5427)
Alkaloids (149)Coumarins (22)Lignans (37)Phenols (1790)Phenylpropanane (56)Quinones (34)Natural Products-Other Structure (3364)
Calophyllaceae (8)
Pseudostellaria (2)Stellaria (1)Vaccaria (5)
Campanulaceae (14)
Codonopsis (1)Lobelia (2)Platycodon (10)Sphenoclea (1)
Cannabaceae (11)
Cannabis (3)Humulus (8)
Caprifoliaceae (23)
Lonicera (20)Sambucus (1)Viburnum (2)
Celastraceae (15)
Celastrus (3)Euonymus (1)Maytenus (1)Tripterygium (10)
Cephalotaxaceae (10)
Cephalotaxus (10)
Chenopodiaceae (3)
Kochia (1)Spinacia (1)Suaeda (1)
Chloranthaceae (11)
Chloranthus (10)Sarcandra (1)
Clusiaceae (94)
Alliaria (1)Brassica (6)Calophyllum (6)Cratoxylum (2)Descurainia (1)Eruca (1)Garcinia (47)Hypericum (15)Isatis (2)Lepidium (4)Mammea (1)Mesua (1)Raphanus (3)Sinapis (3)Symphonia (1)
Combretaceae (6)
Calycopteris (1)Combretum (2)Terminalia (3)
Convolvulaceae (2)
Erycibe (1)Ipomoea (1)
Coriariaceae (2)
Coriaria (2)
Cornaceae (3)
Cornus (3)
Crassulaceae (12)
Rhodiola (7)Sedum (5)
Cucurbitaceae (44)
Bolbostemma (1)Bryonia (1)Cucumis (1)Cucurbita (1)Echinocystis (1)Gynostemma (4)Hemsleya (2)Herpetospermum (1)Lagenaria (3)Luffa (1)Momordica (9)Siraitia (17)Trichosanthes (2)
Cupressaceae (11)
Chamaecyparis (2)Juniperus (5)Platycladus (4)
Cyperaceae (5)
Carex (2)Cyperus (3)
Daphniphyllaceae (36)
Aquilaria (10)daphne (3)Daphniphyllum (1)Edgeworthia (1)Excoecaria (1)Pieris (2)Stellera (10)Wikstroemia (8)
Dennstaedtiaceae (1)
Dennstaedtia (1)
Dicksoniaceae (4)
Cibotium (4)
Dioscoreaceae (11)
Dioscorea (11)
Dipsacaceae (2)
Dipsacus (2)
Dryopteridaceae (4)
Dryopteris (4)
Elaeagnaceae (7)
Elaeagnus (2)Hippophae (5)
Equisetaceae (3)
Equisetum (3)
Erythroxylaceae (1)
Erythroxylum (1)
Eucommiaceae (12)
Eucommia (12)
Euphorbiaceae (46)
Breynia (1)Croton (7)Endospermum (1)Euphorbia (10)Excoecaria (1)Flueggea (1)Hevea (3)Jatropha (5)Macaranga (1)Mallotus (1)Phyllanthus (11)Suregada (2)Trigonostemon (2)
Fabaceae (348)
Abrus (1)Acacia (9)Adenanthera (1)Albizia (1)Ammothamnus (1)Antheroporum (1)Astragalus (23)Butea (1)Caesalpinia (18)Cajanus (3)Campylotropis (1)Cassia (26)Cicer (1)Crotalaria (5)Cytisus (3)Dalbergia (10)Derris (13)Desmodium (3)Erythrina (13)Flemingia (3)Genista (1)Glycine (22)Glycyrrhiza (42)Griffonia (1)Hedysarum (1)Lespedeza (5)Leucaena (3)Lotus (5)Lupinus (8)Maackia (4)Medicago (1)Millettia (6)Mimosa (1)Mucuna (2)Ononis (2)Parochetus (2)Phyllodium (1)Pisum (1)Pongamia (1)Prosopis (2)Psoralea (18)Pterocarpus (1)Pueraria (25)Robinia (2)Saraca (1)Senna (1)Sophora (36)Spartium (1)Spatholobus (2)Styphnolobium (1)Trifolium (6)Trigonella (2)Vicia (2)Wisteria (2)
Fagaceae (2)
Castanea (1)Lithocarpus (1)
Gentianaceae (28)
Anthocleista (1)Canscora (1)Gentiana (16)Gentianella (1)Halenia (1)Swertia (8)
Geraniaceae (3)
Geranium (2)Pelargonium (1)
Gesneriaceae (1)
Lysionotus (1)
Ginkgoaceae (9)
Ginkgo (9)
Gnetaceae (4)
Gnetum (4)
Hamamelidaceae (2)
Hamamelis (1)Loropetalum (1)
Hernandiaceae (128)
Ammi (2)Angelica (32)Bupleurum (13)Centella (4)Cnidium (9)Ferula (3)Heracleum (13)Hernandia (2)Ledebouriella (1)Ligusticopsis (1)Ligusticum (9)Notopterygium (7)Oenanthe (1)Petroselinum (2)Peucedanum (20)Pimpinella (1)Saposhnikovia (7)Seseli (1)
Hippocastanaceae (5)
Aesculus (5)
Illiciaceae (6)
Illicium (6)
Iridaceae (19)
Belamcanda (8)Crocus (6)Eleutherine (3)Iris (2)
Juglandaceae (6)
Diospyros (2)Engelhardtia (1)Juglans (1)Sesamum (2)
Juncaceae (5)
Juncus (5)
Lamiaceae (140)
Ajuga (2)Ballota (1)Clinopodium (3)Coleus (2)Dracocephalum (3)Elsholtzia (1)Isodon (5)Lamiophlomis (1)Leonurus (9)Marrubium (2)Mentha (4)Mosla (2)Perilla (4)Phlomis (1)Plectranthus (1)Pogostemon (1)Rosmarinus (6)Salvia (44)Scutellaria (40)Stachys (2)Tectona (1)Thymus (5)
Lauraceae (23)
Cinnamomum (7)Cryptocarya (3)Endlicheria (1)Laurus (1)Lindera (4)Litsea (1)Nectandra (2)Ocotea (4)
Lepidoziaceae (1)
Lepidozia (1)
Lichenes (1)
Usnea (1)
Liliaceae (80)
Aloe (4)Anemarrhena (9)Asparagus (1)Dracaena (11)Fritillaria (3)Hosta (1)Lilium (4)Liriope (3)Ophiopogon (28)Paris (9)Polygonatum (3)Smilax (1)Trillium (1)Tupistra (1)Veratrum (1)
Linaceae (2)
Linum (2)
Loganiaceae (5)
Buddleja (2)Gelsemium (1)Strychnos (2)
Loranthaceae (1)
Taxillus (1)
Lycopodiaceae (3)
Lycopodium (3)
Lygodiaceae (1)
Lygodium (1)
Lythraceae (11)
Lawsonia (4)Punica (7)
Magnoliaceae (24)
Liriodendron (4)Magnolia (19)Michelia (1)
Malvaceae (5)
Abelmoschus (1)Gossypium (1)Guazuma (2)Hibiscus (1)
Meliaceae (24)
Aglaia (12)Amoora (2)Aphanamixis (3)Melia (4)Walsura (3)
Menispermaceae (13)
Cocculus (2)Diploclisia (1)Menispermum (1)Stephania (5)Tinospora (3)Triclisia (1)
Moraceae (69)
Artocarpus (2)Broussonetia (13)Cudrania (16)Morus (37)Trilepisium (1)
Moringaceae (7)
Moringa (7)
Musaceae (13)
Musa (10)Musella (3)
Myricaceae (6)
Morella (6)
Myristicaceae (7)
Myristica (7)
Myrsinaceae (1)
Ardisia (1)
Myrtaceae (27)
allspice (1)Eucalyptus (16)Psidium (6)Rhodomyrtus (1)Syzygium (3)
Nartheciaceae (4)
Narthecium (1)Philydrum (1)Xanthorrhoea (2)
Nelumbonaceae (3)
Nelumbo (3)
Nyctaginaceae (34)
Atropa (1)Boerhavia (3)Capsicum (5)Datura (7)Lycium (3)Mirabilis (1)Nicotiana (2)Physalis (4)Scopolia (1)Solanum (6)Withania (1)
Nyssaceae (51)
Camptotheca (6)Gaultheria (1)Pyrola (2)Rhododendron (5)Vaccinium (37)
Oleaceae (36)
Abeliophyllum (1)Forsythia (12)Fraxinus (4)Jasminum (6)Ligustrum (11)Osmanthus (1)Syringa (1)
Orchidaceae (28)
Anoectochilus (1)Bletilla (2)Cremastra (2)Dendrobium (7)Gastrodia (3)Gymnadenia (8)Pholidota (3)Vanda (1)Vanilla (1)
Orobanchaceae (10)
Cistanche (10)
Paeoniaceae (6)
Paeonia (6)
Palmae (6)
Areca (4)Euterpe (1)Trachycarpus (1)
Pandanaceae (3)
Pandanus (3)
Papaveraceae (26)
Chelidonium (10)Corydalis (8)Glaucium (1)Hylomecon (1)Hypecoum (1)Macleaya (2)Papaver (1)Sanguinaria (2)
Parmeliaceae (4)
Parmelia (4)
Passifloraceae (2)
Passiflora (2)
Pentaphylacaceae (1)
Adinandra (1)
Phyllanthaceae (4)
Securinega (3)Uapaca (1)
Phytolaccaceae (6)
Microtea (1)Phytolacca (5)
Pinaceae (35)
Abies (2)Cedrus (4)Larix (1)Pinus (18)Pseudolarix (9)Tsuga (1)
Piperaceae (28)
Piper (28)
Pittosporaceae (2)
Pittosporum (2)
Plantaginaceae (2)
Picrorhiza (1)Plantago (1)
Plumbaginaceae (2)
Limoniastrum (1)Plumbago (1)
Poaceae (13)
Avena (2)Coix (1)Hordeum (2)Leptochloa (1)Oryza (1)Phyllostachys (1)Poa (2)Saccharum (1)Secale (1)Zea (1)
Podocarpaceae (8)
Podocarpus (8)
Polygalaceae (32)
Polygala (31)Securidaca (1)
Polygonaceae (40)
Atraphaxis (2)Fallopia (3)Polygonum (9)Rheum (22)Rumex (4)
Polypodiaceae (2)
Phymatopteris (2)
Polyporaceae (4)
Ganoderma (2)Polyporus (1)Wolfiporia (1)
Pontederiaceae (1)
Monochoria (1)
Portulacaceae (1)
Talinum (1)
Primulaceae (4)
Lysimachia (3)Primula (1)
Proteaceae (4)
Grevillea (1)Helicia (3)
Ranunculaceae (45)
Aconitum (2)Anemone (6)Cimicifuga (9)Clematis (3)Coptis (6)Delphinium (2)Hydrastis (2)Pulsatilla (10)Semiaquilegia (1)Thalictrum (3)Trollius (1)
Resedaceae (1)
Reseda (1)
Rhamnaceae (16)
Hovenia (1)Rhamnus (11)Ziziphus (4)
Rhizophoraceae (3)
Cassipourea (1)Kandelia (2)
Rosaceae (31)
Agrimonia (4)Crataegus (4)Exochorda (5)Filipendula (2)Malus (1)Photinia (1)Potentilla (1)Pourthiaea (1)Prunus (3)Rosa (3)Rubus (2)Sanguisorba (2)Sorbus (1)Spiraea (1)
Rubiaceae (67)
Borreria (1)Cinchona (2)Coffea (3)Emmenopterys (1)Galium (5)Gardenia (10)Hedyotis (8)Knoxia (2)Mitragyna (1)Morinda (4)Mussaenda (1)Nauclea (2)Paederia (5)Pausinystalia (2)Pentas (1)Rubia (13)Uncaria (6)
Rutaceae (161)
Aegle (1)Boenninghausenia (2)Cedrelopsis (1)Citrus (38)Clausena (7)Dictamnus (8)Euodia (1)Evodia (13)Flindersia (1)Fortunella (1)Glycosmis (3)Haplophyllum (3)Melicope (1)Micromelum (11)Murraya (21)Phebalium (2)Phellodendron (8)Ptaeroxylon (1)Ruta (3)Skimmia (1)Tetradium (1)Toddalia (14)Zanthoxylum (19)
Salicaceae (2)
Populus (2)
Santalaceae (3)
Thesium (3)
Sapindaceae (10)
Dodonaea (10)
Saururaceae (6)
Houttuynia (1)Saururus (5)
Saxifragaceae (11)
Astilbe (1)Bergenia (1)Dichroa (3)Hydrangea (5)Penthorum (1)
Schisandraceae (20)
Kadsura (6)Schisandra (14)
Scrophulariaceae (34)
Bacopa (6)Euphrasia (1)Limnophila (1)Linaria (2)Melampyrum (1)Paulownia (1)Pedicularis (2)Picria (3)Rehmannia (12)Scrophularia (5)
Selaginellaceae (3)
Selaginella (3)
Simaroubaceae (32)
Ailanthus (8)Brucea (8)Eurycoma (1)Picrasma (14)Quassia (1)
Sinopteridaceae (17)
Onychium (4)Pteridium (3)Pteris (10)
Stemonaceae (1)
Stemona (1)
Sterculiaceae (4)
Casearia (1)Gynocardia (2)Hydnocarpus (1)
Styracaceae (3)
Styrax (3)
Tamaricaceae (1)
Tamarix (1)
Taxaceae (8)
Taxus (7)Torreya (1)
Taxodiaceae (5)
Cryptomeria (2)Sequoia (3)
Theaceae (9)
Camellia (9)
Tiliaceae (2)
Microcos (1)Tilia (1)
Toricelliaceae (3)
Toricellia (3)
Tropaeolaceae (1)
Tropaeolum (1)
Typhaceae (4)
Typha (4)
Ulmaceae (1)
Ulmus (1)
Valerianaceae (19)
Nardostachys (4)Patrinia (5)Valeriana (10)
Verbenaceae (39)
Callicarpa (10)Clerodendrum (7)Duranta (1)Gmelina (1)Lippia (1)Stachytarpheta (1)Verbena (2)Vitex (16)
Violaceae (7)
Viola (7)
Viscaceae (2)
Viscum (2)
Vitaceae (18)
Ampelopsis (4)Turpinia (2)Vitis (12)
Winteraceae (4)
Drimys (4)
Zingiberaceae (79)
Aframomum (1)Alpinia (25)Amomum (1)Boesenbergia (2)Curcuma (33)Kaempferia (1)Zingiber (16)
Zygophyllaceae (6)
Peganum (4)Tribulus (2)
Pharmaceutical Research
Animal Modeling Agents (46)
Cardio-cerebrovascular Disease Model (2)Diabete Model (1)Inflammation Model (21)Lifestyle-related Disease Model (10)Nervous System Model (5)Pain and Pruritus Model (8)Tumor Model (6)Other Modeling Agents (6)
Classical Positive Drugs (63)
Cardiovascular System (21)Diabete (30)Digestive System (12)
Drug Analysis (673)
Drug Standard (216)Plant Standard (459)
Drug Delivery (473)
Cationic Lipids (119)Cholesterol (10)Fluorescent Lipids (1)Pegylated Lipids (11)Phospholipids (175)
Pharmacy Related (28)
Biomaterial (2)Classical Raw Material Drug (2)Cosolvents (12)Medicinal Excipient (15)
Small Molecule Positive Drugs (2818)
Anti-allergy (5)Anti-inflammation (34)Anti-osteoporosis (2)Anti-rheumatoid Arthritis (6)Anti-tumor (7)Antivirus (66)Depressurization (19)Diabete (30)Neurotransmitter (36)Reduce Blood Lipid (7)Other Compounds (70)Others (2570)
PROTACS
E3 Ligand-Linker Conjugate (167)
CRBN Ligand-Linkers (117)VHL Ligand-Linkers (50)
E3 Ligands (72)
CRBN Inactive Ligand (4)CRBN Ligand (56)IAP Ligand (2)MDM2 Ligand (2)VHL Ligand (8)
Molecular Glue (31)
Bcl-6/PROTAC (3)Casein Kinase 1α/PROTAC (2)Cyclin K/PROTAC (5)GSPT1/PROTAC (5)IKZF1/3/PROTAC (7)mHTT/PROTAC (2)PDE6D/PROTAC (2)RBM39/PROTAC (4)β-catenin/PROTAC (1)
Warhead (1)
Bcr-Abl/Warhead Ligand (1)
Vesicle
Exosome (2592)
ApoE (1)ARF (2)Calcium Channel (270)Ceramidase (4)FGF (2)HBV (150)HIV (444)HSP (160)HSV (75)Integrin (135)LPL Receptor (118)MicroRNA (16)mTOR (187)Neurotransmitter (36)p53 (41)PD-1/PD-L1 (80)Phospholipase (108)Ras (275)STAT (160)TGF-beta/Smad (381)
Parkinson'S Disease and Alzheimer'S Disease (5781)
Akt (208)AMPAR (54)Apoptosis (2139)Caspase (170)CDK (475)CREB (5)Dopamine Receptor (170)Dopamine β-hydroxylase (8)ERK (166)Glucagon Receptor (51)GPCR (200)GSK-3 (125)IL (173)JAK (245)JNK (78)LRRK2 (32)MyD88 (6)NF-κB (420)Notch (26)p53 (41)PI3K (341)PKA (59)PTEN (5)RAGE (3)Ras (275)Rho (14)ROCK (89)ROS (394)Secretase (112)STAT (160)STING (99)Tau Protein (28)TLR (163)TNF (22)Tyrosinase (101)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)Wnt (104)α-synuclein (1)β-catenin (71)
Zoology and Botany
Pesticide Composition (104)
Fungicide (61)Herbicide (17)Insecticide (27)
Home Cart Sign in  
/
Inhibitors/Agonists
/
Cell Cycle
/
Nucleoside Antimetabolite/Analog
/
Cytarabine HCl
/
Inhibitors/Agonists
/
Cell Cycle
DNA Damage
/
Nucleoside Antimetabolite/Analog
/
Chemical Structure| 69-74-9 Chemical Structure| 69-74-9

Structure of Cytarabine HCl
CAS No.: 69-74-9

Chemical Structure| 69-74-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cytarabine hydrochloride, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase, with an IC50 of 16 nM for DNA synthesis. It also has antiviral effects against HSV.

Synonyms: Cytosine β-D-arabinofuranoside hydrochloride; Cytosine Arabinoside hydrochloride; Ara-C hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

Quality Control of Cytarabine HCl Purity: 97% SDS Specification
COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cytarabine HCl

CAS No. :69-74-9
Formula : C9H14ClN3O5
M.W : 279.68
SMILES Code : O=C1N=C(N)C=CN1[C@@H]2[C@@H]([C@H]([C@H](CO)O2)O)O.[H]Cl
Synonyms :
Cytosine β-D-arabinofuranoside hydrochloride; Cytosine Arabinoside hydrochloride; Ara-C hydrochloride
MDL No. :MFCD00012839

Safety of Cytarabine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P280-P305+P351+P338-P310

Related Pathways of Cytarabine HCl

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00317642 Acute Myelogenous Leukemia Phase 3 Completed - -
NCT01794702 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00317642 - Completed - -
NCT03337516 Acute Myeloid Leukemia Not Applicable Recruiting December 31, 2018 France ... More >> Assistance Publique - Hopitaux de Marseille Recruiting Marseille, France Contact: Regis Costello       regis.costello@ap-hm.fr    Principal Investigator: Regis Costello Less <<
NCT00096148 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Childhood Acute Basophilic Leukemia Childhood Acute Eosinophilic Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03069352 Acute Myeloid Leukemia (AML) Phase 3 Recruiting October 7, 2019 -
NCT02485353 - Terminated(Safety concerns) - -
NCT02440568 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting May 5, 2019 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: John G Quigley, MD    312-413-1300    seanq@uic.edu    Contact: Stephanie Barath, BS    (312) 355-5767    sbarat2@uic.edu Less <<
NCT02485353 Leukemia, Myeloid, Acute Not Applicable Terminated(Safety concerns) - United States, Indiana ... More >> Indiana University Health Hospital Indianapolis, Indiana, United States, 46202 Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01025154 Acute Myeloid Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01025154 - Completed - -
NCT03071276 Acute Myeloid Leukemia (AML) Phase 2 Recruiting September 2019 United States, Arizona ... More >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85016 Contact: Jessica Boklan, MD    602-933-0920    jboklan@phoenixchildrens.com    Principal Investigator: Jessica Boklan, MD          United States, California Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Normal J. Lacayo, MD          United States, Illinois University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Jennifer McNeer, MD    773-834-7424    jmcneer@peds.uchicago.edu    Principal Investigator: Jennifer McNeer, MD          United States, Michigan Children's Hospital of Michigan Recruiting Detroit, Michigan, United States, 48201 Contact: Jeffrey W. Taub, MD    313-745-5515    jtaub@med.wayne.edu    Principal Investigator: Jeffrey W. Taub, MD          United States, North Carolina Duke University Medical Center Completed Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Jeffrey E. Rubnitz, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Jeffrey E. Rubnitz, MD, PhD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD    682-885-4007    kenneth.heym@cookchildrens.org    Principal Investigator: Kenneth M. Heym, MD Less <<
NCT03045627 Acute Myeloid Leukemia Phase 2 Recruiting July 2020 China, Shandong ... More >> Qilu hospital, Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Ming Hou       houming@medmail.com.cn    Principal Investigator: Ming Hou Less <<
NCT01662050 Mantle Cell Lymphoma Phase 2 Completed - -
NCT02121418 Chronic Myelomonocytic Leukemi... More >>a-2 Myelodysplastic Syndrome Myeloproliferative Neoplasm Untreated Adult Acute Myeloid Leukemia Less << Not Applicable Completed - United States, Montana ... More >> Bozeman Deaconess Hospital Bozeman, Montana, United States, 59715 United States, Washington Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 EvergreenHealth Medical Center Kirkland, Washington, United States, 98033 Skagit Valley Hospital Mount Vernon, Washington, United States, 98274 Olympic Medical Center Port Angeles, Washington, United States, 98362 Group Health Cooperative Redmond, Washington, United States, 98052 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Multicare Health System Tacoma, Washington, United States, 98415 Wenatchee Valley Hospital and Clinics Wenatchee, Washington, United States, 98801 Less <<
NCT02121418 - Completed - -
NCT01607645 - Terminated(The study was termi... More >>nated early because there were other competing protocols.) Less << - -
NCT03519984 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Blasts 5 Percent or More of Bone Marrow Nucleated Cells Myelodysplastic/Myeloproliferative Neoplasm Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Acute Lymphoblastic Leukemia Refractory Acute Myeloid Leukemia Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Secondary Acute Myeloid Leukemia T Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting May 9, 2021 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Christine Duran, BA    323-865-0371    Duran_C@med.usc.edu    Principal Investigator: Akil A. Merchant, MD Less <<
NCT01066494 Acute Myeloid Leukemia Phase 2 Unknown January 2011 Georgia ... More >> Institute of Haematology and Transfusiology Tbilisi, Georgia, 0177 Medulla - Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia, 0186 Hema - Haematology and Chemotherapy Clinic Tbilisi, Georgia Ukraine Institure of URgent adn Recovery Surgery n.a. V.K. gusaka of Academy Medical Science of Ukraine Donetsk, Ukraine, 83045 Kyiv bone Marrow Transplantation Centre Kiev, Ukraine, 03115 Vinnytsya Regional clinical Hospital Vinnytsya, Ukraine, 21018 Less <<
NCT01607645 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Less << Phase 2 Terminated(The study was termi... More >>nated early because there were other competing protocols.) Less << - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00483067 Leukemia Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01692197 Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00908167 Acute Myeloid Leukemia ... More >> Infantile Leukemia (Both AML and ALL) Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasms Biphenotypic Leukemia Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00098423 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Blastic Phase Chronic Myelogenous Leukemia Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts in Transformation Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02484391 Granulocytic Sarcoma ... More >> Recurrent Adult Acute Myeloid Leukemia Less << Phase 2 Recruiting February 2022 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Scarlett Hutchens    336-713-6915    snhutche@wakehealth.edu    Principal Investigator: Timothy S. Pardee Less <<
NCT00088218 - Completed - -
NCT01692197 - Completed - -
NCT00907517 Myelogenous Leukemia, Acute ... More >> Leukemia, Lymphocytic, Acute Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Myelogenous Leukemia, Chronic, Aggressive Phase Less << Phase 1 Terminated - -
NCT01636609 Acute Myeloid Leukemia ... More >> High Risk Myelodysplastic Syndrome Less << Phase 1 Phase 2 Active, not recruiting November 30, 2018 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01302106 Myelodysplastic Syndromes Phase 2 Withdrawn(For increased induct... More >>ion mortality in older patients due to specific combinations of drugs, other clinical factors such as patient age and comorbidities.) Less << - Italy ... More >> SC Ematologia-AO SS.Antonio e Biagio e Cesare Arrigo Alessandria, Italy, 15121 Dipartimento Scienze Mediche e Chirurgiche-Ospedale di Torrette Ancona, Italy, 60020 Ematologia con trapianto-AO Policlinico Bari Bari, Italy, 70124 SC di Ematologia-Spedali Civili Brescia, Italy, 25123 centro di ricerca e di formazione ad alta tecnologia nelle Scienze-Università Cattolica Campobasso Campobasso, Italy, 86100 Ematologia e Trapianto di Midollo Osseo-Ospedale Ferrarotto Alessi Catania, Italy, 95123 Dipartimento di medicina Interna-Università di genova Genova, Italy, 16132 UO Ematologia Vito Fazzi Lecce, Italy, 73100 SC Ematologia-Azienda Ospedaliero Papardo Messina, Italy, 98158 UO Ematologia-Ospedale San gennaro-ASL1 Napoli, Italy, 80131 Divisione di Ematologia e Trapianto Cellule Staminali-Ospedale A.Cardelli Napoli, Italy Medicina interna II- Azienda Ospedaliera S.Luigi Gonzaga Orbassano, Italy, 10043 Divisione di Ematologia-Ospedale Vincenzo Cervello Palermo, Italy, 90146 Dipartimento di Ematologia-Ospedale Spirito Santo Pescara Pescara, Italy, 65100 Divisione di Ematologia- Azienda Ospedaliera Pisana Ospedale "S.Chiara" Pisa, Italy, 56100 Divisione Ematologia- AO Bianchi Melacrino Morelli Reggio Calabria, Italy, 89100 UO Ematologia e Trapianto Cellule Staminali, IRCCS, Centro di Riferimento Oncologico della Basilicata Rionero in Vulture, Italy, 85028 Ematologia-Azienda Ospedaliera Sant'Andrea Roma, Italy, 00189 Divisione di Ematologia, Centro Trapianto di cellule staminali-IRCCS "Casa Sollievo della Sofferenza" San Giovanni Rotondo, Italy, 71013 UO Ematologia 2-Ospedale San Giovanni Battista Torino, Italy, 10126 Divisione di Ematologia-Ospedale Cardinale Panico Tricase, Italy, 73039 Less <<
NCT00907517 - Terminated - -
NCT00088218 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03634228 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia TP53 Gene Mutation Negative Less << Phase 1 Phase 2 Not yet recruiting May 1, 2020 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Kiran Naqvi    713-745-6877    knaqvi@mdanderson.org    Principal Investigator: Kiran Naqvi Less <<
NCT01246622 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting December 1, 2018 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT02532010 - Terminated(The study was put o... More >>n clinical hold by the sponsor since Feb 9th 2016, and was later decided not to re-open due to financial constraints.) Less << - -
NCT00655395 Acute Myeloid Leukemia (AML) ... More >> Myelodysplastic Syndrome (MDS) Less << Phase 1 Phase 2 Terminated - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT01555268 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Rochester, New York, United States, 14642 Less <<
NCT02287233 Acute Myelogenous Leukemia ... More >> AML Less << Phase 1 Phase 2 Active, not recruiting May 7, 2020 United States, Kansas ... More >> Univ Kansas Med Ctr /ID# 131175 Kansas City, Kansas, United States, 66160 United States, New York Weill Cornell Medical College /ID# 131170 New York, New York, United States, 10021 United States, Pennsylvania University of Pittsburgh MC /ID# 131168 Pittsburgh, Pennsylvania, United States, 15260 United States, Tennessee Vanderbilt Univ Med Ctr /ID# 131177 Nashville, Tennessee, United States, 37232-0011 United States, Washington Fred Hutchinson Cancer Researc /ID# 131178 Seattle, Washington, United States, 98109 Australia, New South Wales Calvary Mater Newcastle /ID# 136076 Waratah, New South Wales, Australia, 2298 Australia, Victoria Alfred Health /ID# 131180 Melbourne, Victoria, Australia, 3004 Germany Univ Klinik Eppendorf Hamburg /ID# 133979 Hamburg, Germany, 20246 Italy A.O.U. Policlinico S.Orsola-Malpighi /ID# 131183 Bologna, Emilia-Romagna, Italy, 40138 Less <<
NCT00632749 Leukemia, Myeloid, Acute Phase 2 Completed - Germany ... More >> 1247.3.49007 Boehringer Ingelheim Investigational Site Berlin, Germany 1247.3.49005 Boehringer Ingelheim Investigational Site Frankfurt/Main, Germany 1247.3.49004 Boehringer Ingelheim Investigational Site Freiburg, Germany 1247.3.49006 Boehringer Ingelheim Investigational Site Hamburg, Germany 1247.3.49003 Boehringer Ingelheim Investigational Site Heidelberg, Germany 1247.3.49002 Boehringer Ingelheim Investigational Site Münster, Germany 1247.3.49001 Boehringer Ingelheim Investigational Site Ulm, Germany Less <<
NCT02532010 Acute Myeloid Leukemia (AML) Phase 2 Terminated(The study was put o... More >>n clinical hold by the sponsor since Feb 9th 2016, and was later decided not to re-open due to financial constraints.) Less << - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT02109627 Acute Myeloid Leukemia ... More >> Relapsed Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Less << Phase 1 Recruiting June 2020 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94143 Contact: Nancy Kang    415-476-9608    KangM@cc.ucsf.edu    Sub-Investigator: Victoria Wang, MD, PhD          Sub-Investigator: Pamela Munster, MD          Sub-Investigator: Thomas Martin, MD Less <<
NCT00528398 Leukemia Phase 2 Completed - United States, Arizona ... More >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00303290 Chronic Myeloid Leukemia Phase 1 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00528398 - Completed - -
NCT01515527 Leukemia Phase 2 Recruiting February 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02971397 Acute Myeloid Leukemia Phase 2 Active, not recruiting March 2020 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00632749 - Completed - -
NCT00927498 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> CH Argenteuil, France, 95107 Hopital Avicenne Bobigny, France, 93309 CH Caen, France, 14033 Hopital Percy Clamart, France, 92141 CHU Creteil, France, 94010 CHU Dijon, France, 21034 CH Lens, France, 62307 CHU Lille, France, 59037 CH Limoges, France, 87042 Hopital Edouard Herriot Lyon, France, 69437 CH Meaux, France, 77104 Hopital Pitie-Salpetriere Paris, France, 75651 Hopital Saint-Louis Paris, France CH Roubaix, France, 59100 CHU Rouen, France, 76038 CNLCC Saint-Cloud, France, 92210 CH Valenciennes, France, 59322 Hospital Central Versailles, France, 78157 IGR Villejuif, France, 94805 Less <<
NCT00472849 Richter's Transformation ... More >> Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00472849 - Completed - -
NCT02576301 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 1 Phase 2 Recruiting October 2020 United States, California ... More >> David Geffen School of Medicine at UCLA Recruiting Los Angeles, California, United States, 90095 Contact: Bruck Habtemariam    310-794-0242    bhabtemariam@mednet.ucla.edu    Principal Investigator: Gary Schiller, MD          United States, Florida University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Christina Cline, RN    352-273-6840    clcline@ufl.edu    Principal Investigator: Christopher Cogle R Cogle, MD          University of Miami Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Yvonne Dinh    305-243-9899    y.dinh@med.miami.edu    Principal Investigator: Justin Watts, MD          United States, Kansas University of Kansas Cancer Center and Medical Pavilion Recruiting Westwood, Kansas, United States, 66205 Contact: Michelle Cairns, MA    913-945-7547    mcairns3@kumc.edu    Principal Investigator: Tara Lin, MD Less <<
NCT00780143 Relapsed/Refractory Leukemia Phase 1 Phase 2 Terminated(Poor recruitment) - United States, New Jersey ... More >> The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Less <<
NCT00991744 Acute Lymphoblastic Leukemia Phase 3 Suspended(Sterility problems i... More >>n DepoCyte production) Less << December 2018 Denmark ... More >> Department of Pediatrics, Rigshospitalet Copenhagen, Denmark, 2100 Finland Helsinki University Hospital Helsinki, Finland Iceland University of Reykjavik, Iceland Reykjavik, Iceland Norway University Hospital of Trondheim, Norway Trondheim, Norway Sweden Department of Pediatrics, Drottning Sylvias Pediatric Hospital Gothenburg, Sweden Less <<
NCT00780143 - Terminated(Poor recruitment) - -
NCT01019317 Leukemia AML ... More >> MDS CML Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01019317 - Completed - -
NCT00480090 Prostate Cancer Phase 2 Completed - Canada, Ontario ... More >> University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01249430 Recurrent Adult Acute Myeloid ... More >>Leukemia Refractory Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT02403310 Leukemia Acut... More >>e Myeloid Leukemia AML Less << Phase 1 Active, not recruiting March 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02545283 Leukemia, Myeloid, Acute Phase 3 Recruiting May 26, 2021 -
NCT00940524 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01289457 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00451997 Leukemia, Myeloid ... More >> Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03381118 Acute Myeloid Leukemia Phase 2 Recruiting October 30, 2020 Russian Federation ... More >> Boris V Afanasyev, MD, Prof. Recruiting Saint Petersburg, Russian Federation, 197089 Contact: Anna Smirnova, PhD    +7-921-370-74-35    dr.annasmirnova@gmail.com    Contact: Sergey Bondarenko, PhD    +7-921-994-35-70    dr.sergeybondarenko@gmail.com    Sub-Investigator: Olesya Smykova, MD Less <<
NCT01804101 Acute Biphenotypic Leukemia ... More >> Acute Myeloid Leukemia Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Less << Not Applicable Completed - United States, California ... More >> Stanford Cancer Institute Palo Alto, California, United States, 94304 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01804101 - Completed - -
NCT01701375 - Terminated(Material sponsor wi... More >>thdrew support) Less << - -
NCT03623373 Mantle Cell Lymphoma Phase 1 Recruiting November 30, 2025 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Brad S Kahl, M.D.    314-747-6250    bkahl@wustl.edu    Principal Investigator: Brad S Kahl, M.D.          Sub-Investigator: Nancy Bartlett, M.D.          Sub-Investigator: Amanda F Cashen, M.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: Armin Ghobadi, M.D.          Sub-Investigator: Daniel Guy, M.D.          Sub-Investigator: Neha Mehta-Shah, M.D.          Sub-Investigator: Kathryn Trinkaus, Ph.D. Less <<
NCT00516828 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Phase 2 Completed - Canada, Nova Scotia ... More >> QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT01265199 Acute Myelogenous Leukemia (AM... More >>L) Less << Phase 1 Terminated(Study was terminate... More >>d before a MTD was determined for administrative reasons) Less << - United States, Illinois ... More >> Univerity of Chicago Chicago, Illinois, United States United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States United States, Missouri Washington University at St. Louis Siteman Cancer Center St. Louis, Missouri, United States United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States Temple University at Jeanes Hospital Philadelphia, Pennsylvania, United States Less <<
NCT00470275 Sarcoma Phase 2 Completed - -
NCT00992134 Lymphoma, Mantle-Cell Phase 2 Completed - Italy ... More >> Department of Hematology, Ospedale San Bortolo Vicenza, VI, Italy, 36100 Less <<
NCT00004263 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Completed - United States, Ohio ... More >> Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01701375 Relapsed Acute Leukemia ... More >> Refractory Acute Leukemia High-Risk Myelodysplasia Less << Phase 1 Terminated(Material sponsor wi... More >>thdrew support) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 United States, New York Weill Cornell Medical Center New York, New York, United States, 10065 Less <<
NCT01534702 Acute Myeloid Leukemia Phase 1 Phase 2 Unknown September 2015 Germany ... More >> Universitätsklinikum Düsseldorf Not yet recruiting Düsseldorf, Germany, 40225 Contact: Andrea Kuendgen, MD       andrea.kuendgen@med.uni-duesseldorf.de    Principal Investigator: Andrea Kuendgen, MD          Klinikum Essen-Werden Recruiting Essen, Germany, 45239 Contact: Mohammad Wattad, MD       m.wattad@kliniken-essen-sued.de    Principal Investigator: Mohammad Wattad, MD          Universitätsklinikum Freiburg Recruiting Freiburg, Germany, D-79106 Contact: Michael Luebbert, MD       luebbert@mm11.ukl.uni-freiburg.de    Principal Investigator: Michael Luebbert, MD          Universitätsklinikum Hamburg-Eppendorf Not yet recruiting Hamburg, Germany, 20246 Contact: Walter Fiedler, MD       fiedler@uke.uni-hamburg.de    Principal Investigator: Walter Fiedler, MD          Hannover Medical School Recruiting Hannover, Germany, D-30625 Contact: Juergen Krauter, MD    +49-511-532-3720    Krauter.Juergen@MH-Hannover.de    Principal Investigator: Juergen Krauter, MD          Klinikum Rechts der Isar Not yet recruiting Muenchen, Germany, 81675 Contact: Justus Duyster       justus.duyster@lrz.tum.de    Principal Investigator: Justus Duyster, MD          Universitätsklinikum Ulm Not yet recruiting Ulm, Germany, 89081 Contact: Richard Schlenk, MD       Richard.Schlenk@uniklinik-ulm.de    Principal Investigator: Richard Schlenk, MD Less <<
NCT02212561 Acute Myeloid Leukemia (AML) ... More >> Acute Lymphoblastic Leukemia (ALL) Myelodysplastic Syndrome (MDS) Mixed Phenotype Acute Leukemia (MPAL) Less << Phase 1 Completed - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85016 United States, California Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 Less <<
NCT01839240 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting September 2018 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT00081822 Acute Myeloid Leukemia Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, Nebraska The University of Nebraska Omaha, Nebraska, United States, 68198 United States, Ohio The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT01193400 Acute Myelogenous Leukemia Phase 2 Terminated - Spain ... More >> Hospital General de Alicante. Alicante, Spain Hospital de la Santa Creu i Sant Pau. Barcelona, Spain Hospital Durán i Reynals (Bellvitge). Barcelona, Spain Hospital Vall d' Hebron Barcelona, Spain ICO Hospital Germans Trias I Pujol. Barcelona, Spain Hospital Reina Sofía. Córdoba, Spain Hospital Juan Canalejo. La Coruña, Spain Hospital 12 de Octubre. Madrid, Spain Hospital Ramón y Cajal. Madrid, Spain Hospital San Pedro de Alcántara. Málaga, Spain Hospital Central de Asturias. Oviedo, Spain Hospital Clínico Universitario de Salamanca. Salamanca, Spain Hospital Virgen del Rocío Sevilla, Spain Hospital Clínico de Valencia. Valencia, Spain Hospital Universitario La Fe. Valencia, Spain Less <<
NCT00074737 Acute Myelogenous Leukemia Phase 2 Completed - United States, California ... More >> University of California, San Diego La Jolla, California, United States, 92093-0960 United States, Florida University of Miami Health Center Miami, Florida, United States, 33136 United States, Missouri Washington University Medical Center (Siteman Cancer Center) St. Louis, Missouri, United States, 63110 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 North Shore University Hospital Lake Success, New York, United States, 11041 United States, Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00422591 Leukemia Acut... More >>e Myeloid Leukemia AML Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00422591 - Completed - -
NCT01444742 Leukemia Myel... More >>oproliferative Diseases Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02635074 Recurrent Adult Acute Myeloid ... More >>Leukemia Less << Phase 1 Terminated(safety) - United States, California ... More >> Stanford University, School of Medicine Palo Alto, California, United States, 94304 Less <<
NCT01444742 - Completed - -
NCT01870596 - Completed - -
NCT00470275 - Completed - -
NCT01272245 Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01849276 - Terminated(Slow accrual) - -
NCT02686593 Acute Myeloid Leukemia Phase 2 Completed - Hong Kong ... More >> The University of Hong Kong Hong Kong, Hong Kong Less <<
NCT01272245 - Completed - -
NCT00513305 Acute Myeloid Leukemia Phase 3 Terminated(Study has been stop... More >>ped by sponsor decision) Less << - United States, California ... More >> USC / Norris Cancer Hospital Los Angeles, California, United States, 90033 UCLA Medical Center Los Angeles, California, United States, 90095 United States, Illinois University of Illinois Chicago, Illinois, United States, 60612 United States, Indiana Indiana Oncology Hematology Consultants Indianapolis, Indiana, United States, 46202 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 St. Vincent's Comprehensive Cancer Center New York, New York, United States, 10011 Weill Medical College of Cornell University New York, New York, United States, 10021 United States, North Carolina Brody School of Medicine Greenville, North Carolina, United States, 27834 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas UT Health Science Center San Antonio, Texas, United States, 78229 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G2M9 Less <<
NCT01849276 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Blastic Phase Chronic Myelogenous Leukemia Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Terminated(Slow accrual) - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00591526 Leukemia, Promyelocytic, Acute Phase 3 Completed - -
NCT03016988 Mantle Cell Lymphoma Phase 2 Not yet recruiting December 2020 -
NCT01870596 Adult Acute Megakaryoblastic L... More >>eukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Recurrent Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Georgia Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States, 21231 Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01656031 Leukemia Phase 2 Completed - United States, North Carolina ... More >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00583102 Acute Myeloid Leukemia Phase 1 Phase 2 Terminated(Slow accrual, PI le... More >>ft institution) Less << - United States, Iowa ... More >> Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 Less <<
NCT00513305 - Terminated(Study has been stop... More >>ped by sponsor decision) Less << - -
NCT00583102 - Terminated(Slow accrual, PI le... More >>ft institution) Less << - -
NCT02101983 Acute Myeloid Leukemia Not Applicable Completed - United States, New York ... More >> University of Rochester Rochester, New York, United States, 14642 Less <<
NCT02957032 Acute Myeloid Leukemia, Relaps... More >>ed, Adult Less << Phase 1 Active, not recruiting December 2019 Germany ... More >> Münster University Hospital Münster, Germany, 48149 Less <<
NCT02101983 - Completed - -
NCT02840539 Mantle Cell Lymphoma Phase 2 Recruiting June 2025 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Eunhee Park, CRN    82-2-743-1453    eh.park@daum.net    Sub-Investigator: Junghoon Shin, MD Less <<
NCT02658487 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia With Multilineage Dysplasia Myeloid Sarcoma Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Therapy-Related Myelodysplastic Syndrome Less << Phase 2 Suspended(Statistical analysis... More >>) Less << July 2020 United States, California ... More >> University of California-Los Angeles Los Angeles, California, United States, 90024 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, South Carolina Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT03021330 AML Phase 3 Recruiting December 2022 China, Tianjin ... More >> Institute of Hematology & Blood Diseases Hospital Recruiting Tianjin, Tianjin, China Contact: lijun Liu    86-22-23909237    bloodgcp@126.com Less <<
NCT01999413 Acute Myeloid Leukemia (AML) Phase 2 Completed - France ... More >> Emmanuel GYAN Tours, France, 37044 Less <<
NCT02670707 Langerhans Cell Histiocytosis Phase 3 Recruiting January 2025 United States, Texas ... More >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carl Allen, MD, PhD    832-826-0860    ceallen@txch.org Less <<
NCT00541866 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - United States, Colorado ... More >> HealthOne Presbyterian/St. Luke's Medical Center Denver, Colorado, United States, 80218 Rocky Mountain Cancer Centers Denver, Colorado, United States, 80218 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46206 United States, Maryland Johns Hopkins University - Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21205 United States, New York New York Presbyterian Hospital-Weill Cornell Medical College New York, New York, United States, 10065 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01056523 - Completed - -
NCT01034410 Acute Myeloid Leukemia Phase 2 Terminated - United States, California ... More >> UCLA Los Angeles, California, United States, 90095 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10021 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Australia, New South Wales Royal North Shore Hospital St Leonards, New South Wales, Australia, 2065 Westmead Hospital Westmead, New South Wales, Australia, 2145 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria The Alfred Hospital Melbourne, Victoria, Australia, 3004 Australia, Western Australia Royal Perth Hospital Perth, Western Australia, Australia, 6000 New Zealand Christchurch Hospital Christchurch, New Zealand Taiwan Changhua Christian Hospial Changhua City, Changhua Country, Taiwan, 500 China Medical University Hospital Taichung City, Taiwan, 40447 Tri-Service General Hospital Taipei City, Taiwan, 114 Taipei Veterans General Hospital Taipei, Taiwan, 112 National Taiwan University Hospital Taipei, Taiwan Less <<
NCT00541866 - Completed - -
NCT01656031 - Completed - -
NCT01960387 Acute Myeloid Leukemia Phase 2 Terminated(lack of accrual) - United States, Pennsylvania ... More >> UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01056523 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - Canada, Quebec ... More >> Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT01960387 - Terminated(lack of accrual) - -
NCT02024308 Acute Myeloid Leukemia ... More >> AML1-ETO Fusion Protein Expression Less << Phase 4 Unknown December 2016 China ... More >> Department of Hematology, Changhai Hospital Recruiting Shanghai, China, 200433 Contact: Xianmin Song    86-21-31161285    shongxm@gmail.com    Principal Investigator: Xianmin Song Less <<
NCT02926586 Acute Myeloid Leukemia ... More >> Core-Binding Factor Less << Phase 4 Recruiting July 2020 China, Shanghai ... More >> Xianmin Song Recruiting Shanghai, Shanghai, China, 200080 Contact: Xianmin Song, Doctor    86-21-63240090-3932    shongxm@sjtu.edu.cn Less <<
NCT02930109 Acute Leukemia Phase 1 Phase 2 Recruiting December 2018 United States, Connecticut ... More >> Yale Cancer Center Recruiting New Haven, Connecticut, United States, 06520-8028 Contact: Anne Caldewell    475-434-7321    anne.caldwell@yale.edu    Contact: Rebecca Lilian       rebecca.lilian@yale.edu    Principal Investigator: Thomas Prebet, MD          United States, Florida Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Nancy Hillgruber       nancy.hillgruber@moffitt.org    Principal Investigator: Jeffrey Lancet, MD Less <<
NCT03459859 Acute Myelogenous Leukemia ... More >> AML Advanced Myelodysplastic Syndromes MDS Less << Phase 1 Recruiting March 2023 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Justin Watts, MD    305-243-3084    jwatts@med.miami.edu Less <<
NCT01191801 Acute Myeloid Leukemia Phase 3 Completed - -
NCT02718755 Hematologic Malignancy Phase 2 Withdrawn(Problem with drug su... More >>pply) Less << May 2022 -
NCT01587430 Acute Myeloid Leukemia Phase 4 Unknown January 2015 Russian Federation ... More >> National Research Center for Hematology Moscow, Russian Federation, 125167 Less <<
NCT02891278 Acute Myeloid Leukemia Phase 1 Recruiting December 2020 United States, Maryland ... More >> Johns Hopkins University Medical Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Ivana Gojo    410-502-7726    igojo1@jhmi.edu    Principal Investigator: Ivana Gojo, MD          United States, New York Columbia University Recruiting New York, New York, United States, 10032 Contact: Maria Katsigeorgis, MS       mk3941@cumc.columbia.edu    Contact: Ryan Shelton, BS       rs3323@cumc.columbia.edu    Sub-Investigator: Mark Frattini, MD          Principal Investigator: Daniel J Lee, MD Less <<
NCT00334074 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndromes Chronic Myelogenous Leukemia Less << Phase 2 Completed - United States, Texas ... More >> Baylor University Medical Center Dallas, Texas, United States, 75246 Less <<
NCT02649764 Leukemia Phase 1 Active, not recruiting May 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01615757 Acute Myeloid Leukemia Phase 3 Unknown September 2014 India ... More >> AIIMS Recruiting Delhi, India, 110001 Contact: Prashant Mehta, MD    09013590847    prashantcipher@yahoo.co.in    Principal Investigator: Prashant Mehta, MD Less <<
NCT01191541 Leukemia Not Applicable Unknown December 2018 China ... More >> Department of Pediatrics, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, PR China Recruiting Tianjin, China, 300020 Contact: Xiaofan Zhu, MD    +86 22 23909001    zhuxiaof@yahoo.com.cn    Principal Investigator: xiaofan Zhu, MD Less <<
NCT01191801 - Completed - -
NCT00334074 - Completed - -
NCT02652871 Leukemia Phase 1 Recruiting May 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01399372 Chemotherapeutic Agent Toxicit... More >>y Cognitive/Functional Effects Lymphoma Neurotoxicity Radiation Toxicity Less << Phase 2 Active, not recruiting September 2026 -
NCT00005793 Leukemia Phase 1 Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT00469859 Leukemia Phase 1 Phase 2 Completed - -
NCT00740181 - Terminated(Lack of efficacy) - -
NCT00469859 - Completed - -
NCT01083342 CNS Lymphoma Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01527149 Stage I Mantle Cell Lymphoma ... More >> Stage II Contiguous Mantle Cell Lymphoma Stage II Non-Contiguous Mantle Cell Lymphoma Stage III Mantle Cell Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 2 Active, not recruiting October 5, 2021 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00740181 Myelodysplasia ... More >> Leukemia Less << Phase 2 Terminated(Lack of efficacy) - United States, Rhode Island ... More >> Lifespan Hospitals Providence, Rhode Island, United States, 02903 Less <<
NCT01238211 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Core Binding Factor Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting - -
NCT00093483 Leukemia Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT02473146 Acute Myeloid Leukemia Phase 2 Phase 3 Recruiting November 2020 France ... More >> C.H.U d'Amiens - Hôpital Sud Recruiting Amiens, France Contact: Bérangère GRUSON          Principal Investigator: Bérangère GRUSON          Hôpital V. Dupouy Recruiting Argenteuil, France Contact: Ahmad AL JIJAKI          Principal Investigator: Ahmad AL JIJAKI, MD          CH Avicenne Recruiting Bobigny, France Contact: Claude GARDIN          Principal Investigator: Claude GARDIN, MD          CHU Caen Recruiting Caen, France Contact: Sylvain CHANTEPIE          Principal Investigator: Sylvain CHANTEPIE, MD          HIA Percy Recruiting Clamart, France, 92140 Contact: Jean-Valère MALFUSON, MD          Principal Investigator: Jean-Valère MALFUSON, MD          Hopital Henri Mondor Recruiting Creteil, France Contact: Cecile PAUTAS          Principal Investigator: Cecile PAUTAS, MD          CHU Dijon Recruiting Dijon, France Contact: Denis CAILLOT          Principal Investigator: Denis CAILLOT, MD          CH Dunkerque Recruiting Dunkerque, France Contact: Iriné Maxime BEMBA          Principal Investigator: Iriné Maxime BEMBA, MD          CH Versailles Recruiting Le Chesnay, France, 78157 Contact: Juliette LAMBERT, MD          Principal Investigator: Juliette LAMBERT, MD          Hôpital Huriez, CHU de Lille Recruiting Lille, France Contact: Bruno QUESNEL          Principal Investigator: Bruno QUESNEL, MD          CHU Limoges Recruiting Limoges, France Contact: Pascal TURLURE          Principal Investigator: Pascal TURLURE, MD          Hôpital de la Conception Active, not recruiting Marseille, France, 13005 Centre Antoine Lacassagne Recruiting Nice, France, 06100 Contact: Lauris GASTAUD, MD          Principal Investigator: Lauris GASTAUD, MD          CHU d'Orléans Recruiting Orléans, France, 45100 Contact: Diana CARP, MD          Principal Investigator: Diana CARP, MD          Hopital Necker Recruiting Paris, France Contact: Olivier HERMINE          Principal Investigator: Olivier HERMINE, MD          Hopital St Louis Recruiting Paris, France Contact: Hervé Dombret, MD          Principal Investigator: Hervé Dombret, MD          Principal Investigator: Pierre FENAUX, MD          Hôpital Saint Antoine Recruiting Paris, France Contact: Ollivier LEGRAND, MD          Principal Investigator: Ollivier LEGRAND, MD          CHU Lyon Sud Recruiting Pierre Benite, France Contact: Xavier THOMAS          Principal Investigator: Xavier THOMAS          Centre H Becquerel Recruiting Rouen, France Contact: Emilie LEMASLE          Principal Investigator: Emilie LEMASLE, MD          Institut de Cancérologie de la Loire Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Emmanuelle TAVERNIER-TARDY, MD          Principal Investigator: Emmanuelle TAVERNIER-TARDY, MD          IGR Not yet recruiting Villejuif, France Contact: Stephane DE BOTTON          Principal Investigator: Stephane DE BOTTON, MD Less <<
NCT01238211 - Active, not recruiting - -
NCT02758925 Diffuse Large B Cell Lymphoma Phase 2 Unknown December 2018 -
NCT01788189 B-cell Lymphoma Phase 1 Phase 2 Recruiting June 2019 Germany ... More >> Klinik für Hämatologie, Universitätsklinikum Essen Recruiting Essen, Germany, 45147 Contact: Ulrich Dührsen, Prof. Dr. med.    +49-201-723 ext 2417    ulrich.duehrsen@uk-essen.de    Principal Investigator: Ulrich Dührsen, Prof. Dr. med. Less <<
NCT01063439 Non Hodgkin's Lymphoma Phase 2 Unknown February 2015 Korea, Republic of ... More >> Inje University Busan Paik Hospital Recruiting Busan, Korea, Republic of Contact: Won Sik Lee, Dr. PhD.    +82-51-890-6407    wonsik112@gmail.com    Principal Investigator: Won Sik Lee, M.D. PhD.          Asan Medical Center, University of Ulsan Recruiting Seoul, Korea, Republic of Principal Investigator: Je Hwan Lee, M.D. Ph.D.          Seoul National University Hospital Recruiting Seoul, Korea, Republic of Principal Investigator: Sung Soo Yoon, M.D. Ph.D.          Yeonsei University Hospital Recruiting Seoul, Korea, Republic of Principal Investigator: Jin Seok Kim, M.D. Ph.D.          Ulsan University Hospital Recruiting Ulsan, Korea, Republic of Principal Investigator: Hawk Kim, M.D. Ph. D. Less <<
NCT03263936 Acute Myelogenous Leukemia Phase 1 Recruiting July 2020 -
NCT02389400 Langerhans Cell Histiocytosis Phase 2 Completed - China ... More >> Peking union medical college hospital Beijing, China, 100730 Less <<
NCT01696084 High Risk Acute Myeloid Leukem... More >>ia Less << Phase 3 Active, not recruiting November 2019 -
NCT00268229 Leukemia Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01696084 - Active, not recruiting - -
NCT01838395 Acute Myeloid Leukemia Phase 2 Completed - United States, Florida ... More >> Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Israel Rambam Medical Center Haifa, Israel, 31096 Shaare Zedek Medical Center Jerusalem, Israel, 91031 Meir Medical Center Kfar Saba, Israel Chaim Sheba Medical Center Ramat Gan, Israel, 52621 Tel-Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 Less <<
NCT01488344 Acute Myeloid Leukemia Phase 1 Phase 2 Unknown - Germany ... More >> Universitätsklinikum Münster, Medizinische Klinik und Poliklinik A Münster, Germany, 48149 Less <<
NCT00967512 Acute Myelogenous Leukemia Phase 2 Withdrawn(Study Was Terminated... More >> due to lack of Funding.) Less << - -
NCT01627041 Acute Myeloid Leukemia ... More >> Adult Acute Basophilic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting - United States, Maine ... More >> Lafayette Family Cancer Center-EMMC Brewer, Maine, United States, 04412 United States, New York Montefiore Medical Center-Weiler Hospital Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Columbia University/Herbert Irving Cancer Center New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT01237808 Acute Myeloid Leukemia (AML) Phase 3 Completed - Germany ... More >> Ubbo-Emmius Klinik Aurich Aurich, Germany, 26603 Charité Universitätsmedizin Berlin Berlin, Germany, 13353 University Hospital of Bonn Bonn, Germany, 53111 Städtisches Klinikum Braunschweig Braunschweig, Germany, 38114 Klinikum Bremen-Mitte gGmbH Bremen, Germany, 28177 Kliniken Essen Süd, Evangelischs Krankenhaus Essen, Germany, 45239 Klinikum Esslingen Esslingen, Germany, 73730 Medizinische Universitätsklinik Freiburg, Germany, 79106 Medizinisches Versorgungszentrum Osthessen GmbH Fulda, Germany, 36043 Universitätsklinikum Gießen Gießen, Germany, 35392 Wilhelm- Anton- Hospital gGmbH Goch, Germany, 47574 Universitätsmedizin Göttingen Göttingen, Germany, 37075 University Hospital of Hamburg Eppendorf Hamburg, Germany, 20246 Asklepios Klinik Altona Hamburg, Germany, 22763 Medical Department III, Hospital of Hannover-Siloah Hannover, Germany, 30449 Medizinische Hochschule Hannover Hannover, Germany, 30625 SLK-Kliniken Heilbronn GmbH Heilbronn, Germany, 74078 Department of Internal Medicine I, University Hospital of Saarland Homburg, Germany, 66421 Staedtisches Klinikum Karlsruhe Karlsruhe, Germany, 76133 Department of Interial Medicine /Hematology and Oncology, Caritas Hospital Lebach Lebach, Germany, 66822 Klinikum der Johannes Gutenberg Universität Mainz Mainz, Germany, 55131 Klinikum rechts der Isar der TU Muenchen Muenchen, Germany, 81675 Stauferklinikum Schwäbisch Gmünd Mutlangen, Germany, 73557 Pius Hospital Oldenburg Oldenburg, Germany, 26133 Krankenhaus der Barmherzigen Brueder Regensburg, Germany, 93049 Caritas-Klinik St. Theresia Saarbrücken, Germany, 66113 Clinikal Cetner of Stuttgart, Center of Oncology Stuttgart, Germany, 70174 Diakonie-Klinikum Stuttgart Stuttgart, Germany, 70176 Krankenhaus der Barmherzigen Brüder Trier Trier, Germany, 54292 Universitätsklinikum Tübingen Tübingen, Germany, 72076 University hospital of Ulm Ulm, Germany, 89081 Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen Villingen - Schwenningen, Germany, 78050 Helios Klinikum Wuppertal Wuppertal, Germany, 42283 Less <<
NCT00003079 Leukemia Lymp... More >>homa Less << Phase 1 Completed - United States, New York ... More >> New York Presbyterian Hospital - Cornell Campus New York, New York, United States, 10021 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia Massey Cancer Center Richmond, Virginia, United States, 23298-0037 Less <<
NCT00017342 Leukemia Phase 2 Completed - United States, New York ... More >> New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 Less <<
NCT02096289 Acute Myeloid Leukemia Phase 1 Completed - Canada, Ontario ... More >> Juravinski Hospital & Cancer Centre Hamilton, Ontario, Canada, L8V 1C3 Less <<
NCT00505700 Leukemia Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel/ Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00065143 Leukemia, Myeloid ... More >> Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03324243 Relapsed/Refractory FLT3-mutat... More >>ed AML Less << Phase 2 Not yet recruiting December 2020 -
NCT03629171 Recurrent Acute Myeloid Leukem... More >>ia Refractory Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Recruiting June 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: M.       tkadia@mdanderson.org    Principal Investigator: Tapan M. Kadia Less <<
NCT00053144 Leukemia Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00129168 Leukemia, Myeloid Phase 1 Phase 2 Completed - -
NCT00529360 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Less << Phase 1 Phase 2 Completed - United States, New York ... More >> New York Medical College Vallhala, New York, United States, 10595 Less <<
NCT00495287 Acute Myelogenous Leukemia Phase 3 Completed - Italy ... More >> Dipartimento di Ematologia e Medicina Trasfusionale - Azienda Osp. Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy USC Ematologia Azienda Papa Giovanni XXIII Bergamo, BG, Italy Ospedale Generale di Bolzano Bolzano, Bz, Italy S.C. Ematologia - Azienda Ospedaliera S.Croce e Carle Cuneo, CN, Italy Ematologia - AOU Careggi Firenze, FI, Italy Istituto Clinico Humanitas Rozzano, Milano, Italy Ematologia Centro TMO - Fondazione IRCSS Ospedale Maggiore Milano, MI, Italy Ematologia e TMO - Ospedale San Raffaele Milano, MI, Italy Istituto Nazionale Dei Tumori Milano, MI, Italy Ematologia - TMO - Ospedale San Gerardo Monza, MI, Italy A.O.U San Giovanni Battista-Divisione Ematologica dell'Università Torino, TO, Italy Ematologia 2 - Osp. Molinette San Giovanni Battista Torino, TO, Italy Ospedale Mauriziano Torino, TO, Italy Ospedale dell'Angelo Mestre, Venezia, Italy Ospedale Spedali Civili di Brescia Brescia, Italy Istituti Ospitalieri Cremona, Italy Ospedale di Circolo di Varese Varese, Italy Less <<
NCT01127009 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00096122 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00096122 - Completed - -
NCT02587871 Adult Acute Myeloid Leukemia i... More >>n Remission Childhood Acute Myeloid Leukemia in Remission Less << Phase 2 Withdrawn(PI decided not to pu... More >>rsue study) Less << November 12, 2022 United States, California ... More >> USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT02532192 Lymphoma Phase 1 Withdrawn(Withdrawal of study ... More >>support.) Less << - -
NCT01034839 - Completed - Brazil ... More >> University of Sao Paulo Sao Paulo, Brazil, 05430010 Less <<
NCT00372619 - Completed - -
NCT02085408 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 3 Active, not recruiting - -
NCT00003239 Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00372619 Leukemia Phase 1 Phase 2 Completed - -
NCT02029417 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Terminated(Major revisions nee... More >>ded in study) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT02029417 - Terminated(Major revisions nee... More >>ded in study) Less << - -
NCT00049179 Leukemia Phase 2 Completed - -
NCT01635296 Myelogenous Leukemia, Acute Phase 1 Completed - United States, New York ... More >> Valhalla, New York, United States, 10595 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19107 United States, Texas San Antonio, Texas, United States, 78229 Canada, Ontario Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Montreal, Quebec, Canada, H3T 1E2 France Marseille, France, 13273 Italy Bologna, Emilia-Romagna, Italy, 40138 United Kingdom Glasgow, United Kingdom, G12 0YN Manchester, United Kingdom, M204BX Less <<
NCT01132586 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA Alkylating Agent-Related Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00093600 Acute Myeloid Leukemia (AML) Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 United States, Massachusetts Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201-2014 United States, Texas MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77030 Germany Novartis Investigative Site Dresden, Germany Novartis Investigative Site Mainz, Germany Less <<
NCT01729845 - Completed - -
NCT00926731 Acute Myeloid Leukemia Phase 1 Completed - United States, Ohio ... More >> Research Site Cleveland, Ohio, United States United States, Texas Research Site Houston, Texas, United States France Research Site Le Chesnay Cedex, France Research Site Villejuif Cedex, France Less <<
NCT02983097 Diffuse Large B-cell Lymphoma ... More >>(DLBCL) Follicular Lymphoma Grade III (FL III°) Mantle Cell Lymphoma (MCL), Blastoid Variant Burkitt Lymphoma (BL) Aggressive Marginal Zone Lymphoma (MZL) Less << Phase 1 Phase 2 Terminated(Phase II no scienti... More >>fic interests are given anymore) Less << - Germany ... More >> Diakonie Krankenhaus Bremen Bremen, Germany, 28239 Klinikum Chemnitz Chemnitz, Germany, 09113 Universitätsklinikum Essen Essen, Germany, 45122 Klinikum Frankfurt/Oder Frankfurt/Oder, Germany, 15236 Universitätsklinikum Göttingen Göttingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, 20099 Asklepios Klinik Altona Hamburg, Germany, 22763 Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Universitätsklinikum des Saarlandes Homburg, Germany, 66421 Westpfalz Klinikum Kaiserslautern, Germany, 67665 Städtisches Klinikum Karlsruhe Karlsruhe, Germany, 76133 LMU Klinikum München-Großhadern München, Germany, 81377 Less <<
NCT03053206 Acute Myeloid Leukemia, in Rel... More >>apse Less << Phase 2 Not yet recruiting December 31, 2019 -
NCT01729845 Previously Treated Myelodyspla... More >>stic Syndrome Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 EvergreenHealth Medical Center Kirkland, Washington, United States, 98033 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00295841 Leukemia Phase 1 Completed - United States, North Carolina ... More >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00503880 - Terminated(Genzyme discontinue... More >>d Funding) Less << - -
NCT00880243 Acute Myeloid Leukemia Phase 3 Completed - -
NCT00002818 Drug/Agent Toxicity by Tissue/... More >>Organ Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Less << Phase 1 Completed - United States, Virginia ... More >> Massey Cancer Center Richmond, Virginia, United States, 23298-0037 Less <<
NCT00503880 Myelodysplastic Syndromes Phase 1 Phase 2 Terminated(Genzyme discontinue... More >>d Funding) Less << - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT00602225 - Completed - -
NCT00512252 Leukemia, Myeloid, Acute Phase 1 Phase 2 Completed - United States, Missouri ... More >> Washington University St. Louis, Missouri, United States, 63110 Less <<
NCT03055286 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting October 2020 United States, Texas ... More >> The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Jorge Cortes, MD    713-794-5783    jcortes@mdanderson.org    Principal Investigator: Jorge Cortes, MD          United States, Washington University of Washington Recruiting Seattle, Washington, United States, 98195 Contact: Pamela S. Becker, MD          Contact    +1 206 616 1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker, MD          Korea, Republic of Samsung medical center Recruiting Seoul, Gangnam-gu, Korea, Republic of Contact: Chulwon Jung    +82 2 3410 3459    chulwon1.jung@samsung.com    Principal Investigator: Chulwon Jung          Seoul National University Hospital Recruiting Seoul, Jongno-gu, Korea, Republic of Contact: Sungsu Yoon    +82 2 2072 3079    ssysmc@snu.ac.kr    Principal Investigator: Sungsu Yoon          Asan Medical Center Recruiting Seoul, Songpa-Gu, Korea, Republic of Contact: Jaehwan Lee    02-3010-3218    jhlee3@amc.seoul.kr    Principal Investigator: Jaehwan Lee Less <<
NCT00602225 Acute Myeloid Leukemia ... More >> Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Promyelocytic Leukemia (M3) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01969435 Hodgkin Disease ... More >> Lymphoma, Non-Hodgkin Less << Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02043587 Acute Lymphocytic Leukemia ... More >> Adult Lymphoblastic Lymphoma Less << Phase 2 Active, not recruiting January 2020 United States, California ... More >> UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center La Jolla, California, United States, 92093 Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 Less <<
NCT01969435 - Completed - -
NCT00589082 AML Elderly Phase 3 Completed - -
NCT00070538 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4095 Less <<
NCT03531918 Acute Myeloid Leukemia ... More >> High-Grade Myeloid Neoplasm Less << Phase 1 Phase 2 Recruiting July 1, 2025 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Roland Walters    206-667-3599    rwalter@fredhutch.org    Principal Investigator: Roland Walters Less <<
NCT00085709 Leukemia Phase 3 Completed - -
NCT00774046 - Completed - -
NCT01876953 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00945815 Leukemia Phase 2 Completed - -
NCT00512252 - Completed - -
NCT00273884 Acute Myeloid Leukemia Phase 2 Completed - -
NCT00064090 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4095 Less <<
NCT00085709 - Completed - -
NCT03082144 Leptomeningeal Metastasis Phase 2 Recruiting December 2018 China, Jilin ... More >> The First Hospital of Jilin University Recruiting Changchun, Jilin, China, 130021 Contact: Zhenyu Pan, Professor    +8615804302753    dr-zypan@163.com    Contact: Guozi Yang, Professor    +8615804302755    guoziyang_1982@163.com Less <<
NCT00945815 - Completed - -
NCT01700413 Di Novo Acute Myeloid Leukemia Phase 2 Completed - Spain ... More >> Hospital Universitari Germans Trias I Pujol de Badalona Badalona, Spain, 08916 Hospital de La Santa Creu I Sant Pau Barcelona, Spain, 08025 Hospitals Vall D'Hebron Barcelona, Spain, 08035 Hospital Clinic I Provincial de Barcelona Barcelona, Spain, 08036 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT00774046 Myelodysplastic Syndrome ... More >> Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00776503 Myelodysplastic Syndromes Phase 1 Phase 2 Completed - France ... More >> Hôpital de la Durance Avignon, France, 84902 Hopital Avicenne Bobigny, France, 93009 CH René Dubos Cergy-pontoise, France, 95303 Hematology Dpt, Hôpital Sud Francilien Corbeil-essonnes, France, 91100 CHU Grenoble Grenoble, France, 38043 Hôpital Edouard Heriot, dpt Hématologie Clinique Lyon, France, 69437 Hematology Dpt, Institut Paoli Calmettes Marseille, France, 13009 Hematology Dpt, Hopital de l'Hotel Dieu Nantes, France, 44093 Hematology Dpt, Hopital Saint Louis Paris, France, 75475 Hematology Dpt, Hopital Cochin Paris, France, 75679 Centre Henri Bequerel Rouen, France, 76038 Centre René Huguenin Saint Cloud, France, 92210 Hematology Dpt, Hopital Haute Pierre Strasbourg, France, 67098 Hematology Dpt, Hopital Purpan Toulouse, France, 40031 Less <<
NCT00838240 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Phase 2 Unknown - Belgium ... More >> A.Z. Sint-Jan Recruiting Brugge, Belgium Principal Investigator: Dominik Selleslag          Institut Jules Bordet Not yet recruiting Brussel, Belgium Principal Investigator: Dominique Bron          CHU Sart-Tilman Not yet recruiting Liège, Belgium Principal Investigator: Frédéric Baron          Croatia University Hospital Rebro Not yet recruiting Zagreb, Croatia Principal Investigator: Boris Labar          France Hôpital Saint Antoine AP-HP Not yet recruiting Paris, France Principal Investigator: Olivier Legrand          Italy Azienda Ospedallera Universitaria - Policlinico Tor Vergata Recruiting Roma, Italy Principal Investigator: Sergio Amadori          Univesita Degli Studi "La Sapienza" Recruiting Roma, Italy Principal Investigator: Giovanna Meloni          Netherlands Leiden University Medical Center Active, not recruiting Leiden, Netherlands Radboud University Nijmegen Medical Center Recruiting Nijmegen, Netherlands Principal Investigator: Petra Muus          Jeroen Bosch Ziekenhuis Recruiting s' Hertogenbosch, Netherlands Principal Investigator: Hans Pruijt Less <<
NCT00166439 Lymphoma Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03417427 Leukemia, Myeloid Phase 2 Recruiting January 31, 2025 China, Guangdong ... More >> Nanfang Hospital of Southern Medical University Recruiting Guanzhou, Guangdong, China, 510515 Contact: Xuejie Jiang, doctor    +8618688869522    jxj3331233@163.com Less <<
NCT03118466 AML Phase 2 Recruiting September 30, 2024 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02062 Contact: Richard Stone, MD    617-632-2214    Richard_Stone@dfci.harvard.edu    Principal Investigator: Richard Stone, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Lourdes Mendez, MD    617-667-9920       Principal Investigator: Lourdes Mendez, MD          Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Andrew Brunner, MD    617-724-1124    Andrew_Brunner@DFCI.HARVARD.EDU    Principal Investigator: Andrew Brunner, MD Less <<
NCT01661881 - Active, not recruiting - -
NCT01044966 Glioblastoma Multiforme ... More >> Glioma Astrocytoma Brain Tumor Less << Phase 1 Phase 2 Terminated(The study was termi... More >>nated due to lack of adequate patient enrollment into trial.) Less << - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01661881 Mantle Cell Lymphoma Phase 2 Active, not recruiting March 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02113 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00776373 ALL Burkitt's... More >> Lymphoma Lymphoblastic Leukemia CML Less << Phase 1 Phase 2 Terminated - United States, Pennsylvania ... More >> University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19066 Less <<
NCT00795002 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00795002 - Completed - -
NCT00470197 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Malignant Neoplasm Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00136448 Acute Myelogenous Leukemia Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00620321 Acute Myeloid Leukemia Phase 2 Completed - United States, Michigan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ann Arbor, Michigan, United States, 48105 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States, 77030 Less <<
NCT02488408 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 1 Phase 2 Recruiting August 2018 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Karen Parrott    319-353-6347    karen-parrott@uiowa.edu    Principal Investigator: Carlos E Vigil, MD          United States, Ohio James Cancer Hospital & Solove Research Institute Recruiting Columbus, Ohio, United States, 43210 Contact: Molly Vittorio    614-293-7940    molly.vittorio@osumc.edu    Principal Investigator: William Blum, Professor          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Cora Cheung    713-792-3461    cmcheung@mdanderson.org    Principal Investigator: Jorge Cortes, Professor          Germany Universitätsklinikum Frankfurt, Medizinische Klinik II Recruiting Frankfurt, Germany, 60596 Contact: Laura Hefermehl    +49 69 6301 86708    Laura.Hefermehl@kgu.de    Principal Investigator: Jörg Chromik, Dr          University Medical Center Hamburg-Eppendorf Martinistrasse Recruiting Hamburg, Germany, 20246 Contact: Sonja T Loges, MD, PhD    +49 407-410-51969    s.loges@uke.de    Principal Investigator: Sonja Loges, MD, PhD          Medizinische Hochschule Hannover Recruiting Hannover, Germany, 30625 Contact: Gabriele Samson    +49 (511) 532 9321    samson.gabriele@mh-hannover.de    Principal Investigator: Michael Heuser, Dr          Universitätsklinikum Ulm, Oberer Eselsberg, Zentrum für Innere Medizin III Recruiting Ulm, Germany, 89081 Contact: Manuela Wetzel    +49 (0) 731 500 45709    manuela.wetzel@uniklinik-ulm.de    Principal Investigator: Peter Paschka, Dr          Norway Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Marianne Emblem Lehmann    +47 59972890/ 95975516    marianne.emblem.lehmann@helse-bergen.no    Principal Investigator: Bjørn Tore Gjertsen, Professor Less <<
NCT02070458 Recurrent Adult Acute Myeloid ... More >>Leukemia Refractory Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT02676323 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 1 Terminated(Slow accrual) - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 Rady Children's Hospital and Health Center San Diego, California, United States, 92123 United States, Michigan Children's Hospital of Michigan Detroit, Michigan, United States, 48201 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00840177 Leukemia Phase 2 Active, not recruiting July 2019 -
NCT00016016 Recurrent Adult Acute Lymphobl... More >>astic Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT01296256 Bendamustine ... More >>Conditioning Therapy Autologous Stem Cell Transplant Aggressive Non Hodgkin's Lymphoma Less << Phase 2 Completed - Spain ... More >> Complejo Hospitalario Universitario de Santiago Santiago, A Coruña, Spain, 15706 Hospital Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11407 Hospital Son Llátzer Palma de Mallorca, Mallorca, Spain, 07198 Hospital Universitario Virgen de Arrixaca El Palmar, Murcia, Spain, 30120 Clinica Universitaria de Navarra Pamplona, Navarra, Spain Hospital Universitario de Canarias Santa Cruz de Tenerife, Tenerife, Spain Hospital Vall d´Hebron Barcelona, Spain, 08035 Hospital Clinic i Provincial Barcelona, Spain, 08036 H. de la Santa Creu i Sant Pau Barcelona, Spain H.U. 12 de Octubre, Madrid, Spain H.U. Gregorio Marañón, Madrid, Spain H.U. La Paz Madrid, Spain H.U. La Princesa Madrid, Spain Hospital Ramon y Cajal Madrid, Spain H. Clínico Universitario de Salamanca Salamanca, Spain H. U. Marqués de Valdecilla. Santander, Spain Hospital Clinico de Valencia Valencia, Spain, 46010 Hospital Arnau de Vilanova Valencia, Spain, 46015 H. La Fe Valencia, Spain Hospital Clínico Lozano Blesa Zaragoza, Spain, 50009 Less <<
NCT00990054 Acute Myeloid Leukemia Phase 1 Completed - United States, California ... More >> Duarte, California, United States United States, Massachusetts Boston, Massachusetts, United States United States, Michigan Ann Arbor, Michigan, United States United States, Missouri St. Louis, Missouri, United States United States, New York Rochester, New York, United States United States, Ohio Cleveland, Ohio, United States United States, Texas Houston, Texas, United States United States, Washington Seattle, Washington, United States Less <<
NCT00085124 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 3 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00112554 Leukemia Phase 3 Completed - -
NCT00593645 Myelodysplastic Syndromes ... More >> Acute Myeloid Leukemia Less << Phase 2 Terminated(toxicities were wor... More >>se than expected) Less << - United States, Missouri ... More >> Ravi Vij, M.D. St. Louis, Missouri, United States, 63110 Less <<
NCT00850304 Leukemia, Myeloid, Acute Phase 2 Completed - Iran, Islamic Republic of ... More >> Hematology-Oncology and SCT Research Center Tehran, Iran, Islamic Republic of, 14114 Less <<
NCT00703820 Acute Myeloid Leukemia Phase 3 Active, not recruiting June 30, 2020 United States, California ... More >> Stanford University Medical Center Palo Alto, California, United States, 94304 Rady Children's Hospital San Diego, California, United States, 92123 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Dana Farber Cancer Institute and Children's Hospital Boston, Massachusetts, United States, 02215-5450 United States, Michigan Children's Hospital of Michigan Detroit, Michigan, United States, 48201 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook's Children's Medical Center Fort Worth, Texas, United States, 76104 Singapore National University Health System Singapore, Singapore, 119228 Less <<
NCT00593645 - Terminated(toxicities were wor... More >>se than expected) Less << - -
NCT02182596 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - France ... More >> Hopital Avicenne Bobigny, France CH Caen, France, 14033 Hopital Percy Clamart, France, 92141 CHU Creteil, France, 94010 CHU Lille, France, 59037 CH Limoges, France, 87042 Hopital Edouard Herriot Lyon, France CH Meaux, France, 77104 St Antoine Hospital Paris, France, 75012 Hopital Saint-Louis Paris, France CH Roubaix, France, 59100 CHU Rouen, France, 76038 CNLCC Saint-Cloud, France CH Versailles, France IGR Villejuif, France, 94805 Less <<
NCT02328950 - Unknown December 2017 China, Fujian ... More >> Union Hospital,Fujian Medical University Recruiting Fuzhou, Fujian, China, 350001 Contact: Ting Yang, Prof.    +86-591-83357896 ext 8041    yang.hopeting@gmail.com    Contact: Jianda Hu, Prof.    +86-591-83357896 ext 8041    jdhu@medmail.com.cn    Principal Investigator: Jianda Hu, Dr.          Sub-Investigator: Ting Yang, Dr. Less <<
NCT01031368 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Acute Promyelocytic Leukemia (M3) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03585686 Langerhans Cell Histiocytosis Phase 2 Recruiting December 2020 Russian Federation ... More >> Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Recruiting Moscow, Russian Federation, 117997 Contact: Zhanna Shekhovtsova, MD    4956647078 ext 7538    zhanna.shekhovtsova@fccho-moscow.ru    Contact: Eugene Pashanov, PhD    +79262205578    e.pashanov@gmail.com    Sub-Investigator: Dmitry Evseev, MD          Principal Investigator: Michael Maschan, PhD Less <<
NCT03701308 Acute Myeloid Leukemia Phase 2 Phase 3 Not yet recruiting December 1, 2025 -
NCT00703820 - Active, not recruiting - -
NCT01721876 Leukemia, Myeloid, Acute Phase 3 Active, not recruiting December 31, 2019 -
NCT00503594 Lymphoma Phase 2 Unknown July 2012 France ... More >> Groupe hospitalier la Pitié Salpétrière Recruiting Paris, France, 75013 Contact: Antonio OMURO, MD,PhD    + 33(0) 1 42 16 41 60    antonio.omuro@psl.aphp.fr Less <<
NCT00047021 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-7284 Less <<
NCT00028847 Leukemia Phase 1 Phase 2 Unknown - Belgium ... More >> AZ Sint-Jan Brugge, Belgium, 8000 Institut Jules Bordet Brussels, Belgium, 1000 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Clinique Universitaire De Mont-Godinne Mont-Godinne Yvoir, Belgium, 5530 Netherlands HagaZiekenhuis - Locatie Leyenburg 's-Gravenhage, Netherlands, 2545 CH Meander Medisch Centrum Amersfoort, Netherlands, 3816 CP Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 10P 1HV Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7500 KA University Medical Center Groningen Groningen, Netherlands, 9713 EZ Leiden University Medical Center Leiden, Netherlands, 2300 RC Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, 6500 HB Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Isala Klinieken - locatie Sophia Zwolle, Netherlands, 8000 GK Less <<
NCT00055874 Leukemia Phase 3 Completed - -
NCT00932412 Acute Myeloid Leukemia Phase 2 Completed - France ... More >> Hôpital Sud - CHU Amiens Amiens, France, 80054 Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 Hôpital Victor Dupouy Argenteuil, France, 95107 Hôpital Avicenne - bobigny Bobigny, France, 93009 Centre Hospitalier Boulogne/Mer Boulogne / Mer, France, 62280 Hôpital Clemenceau - chu Caen Caen, France, 14033 Centre Hospitalier René Dubos Cergy Pontoise, France, 95303 HIA Percy Clamart, France, 92141 Hôpital de Corbeil Corbeil, France, 91100 Hôpital Mondor Créteil, France, 94010 Hôpital Dubocage Dijon, France, 21000 Centre Hospitalier Dunkerque Dunkerque, France, 59395 Hôpital Michallon Grenoble, France, 38043 Centre Hospitalier Versailles Le Chesnay, France, 78150 Centre Hospitalier Schaffner Lens, France, 62307 Hôpital Huriez Lille, France, 59037 CHU Dupuytren Limoges, France, 87042 Institut Paoli-Calmette Marseille, France, 13273 Centre Hospitalier Meaux Meaux, France, 77104 CHU - Hôtel Dieu Nantes, France, 44093 Centre A. Lacassagne Nice, France, 06100 Hôpital Archet 1 Nice, France, 06202 Hôpital St Louis Paris, France, 75010 Pitié-Salpetrière Paris, France, 75013 Paris Necker Paris, France, 75743 Hôpital Haut Lévêque Pessac, France, 33604 Hospices Civils de Lyon - Centre Hospitalier Lyon Sud Pierre-benite, France, 69495 Hôpital V. Provo Roubaix, France, 59056 Centre Henri Becquerel - CHRU ROUEN Rouen, France, 76038 Centre Hospitalier Huguenin Saint Cloud, France, 92210 Hôpital Purpan Toulouse, France, 31059 Centre Hospitalier Valenciennes Valenciennes, France, 59322 CHU de Brabois Vandoeuvre Les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT01848652 Cerebral Lymphoma B Cell Refra... More >>ctory Less << Phase 2 Terminated(The laboratory's pa... More >>rtner on this study decides to terminate the contract with the CHRU Brest, because of the difficulty of the recruitment.) Less << - France ... More >> CHRU de Brest Brest, France, 29609 Hôpital Pitié Salpêtrière Paris, France, 75651 CHU de Rennes Hôpital Pontchaillou Rennes, France, 35033 Less <<
NCT02858258 Mantle Cell Lymphoma Phase 3 Recruiting May 2026 -
NCT00046930 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - -
NCT00069966 Lymphoma Phase 2 Unknown - -
NCT00046930 - Completed - -
NCT01228331 Leukemia Phase 2 Phase 3 Recruiting September 2021 Germany ... More >> Krankenanstalten Gilead gCmbH Neurochirurgische Klinik Recruiting Bielefeld, Germany, 33617 Contact: Contact Person    49-521-144-2728       Klinikum Bremen-Mitte Recruiting Bremen, Germany, D-28205 Contact: Contact Person    49-421-497-5413       Universitaetsklinikum Duesseldorf Recruiting Duesseldorf, Germany, D-40225 Contact: Contact Person    49-211-81-17662       Klinik und Poliklinik Fuer Kinder-und Jugendmedizin - Universitaetsklinikum Greifswald Recruiting Greifswald, Germany, 17487 Contact: Contact Person    49-3834-86-6321       University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Contact Person    49-407-4105-2580    horstmann@uke.uni-hamburg.de    Clinic for Bone Marrow Transplantation and Hematology and Oncology Recruiting Idar-Oberstein, Germany, D-55743 Contact: Contact Person    49-6781-66-1582       Klinikum Krefeld GmbH Recruiting Krefeld, Germany, D-47805 Contact: Contact Person    49-2151-322-375       Universitaets - Kinderklinik Recruiting Leipzig, Germany, D-04317 Contact: Contact Person    49-341-9726-113       Johannes Gutenberg University Recruiting Mainz, Germany, D-55101 Contact: Contact Person    49-6131-17-2642       Dr. von Haunersches Kinderspital der Universitaet Muenchen Recruiting Munich, Germany, D-80337 Contact: Contact Person    49-89-5160-2843       Staedtisches Krankenhaus Muenchen - Harlaching Recruiting Munich, Germany, D-81545 Contact: Contact Person    49-89-6210-2720       Klinik St. Hedwig-Kinderklinik Recruiting Regensburg, Germany, 93049 Contact: Contact Person    49-941-2080-493       Dr. Horst-Schmidt-Kliniken Recruiting Wiesbaden, Germany, D-65199 Contact: Contact Person    49-611-43-2564       Helios Kliniken Wuppertal University Hospital Recruiting Wuppertal, Germany, D-42283 Contact: Contact Person    49-202-896-2444 Less <<
NCT00634244 - Completed - -
NCT02583893 Recurrent Adult Acute Myeloid ... More >>Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Recruiting January 2021 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Neil Palmisiano, MD    215-955-8874       Contact: Clinical Trials Office    215-955-1661       Principal Investigator: Neil Palmisiano, MD          Sub-Investigator: Neal Flomenberg, MD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: Manish Sharma, MD          Sub-Investigator: John Wagner, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: S. Onder Alpdogan, MD          Sub-Investigator: Mark Weiss, MD          Sub-Investigator: Ubaldo Martinez Outschoorn, MD          Sub-Investigator: Thomas Klumpp, MD          Sub-Investigator: Michael Ramirez, MD          Sub-Investigator: Sameh Gaballa, MD Less <<
NCT00210314 Lymphoma, B Cell Phase 2 Completed - Switzerland ... More >> Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland, 6500 Less <<
NCT02910752 Leukemia Phase 1 Phase 2 Recruiting September 2020 China ... More >> Rui Jin Hospital, Department of Hematology Recruiting Shanghai, China, 200025 Contact: Jiong HU, M.D.,    86-21-64370045    hujiong@medmail.com.cn    Contact: Ling Wang, M.D.,    86-21-64370045    cclingjar@163.com Less <<
NCT01904643 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Terminated(Accrual factor) - United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less <<
NCT00634244 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Arizona Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa Siouxland Hematology Oncology Associates Sioux City, Iowa, United States, 51101 United States, Maryland Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Ohio The Jewish Hospital Cincinnati, Ohio, United States, 45236 United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States, 17822-2001 Geisinger Medical Center-Cancer Center Hazleton Hazleton, Pennsylvania, United States, 18201 Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Lewistown Hospital Lewistown, Pennsylvania, United States, 17044 Geisinger Medical Group State College, Pennsylvania, United States, 16801 Mount Nittany Medical Center State College, Pennsylvania, United States, 16803 Geisinger Wyoming Valley Wilkes-Barre, Pennsylvania, United States, 18711 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Israel Rambam Medical Center Haifa, Israel, 31096 Less <<
NCT03031249 AML Phase 1 Phase 2 Recruiting December 2022 China, Tianjin ... More >> Institute of Hematology & Blood Diseases Hospital Recruiting Tianjin, Tianjin, China Contact: lijun Liu    86-22-23909237    bloodgcp@126.com Less <<
NCT03719560 Diffuse Large B Cell Lymphoma Phase 2 Not yet recruiting December 31, 2025 United States, Rhode Island ... More >> Kayla Rosati Providence, Rhode Island, United States, 02903 Less <<
NCT03226418 Adult Acute Myeloid Leukemia ... More >> Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Less << Phase 2 Recruiting July 7, 2023 United States, California ... More >> USC / Norris Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90033 Contact: Mojtaba Akhtari       mojtaba.akhtari@med.usc.edu    Principal Investigator: Mojtaba Akhtari          United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Vijaya R. Bhatt    402-559-8008    vijaya.bhatt@unmc.edu    Principal Investigator: Vijaya R. Bhatt Less <<
NCT00003700 Leukemia Phase 2 Completed - -
NCT01861002 Lymphoblastic Leukemia, Acute,... More >> Childhood Myelogenous Leukemia, Acute, Childhood Less << Phase 1 Completed - -
NCT03012672 Acute Leukemia of Ambiguous Li... More >>neage Acute Myeloid Leukemia Myeloid Neoplasm Less << Phase 2 Recruiting July 15, 2020 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern    206-667-6233       Principal Investigator: Anna Halpern Less <<
NCT01067274 Acute Myeloid Leukemia Phase 3 Withdrawn(Study abandoned) - France ... More >> Chu Amiens Sud Amiens, France, 80054 CH Argenteuil, France, 95107 Hopital Avicenne Bobigny, France Chu Boulogne Sur Mer Boulogne Sur Mer, France, 62321 CH Caen, France, 14033 Hopital Percy Clamart, France, 92141 Ch Sud Francilien Corbeil Essonnes, France, 94010 Hopital Henri Mondor Creteil, France Ch Dunkerque Dunkerque, France, 59385 CH Lens, France, 62307 CHU Lille, France, 59037 CH Limoges, France, 87042 Hopital Edouard Herriot Lyon, France CH Meaux, France, 77104 Centre Antoine Lacassagne Nice, France, 06189 Necker Hospital Paris 15, France, 75015 St Antoine Hospital Paris, France, 75012 Hopital Pitie-Salpetriere Paris, France, 75651 Hopital Saint-Louis Paris, France Ch Rene Dubos Pontoise, France, 95303 CH Roubaix, France, 59100 CHU Rouen, France, 76038 CNLCC Saint-Cloud, France, 92210 CH Valenciennes, France, 59322 CH Versailles, France IGR Villejuif, France Less <<
NCT00074178 Lymphoma Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00780104 Myeloid Leukemias ... More >> AML Leukemia CML Less << Phase 1 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00074191 Lymphoma Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT02008006 Follicular Lymphoma Phase 2 Recruiting January 2022 France ... More >> CHU de Dijon - Hôpital Le Bocage Recruiting Dijon, Côte d'Or, France, 21000 Contact: René-Olivier CASASNOVAS, Dr    +33380295041    olivier.casasnovas@chu-dijon.fr    Principal Investigator: René-Olivier CASASNOVAS, Dr          Sub-Investigator: Denis CAILLOT, Dr          Sub-Investigator: Emmanuelle FERRAND, Dr          Sub-Investigator: Marie-Lorraine CHRETIEN, Dr          Centre Henri Becquerel Recruiting Rouen, Haute Normandie, France, 76038 Contact: Hervé TILLY, Doctor    +33232082200    herve.tilly@chb.unicancer.fr    Principal Investigator: Hervé TILLY, Doctor          Sub-Investigator: Oana BREHAR, Dr          Sub-Investigator: Nathalie CARDINAEL, Dr          Sub-Investigator: Nathalie CONTENTIN, Dr          Sub-Investigator: Marie-Laure FONTOURA, Dr          Sub-Investigator: Carole FRONVILLE VARNIER, Dr          Sub-Investigator: Fabrice JARDIN, Dr          Sub-Investigator: Hélène LANIC, Dr          Sub-Investigator: Emilie LEMASLE, Dr          Sub-Investigator: Pascal LENAIN, Dr          Sub-Investigator: Stéphane LEPRETRE, Dr          Sub-Investigator: Aspasia STAMATOULLAS-BASTARD, Dr          CHRU de Montpellier, Hôpital Saint-Eloi Recruiting Montpellier, Hérault, France, 34295 Contact: Guillaume CARTRON, Pr    +33467338362    g-cartron@chu-montpellier.fr    Principal Investigator: Guillaume CARTRON, Pr          Sub-Investigator: Yors HICHRI, Dr          Sub-Investigator: Robert NAVARRO, Dr          Sub-Investigator: Philippe QUITTET, Dr          Sub-Investigator: Laure VINCENT, Dr          APHP Hôpital Necker Not yet recruiting Paris, Ile de France, France, 75743 Contact: Richard DELARUE, Dr    +33144495296    richard.delarue@nck.aphp.fr    Principal Investigator: Richard DELARUE, Dr          AP-HP Hôpital Saint-Louis Not yet recruiting Paris, Ile-de-France, France, 75475 Contact: Sandy AMORIM, Doctor    01 42 49 92 36    sandy.amorim@sls.aphp.fr    Principal Investigator: Sandy AMORIM, Doctor          Sub-Investigator: Pauline BRICE, Doctor          Sub-Investigator: Catherine THIEBLEMONT, Profesor          Sub-Investigator: Stéphanie HAREL, Doctor          CHU de Rennes - Hôpital Pontchaillou Not yet recruiting Rennes, Ille et Vilaine, France, 35033 Contact: Thierry LAMY DE LA CHAPELLE, Pr    +33299284291    thierry.lamy.de.la.chapelle@chu-rennes.fr    Principal Investigator: Thierry LAMY DE LA CHAPELLE, Pr          Sub-Investigator: Marc BERNARD, Doctor          Sub-Investigator: Charles DAURIAC, Doctor          Sub-Investigator: Martine ESCOFFRE-BARBE, Doctor          Sub-Investigator: Sophie DE GUIBERT, Doctor          Sub-Investigator: Roch HOUOT, Doctor          Sub-Investigator: Stanislas NIMUBONA, Doctor          Sub-Investigator: Marlène OCHMANN, Doctor          Sub-Investigator: Tony MARCHAND, Doctor          CHU Grenoble - Hôpital Michallon Not yet recruiting Grenoble, Isère, France, 38043 Contact: Rémy GRESSIN, Doctor    +33476765712    rgressin@chu-grenoble.fr    Principal Investigator: Rémy GRESSIN, Doctor          Sub-Investigator: Claude-Eric BULABOIS, Doctor          Sub-Investigator: Jean-Yves CAHN, Doctor          Sub-Investigator: Stéphane COURBY, Doctor          Sub-Investigator: Lysiane MOLINA, Doctor          Sub-Investigator: Sophie PARK, Profesor          Sub-Investigator: Brigitte PEGOURIE-BANDELIER, Doctor          Sub-Investigator: Anne THIEBAUT, Doctor          Sub-Investigator: Martin CARRE, Doctor          Sub-Investigator: Clara MARIETTE, Doctor          CHU de Nantes Hôtel Dieu Recruiting Nantes, Loire Atlantique, France, 44093 Contact: Steven LE GOUILL, Pr    +33240083271    steven.legouill@chu-nantes.fr    Principal Investigator: Steven LE GOUILL, Pr          Sub-Investigator: Nicolas BLIN, Dr          Sub-Investigator: Thomas GASTINNE, Dr          Sub-Investigator: Béatrice MAHE, Dr          Sub-Investigator: Cyrille TOUZEAU          CHU de Nancy Not yet recruiting Vandoeuvre Lès Nancy, Meurthe et Moselle, France, 54511 Contact: Pierre FEUGIER, Doctor    +33383153282    p.feugier@chu-nancy.fr    Principal Investigator: Pierre FEUGIER, Pr          Sub-Investigator: Caroline BONMATI, Dr          Sub-Investigator: Aurore PERROT, Dr          CHRU de Lille Hôpital Claude Huriez Not yet recruiting Lille, Nord Pas de Calais, France, 59037 Contact: Franck MORSCHHAUSER, Doctor    +33320446068    franck.morschhauser@chru-lille.fr    Principal Investigator: Franck MORSCHHAUSER, Doctor          Sub-Investigator: Charles HERBAUX, Doctor          Centre Léon Bérard Recruiting Lyon, Rhône, France, 69473 Contact: Emmanuelle Nicolas-Virelizier, DR    +33 4 78 78 59 15    Emmanuelle.NICOLAS-VIRELIZIER@lyon.unicancer.fr    Sub-Investigator: Amine Belhabri, Dr          Sub-Investigator: Pierre Biron, Dr          Sub-Investigator: Philippe Rey, Dr          Principal Investigator: Emmanuelle Nicolas-Virelizier, Dr          Sub-Investigator: Catherine Sebban, Dr          Sub-Investigator: Anne-Sophie Michallet, Dr          CHU Lyon Sud Recruiting Pierre Bénite, Rhône, France, 69495 Contact: Hervé GHESQUIERES, Professor    +33 4 78 86 43 05    herve.ghesquieres@chu-lyon.fr    Sub-Investigator: Gilles SALLES, Pr          Sub-Investigator: Bertrand COIFFIER, Pr          Sub-Investigator: Emmanuel BACHY, Dr          Sub-Investigator: Fadela BOUAFIA-SAUVY, Dr          Sub-Investigator: Daniel ESPINOUSE, Dr          Sub-Investigator: Lionel KARLIN, Dr          Sub-Investigator: Clémentine SARKOSY, Dr          Principal Investigator: Hervé GHESQUIERES, Pr          CHU Henri Mondor Recruiting Créteil, Val de Marne, France, 94010 Contact: Corinne HAIOUN, Pr    +33149812051    corinne.haioun@hmn.aphp.fr    Principal Investigator: Corinne HAIOUN, Pr          Sub-Investigator: Karim BELHADJ, Dr          Sub-Investigator: Jehan DUPUIS, Dr          Sub-Investigator: Taoufik EL GNAOUI, Dr          Sub-Investigator: Elena Catalina ENACHE, Dr          Sub-Investigator: Fabien LE BRAS, Dr          Sub-Investigator: Elodie SCHERMAN, Dr Less <<
NCT00529880 Acute Myeloid Leukemia Phase 2 Unknown October 2007 Korea, Republic of ... More >> Asan Medical Center Recruiting Songpa-gu, Seoul, Korea, Republic of, 138-833 Contact: Keun-Hee Kim, nurse    82-2-3010-7290    kuny9847@naver.com Less <<
NCT00126321 Leukemia, Myelocytic, Acute Phase 2 Unknown March 2011 Germany ... More >> Medical Clinic & Policlinic III, University Bonn Recruiting Bonn, Germany, 53105 Contact: Marie von Lilienfeld-Toal, MD    +49-228-287-22263    m.lilienfeld.toal@uni-bonn.de    Principal Investigator: Marie von Lilienfeld-Toal, MD Less <<
NCT02392572 Leukemia Phase 1 Phase 2 Recruiting November 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01360125 - Completed - -
NCT00003073 Brain and Central Nervous Syst... More >>em Tumors Leukemia Lymphoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Unknown - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235-8897 Texas Children's Cancer Center Houston, Texas, United States, 77030-2399 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T2T 5C7 Less <<
NCT02019069 Adult Acute Erythroid Leukemia... More >> (M6) Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Less << Phase 2 Recruiting December 2019 United States, California ... More >> Stanford University, School of Medicine Recruiting Stanford, California, United States, 94305 Contact: Jack Taw    650-723-1269    jtaw@stanford.edu    Principal Investigator: Rondeep Brar, MD Less <<
NCT02835222 Untreated Adult Acute Myeloid ... More >>Leukemia Less << Phase 2 Recruiting February 2020 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Timothy S. Pardee    336-716-5847    tspardee@wakehealth.edu    Principal Investigator: Timothy S. Pardee Less <<
NCT02768792 Acute Myeloid Leukemia, in Rel... More >>apse Less << Phase 2 Recruiting September 2025 United States, Maryland ... More >> Johns Hopkins School of Medicine The Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21205 Principal Investigator: Ivana Gojo, MD          United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599-7295 Contact: Clinical Trials Office - Lineberger Comprehensive Cancer Cente    877-668-0683 Less <<
NCT03570983 Multiple Myeloma Phase 2 Recruiting December 2021 United States, Washington ... More >> Swedish Cancer Institute Recruiting Seattle, Washington, United States, 98104 Contact: Neil Bailey       neil.bailey@swedish.org    Principal Investigator: William Bensinger, MD Less <<
NCT00077116 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - Belgium ... More >> AZ Sint-Jan Brugge, Belgium, 8000 Institut Jules Bordet Brussels, Belgium, 1000 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 H. Hartziekenhuis - Roeselaere. Roeselare, Belgium, 8800 Germany Ruprecht - Karls - Universitaet Heidelberg Heidelberg, Germany, D-69117 Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Leiden University Medical Center Leiden, Netherlands, 2300 CA Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Switzerland Universitaetsspital-Basel Basel, Switzerland, CH-4031 Less <<
NCT00952588 Acute Myeloid Leukemia Phase 2 Phase 3 Completed - -
NCT01011920 Central Nervous System Lymphom... More >>a Less << Phase 2 Completed - Germany ... More >> University Hospital Aachen, Germany Universitätsklinikum Erlangen Erlangen, Germany "Klinik für Hämatologie Universitätsklinikum Essen" Essen, Germany Uniklinik Freiburg Freiburg, Germany Universitätskrankenhaus Hamburg-Eppendorf Hamburg, Germany Friedrich Schiller Universitaet Jena Jena, Germany Johannes Gutenberg Universität Mainz Mainz, Germany Technische Universität in München München, Germany Universitätsklinikum Ulm Ulm, Germany Italy A.O. SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Spedali Civili Brescia, Italy San Raffaele H Scientific Institute Milan, Italy Ospedale Umberto I Nocera Inferiore, Italy Ospedale Civile S.Spirito Pescara, Italy Arcispedale Santa Maria Nuova Reggio Emilia, Italy Istituto Nazionale dei Tumori Regina Elena Roma, Italy Università degli Studi La Sapienza Roma, Italy Humanitas Rozzano, Italy Ospedale Maggiore S. Giovanni Battista Torino, Italy Policlinico G.B. Rossi Verona, Italy Switzerland IOSI - Oncology Institute of Southern Switzerland Bellinzona, Switzerland, 6500 United Kingdom Nottingham City Hospital Nottingham, United Kingdom Queen's Hospital Romford, United Kingdom Less <<
NCT02013648 Acute Myeloid Leukemia (AML) Phase 3 Recruiting May 2023 -
NCT03567876 Lymphoma, Mantle-Cell Phase 2 Not yet recruiting July 2025 Italy ... More >> A.O. SS. Antonio e Biagio e Cesare Arrigo, SC Ematologia Not yet recruiting Alessandria, Italy Contact: Marco Ladetto       marco.ladetto@ospedale.al.it    Principal Investigator: Marco Ladetto, MD          Università Politecnica delle Marche, Clinica di Ematologia Not yet recruiting Ancona, Italy Contact: Guido Gini       guido.gini@ospedaliriuniti.marche.it    Principal Investigator: Guido Gini, MD          Centro Riferimento Oncologico, S.O.C. Oncologia Medica A Not yet recruiting Aviano, Italy Contact: Michele Spina       mspina@cro.it    Principal Investigator: Michele Spina, MD          IRCCS Istituto Tumori Giovanni Paolo II, UOC Ematologia Not yet recruiting Bari, Italy Contact: Giacomo Loseto       loseto.giacomo@gmail.com    Principal Investigator: Giacomo Loseto, MD          Policlinico S. Orsola-Malpighi, Istituto di Ematologia "Seragnoli" Not yet recruiting Bologna, Italy Contact: Pier Luigi Zinzani       pierluigi.zinzani@unibo.it    Principal Investigator: Pier Luigi Zinzani, Prof          Ospedale Centrale di Bolzano, Divisione di Ematologia e T.M.O. Not yet recruiting Bolzano, Italy Contact: Michael Mian       michael.mian@asbz.it    Principal Investigator: Michael Mian, Prof          ASST Spedali Civili, Ematologia Not yet recruiting Brescia, Italy Contact: Alessandro Re       alessandro.re@asst-spedalicivili.it    Principal Investigator: Alessandro Re, MD          Ospedale Businco, Ematologia Not yet recruiting Cagliari, Italy Contact: Maria Giuseppina Cabras       cabras.giuseppina@tiscali.it    Principal Investigator: Maria Giuseppina Cabras, MD          Azienda Ospedaliera di Cosenza, UOC Ematologia Not yet recruiting Cosenza, Italy Contact: Massimo Gentile       massimogentile@virgilio.it    Principal Investigator: Massimo Gentile, MD          Azienda Ospedaliera S. Croce e Carle, SC Ematologia Not yet recruiting Cuneo, Italy Contact: Claudia Castellino       castellino.c@ospedale.cuneo.it    Principal Investigator: Claudia Castellino, MD          Azienda Ospedaliera Universitaria Careggi, Unità funzionale di Ematologia Not yet recruiting Firenze, Italy Contact: Luigi Rigacci       luigi.rigacci@unifi.it    Principal Investigator: Luigi Rigacci, MD          Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia, Clinica Ematologica Not yet recruiting Genova, Italy Contact: Marco Gobbi       gobbi@unige.it    Principal Investigator: Marco Gobbi, Prof          Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia, Ematologia Not yet recruiting Genova, Italy Contact: Angela Giovanna Congiu       angelagiovanna.congiu@hsanmartino.it    Principal Investigator: Angela Giovanna Congiu, MD          Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Ematologia Not yet recruiting Meldola, Italy Contact: Gerardo Musuraca       g.musuraca@irst.emr.it    Principal Investigator: Gerardo Musuraca, MD          ASST Grande Ospedale Metropolitano Niguarda, SC Ematologia Not yet recruiting Milano, Italy Contact: Vittorio Ruggero Zilioli       vittorioruggero.zilioli@ospedaleniguarda.it    Principal Investigator: Vittorio Ruggero Zilioli, MD          Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Ematologia Not yet recruiting Milano, Italy Contact: Paolo Corradini       paolo.corradini@unimi.it    Principal Investigator: Paolo Corradini, Prof          Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia Not yet recruiting Milano, Italy Contact: Andrés Ferreri       andres.ferreri@hsr.it    Principal Investigator: Andrés Ferreri, MD          Ospedale Maggiore Policlinico - Fondazione IRCCS Ca' Granda, Ematologia Not yet recruiting Milano, Italy Contact: Luca Baldini       luca.baldini@unimi.it    Principal Investigator: Luca Baldini, Prof          AOU Maggiore della Carità di Novara, SCDU Ematologia Not yet recruiting Novara, Italy Contact: Luca Nassi       luca.nassi@med.uniupo.it    Principal Investigator: Luca Nassi, MD          Azienda Ospedaliera Universitaria di Padova, Ematologia Not yet recruiting Padova, Italy Contact: Francesco Piazza       francesco.piazza@unipd.it    Principal Investigator: Francesco Piazza, MD          A.O. Ospedali Riuniti Villa Sofia-Cervello, Divisione di Ematologia Not yet recruiting Palermo, Italy Contact: Caterina Patti       k.patti@villasofia.it    Principal Investigator: Caterina Patti, MD          IRCCS Policlinico S. Matteo, Divisione di Ematologia Not yet recruiting Pavia, Italy Contact: Luca Arcaini       luca.arcaini@unipv.it    Principal Investigator: Luca Arcaini, Prof          Ospedale Guglielmo Da Saliceto, UO Ematologia Not yet recruiting Piacenza, Italy Contact: Annalisa Arcari       a.arcari@ausl.pc.it    Principal Investigator: Annalisa Arcari, MD          Ospedale delle Croci, Ematologia Not yet recruiting Ravenna, Italy Contact: Monica Tani       monica.tani@auslromagna.it    Principal Investigator: Monica Tani, MD          Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Ematologia Not yet recruiting Reggio Calabria, Italy Contact: Caterina Stelitano       caterinastelitano27@gmail.com    Principal Investigator: Caterina Stelitano, MD          Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova, Ematologia Not yet recruiting Reggio Emilia, Italy Contact: Francesco Merli       merli.francesco@ausl.re.it    Principal Investigator: Francesco Merli, MD          Ospedale degli Infermi, UO Ematologia Not yet recruiting Rimini, Italy Contact: Annalia Molinari       annalia.molinari@auslromagna.it    Principal Investigator: Annalia Molinari, MD          Policlinico Umberto I - Università "La Sapienza", Istituto Ematologia -Dipartimento di Biotecnologie Cellulari ed Ematologia Not yet recruiting Roma, Italy Contact: Maurizio Martelli       martelli@bce.uniroma1.it    Principal Investigator: Maurizio Martelli, Prof          Università Cattolica S. Cuore, Ematologia Not yet recruiting Roma, Italy Contact: Stefan Hohaus       stefan.hohaus@Unicatt.it    Principal Investigator: Stefan Hohaus, MD          Istituto Clinico Humanitas, UO Ematologia Not yet recruiting Rozzano, Italy Contact: Armando Santoro       armando.santoro@cancercenter.humanitas.it    Principal Investigator: Armando Santoro, MD          Casa Sollievo della Sofferenza, UO Ematologia Not yet recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla       n.cascavilla@operapadrepio.it    Principal Investigator: Nicola Cascavilla, MD          Azienda Ospedaliero Universitaria Senese, UOC Ematologia Not yet recruiting Siena, Italy Contact: Alberto Fabbri       fabbri7@unisi.it    Principal Investigator: Alberto Fabbri, MD          A.O.U. Città della Salute e della Scienza di Torino, SC Ematologia Universitaria Not yet recruiting Torino, Italy Contact: Federica Cavallo       f.cavallo@unito.it    Principal Investigator: Federica Cavallo, MD          A.O.U. Città della Salute e della Scienza di Torino, SC Ematologia Not yet recruiting Torino, Italy Contact: Annalisa Chiappella       achiappella@cittadellasalute.to.it    Principal Investigator: Annalisa Chiappella, MD          Ospedale Ca' Foncello, SC Ematologia Not yet recruiting Treviso, Italy Contact: Piero Maria Stefani       pmstefani@ulss.tv.it    Principal Investigator: Piero Maria Stefani, MD          Azienda Ospedaliera C. Panico, UOC Ematologia e Trapianto Not yet recruiting Tricase, Italy Contact: Vincenzo Pavone       salentoematologia@piafondazionepanico.it    Principal Investigator: Vincenzo Pavone, MD          Azienda Sanitaria Universitaria Integrata di Udine, Clinica Ematologica Not yet recruiting Udine, Italy Contact: Francesco Zaja       francesco.zaja@asuiud.sanita.fvg.it    Principal Investigator: Francesco Zaja, Prof          Ospedale di Circolo, UOC Ematologia Not yet recruiting Varese, Italy Contact: Michele Merli       michelepavia@hotmail.com    Principal Investigator: Michele Merli, MD          Azienda Ospedaliera Universitaria Integrata di Verona, UO Ematologia Not yet recruiting Verona, Italy Contact: Fabio Benedetti       fabio.benedetti@univr.it    Principal Investigator: Fabio Benedetti, MD          Ospedale San Bortolo, Divisione di Ematologia Not yet recruiting Vicenza, Italy Contact: Carlo Visco       carlo.visco@aulss8.veneto.it    Principal Investigator: Carlo Visco, MD Less <<
NCT00565058 Acute Myeloid Leukemia Phase 2 Completed - United States, California ... More >> San Francisco Veterans Affairs Medical Center San Francisco, California, United States, 94121 UCSF Medical Center San Francisco, California, United States, 94121 United States, Georgia Northside Hospital Atlanta, Georgia, United States, 30342 United States, Indiana Indiana Cancer Research Institute Indianapolis, Indiana, United States, 46202 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 The Mount Sinai Hospital New York, New York, United States, 10029 United States, Ohio The Ohio State University Columbus, Ohio, United States, 43210-1240 Less <<
NCT03181815 Acute Myeloid Leukemia ... More >> Relapse Leukemia Less << Phase 2 Recruiting May 1, 2019 China, Guangdong ... More >> Liang Wang Recruiting Guangzhou, Guangdong, China, 510060 Contact: Liang Wang, M.D.    +862087342439    wangliang@sysucc.org.cn Less <<
NCT02269579 Acute Myeloid Leukemia (AML) ... More >> Acute Lymphoblastic Leukemia (ALL) Myelodysplastic Syndrome (MDS) Less << Phase 2 Withdrawn June 2017 United States, California ... More >> Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 United States, Florida Shands Cancer Hospital @ University of Florida Gainesville, Florida, United States, 32610 United States, Indiana Franciscan St. Francis Health Indianapolis, Indiana, United States, 46237 United States, New Jersey John Theurer Cancer Center @ Hackensack Medical University Medical Center Hackensack, New Jersey, United States, 07601 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00354276 Leukemia Phase 2 Unknown - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 France Hopital Haut Leveque Pessac, France, 33604 United Kingdom University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00004643 Lupus Erythematosus, Systemic Phase 2 Completed - -
NCT00952588 - Completed - -
NCT00512083 Leukemia, Myeloid Phase 2 Completed - United States, California ... More >> UCLA Medical Center Los Angeles, California, United States, 90095 United States, Colorado Univeristy of Colorado Health Cancer Center Aurora, Colorado, United States, 80010 United States, Indiana St. Francis Hospital and Health Center Beech Grove, Indiana, United States, 46107 United States, Kentucky University of Louisville, James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 United States, Missouri Washington University St Louis, Missouri, United States, 63110 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Cancer Therapy and Research Center - Institute for Drug development San Antonio, Texas, United States, 78229 New Zealand Christchurch Hospital Christchurch, New Zealand Less <<
NCT03569995 Primary CNS Lymphoma Phase 2 Recruiting June 15, 2025 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Gangnam-gu,, Korea, Republic of, 06351 Contact: Kaeun Park, CRA    82-70-7014-4162    kaeun.park@samsung.com Less <<
NCT00565058 - Completed - -
NCT00840684 Leukemia Phase 1 Phase 2 Completed - France ... More >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Less <<
NCT00336583 Non-Hodgkin's Lymphoma Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT02502968 Acute Myeloid Leukemia Phase 2 Unknown - Germany ... More >> Univeritätsklinikum Halle, Klinik Innere Medizin 4 Recruiting Halle, Germany, 06120 Contact: Carsten Müller-Tidow Less <<
NCT00101153 Leukemia Phase 1 Completed - Canada, Ontario ... More >> McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario, Canada, L8N 3Z5 London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada, N6A 465 Less <<
NCT03318419 Acute Lymphoblastic Leukemia Phase 2 Recruiting December 31, 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510060 Contact: yue lu, MD.    0086-02087342438    dr_luyue@sina.com Less <<
NCT00505232 Mantle Cell Lymphoma Phase 2 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital Marques de Valdecilla Santander, Cantabria, Spain, 39008 Hospital del Mar Barcelona, Cataluña, Spain, 08003 Hospital Clinico de Valencia Valencia, Comunidad Valenciana, Spain, 46010 Hospital Dr. Peset Valencia, Comunidad Valenciana, Spain, 46017 Hospital Clínico de Santiago de Compostela Santiago de Compostela, Galica, Spain, 15705 Clinica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Clinica Ruber Madrid, Spain, 28006 Hospital La Princesa Madrid, Spain, 28006 Clinica Moncloa Madrid, Spain, 28008 Hospital Ramon y Cajal Madrid, Spain, 28034 Hospital Universitario Puerta de Hierro Madrid, Spain, 28035 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Quiron Madrid, Spain, 28224 Hospital Morales Meseguer Murcia, Spain, 30008 Hospital Clínico de Salamanca Salamanca, Spain, 37007 Less <<
NCT03335267 Leukemia, Myeloid, Acute Phase 2 Recruiting October 2022 United States, New York ... More >> Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Ellen K Ritchie, MD    646-962-2700    ritchie@med.cornell.edu    Contact: Elena Lascu, MA    212-746-0974    ell2028@med.cornell.edu Less <<
NCT00066794 Leukemia Phase 2 Completed - -
NCT00290498 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02937662 Acute Myeloid Leukemia Phase 2 Recruiting December 2018 China ... More >> Institute of Hematology & Blood Diseases Hospital Recruiting Tianjin, China Contact: lijun Liu Less <<
NCT02413021 Acute Myeloid Leukemia ... More >> Acute Lymphoid Leukemia Less << Phase 1 Unknown October 2016 -
NCT01338974 - Completed - -
NCT00014495 - Completed - -
NCT01674985 Myelodysplastic Syndromes Phase 1 Phase 2 Completed - China, Beijing ... More >> Affiliated Hospital of Academy of Military Medical Sciences Beijing, Beijing, China, 100071 Less <<
NCT00336583 - Completed - -
NCT00801489 Acute Myeloid Leukemia With In... More >>v(16)(p13.1q22); CBFB-MYH11 Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Inv(16) Myelodysplastic Syndrome With Excess Blasts t(16;16) t(8;21) Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Recruiting April 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Gautam Borthakur    713-563-1586       Principal Investigator: Gautam Borthakur Less <<
NCT00411905 Myelodysplastic Syndromes Phase 1 Phase 2 Unknown - France ... More >> CHU Angers Not yet recruiting Angers, France, 43033 Contact: Mathilde HUNAULT-BERGER, Professor    00 33 241354475    MaHunault@chu-angers.fr    Contact: Martine Gardembas-Pain, MD    00 33 241354705    MaGardembas@chu-angers.fr    Principal Investigator: Mathilde HUNAULT-BERGER, MD PhD          Hopital Avicenne Recruiting Bobigny, France, 93009 Contact: Pierre FENAUX, MD    00 33 1 48 95 70 50    pierre.fenaux@avc.aphp.fr    Contact: Fatima Hamza, CRA    00 33 1 48 95 58 90    fatima.hamza@avc.aphp.fr    Principal Investigator: Pierre FENAUX, MD PhD          Institut Bergonie Not yet recruiting Bordeaux, France, 33076 Contact: Josy REIFFERS, Profesor    00 33 05 56 33 33 00    reiffers@bergonie.org    Contact: Gabriel ETIENNE, MD    00 33 5 56 33 44 19    gabriel.etienne@chu-bordeaux.fr    Principal Investigator: Josy Reiffers, Profesor          Sub-Investigator: Gabriel ETIENNE, MD          CHU de Caen Not yet recruiting Caen, France, 14033 Contact: Stéphane CHEZE, MD    00 33 2 31 27 23 60    cheze-s@chu-caen.fr    Principal Investigator: Stéphane CHEZE, MD          CHU Dijon Recruiting Dijon, France, 21000 Contact: Elisabeth BERGER, MD    00 33 3 80 29 50 41    elisabeth.berger@chu-dijon.fr    Contact: Monique Grandjean, CRE    00 33 80 29 50 47    monique.grandjean@chu-dijon.fr    Sub-Investigator: Eric SOLARY, MD          Principal Investigator: Elisabeth BERGER, MD          CHU Albert Michallon Recruiting Grenoble, France, 38043 Contact: Jean-Yves CAHN, Professor    00 33 4 76 76 94 45    JYCahn@chu-grenoble.fr    Contact: Stephane COURBY, MD    00 33 4 76 76 59 53    Scourby@chu-grenoble.fr    Principal Investigator: Jean-Yves CAHN, MD          CHU de Limoges Not yet recruiting Limoges, France, 87046 Contact: Dominique BORDESSOULE, Profesor    00 33 5 55 05 66 42    bordessoule@unilim.fr    Principal Investigator: Dominique BORDESSOULE, Profesor          Hopital Paoli Calmette Recruiting Marseille, France, 13273 Contact: Norbert VEY, MD    00 33 4 31 22 36 95    veyn@marseille.fnclcc.fr    Principal Investigator: Norbert VEY, MD          Sub-Investigator: Aude CHARBONNIER, MD          Sub-Investigator: Reda BOUABDALLAH, MD          CHU Archet Not yet recruiting Nice, France, 06202 Contact: Laurence LEGROS, DOCTOR    00 33 4 92 03 58 44    legros@nice.fr    Principal Investigator: Laurence LEGROS, MD          Hopital Cochin Recruiting Paris, France, 75014 Contact: FRANCOIS DREYFUS, Profesor    00 33 1 58 41 21 20    francois.dreyfus@ch.aphp.fr    Contact: Nathalie Klein, CRE    00 33 1 58 41 20 44    nathalie.klein@cch.aphp.fr    Principal Investigator: François DREYFUS, Profesor          Centre Hospitalier Joffre Not yet recruiting Perpignan, France, 66046 Contact: Laurence Sanhes, MD    00 33 468616448    laurence.sanhes@ch-perpignan.fr    Principal Investigator: Laurence Sanhes, MD          Centre Henry Becquerel Active, not recruiting Rouen, France, 76038 Centre Hospitalier Universitaire de STRASBOURG Recruiting Strasbourg, France, 67098 Contact: Shanti NATARAJAN-AME, MD    00 33 3 88 12 76 70    shanti.ame@chru-strasbourg.fr    Contact: Marjorie SIDHOUM, CRA    00 33 3 88 12 81 48    marjorie.sidhoum@chru-strasbourg.fr    Principal Investigator: Shanti NATARAJAN-AME, MD          CHU Purpan Not yet recruiting Toulouse, France, 31059 Contact: Guy Laurent, MD    00 33 5 61 77 20 78    beynerauzy.o@chu-toulouse.fr    Principal Investigator: Guy LAURENT, MD          Sub-Investigator: Odile BEYNE-RAUZY, MD          CHU Brabois Recruiting Vandoeuvre, France, 54511 Contact: Agnes GUERCI-BRESLER, MD    00 33 3 83 15 3281    a.guerci@chu-nancy.fr    Principal Investigator: Agnes GUERCI-BRESLER, MD Less <<
NCT01247493 Acute Myeloid Leukemia Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00001048 HIV Infections ... More >> Leukoencephalopathy, Progressive Multifocal Less << Phase 2 Completed - United States, Colorado ... More >> University of Colorado Hospital CRS Aurora, Colorado, United States, 80262 United States, Florida Univ. of Miami AIDS CRS Miami, Florida, United States, 331361013 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital ACTG CRS Boston, Massachusetts, United States, 02114 United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York Univ. of Rochester ACTG CRS Rochester, New York, United States, 14642 United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States, 275997215 United States, Washington University of Washington AIDS CRS Seattle, Washington, United States, 981224304 Less <<
NCT03350152 - Completed - France ... More >> CORTIAL Pierre-Bénite, Rhone, France, 69310 Less <<
NCT00014495 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan - Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01555541 Diffuse Large Cell Lymphoma Re... More >>lapsed/Refractory Less << Phase 2 Recruiting June 2019 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94143 Principal Investigator: Charalambos Andreadis, MD, MSCE Less <<
NCT01027923 Leukemia, Myeloid, Acute Phase 1 Terminated(Withdrawal of suppo... More >>rt from sponsor) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02135874 Acute Bilineal Leukemia ... More >> Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Mixed Phenotype Acute Leukemia Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified Recurrent Mixed Phenotype Acute Leukemia Less << Phase 2 Recruiting October 30, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-4764       Principal Investigator: Elias Jabbour Less <<
NCT00389428 Hematologic Neoplasms Phase 1 Completed - United States, District of Col... More >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Florida H. Lee Moffit Cancer Center & Research Institute at the University of S. Florida Tampa, Florida, United States, 33612-9497 United States, New York North Shore University Hospital Manhasset, New York, United States, 11030 New York Presbyterian Hospital Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT01300156 Hodgkin's Lymphoma Phase 2 Unknown December 2013 Korea, Republic of ... More >> National Cancer Center, Korea Recruiting Goyang, Korea, Republic of Contact: Hyewon Lee, MD    +82-31-920-1765    hwlee@ncc.re.kr    Principal Investigator: Hyeon Seok Eom, MD, PhD Less <<
NCT00795756 Acute Lymphoblastic Leukemia Phase 2 Phase 3 Completed - Italy ... More >> USC Ematologia, Ospedale Civile Alessandria, (al), Italy USC Ematologia, Ospedali Riuniti Bergamo, (bg), Italy, 24128 Divisione di Ematologia - Spedali Civili Brescia, (bs), Italy Divisione di Ematologia e TMO, Ospedale San Maurizio Bolzano, (bz), Italy Ematologia e centro TMO - Ospedale Armando Businco Cagliari, (ca), Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, (cn), Italy Ematologia e centro TMO, Istituti Ospedalieri Cremona, (cr), Italy Ematologia - AOU Careggi Firenze, (fi), Italy Ematologia e centro TMO - IRCSS Mangiagalli Regina Elena Milano, (mi), Italy Ematologia e centro TMO, Ospedale San Raffaele Milano, (mi), Italy Ematologia e centro TMO, Ospedale San Gerardo Monza, (mi), Italy Oncoematologia e TMO - Dipartimento Oncologico La Maddalena Palermo, (pa), Italy Ematologia 2 - Ospedale San Giovanni Battista Torino, (to), Italy Medicina Interna I - Ospedale di Circolo Varese, (va), Italy Onco-Ematologia - Ospedale Civile Noale, (ve), Italy Ematologia - Ospedale San Bortolo Vicenza, (vi), Italy Less <<
NCT03718143 Myelofibroses ... More >> Acute Myeloid Leukemia Myelodysplastic Syndromes Less << Phase 2 Not yet recruiting May 1, 2021 -
NCT00488709 Acute Myeloid Leukemia Phase 4 Completed - Spain ... More >> Hospital Juan Canalejo A Coruña, Spain Hospital Ntra. Sra. de Sonsoles Avila, Spain Hospital germans Trias i Pujol Badalona, Spain Centro Médico Teknon Barcelona, Spain Hospital Sant Pau Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital General Yagüe Burgos, Spain Hospital de Jerez Cadiz, Spain Complejo hospitalario Xeral-Calde Lugo, Spain Hospital Clínico Universitario San Carlos Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Virgen de la Victoria Málaga, Spain Hosptal Joan XXIII Tarragona, Spain Hospital Verge de la Cinta Tortosa, Spain Hospital Rio Hortega Valladolid, Spain Hospital Clinico Lozano Blesa Zaragoza, Spain Less <<
NCT00004217 Leukemia Phase 2 Completed - -
NCT00180167 Leukemia, Nonlymphocytic, Acut... More >>e Less << Phase 4 Completed - Germany ... More >> Universitätsklinikum Dresden, Sachsen, Germany, D-1307 Less <<
NCT01126814 Leukemia Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01960192 Primary CNS Lymphoma (PCNSL) Phase 4 Recruiting June 2020 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com Less <<
NCT00260832 Acute Myeloid Leukemia Phase 3 Completed - -
NCT02728050 Acute Biphenotypic Leukemia ... More >> Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Myelodysplastic Syndrome Myeloproliferative Neoplasm Less << Phase 1 Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern    206-314-5944    halpern2@uw.edu    Principal Investigator: Anna Halpern Less <<
NCT00015951 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342-1601 United States, Maryland Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT03346096 Malignant Lymphoma Phase 2 Not yet recruiting December 2021 -
NCT00219765 Chronic Myeloid Leukemia Phase 1 Phase 2 Terminated - France ... More >> University Hospital Poitiers, France, 86021 Less <<
NCT00023777 Leukemia Phase 2 Completed - -
NCT00544999 Leukemia Phase 1 Unknown - France ... More >> Hopital Cochin Recruiting Paris, France, 75674 Contact: Sophie Park, MD    33-140-514-543 Less <<
NCT02428543 Acute Myeloid Lukemia Phase 1 Phase 2 Recruiting September 2020 France ... More >> Dr Abdelaziz CHAIB Recruiting Aix-en-Provence, France, 13600 Contact: Abdelaziz CHAIB       achaib@ch-aix.fr    Principal Investigator: Abdelaziz CHAIB          Chu Amiens Recruiting Amiens, France, 80054 Contact: MAROLLEAU Jean Pierre          Principal Investigator: MAROLLEAU Jean Pierre          CHU d'Angers Recruiting Angers, France, 49033 Contact: Martine GARDEMBAS       Magardembas@chu-angers.fr    Principal Investigator: Martine GARDEMBAS          Hôpital VICTOR DUPOUY Recruiting Argenteuil, France, 95107 Contact: AL JIJAKLI Ahmad       ahmad.aljijakli@ch-argenteuil.fr    Principal Investigator: AL JIJAKLI Ahmad          Dr Edouard RANDIAMALALA Recruiting Bayonne, France, 64100 Contact: Edouard RANDIAMALALA       erandiamalala@ch-cotebasque.fr    Principal Investigator: Edouard RANDIAMALALA          CHU de Besançon Recruiting Besançon, France, 25030 Contact: Fabrice LAROSA       flarosa@chu-besançon.fr    Principal Investigator: Fabrice LAROSA          Dr Thorsten BRAUN Recruiting Bobigny, France, 93000 Contact: Thorsten BRAUN       thorsten.braun@aphp.fr    Principal Investigator: Thorsten BRAUN          CHU Boulogne Sur Mer Recruiting Boulogne Sur Mer cedex, France, 62321 Contact: CHOUFI Bachra       b.choufi@ch-boulogne.fr    Principal Investigator: CHOUFI Bachra          Chr Clemenceau Recruiting Caen Cedex, France, 14033 Contact: REMAN Oumédaly       reman-o@chu-caen.fr    Principal Investigator: REMAN Oumédaly          Hôpital d'Instruction des Armées PERCY Recruiting Clamart, France, 92141 Contact: Jean Valère MALFUSSON       jvmalf@free.fr    Principal Investigator: Jean Valère MALFUSSON          Dr Stéphanie HAÏAT Recruiting Corbeil-essonnes, France, 91100 Contact: Stéphanie HAÏAT          Principal Investigator: Stéphanie HAÏAT          Hôpital Henri Mondor Recruiting Créteil, France, 94010 Contact: PAUTAS Cécile       cecile.pautas@hmn.aphp.fr    Principal Investigator: PAUTAS Cécile          CHU de Dijon Not yet recruiting Dijon, France, 21079 Contact: CAILLOT Denis       denis.caillot@chu-dijon.fr    Principal Investigator: CAILLOT Denis          Centre hospitalier de Versailles Recruiting Le Chesnay cedex, France, 78157 Contact: Rousselot Philippe    003339638622    phrousselot@ch-versailles.fr    Principal Investigator: Rousselot Philippe          Hôpital Claude Huriez Recruiting Lille cedex, France, 59037 Contact: QUESNEL Bruno       bquesnel@chru-lille.fr    Principal Investigator: QUESNEL Bruno          CHRU Dupuytren Not yet recruiting Limoges cedex, France, 87042 Contact: TURLURE Pascal       pascal.turlure@chu-limoges.fr    Principal Investigator: TURLURE Pascal          Hôpital Edouard Herriot Recruiting Lyon cedex 03, France, 69437 Contact: THOMAS Xavier       xavier.thomas@chu-lyon.fr    Principal Investigator: THOMAS Xavier          Dr Regis COSTELLO Recruiting Marseille, France, 13000 Contact: Regis COSTELLO       regis.costello@ap-hm.fr    Principal Investigator: Regis COSTELLO          Centre Hospitalier de Meaux Recruiting Meaux, France, 77104 Contact: FRAYFER Jamilé       j-frayfer@ch-meaux.fr    Principal Investigator: FRAYFER Jamilé          Dr Mario OJEDA-URIBE Recruiting Mulhouse, France, 68000 Contact: Mario OJEDA-URIBE       ojedam@ch-mulhouse.fr    Principal Investigator: Mario OJEDA-URIBE          Dr Jacques DELAUNAY Recruiting Nantes, France, 44000 Contact: Jacques DELAUNAY       jacques.delaunay@chu-nantes.fr    Principal Investigator: Jacques DELAUNAY          CHU Nice, Hôpital Archet 1 Recruiting Nice cedex 3, France, 06202 Contact: MANNONE Lionel       mannone.l@chu-nice.fr    Principal Investigator: MANNONE Lionel          CHU de Nîmes Recruiting Nîmes, France, 30029 Contact: Eric JOURDAN       eric.jourdan@chu-nimes.fr    Principal Investigator: Eric Jourdan          Hôpital Saint Antoine Recruiting Paris cedex 12, France, 75751 Contact: ISNARD Françoise       francoise.isnard@sat.aphp.fr    Principal Investigator: ISNARD Françoise          Hôpital Necker Enfants Malades Recruiting Paris cedex 15, France, 75743 Contact: SUAREZ Felipe       felipe.suarez@nck.aphp.fr    Principal Investigator: SUAREZ Felipe          Hôpital Saint Louis Recruiting Paris, France, 75010 Contact: RAFFOUX Emmanuel       emmanuel.raffoux@sls.ap-hop-paris.fr    Principal Investigator: RAFFOUX Emmanuel          Hôpital La Pitié Salpêtrière Recruiting Paris, France, 75013 Contact: UZUNOV Madalina       madalina.uzunov@psl.aphp.fr    Principal Investigator: UZUNOV Madalina          Dr Laurence SANHES Suspended Perpignan, France, 66000 Dr Arnaud PIGNEUX Recruiting Pessac, France, 33604 Contact: Arnaud PIGNEUX       arnaud.pigneux@chu-bordeaux.fr    Principal Investigator: Arnaud PIGNEUX          Centre Hospitalier René Dubos Recruiting Pontoise Cedex, France, 95303 Contact: VAIDA Iona Dana       ioana.vaida@ch-pontoise.fr    Principal Investigator: VAIDA Iona Dana          Marc BERNARD Recruiting Rennes, France, 35000 Contact: Marc BERNARD       marc.bernard@chu-rennes.fr    Principal Investigator: Marc BERNARD          Dr Emilie LEMASLE Recruiting Rouen, France, 76000 Contact: Emilie LEMASLE       emilie.lemasle@chb.unicancer.fr    Principal Investigator: Emilie LEMASLE          Centre Hospitalier René Huguenin Suspended Saint Cloud, France, 92210 Institut de Cancérologie de la Loire Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Emmanuelle TAVERNIER-TARDY       emmanuelle.tavernier@icloire.fr    Principal Investigator: Emmanuelle TAVERNIER-TARDY          Dr Réda GARIDI Recruiting Saint-Quentin, France, 02100 Contact: Réda GARIDI          Principal Investigator: Réda GARIDI          Dr Christian RECHER Recruiting Toulouse, France, 31000 Contact: Christian RECHER          Principal Investigator: Christian RECHER          Centre Hospitalier de Valenciennes Recruiting Valenciennes, France, 59322 Contact: FERNANDES José       fernandes-j@ch-valenciennes.fr    Principal Investigator: FERNANDES José Less <<
NCT00086099 Leukemia Acut... More >>e Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, California ... More >> Scripps Cancer Center San Diego, California, United States, 92121 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Indiana Cancer Care Center New Albany, Indiana, United States, 47150 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 Spectrum Health Hospitals-Cook Research Dept. (No longer recruiting) Grand Rapids, Michigan, United States, 49503 Great Lakes Cancer Center Management Specialties Grosse Point Woods, Michigan, United States, 48236 Cancer Management Specialists (No longer Recruiting) Grosse Pointe Woods, Michigan, United States, 48236 United States, New Jersey St. Barnabas Health Care Center Newark, New Jersey, United States, 07112 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, North Carolina Wake Forest University School of Medicine Winston-Salem, North Carolina, United States, 27157-1082 United States, Ohio Cleveland Clinic Foundation-Hemoatology/Oncology Cleveland, Ohio, United States, 44195-001 United States, Pennsylvania Thomas Jefferson University Medical College Philadelphia, Pennsylvania, United States, 19107 United States, Tennessee Baptist Clinical Research Center Memphis, Tennessee, United States, 38120 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Israel Rambam Medical Center Haifa, Israel, 31096 Rabin Medical Center Petach Tikva, Israel, 49100 Kaplan Med. Center Rehovot, Israel, 76100 Sheba Medical Center Tel Hasomer, Israel, 52620 Less <<
NCT01242774 Acute Myeloid Leukemia (AML) Phase 1 Completed - United States, California ... More >> Stanford University Medical Center Stanford U Stanford, California, United States, 94304 United States, Massachusetts Dana Farber Cancer Institute Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02115 United States, Ohio Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept.ofJamesCancerHospital Columbus, Ohio, United States, 43210 United States, South Carolina Medical University of South Carolina -Hollings Cancer Center MUSC/HCC (2) Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt 3 Nashville, Tennessee, United States, 37212 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Ulm, Germany, 89081 Spain Novartis Investigative Site Salamanca, Castilla y Leon, Spain, 37007 Novartis Investigative Site Barcelona, Spain, 08025 Less <<
NCT01859819 Diffuse Large Cell Lymphoma ... More >> Burkitt's Lymphoma High Grade B-cell Lymphoma Less << Phase 2 Recruiting December 2019 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Matthew Barth, MD       Matthew.Barth@RoswellPark.org    New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell S Cairo, MD    914-594-2150    mitchell_cairo@nymc.edu    Contact: Lauren Harrison, MSN       lauren_harrison@nymc.edu    United States, North Carolina Levine Children's Hospital Recruiting Charlotte, North Carolina, United States, 28204 Contact: Javier Oesterheld, MD       Javier.Oesterheld@carolinashealthcare.org    United States, Oklahoma University of Oklahoma Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Kimble Frazer, MD       kimble-frazer@ouhsc.edu    United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Michael Pulsipher, MD       michael.pulsipher@hsc.utah.edu Less <<
NCT00411281 Leukemia Phase 3 Withdrawn(Per Group Chair This... More >> study will not move forward.) Less << - -
NCT03709758 Acute Myeloid Leukemia Phase 1 Recruiting June 1, 2025 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Richard Stone, MD    617-632-5157    Richard_Stone@dfci.harvard.edu    Contact: Jeremy Stewart    617-582-8063    jeremym_stewart@dfci.harvard.edu    Principal Investigator: Richard Stone, MD Less <<
NCT00716066 Autoimmune Disease Phase 2 Recruiting December 1, 2021 United States, Colorado ... More >> Colorado Blood Cancer Institute Recruiting Denver, Colorado, United States, 80218 Contact: Richard A. Nash    720-754-4800    Richard.Nash@Healthonecares.com    Principal Investigator: Richard A. Nash          United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: George E. Georges    206-667-6886    ggeorges@fhcrc.org    Principal Investigator: George E. Georges          Swedish Medical Center-First Hill Recruiting Seattle, Washington, United States, 98122-4307 Contact: James Bowen    206-320-2200       Principal Investigator: James Bowen Less <<
NCT03031262 AML Phase 1 Phase 2 Recruiting December 2022 China, Tianjin ... More >> Institute of Hematology & Blood Diseases Hospital Recruiting Tianjin, Tianjin, China Contact: lijun Liu    86-22-23909237    bloodgcp@126.com Less <<
NCT03563560 Acute Myeloid Leukemia Phase 1 Recruiting October 31, 2019 Japan ... More >> Chugoku Central Hospital Not yet recruiting Fukuyama, Hiroshima, Japan Contact: Chugoku Central Hospital          Hokkaido University Hospital Not yet recruiting Sapporo, Hokkaido, Japan Contact: Hokkaido University Hospital          University of Tsukuba Hospital Not yet recruiting Tsukuba, Ibaraki, Japan Contact: University of Tsukuba Hospital          Tokai University Hospital Recruiting Isehara, Kanagawa, Japan Contact: Tokai University Hospital          Osaka City Hospital Organization Not yet recruiting Miyakojima-ku, Osaka, Japan Contact: Osaka City Hospital Organization          Kindai University Hospital Not yet recruiting Osakasayama, Osaka, Japan Contact: Kindai University Hospital          NTT Medical Center Tokyo Not yet recruiting Shinagawa-ku, Tokyo, Japan Contact: NTT Medical Center Tokyo          Kyushu University Hospital Not yet recruiting Fukuoka, Japan Contact: Kyushu University Hospital          National Hospital Organization Kyushu Medical Center Not yet recruiting Fukuoka, Japan Contact: National Hospital Organization Kyushu Medical Center          Fukushima Medical University Hospital Not yet recruiting Fukushima, Japan Contact: Fukushima Medical University Hospital Less <<
NCT00006343 Leukemia Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less <<
NCT00260832 - Completed - -
NCT01656252 Acute Myeloid Leukemia Phase 1 Phase 2 Terminated(Study stopped per N... More >>ovartis request due to futility from another study.) Less << - United States, Massachusetts ... More >> University of Massachusetts Worcester Worcester, Massachusetts, United States, 01655 United States, Minnesota Mayo Clinic, Rochester Rochester, Minnesota, United States, 55905 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Pennsylvania Penn State Hershey Cancer Institute Hershey, Pennsylvania, United States, 17033 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01854372 Newly Diagnosed Diffuse Large ... More >>B-Cell Lymphoma Intermediate (Burkitt-Like) Lymphoma Less << Phase 2 Withdrawn - -
NCT00854867 Solid Tumour Neoplastic Mening... More >>itis Brain Metastases Less << Phase 1 Completed - Austria ... More >> Feldkirch Regional Hospital Feldkirch, Austria Graz Medical University Graz, Austria Univeristy Clinic for Radiotherapy and Radio-Oncology Innsbruck, Austria Klagenfurt Regional Hospital Klagenfurt, Austria University Internal Medicine Clinic III Salzburg, Austria Kaiser-Franz-Josef-Spital Vienna, Austria Germany Heidelbert, Germany Less <<
NCT03654716 Leukemia Brai... More >>n Tumor Solid Tumor Lymphoma Less << Phase 1 Recruiting June 1, 2022 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Steven Dubois, MD    617-632-5460    steven_dubois@dfci.harvard.edu    Principal Investigator: Steven DuBois, MD Less <<
NCT00651261 Leukemia Phase 3 Active, not recruiting - -
NCT01656252 - Terminated(Study stopped per N... More >>ovartis request due to futility from another study.) Less << - -
NCT02432872 Acute Myeloid Leukemia Not Applicable Recruiting May 2021 China, Tianjin ... More >> Treatment and Diagnosis Center of Leukemia Recruiting Tianjin, Tianjin, China, 300020 Contact: Jianxiang Wang, MD    +862223909120    wangjx@medmail.com.cn    Contact: Chunlin Zhou, MD    +8613820429085    zcl7317@sina.com Less <<
NCT00651261 - Active, not recruiting - -
NCT02144675 - Completed - -
NCT01716793 Leukemia, Myelocytic, Acute Phase 2 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 ICO Hospital Universitari de Bellvitge L'Hospitalet del Llobregat, Barcelona, Spain, 08907 Hospital A Coruña A Coruña, Coruña, Spain, 15006 Hospital Universitari Son Espases Palma de Mallorca, Mallorca, Spain, 07198 Joan Bargay Palma de Mallorca, Mallorca, Spain, 07198 Hospital Verge de la Cinta Tortosa, Tarragona, Spain, 43517 Hospital del Mar Barcelona, Spain, 08003 Centro Medico Teknon Barcelona, Spain, 08022 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Vall d'Hebron Barcelona, Spain, 08035 Jordi Esteve Barcelona, Spain, 08036 Hopital Universitari de Girona Dr. Josep Trueta Girona, Spain, 17007 Hospital Universitari Arnau de Vilanova Lleida, Spain, 25006 Hospital Universitario Virgen de la Victoria Malaga, Spain, 29010 Hospital General Universitario de Murcia Murcia, Spain, 30008 Hospital Universitari Joan XXIII Tarragona, Spain, 43007 Mutua de Terrassa Terrassa, Spain, 08225 Hospital Clínico Universitario de Valencia Valencia, Spain, 496010 Hospital Universitario Rio Hortega Valladolid, Spain, 41010 Less <<
NCT00002800 Leukemia Myel... More >>odysplastic Syndromes Neutropenia Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01502982 Diffuse Large B-Cell Lymphoma Phase 2 Completed - Denmark ... More >> Odense University Hospital Odense, Denmark Finland Helsinki University central Hospital Helsinki, Finland Norway Oslo University Hospital Oslo, Norway Sweden Lund University Hospital Lund, Sweden Less <<
NCT01435343 Acute Myeloblastic Leukemia Phase 1 Phase 2 Completed - Spain ... More >> Hospital Universitari Germans Trials i Pujol Badalona, Spain Hospital Clínic de Barcelona Barcelona, Spain Hospital de la Santa Creu i Sant Pau. Barcelona, Spain Hospital Duran i Reynals - ICO L'Hospitalet Barcelona, Spain Hospital Universitario Vall d'Hebron Barcelona, Spain Hospital Universitario Reina Sofía Córdoba, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario 12 de Octubre Madrid, Spain Hospital Clínico Universitario de Salamanca Salamanca, Spain Hospital Universitari La Fe Valencia, Spain Less <<
NCT00909168 Acute Myeloid Leukemia Phase 2 Phase 3 Completed - Italy ... More >> University Hospital, Udine Udine, Italy, 33100 Less <<
NCT02046122 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 1 Phase 2 Active, not recruiting July 2020 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01451437 Acute Myelogenous Leukemia (AM... More >>L) Less << Phase 1 Terminated(The study was termi... More >>nated early due to business reasons.) Less << - -
NCT02144675 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT01451437 - Terminated(The study was termi... More >>nated early due to business reasons.) Less << - -
NCT02299518 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT02046122 - Active, not recruiting - -
NCT00003758 Leukemia Phase 2 Unknown - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 A.Z. St. Jan Brugge, Belgium, 8000 Institut Jules Bordet Brussels, Belgium, 1000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Croatia Medical School/University of Zagreb Zagreb, Croatia, 41000 University Hospital Rebro Zagreb, Croatia, 41000 France Hotel Dieu de Paris Paris, France, 75181 Hopital Necker Paris, France, 75743 Italy Ospedale San Eugenio Rome, Italy, 00144 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 Netherlands Groot Ziekengasthuis 's-Hertogenbosch 's-Hertogenbosch, Netherlands, 5211 NL Leiden University Medical Center Leiden, Netherlands, 2300 ZA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6252 HB Sint Joseph Ziekenhuis Veldhoven, Netherlands, 5500 MB DB Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Turkey Ibn-i Sina Hospital, Ankara Univeristy Ankara, Turkey, 06100 Less <<
NCT00823719 - Completed - -
NCT00823719 Lymphoma, Large-Cell, Diffuse Phase 2 Completed - -
NCT02236013 Acute Myeloid Leukemia Phase 1 Recruiting July 2022 United States, California ... More >> Site US10003 Recruiting Los Angeles, California, United States, 90095 United States, Connecticut Site US10013 Recruiting New Haven, Connecticut, United States, 06520 United States, Illinois Site US10004 Recruiting Chicago, Illinois, United States, 60611 United States, Kansas Site US10009 Recruiting Westwood, Kansas, United States, 66205 United States, Maryland Site US10001 Recruiting Baltimore, Maryland, United States, 21231 United States, New York Site US10002 Recruiting New York, New York, United States, 10032 United States, Ohio Site US10014 Recruiting Cleveland, Ohio, United States, 44106 Site US10008 Withdrawn Columbus, Ohio, United States, 43201 United States, Oklahoma Site US10019 Recruiting Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Site US10006 Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Texas Site US10010 Recruiting San Antonio, Texas, United States, 78229 Less <<
NCT02323607 Recurrent Adult Acute Myeloid ... More >>Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Suspended(internal data analys... More >>is) Less << September 30, 2018 United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT02461537 Acute Myeloid Leukemia Phase 3 Recruiting May 2020 Germany ... More >> Universitätsmedizin Mannheim III. Medizinische Klinik Hämatologie und Onkologie Recruiting Mannheim, Baden-Württemberg, Germany, 68167 Contact: Michaela Hausmann          Principal Investigator: Stefan A. Klein, PD Dr med          Robert-Bosch-Krankenhaus Recruiting Stuttgart, Baden-Württemberg, Germany, 70376 Contact: Sandra Heidmann          Principal Investigator: Martin Kaufmann, Dr. med.          Universitätsklinikum Tübingen Medizinische Klinik und Poliklinik Onkologie, Hämatologie, Rheumatologie und Pulmologie Recruiting Tübingen, Baden-Württemberg, Germany, 72076 Contact: Anja Junker          Principal Investigator: Wolfgang Bethge, Prof Dr Med          Rems-Murr-Kliniken gGmbH Recruiting Winnenden, Baden-Württemberg, Germany, 71364 Contact: Kathrin Kühn    07195591 ext 36022    kathrin.kuehn@rems-murr-klinikemn.de    Principal Investigator: Markus Schaich, Prof.Dr.med.          Klinikum Augsburg Recruiting Augsburg, Bavaria, Germany, 86156 Contact: Franziska Knieler          Contact: Silvia Söllner          Principal Investigator: Christoph Schmid, PD Dr. med.          Universitätsklinikum Erlangen Recruiting Erlangen, Bavaria, Germany, 91054 Contact: Ulrike Höfer          Contact: Evi Weiß          Principal Investigator: Stefan Krause, Prof Dr med          Klinikum Nürnberg Nord Medizinische Klinik 5 Recruiting Nürnberg, Bavaria, Germany, 90419 Contact: Karin Westphal          Principal Investigator: Kerstin Schäfer-Eckart, Dr Med          University Hospital Recruiting Dresden, Free State of Saxony, Germany, 01307 Contact: Johannes Schetelig, Prof          Elblandkliniken Stiftung & Co. KG Recruiting Riesa, Free State of Saxony, Germany, 01589 Contact: Maria Sonnenfeld    0352575 ext 3075    maria.sonnenfeld@elblandkliniken.de    Principal Investigator: Jörg Schubert, Prof.Dr.med.          Universitätsklinikum Frankfurt, Med. Klinik II - Hämatologie/Onkologie Recruiting Frankfurt am Main, Hessen, Germany, 60595 Contact: Wagner-Scherneck          Principal Investigator: Gesine Bug, PD Dr. med.          Universitätsklinikum Aachen, AÖR Recruiting Aachen, Nordrhein-Westphalen, Germany, 52074 Contact: Carmen Döring    024180 ext 35168    cdoering@ukaachen.de    Principal Investigator: Edgar Jost, PD Dr. med.          Universitätsklinikum Essen (AöR) Not yet recruiting Essen, Nordrhein-Westphalen, Germany, 45147 Contact: Elke Günther    0201723 ext 1861       Principal Investigator: Richard Noppeney, Dr.med.          Universitätsklinikum Münster, KMT-Zentrum Recruiting Münster, North Rhine-Westphalia, Germany, 48149 Contact: Vera Gordon          Contact: Birgit Mayerhoffer          Principal Investigator: Matthias Stelljes, Prof Dr Med          III. Medizinische Klinik und Poliklinik Universitätsmedizin der Johannes Gutenberg-Universität Mainz Recruiting Mainz, Rhineland-Palatinate, Germany, 55131 Contact: Christiane Schön          Contact: Andrea Schulz          Principal Investigator: Eva Wagner, Dr Med          Universitätsklinikum Halle (Saale) Klinik für Innere Medizin IV Hämatologie/Onkologie/Hämostaseologie Recruiting Halle, Saxony-Anhalt, Germany, 06120 Contact: Antje Kleinbauer          Principal Investigator: Lutz Peter Müller, Dr med habil          Helios Klinikum Berlin Buch Not yet recruiting Berlin, Germany, 13125 Contact: Katrin Müller    0309401 ext 52189       Principal Investigator: Herrad Baurmann, Dr.med. Less <<
NCT01253070 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia (Megakaryoblastic) With t(1;22)(p13.3;q13.1); RBM15-MKL1 Acute Myeloid Leukemia With a Variant RARA Translocation Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214 Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2A Acute Myeloid Leukemia With Variant MLL Translocations Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting - -
NCT03026842 Acute Myeloid Leukemia Phase 4 Active, not recruiting October 2024 China, Jilin ... More >> First Hospital of Jilin University Changchun, Jilin, China, 130021 Less <<
NCT02283177 Newly Diagnosed AML With FLT3 ... More >>Activating Mutations Less << Phase 2 Active, not recruiting January 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Cornell Medical College New York, New York, United States, 10065 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98195 Less <<
NCT02560025 - Active, not recruiting - -
NCT03023384 - Recruiting January 2022 Brazil ... More >> Hospital das Clinicas de Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil Contact: Rosane I Bittencourt, MD       rbittencourt@hcpa.edu.br    Principal Investigator: Rosane I Bittencourt, MD          Hospital das Clínicas da Unicamp Recruiting Campinas, São Paulo, Brazil Contact: Katia BB Pagnano, MD       kborgia@unicamp.br    Principal Investigator: Katia BB Pagnano, MD          Hospital das Clinicas de Ribeirão Preto Recruiting Ribeirao Preto, São Paulo, Brazil Contact: Luisa CA Koury, MD    +55-16-98106-9709    luisa.koury.lk@gmail.com    Sub-Investigator: Luisa CA Koury, MD          Hospital Mario Covas Recruiting Santo Andre, São Paulo, Brazil Contact: Ronald S Pallotta, MD       rp.cohs@yahoo.com.br    Principal Investigator: Ronald S Pallotta, MD          Hospital de Base de São José do Rio Preto Recruiting Sao Jose do Rio Preto, São Paulo, Brazil Contact: Marcos RP Oltramari, MD       marcos.oltramari@gmail.com    Principal Investigator: Marcos RP Oltramari, MD          Hospital São Paulo Recruiting Sao Paulo, São Paulo, Brazil Contact: Thiago R Noronha, MD       thinoronha@yahoo.com.br    Sub-Investigator: Thiago R Noronha, MD Less <<
NCT00004215 Anemia Leukem... More >>ia Neutropenia Thrombocytopenia Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01253070 - Active, not recruiting - -
NCT00078949 - Active, not recruiting - -
NCT00571493 Non-hodgkin's Lymphoma ... More >> Mantle Cell Lymphoma Less << Phase 1 Phase 2 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center, Section of Oncology/Hematology Omaha, Nebraska, United States, 68198-7680 Less <<
NCT02560025 Acute Myeloid Leukemia Phase 2 Active, not recruiting October 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00571493 - Completed - -
NCT02229266 Acute Myeloid Leukemia Phase 2 Recruiting September 2020 Germany ... More >> Klinikum Bayreuth Not yet recruiting Bayreuth, Germany Contact: Alexander Kiani, Prof. Dr. med.       alexander.kiani@klinikum-bayreuth.de    Principal Investigator: Alexander Kiani, Prof. Dr. med.          Klinikum Chemnitz Not yet recruiting Chemitz, Germany Contact: Regina Herbst, Dr. med.       r.herbst@skc.de    Principal Investigator: Mathias Hänel, PD Dr. med.          Universitätsklinikum Dresden Recruiting Dresden, Germany Contact: Malte von Bonin, Dr. med.       Malte.Bonin@uniklinikum-dresden.de    Principal Investigator: Malte von Bonin, Dr. med. Less <<
NCT00078949 Lymphoma Phase 3 Active, not recruiting December 2018 -
NCT00477412 Mantle Cell Lymphoma Phase 1 Phase 2 Active, not recruiting April 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01779843 Acute Myelogenous Leukemia Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02198482 Acute Myeloid Leukemia (AML) ... More >> High-risk Myelodysplastic Syndrome (MDS) Less << Phase 2 Terminated(development program... More >> of study drug volasertib was stopped by Boehringer Ingelheim due to manufacturing problems) Less << - Germany ... More >> Hospital Aschaffenburg Aschaffenburg, Germany, 63739 Helios Hospital Bad Saarow Bad Saarow, Germany, 15526 Vivantes Hospital Am Urban Berlin, Germany, 10967 Vivantes Hospital Neukölln Berlin, Germany, 12351 Charite Berlin Campus Virchow Hospital Berlin, Germany, 13353 Knappschaftskrankenhaus Bochum-Langendeer Bochum, Germany, 44892 University Hospital Bonn Bonn, Germany, 53105 Community Hospital Braunschweig Braunschweig, Germany, 38114 Hospital Darmstadt Darmstadt, Germany, 64283 University Hospital Düsseldorf Düsseldorf, Germany, 40225 Hospital Essen, Protestant Hospital Essen-Werden Essen, Germany, 45239 Hospital Esslingen Esslingen, Germany, 73730 Malteser Hospital St. Franziskus Flensburg, Germany, 24939 Hospital Frankfurt-Höchst Frankfurt, Germany, 65929 Medical Care Unit Osthessen Fulda, Germany, 36043 University Hospital Gießen Gießen, Germany, 35392 Wilhelm-Anton-Hospital Goch Goch, Germany, 47574 University Hospital Göttingen Göttingen, Germany, 37075 University Hospital Hamburg-Eppendorf Hamburg, Germany, 20246 Asklepios Hospital Altona Hamburg, Germany, 22763 Hospital Hanau Hanau, Germany, 63450 KRH Hospital Siloah-Oststadt-Heidehaus Hannover, Germany, 30459 Hannover Medical School Hannover, Germany, 30625 SLK-Hospital Heilbronn Heilbronn, Germany, 74078 Marienhospital Herne Herne, Germany, 44625 University Hospital des Saarlandes Homburg/Saar, Germany, 66421 Community Hospital Karlsruhe Karlsruhe, Germany, 76133 University Hospital Schleswig-Holstein Kiel, Germany, 24105 Caritas Hospital Lebach Lebach, Germany, 66822 Hospital Lippe-Lemgo Lemgo, Germany, 32657 University Hospital Magdeburg Magdeburg, Germany, 39120 University Hospital Johannes Gutenberg Mainz Mainz, Germany, 55131 Johannes Wesling Hospital Minden Minden, Germany, 32429 Stauferklinikum Schwäbisch-Gmünd Mutlangen, Germany, 73557 Hospital Schwabing München, Germany, 80804 Hospital rechts der Isar München München, Germany, 81675 Hospital Oldenburg Oldenburg, Germany, 26133 Hospital Passau Passau, Germany, 94032 Hospital Stuttgart Stuttgart, Germany, 70174 Diakonie Hospital Stuttgart Stuttgart, Germany, 70176 Hospital Traunstein Traunstein, Germany, 83278 Mutterhaus der Borromäerinnen Trier, Germany, 54290 Hospital Barmherzige Brüder Trier Trier, Germany, 54292 University Hospital Tübingen Tübingen, Germany, 72076 University Hospital Ulm Ulm, Germany, 89081 Less <<
NCT03412409 Acute Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 2 Recruiting March 1, 2020 China ... More >> Peking University, Institute of Hematolgoy Recruiting Beijing, China Contact: Xiao-Dong Mo Less <<
NCT01187810 Acute Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia Non-Hodgkin's Lymphoma Less << Phase 1 Active, not recruiting April 2018 United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03575325 Lymphoid Leukemia ... More >> Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia Relapsed Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting October 2022 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Elyce Turba    813-745-1706    elyce.turba@moffitt.org    Contact: Anthony McLaughlin    813-745-5941    anthony.mclaughlin@moffitt.org    Principal Investigator: Bijal Shah, M.D. Less <<
NCT01700673 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting November 2019 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 Less <<
NCT00850382 Acute Myeloid Leukemia (AML) Phase 1 Phase 2 Completed - -
NCT02575963 AML Phase 1 Phase 2 Recruiting February 2019 United States, California ... More >> UCLA Medical Center, Division of Hematology/Oncology Recruiting Los Angeles, California, United States, 90095 United States, Kentucky University of Kentucky, Markey Cancer Center Completed Lexington, Kentucky, United States, 40536 University of Louisville, James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 United States, Louisiana Ochsner Medical Center, The Gayle and Tom Benson Cancer Center Recruiting New Orleans, Louisiana, United States, 70121 United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 United States, New York Weill Medical College of Cornell University Recruiting New York, New York, United States, 10021 Columbia University Medical, Herbert Irving Comprehensive Cancer Center Recruiting New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center Completed New York, New York, United States, 10065 United States, North Carolina Duke Cancer Center Recruiting Durham, North Carolina, United States, 27705 United States, Pennsylvania University of Pennsylvania, Perelman Center for Advanced Medicine Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina St. Francis Cancer Center Recruiting Greenville, South Carolina, United States, 29607 United States, Texas Baylor Scott and White Research Institute, Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States, 75246 United States, Washington Swedish Cancer Institute, Center for Blood Disorders and Stem Cell Transplantation Recruiting Seattle, Washington, United States, 98104 Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 United States, West Virginia West Virginia University, Mary Babb Randolph Cancer Center Recruiting Morgantown, West Virginia, United States, 26506 United States, Wisconsin Medical College of Wisconsin Cancer Center Recruiting Milwaukee, Wisconsin, United States, 53226 Puerto Rico VA Caribbean Healthcare System Recruiting San Juan, Puerto Rico, 00921 Less <<
NCT01184898 - Completed - -
NCT01184898 AML Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT03384212 High Risk Acute Myeloid Leukem... More >>ia Allogeneic Hematopoeitic Stem Cell Transplantation Less << Phase 3 Recruiting July 31, 2020 China, Shanghai ... More >> Shanghai general hospital, Shanghai Jiaotong university school of medicine Recruiting Shanghai, Shanghai, China, 200080 Contact: Xingpeng Wang, M.D.,Ph. D.    86-21-63069298    sfph_edu2@163.com    Contact: Yanhong Zhu    86-21-63240090 ext 6213    sfph_edu2@shumu.edu.cn    Sub-Investigator: Jieling Jiang, M.D.          Principal Investigator: Xiaoxia Hu, M.D.          Principal Investigator: Qiang Liu, M.D.          Principal Investigator: Yajing Xu, M.D.          Principal Investigator: Ting Yang, M.D.          Principal Investigator: Huangfang Wang, M.D.          Sub-Investigator: Yang Cao, M.D. Less <<
NCT03054883 - Completed - -
NCT02809092 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting September 2020 Brazil ... More >> Centro Terapia e Tecnologia Celular Recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903 Contact: Lucia Silla, PhD    55 51 33597516    dralucia.silla@gmail.com    Contact: Vanessa Valim, Msc    55 51 33598850    vanessavalim@gmail.com Less <<
NCT02243436 CLASSICAL HODGKIN LYMPHOMA Phase 1 Phase 2 Active, not recruiting January 2019 Spain ... More >> Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Institut Català d'Oncologia, Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital Son Espases Palma, Islas Baleares, Spain Hospital del Mar Barcelona, Spain, 08003 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital General Universitario Gregorio Marañon Madrid, Spain, 28007 Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario de Canarias Santa Cruz de Tenerife, Spain, 38320 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Hospital Clínico de Valencia Valencia, Spain, 46010 Less <<
NCT03384225 High Risk Acute Myeloid Leukem... More >>ia Allogeneic Hematopoeitic Stem Cell Transplantation Less << Phase 3 Recruiting July 31, 2020 China, Shanghai ... More >> Shanghai general hospital, Shanghai Jiaotong university school of medicine Recruiting Shanghai, Shanghai, China, 200080 Contact: Xingpeng Wang, M.D.,Ph. D.    86-21-63069298    sfph_edu2@163.com    Contact: Yanhong Zhu    86-21-63240090 ext 6213    sfph_edu2@shumu.edu.cn    Sub-Investigator: Jieling Jiang, M.D.          Principal Investigator: Xiaoxia Hu, M.D.          Principal Investigator: Qiang Liu, M.D.          Principal Investigator: Yajing Xu, M.D.          Principal Investigator: Ting Yang, M.D.          Principal Investigator: Huangfang Wang, M.D.          Sub-Investigator: Yang Cao, M.D. Less <<
NCT03194932 Acute Myeloid Leukemia Phase 1 Recruiting August 2020 United States, California ... More >> Children's Hospital of Orange County Recruiting Orange, California, United States, 92868 Contact: Jamie Frediani, MD    714-509-8636    jfrediani@choc.org    Principal Investigator: Jamie Frediani, MD          Lucille Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Norman J. Lacayo, MD          United States, North Carolina UNC Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Thomas B. Alexander, MD    877-668-0683    talex@email.unc.edu    Principal Investigator: Thomas B. Alexander, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Jeffrey E Rubnitz, MD, PhD    866-278-5833    info@stjude.org    Principal Investigator: Jeffrey E Rubnitz, MD, PhD Less <<
NCT00180115 Leukemia, Nonlymphoblastic, Ac... More >>ute Less << Phase 4 Completed - Germany ... More >> Medical Department I, University Hospital Carl Gustav Carus Dresden, Germany, 01307 Less <<
NCT00143975 Leukemia, Myeloid, Acute Phase 2 Completed - Austria ... More >> Department of Hematology / Oncology, University Hospital of Innsbruck Innsbruck, Austria, A-6020 St. Johann Hospital, Clinical Center of Salzburg Salzburg, Austria, A-5020 Medical Department III, Hanusch-Hospital Wien, Austria, A-1140 Germany Medical Department II, Central Hospital of Augsburg Augsburg, Germany, 86156 Department of General Internal Medicine, University Hospital of Bonn Bonn, Germany, 53127 Department of Hematology and Oncology, Hospital Essen-Süd, Ev. Hospital of Essen-Werden Essen, Germany, 45239 Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst Frankfurt, Germany, 65929 Medical Department IV, University Hospital of Gießen Gießen, Germany, 35392 Department of Internal Medicine, Wilhelm-Anton-Hospital gGmbH Goch, Germany, 47574 Centre of Internal Medicine, University Hospital of Göttingen Göttingen, Germany, 37075 Department of Oncology and Hematology, University Hospital Eppendorf Hamburg, Germany, 20246 Medical Department III, Clinical Center Hanau Hanau, Germany, 63450 Medical Department III, Clinical Center Hannover-Siloah Hannover, Germany, 30449 Department of Hematology, Hemostaseology and Oncology, Medizinische Hochschule Hannover Hannover, Germany, 30625 Department of Internal Medicine I, University Hospital of Saarland Homburg, Germany, 66421 Medical Department II, City Hospital Karlsruhe gGmbH Karlsruhe, Germany, 76133 Medical Department II, University Hospital of Kiel Kiel, Germany, 24116 Department of Internal Medicine / Hematology and Oncology, Caritas Hospital Lebach Lebach, Germany, 66822 Department of Hematology / Oncology, Clinical center of Lüdenscheid Luedenscheid, Germany, 58515 Department of Hematology and internal Oncology, University Hospital of Mainz Mainz, Germany, 55101 Medical Department III, Clinical Center rechts der Isar München, Germany, 81675 Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH Oldenburg, Germany, 26133 Department of Hematology and Oncology / Caritas Hospital St. Theresia Saarbrucken, Germany, 66113 Department of Oncology / Clinical Center of Stuttgart Stuttgart, Germany, 70174 Department of Internal Medicine II, University Hospital of Tübingen Tübingen, Germany, 72076 Department of Internal Medicine III, University of Ulm Ulm, Germany, 89070 Medical Department I, Helios Hospital Wuppertal Wuppertal, Germany, 42283 Less <<
NCT00944008 Acute Lymphoblastic Leukemia Phase 3 Terminated - Spain ... More >> Hoapital General Alicante, Spain Hospital Clínic Barcelona, Spain Hospital de Sant Pau Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Duran i Reynals Barcelona, Spain Hospital vall d'Hebrón Barcelona, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico Madrid, Spain Hospital La Paz. Madrid, Spain Hospital Morales Meseguer. Murcia, Spain Hospital Virgen de la Arrixaca Murcia, Spain Hospital Carlos Haya. Málaga, Spain Hospital Clínico Virgen de la Victoria Málaga, Spain Hospital Son Dureta. Palma de Mallorca, Spain Hospital Clínico Universitario Salamanca, Spain Hospital Universitario Virgen del Rocío. Sevilla, Spain Hospital clínico Universitario Valencia, Spain Less <<
NCT03412266 Myelodysplastic Syndromes Phase 2 Recruiting March 1, 2020 China, Beijing ... More >> Peking University Institute of Hematology,Beijing Recruiting Beijing, Beijing, China, 100044 Contact: Xiao-Dong Mo       mxd453@163.com    Principal Investigator: Xiao-Jun Huang, MD Less <<
NCT00288626 Relapsing-Remitting Multiple S... More >>clerosis Less << Phase 2 Completed - United States, Ohio ... More >> Ohio State University School of Medicine Columbus, Ohio, United States, 43210 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 M.D. Anderson Cancer Center; Transplant site, please contact Baylor College of Medicine Houston, Texas, United States, 77230-1402 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT03724084 Acute Myeloid Leukemia ... More >> KMT2A Gene Rearrangement Less << Phase 1 Phase 2 Not yet recruiting June 30, 2019 -
NCT00651781 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - Spain ... More >> Hospital Germans Trias I Pujol Badalona, Spain Hospital Clinic y Provincial de Barcelona Barcelona, Spain Hospital Santa Creu y Sant Pau.Barcelona Barcelona, Spain Hospital Vall d´hebron Barcelona, Spain Hospital Juan Canalejo La Coruña, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos. Madrid, Spain Hospital Ramón y Cajal. Madrid Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Central de Asturias Oviedo, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital La Fe de Valencia Valencia, Spain Hospital Lozano Blesa Zaragoza, Spain Less <<
NCT00005601 Lymphoma Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Health Plaza Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 United States, Ohio CCOP - Toledo Community Hospital Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57104 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT02038777 Acute Myeloid Leukemia Phase 1 Recruiting October 31, 2019 Japan ... More >> Japanese Red Cross Nagoya First Hospital Recruiting Nagoya, Aichi, Japan, 453-8511 Kobe University Hospital Recruiting Kobe-shi, Hyogo, Japan, 650-0017 Tohoku University Hospital Recruiting Sendai, Miyagi, Japan, 980-8574 National Cancer Center Hospital Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Akita University Hospital Recruiting Akita, Japan, 010-8543 Kyushu University Hospital Recruiting Fukuoka, Japan, 812-8582 Tokyo Medical University Hospital Recruiting Tokyo, Japan, 160-0023 Less <<
NCT00003268 Drug/Agent Toxicity by Tissue/... More >>Organ Leukemia Less << Phase 1 Completed - United States, Pennsylvania ... More >> Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States, 19107-5541 Less <<
NCT00003827 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Unknown - United States, California ... More >> Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States, 91010-3000 Less <<
NCT00288626 - Completed - -
NCT01653067 Diffuse Large B-Cell Lymphoma Phase 2 Unknown July 2018 Germany ... More >> University Hospital Freiburg Freiburg, Baden-Württemberg, Germany, 79106 University of Heidelberg Hospital Heidelberg, Baden-Württemberg, Germany, 69120 University Hospital Ulm Ulm, Baden-Württemberg, Germany, 89081 University Hospital Erlangen Erlangen, Bayern, Germany, 91054 Ludwig-Maximilians-University of Munich Munich, Bayern, Germany, 81377 Technische Universität München Munich, Bayern, Germany, 81675 Johann Wolfgang Goethe University Hospitals, Frankfurt Frankfurt, Hessen, Germany, 60590 Johannes Guttenberg University Mainz Mainz, Rheinland-Pfalz, Germany, 55101 Charité University Berlin Berlin, Germany, 12200 Less <<
NCT02238925 - Completed - -
NCT02238925 Acute Myeloid Leukemia (AML) ... More >> Acute Lymphoblastic Leukemia (ALL) Myelodysplastic Syndrome (MDS) Less << Phase 2 Completed - United States, Indiana ... More >> Franciscan Saint Francis Health Indianapolis, Indiana, United States, 46237 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00559221 Acute Myeloid Leukemia Phase 2 Unknown June 2008 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Yae-Eun , Jang    82-2-3010-7290    redpin75@paran.com    Principal Investigator: Hawk Kim, professor Less <<
NCT02412475 Leukemia, Acute Myeloid Phase 1 Active, not recruiting February 2019 United States, Minnesota ... More >> Children's Hospitals and Clinics of Minnesota Minneapolis, Minnesota, United States, 55404 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00931138 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> CH Caen, France, 14033 Hopital Percy Clamart, France, 92141 CHU Creteil, France, 94010 CH Lens, France, 62307 CHU Lille, France, 59037 CH Limoges, France, 87042 Hopital Edouard Herriot Lyon, France St Antoine Hospital Paris, France, 75012 Hopital Pitie-Salpetriere Paris, France, 75651 Hopital Saint-Louis Paris, France CH Roubaix, France, 59100 CHU Rouen, France, 76038 CNLCC Saint-Cloud, France, 92210 CH Valenciennes, France, 59322 CH Versailles, France IGR Villejuif, France, 94805 Less <<
NCT02286726 Leukemia Phase 2 Active, not recruiting May 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03315520 Relapsed/Refractory Malignant ... More >>Lymphomas Less << Phase 2 Recruiting December 31, 2020 Russian Federation ... More >> The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation Recruiting Moscow, Russian Federation, 105203 Contact: Vladislav Sarzhevskiy, MD, PhD    +74956037217    vladsar100@gmail.com    Contact: Nikita Mochkin, MD, PhD    +74956037217    nickmed@yandex.ru Less <<
NCT02520011 Acute Myeloid Leukemia Phase 2 Recruiting December 2019 -
NCT01810705 Acute Myeloid Leukemia Phase 2 Completed - France ... More >> Hôpital l'Archet 1 Nice, Alpes Maritimes, France, 06200 Institut Paoli Calmettes Marseille, Bouche Du Rhone, France, 13000 Hôpital JEAN MINJOZ Besancon, Doubs, France, 25000 Hopital Morvan Brest, Finistere, France, 29200 Hôpital Haut-Lévèque Pessac, Gironde, France, 33600 CHRU de Nîmes Nimes, Guard, France, 30000 Hopital de Hautepierre Strasbourg, Haut Rhin, France, 67000 Hopital De Purpan CHU Toulouse Toulouse, Haute Garonne, France, 31500 Hopital Région d'Annecy Pringy, Haute Savoie, France, 74000 Hôpital Saint Eloi Montpellier, Hérault, France, 34295 Hôtel Dieu - CHU de NANTES Nantes, Loire Atlantique, France, 44200 Institut de Cancérologie de la Loire Saint-priest-en-jarez, Loire, France, 42270 Chu D'Angers Angers, Maine Et Loire, France, 49000 Hopital de Brabois Vandoeuvre Les Nancy, Meurthe Et Moselle, France, 54500 Hôpital Claude-Huriez Lille, Nord, France, 59800 CHU Estaing Clermont-ferrand, Puy De Dome, France, 63000 hopital de Perpignan Perpignan, Pyrénées Orientales, France, 66100 Centre Léon Bérard Lyon, Rhone Alpes, France, 69008 Centre hospitalier Lyon Sud Pierre Benite, Rhone Alpes, France, 69310 Centre Henri Becquerel Rouen, Seine Maritime, France, 76100 Groupe Hospitalier Sud Amiens, Somme, France, 80090 Less <<
NCT00041132 Lymphoma Phase 2 Completed - -
NCT00041132 - Completed - -
NCT00400673 Acute Myelogenous Leukemia Phase 2 Completed - Italy ... More >> USC Ematologia Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24128 Divisione Ematologia Spedali Civili di Brescia Brescia, BS, Italy, 25123 Divisione di Ematologia e TMO Ospedale San Maurizio Bolzano, BZ, Italy, 39100 Ematologia Azienda Ospedaliera S. Croce e Carle Cuneo, CN, Italy, 12100 Ematologia e TMO Ospedale San Raffaele Milano, MI, Italy, 20132 Ematologia e TMO Istituto Nazionale dei Tumori Milano, MI, Italy, 20133 Ematologia-TMO Ospedale San Gerardo Monza, MI, Italy, 20052 Oncoematologia e TMO Dipartimento Oncologico Palermo, PA, Italy, 90146 Ematologia 2 Ospedale San Giovanni Battista Torino, TO, Italy, 10126 Medicina Interna I Ospedale di Circolo Varese, VA, Italy, 21100 Divisione Ematologia Ospedale Umberto I Mestre Mestre, VE, Italy, 30172 Dipartimento di Oncologia e di Ematologia Oncologica Regione Veneto ULSS n.13- Presidi Ospedalieri di Noale, Dolo, Mirano Noale, VE, Italy, 30033 Less <<
NCT00029523 Meningeal Neoplasms Phase 4 Completed - -
NCT01546038 Acute Myeloid Leukemia Phase 2 Active, not recruiting June 2019 -
NCT00003934 Adult Acute Myeloid Leukemia W... More >>ith t(15;17)(q22;q12) Adult Acute Promyelocytic Leukemia (M3) Childhood Acute Promyelocytic Leukemia (M3) Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 United States, North Carolina Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT02310321 Acute Myeloid Leukemia Phase 1 Active, not recruiting April 2020 Japan ... More >> Site JP00003 Aichi, Japan Site JP00001 Fukuoka, Japan Site JP00002 Gunma, Japan Site JP00007 Hyogo, Japan Site JP00006 Kanagawa, Japan Site JP00005 Tokyo, Japan Less <<
NCT00408278 Acute Promyelocytic Leukemia Phase 4 Completed - Poland ... More >> PALG Lodz, Poland Spain Hospital General Albacete, Spain Hospital general Alicante, Spain Hospital germans Trias i Pujol Badalona, Spain Hospital Clinic Barcelona, Spain Hospital de Sant Pau Barcelona, Spain Institut Català d'Oncologái Barcelona, Spain Basurtuko Ospitalea Bilbao, Spain Hospital general Castellon, Spain Hospital de Fuenlabrada Fuenlabrada, Spain Hospital "Dr. Trueta" Gerona, Spain Hospital de Jerez de la Frontera Jerez de la Frontera, Spain Hospital Juan Canalejo La Coruña, Spain Hospital Insular de las Palmas Las Palmas de Gran Canaria, Spain Complejo Hospitalario León Leon, Spain Complexo Hospitalario Xeral-Calde Lugo, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Puerta de Hierro Madrid, Spain Hospital Reina Sofia Madrid, Spain Hospital San Pedro de Alcántara Madrid, Spain Hospital Severo Ochoa Madrid, Spain Hospital Sta. Maria del Rosell Murcia, Spain H. Carlos Haya Málaga, Spain H. Universitario Virgen de la Victoria Málaga, Spain Hospital Central de Asturias Oviedo, Spain Hospital Dr Negrín Palma de Gran Canaria, Spain Hospital de Navarra Pamplona, Spain Hospital de Montecelo Pontevedra, Spain Hospital Clínico Universitario Salamanca, Spain Hospital de Cruces Santander, Spain Hospital de Santiago de Compostela Santiago de Compostela, Spain H.U. Virgen del Rocio Sevilla, Spain Hospital Joan XXIII Tarragona, Spain Hospital Dr. Peset Valencia, Spain Hospital general Valencia, Spain Hospital La Fe Valencia, Spain Hospital Clínico de Valladolid Valladolid, Spain Hospital Txagorritxu Vitoria, Spain Hospital Virgen de la Concha Zamora, Spain Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain Uruguay Hospital Maciel Montevideo, Uruguay Less <<
NCT00517699 Lymphoma Phase 2 Terminated(Study was terminate... More >>d early due to lack of enrollment.) Less << - Canada, Quebec ... More >> Greenfield Park, Quebec, Canada, J4V 2H1 Quebec City, Quebec, Canada, G1J 1Z4 Less <<
NCT00517699 - Terminated(Study was terminate... More >>d early due to lack of enrollment.) Less << - -
NCT01653418 Multiple Myeloma Phase 2 Terminated(Due to the high rat... More >>e of morbidity and mortality) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63122 Less <<
NCT01653418 - Terminated(Due to the high rat... More >>e of morbidity and mortality) Less << - -
NCT02582359 Acute Myeloid Leukemia Phase 1 Recruiting February 2022 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Philip C Amrein, MD    617-724-1124       Principal Investigator: Philip C Amrein, MD Less <<
NCT01423175 Acute Myeloid Leukemia ... More >> MDS Less << Phase 2 Unknown - Germany ... More >> Hannover Medical School Recruiting Hannover, Germany, 30625 Contact: Arnold Ganser, Prof. Dr.    ++49-511-532-3020    ganser.arnold@mh-hannover.de    Universitaetsklinikum des Saarlandes Not yet recruiting Homburg/Saar, Germany, 66421 Contact: Michael Pfreundschuh, Prof. Dr.    ++49-6841-16-23002    pfreundschuh@unikliniksaarland.de    Universitaetsklinikum Leipzig AoeR Not yet recruiting Leipzig, Germany, 04103 Contact: Dietger Niederwieser, Prof. Dr.    ++49-341-0713050    dietger.niederwieser@medizin.uni-leipzig.de Less <<
NCT00004862 Leukemia Phase 1 Completed - United States, Ohio ... More >> Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210-1240 Less <<
NCT01546038 - Active, not recruiting - -
NCT03453255 Chemotherapy Phase 1 Phase 2 Recruiting December 31, 2020 China ... More >> Chinese PLA General Hospital Recruiting Beijing, China, 100853 Contact: Li Yu, M.D. Ph.D.    86-010-55499003    chunhuiliyu@yahoo.com    Principal Investigator: Li Yu, M.D. Ph.D. Less <<
NCT00258271 Leukemia Phase 1 Completed - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT01188174 AML Phase 2 Completed - France ... More >> CHU de Bordeaux Bordeaux, France CHU Caen Caen, France CHRU lille Lille, France Hôpital Edouard Herriot Lyon, France Institut Paoli Calmette Marseille, France Nantes University hospital Nantes, France, 44200 Paris saint Louis Paris, France CHRU de Strasbourg Strasbourg, France CHU Toulouse Toulouse, France Less <<
NCT00219739 Chronic Myeloid Leukemia Phase 3 Completed - France ... More >> University Hospital Poitiers, France, 86021 Less <<
NCT02275663 Acute Myeloid Leukemia Phase 2 Unknown October 2018 Saudi Arabia ... More >> King Fahad Medical City Recruiting Riyadh, Saudi Arabia, 11525 Contact: Ibraheem Motabi, MD    +966112889999 ext 11998    imotabi@kfmc.med.sa Less <<
NCT02441803 Leukemia Phase 2 Active, not recruiting September 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03512197 Acute Myeloid Leukemia (AML) Phase 3 Recruiting April 20, 2026 -
NCT02329080 Diffuse Large B-cell Lymphoma Phase 2 Recruiting December 2023 Czechia ... More >> Facultni nemocnice Recruiting Brno, Czechia Contact: Andrea Janikova          Principal Investigator: Andrea Janikova          FNKV (Facultni Nemocnice Kralovske Vinohrady) Recruiting Praha, Czechia Contact: Heidi Mocikova          Principal Investigator: Heidi Mocikova          Vseobecna facultni nemocnice v Praze Not yet recruiting Praha, Czechia Contact: Robert Pytlik          Principal Investigator: Robert Pytlik          Italy Spedali Civili Recruiting Brescia, Italy Contact: Giuseppe Rossi          Principal Investigator: Giuseppe Rossi          UO Ematologia e CTMO, PO Businco Recruiting Cagliari, Italy Contact: Giuseppina Cabras          Principal Investigator: Giuseppina Cabras          IRST Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Recruiting Meldola, Italy Contact: Gerardo Musuraca          Principal Investigator: Gerardo Musuraca          UO Ematoliga Ospedale dell'Angelo Recruiting Mestre, Italy Contact: Renato Bassan          Principal Investigator: Renato Bassan          Istituto Nazionale Tumori Recruiting Milano, Italy Principal Investigator: Liliana Devizzi          Ospedale Maggiore Policlinico Recruiting Milano, Italy Contact: Maria Cecilia Goldaniga          Principal Investigator: Maria Cecilia Goldaniga          San Raffaele H Scientific Institute Recruiting Milan, Italy Contact: Andres Ferreri, MD       ferreri.andres@hsr.it    Principal Investigator: Andrés JM Ferreri, MD          AOU Policlinico di Modena Recruiting Modena, Italy Contact: Franco Narni          Principal Investigator: Franco Narni          SCDU Ematologia Recruiting Novara, Italy Contact: Gianluca Gaidano          Principal Investigator: Gianluca Gaidano          Ematologia ed Immunologia Clinica - AO di Padova Recruiting Padova, Italy Contact: Renato Zambello          Principal Investigator: Renato Zambello          UO Oncoematologia Ospedale Tortora Recruiting Pagani, Italy Contact: Catello Califano          Principal Investigator: Catello Califano          Villa Sofia - Cervello Recruiting Palermo, Italy Contact: Caterina Patti          Principal Investigator: Caterina Patti          Ematologia AOU Recruiting Parma, Italy Contact: Francesca Re          Principal Investigator: Francesca Re          Ematologia Ospedale S.Maria delle Croci Recruiting Ravenna, Italy Contact: Claudia Cellini          Principal Investigator: Claudia Cellini          A.O. Bianchi-Melacrino-Morelli, Divisione di Ematologia Recruiting Reggio Calabria, Italy Contact: Caterina Stelitano, MD          Principal Investigator: Caterina Stelitano, MD          Arcispedale Santa Maria Nuova, Azienda Ospedaliera di Reggio Emilia Recruiting Reggio Emilia, Italy Contact: Fiorella Ilariucci          Principal Investigator: Fiorella Ilariucci          Ematologia Università La Sapienza Recruiting Roma, Italy Contact: Maurizio Martelli          Principal Investigator: Maurizio Martelli          IRCCS Istituto Regina Elena (IFO) Recruiting Roma, Italy Contact: Francesca Palombi          Principal Investigator: Francesca Palombi          Policlinico Universitario Campus Bio-Medico Recruiting Rome, Italy Contact: Ombretta Annibali          Principal Investigator: Ombretta Annibali          IRCCS Casa Sollievo Della Sofferenza Recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla          Principal Investigator: Nicola Cascavilla          AOU Senese Recruiting Siena, Italy Contact: Alberto Fabbri          Principal Investigator: Alberto Fabbri          AO S.Maria di Terni Recruiting Terni, Italy Contact: Anna Marina Liberati          Principal Investigator: Anna Marina Liberati          SC Ematologia AO Città della Salute e della Scienza Recruiting Torino, Italy Contact: Barbara Botto          Principal Investigator: Barbara Botto          UO Ematologia Ospedale Panico Recruiting Tricase, Italy Contact: Vincenzo Pavone          Principal Investigator: Vincenzo Pavone          AOU Santa Maria della Misericordia Recruiting Udine, Italy Contact: Francesco Zaja          Principal Investigator: Francesco Zaja          UOC Ematologia Policlinico Rossi Recruiting Verona, Italy Contact: Achille Ambrosetti          Principal Investigator: Achille Ambrosetti          Ematologia Ospedale S. Bortolo Recruiting Vicenza, Italy Contact: Maurizio Frezzato          Principal Investigator: Maurizio Frezzato          Netherlands Erasmus MC Recruiting Rotterdam, Netherlands Contact: Jeanette Doorduijn          Principal Investigator: Jeanette Doorduijn          United Kingdom Beatson Cancer Center Recruiting Glasgow, United Kingdom Contact: Pam Mc Kay          Principal Investigator: Pam Mc Kay          Liverpool Aintree Recruiting Liverpool, United Kingdom Contact: Jeffery Smith          Principal Investigator: Jeffery Smith          UCLH University College London Hospitals NHS foundation trust Recruiting London, United Kingdom Contact: Kate Cwynarski          Principal Investigator: Kate Cwynarski          The Christie Hospital Recruiting Manchester, United Kingdom Contact: Kim Linton          Principal Investigator: Kim Linton          Southampton General Hospital Not yet recruiting Southampton, United Kingdom Contact: Andrew Davies          Principal Investigator: Andrew Davies Less <<
NCT03207334 Acute Myeloid Leukemia Phase 2 Withdrawn(Insufficient funding... More >>) Less << January 2022 United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT01169363 - Completed - -
NCT02527174 Leukemia, Myeloid, Acute ... More >> Leukemia, Monocytic, Acute Leukemia, Myelomonocytic, Acute Leukemia, Erythroblastic, Acute Leukemia, Megakaryoblastic, Acute Less << Phase 1 Withdrawn(Volasertib no longer... More >> available) Less << September 2018 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2G3 Less <<
NCT01588951 Acute Myeloid Leukemia Phase 2 Phase 3 Terminated(Low accrual) - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 Less <<
NCT01324063 Leukemia Phase 3 Completed - -
NCT00107523 Leukemia Phase 1 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00136084 Leukemia, Myelocytic, Acute Phase 3 Completed - United States, California ... More >> Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Children's Hospital of Michigan (Wayne State University) Detroit, Michigan, United States, 48201 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 MD Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Cancer Center Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00136084 - Completed - -
NCT03735446 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 1 Not yet recruiting June 1, 2021 United States, Massachusetts ... More >> Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Eric s Winer, MD    617-632-3000    EricS_Winer@DFCI.HARVARD.EDU    Principal Investigator: Eric S. Winer, MD Less <<
NCT02416388 Acute Myeloid Leukemia (AML) Phase 2 Phase 3 Recruiting - -
NCT03092674 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts-2 Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Phase 3 Suspended(Other - Safety data ... More >>review, unscheduled) Less << August 1, 2023 -
NCT01588951 - Terminated(Low accrual) - -
NCT03583424 Hematopoietic Cell Transplanta... More >>tion Recipient Recurrent Diffuse Large B-Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Marginal Zone Lymphoma Refractory Non-Hodgkin Lymphoma Refractory Transformed Indolent Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Recruiting December 31, 2021 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Basem M. William, MD    614-688-7942    Basem.William@osumc.edu    Principal Investigator: Basem M. William, MD Less <<
NCT00037596 Acute Myeloid Leukemia Phase 2 Completed - -
NCT01449344 Mantle Cell Lymphoma Phase 3 Active, not recruiting December 2018 -
NCT01698879 Novo Acute Myeloid Leukemia Phase 2 Unknown December 2016 Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Clinic Barcelona Barcelona, Spain, 08036 Hospital Clinico Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario Virgen del Rocio Sevilla, Spain, 41013 Hospital Clínico Universitario de Valencia Valencia, Spain, 496010 Less <<
NCT00235560 Acute Myeloid Leukemia Phase 2 Completed - France ... More >> Service d'Hématologie, CHU Angers, France, 49100 Service d'Hématologie, Hôpital Jean Minjoz BESANçON, France, 25000 Service d'Hématologie CHU Purpan Toulouse, France, 31059 Less <<
NCT02835729 Acute Myeloid Leukemia Phase 1 Recruiting July 2018 United States, Georgia ... More >> Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Sandra Wall, RN    706-721-4430    swall@augusta.edu    Principal Investigator: Jeremy Pantin, MD          United States, Maryland University of Maryland Recruiting Baltimore, Maryland, United States, 21201 Contact: Mohammad Imran, M.D.    410-328-2243    mohammad.imran@umm.edu    Principal Investigator: Ashkan Emadi, M.D., Ph.D.          Johns Hopkins Not yet recruiting Baltimore, Maryland, United States, 21287 Principal Investigator: B. Douglas Smith, MD Less <<
NCT00121303 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - United Kingdom ... More >> North Hampshire Hospital Basingstoke, England, United Kingdom, RG24 9NA Kent and Canterbury Hospital Canterbury, England, United Kingdom, CT2 7NR Medway Maritime Hospital Gillingham Kent, England, United Kingdom, ME7 5NY Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Royal Cornwall Hospital Truro, Cornwall, England, United Kingdom, TR1 3LJ University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT01411267 Lymphoblastic Leukemia, Acute,... More >> Childhood Myelogenous Leukemia, Acute, Childhood Less << Phase 1 Completed - -
NCT00788892 Acute Myeloid Leukemia Phase 2 Completed - -
NCT00788892 - Completed - -
NCT01055483 Acute Myeloid Leukemia Phase 1 Completed - France ... More >> Novartis Investigative Site Paris Cedex 4, France, 75181 Novartis Investigative Site Paris, France, 75475 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Ulm, Germany, 89081 Less <<
NCT00299182 Lymphoma Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00779714 Melanoma Phase 3 Unknown April 2013 Germany ... More >> Dept of Dermatology, University of Aachen Recruiting Aachen, Germany, 52074 Principal Investigator: Hans F Merk, Prof. (MD)          Dept of Dermatology, University of Berlin Charite Recruiting Berlin, Germany, 10117 Principal Investigator: Uwe Trefzer, PD (MD)          Dept of Dermatology, University of Bochum Recruiting Bochum, Germany, 44791 Principal Investigator: Norbert Brockmeyer, Prof. (MD)          Medizinisches Zentrum Bonn Friedensplatz Recruiting Bonn, Germany, 53111 Principal Investigator: Uwe Reinhold, Prof. (MD)          Dept of Dermatology, University of Essen Recruiting Essen, Germany, 45147 Principal Investigator: Dirk Schadendorf, Prof. (MD)          Dept of Dermatology, University of Frankfurt Recruiting Frankfurt / Main, Germany, 60590 Principal Investigator: Roland Kaufmann, Prof. (MD)          Dermatology, Klinikum Frankfurt/Oder Recruiting Frankfurt/Oder, Germany, 15236 Principal Investigator: Anett Milling, Dr. (MD)          Dept of Dermatology, University of Hannover Recruiting Hannover, Germany, 30449 Principal Investigator: Ralf Gutzmer, PD (MD)          Dept of Dermatology, Saarland University Recruiting Homburg/Saar, Germany, 66421 Principal Investigator: Knuth Rass, Dr. (MD)          Dept of Dermatology, University of Jena Recruiting Jena, Germany, 07740 Principal Investigator: Martin Kaatz, Dr. (MD)          Dept of Dermatology, University of Schleswig-Holstein Campus Kiel Recruiting Kiel, Germany, 24105 Principal Investigator: Axel Hauschild, Prof. (MD)          Dermatology, Klinikum Ludwishafen Recruiting Ludwigshafen, Germany, 67063 Principal Investigator: Edgar Dippel, Prof. (MD)          Dept of Dermatology, University of Schleswig-Holstein Campus Luebeck Recruiting Luebeck, Germany, 23538 Principal Investigator: Patrick Terheyden, Dr. (MD)          Dept of Dermatology, Univeristy of Magdeburg Recruiting Magdeburg, Germany, 39120 Principal Investigator: Martin Leverkus, Prof. (MD)          Dept of Dermatology, University of Mainz Recruiting Mainz, Germany, 55131 Principal Investigator: Carmen Loquai, Dr. (MD)          Dept of Dermatology, University of Mannheim Recruiting Mannheim, Germany, 68167 Principal Investigator: Jessica Hassel, Dr. (MD)          Dept of Dermatology, University of Marburg Recruiting Marburg, Germany, 35033 Principal Investigator: Michael Hertl, Prof. (MD)          Dept of Dermatology, University of Muenchen Recruiting Muenchen, Germany, 80337 Principal Investigator: Carola Berking, Prof. (MD)          Dept of Dermatology, University of Muenster Recruiting Muenster, Germany, 48149 Principal Investigator: Cord Sunderkoetter, Prof. (MD)          Dept of Medical Oncology, Fachklinik Hornheide Recruiting Muenster, Germany, 48157 Principal Investigator: Michael Fluck, Dr. (MD)          Dermatology, Klinikum Dorothea Christiane Erxleben Recruiting Quedlinburg, Germany, 06484 Principal Investigator: Jens Ulrich, PD (MD)          Dept of Dermatology, University of Tuebingen Recruiting Tuebingen, Germany, 72086 Principal Investigator: Claus Garbe, Prof. (MD)          Dept of Dermatology, University of Wuerzburg Recruiting Wuerzburg, Germany, 97080 Principal Investigator: Selma Ugurel, Prof. (MD) Less <<
NCT00538876 Acute Myeloid Leukemia Phase 1 Completed - United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT01801046 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myeloid Leukemia in Remission Childhood Acute Myelomonocytic Leukemia (M4) Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 1 Terminated(Insufficient Accrua... More >>l) Less << - United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01481272 Diffuse Large B Cell Lymphoma Phase 2 Completed - Poland ... More >> Dolnośląskie Centrum Transplantacji Komórkowych Wrocław, Dolnośląskie, Poland, 53-439 Instytut Hematologii i Transfuzjologii Warszawa, Mazowieckie, Poland, 02-776 Centrum Onkologii - Istytut im. M.Sklodowskiej-Curie Warszawa, Mazowieckie, Poland, 02-781 Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. ks. Bronisława Markiewicza Brzozów, Podkarpackie, Poland, 16-200 Uniwersyteckie Cenrum Medyczne Gdańsk, Pomorskie, Poland, 80-952 Szpital Morski im. PCK Oddz. Onkologii i Radioterapii Gdynia, Pomorskie, Poland, 81-519 Klinika Transplantacji Szpiku i Onkohematologii; Centrum Onkologii Instytut im. M.Sklodowskiej-Curie, Oddz. w Gliwicach Gliwice, Slaskie, Poland, 44-101 Oddz. Hematologii, Samodzielny Publiczny ZOZ MSW z Warminsko-Mazurskim Centrum Onkologii w Olsztynie Olsztyn, Warminsko-Mazurskie, Poland, 10-228 Less <<
NCT00003061 Lymphoma Phase 2 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Gustave Roussy Villejuif, France, F-94805 Netherlands Atrium Medical Centre Heerlen, Netherlands, 6419 PC Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA Dr. Bernard Verbeeten Instituut Tilburg, Netherlands, 5042 SB Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3508 GA Less <<
NCT01458730 Central Nervous System Lymphom... More >>a Less << Phase 2 Active, not recruiting October 2020 Denmark ... More >> Elisa Jacobsen Pulczynski Aarhus, Denmark, DK-8000 Less <<
NCT00368355 Acute Lymphoblastic Leukemia ... More >> Non Hodgkins Lymphoma Myelodysplastic Syndrome Acute Myeloid Leukemia Chronic Myelogenous Leukemia Hemophagocytic Lymphohistiocytosis (HLH) Familial Hemophagocytic Lymphohistiocytosis (FLH) Viral-associated Hemophagocytic Syndrome (VAHS) X-linked Lymphoproliferative Disease (XLP) Less << Phase 2 Recruiting April 2020 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Robert A. Krance, MD    832-824-4661    rakrance@txch.org    Contact: Marlen Dinu    832-824-4881    mxdinu@txch.org    Texas Children's Hosptial Recruiting Houston, Texas, United States, 77030 Contact: Robert A. Krance, MD    832-824-4661    rakrance@txch.org    Contact: Marlen Dinu    832-824-4881    mxdinu@txch.org Less <<
NCT02298166 Acute Myeloid Leukemia Phase 3 Recruiting October 2023 Germany ... More >> Ulm University Hospital Recruiting Ulm, Germany, 89081 Contact: Hartmut Döhner, Prof. Dr.    0049-731-500- ext 45521    hartmut.doehner@uniklinik-ulm.de Less <<
NCT00410423 Relapsed Acute Leukemia ... More >> Refractory Acute Leukemia Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00209833 De Novo Akute Myeloid Leukemia... More >> (AML) Secondary Acute Myeloid Leukemia (AML) Refractory Anemia With Excess of Blasts in Transformation Less << Phase 2 Phase 3 Unknown - Germany ... More >> Hannover Medical School Hannover, Germany, 30625 Less <<
NCT00410423 - Completed - -
NCT02504190 - Recruiting July 2018 France ... More >> Recruiting Paris, France Less <<
NCT01681537 Acute Myelogenous Leukemia Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00053105 Lymphoma Phase 1 Unknown - United States, Arizona ... More >> Arizona Clinical Research Center Tucson, Arizona, United States, 85712 United States, Arkansas Highlands Oncology Group Springdale, Arkansas, United States, 72764 United States, California USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033-0800 United States, Maryland Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5055 United States, Tennessee Boston Baskin Cancer Group, University Tennessee Memphis, Tennessee, United States, 38104 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01159028 Recurrent Adult Acute Myeloid ... More >>Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndrome Ph1 Positive CML Less << Phase 1 Active, not recruiting December 31, 2019 United States, Texas ... More >> M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00590837 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> Services maladies du sang, cancérologie, Hôpital Sud, CHU Amiens Amiens, France, 80054 Service des maladies du sang, Centre Hospitalier Universitaire d'Angers Angers, France, 49033 Service Hématologie, Centre Hospitalier Annecy Annecy, France, 74011 C.H Victor Dupouy Argenteuil, France, 95100 Service Médecine Interne, Onco-Hématologie, Maladies Infectieuses, Hôpital Henri Duffaut, Centre Hospitalier Avignon Avignon, France, 84000 Service Hématologie, Centre Hospitalier de la Côte Basque Bayonne, France, 64109 Service Hématologie, Hôpital Minjoz Besançon, France, 25030 Unité Hématologie, Centre Hospitalier Blois Blois, France, 41016 Service des maladies du sang - Hôpital Haut-Lévêque Bordeaux - Pessac, France, 33604 Service Hématologie, Hôpital Dr Duchenne Boulogne-sur-Mer, France, 62321 Service Hématologie, Hôpital Augustin Morvan Brest, France, 29609 Service Hématologie et Thérapie cellulaire, Pavillon Villemin Pasteur, CHU Clermont-Ferrand Clermont-Ferrand, France, 63000 Service Oncologie - Hématologie, Hôpital Pasteur, Centre Hospitalier Colmar Colmar, France, 68024 Service Hématologie Clinique, CHU Dijon Hôpital des enfants Dijon, France, 21079 Service Hématologie Clinique, Hôpital Michallon, CHU de Grenoble Grenoble, France, 38043 Service Onco-Hématologie 3, Institut Paoli Calmettes Marseille, France, 13275 Service Hématologie Oncologie, CHR Metz-Thionville Metz, France, 57038 Service Hématologie Oncologie, Hôpital Lapeyronie, CHU de Montpellier Montpellier, France, 34295 Département d'hématologie, Hôpital E.Muller, Centre Hospitalier de Mulhouse Mulhouse, France, 68070 Service Hématologie Clinique, CHU -Hôtel Dieu Nantes, France, 44093 Service Hématologie Clinique, Hôpital Archet 1 Nice, France, 06202 Service Médecine B - Unité Onco-hématologique, CHU Caremeau Nîmes, France, 30029 Service Oncologie Médicale, Hôpital de la Source Orléans, France, 45067 Unité d'Hématologie, Hôpital Cochin Paris, France, 75679 Service Hématologie, CHG Saint Jean Perpignan, France, 66000 Service Hématologie Clinique, Hôpital Robert Debre Reims, France, 51092 Service Hématologie Clinique, Hôpital Pontchaillou Rennes, France, 35033 Service d'Hématologie, Institut de Cancérologhie de la Loire Saint Priez en Jarez, France, 42270 Département d'Hématologie et d'Oncologie, Hôpital CHRU de Hautepierre Strasbourg, France, 67098 Service Hématologie, Hôpital Purpan Toulouse, France, 31059 Service Hématologie Clinique, Hôpital Bretonneau Tours, France, 37044 Service Hématologie - Médecine Interne, Hôpitaux de Brabois Vandoeuvre-les-Nancy, France, 54511 Less <<
NCT02531841 Diffuse Large B-cell-lymphoma Phase 3 Recruiting December 2019 Germany ... More >> University Hospital Freiburg - Department for Hematology, Oncology and Stem cell Transplantion Recruiting Freiburg, Baden-Wuerttemberg, Germany, 79106 Contact: Juergen Finke, PhD    +49761270 ext 34080    juergen.finke@uniklinik-freiburg.de    Contact: Elisabeth Schorb, PhD    +49761270 ext 33210    elisabeth.schorb@uniklinik-freiburg.de    Klinikum Stuttgart, Clinic of Hematology, Oncology and Palliative Care, Stuttgart Cancer Center / Tumor Center Eva Mayr-Stihl Recruiting Stuttgart, Baden-Wuerttemberg, Germany, 70174 Contact: Gerald Illerhaus, PhD    +49 711 278 ext 30400    G.Illerhaus@klinikum-stuttgart.de    Contact: Kristina Mikesch, PhD    +49 711 278 ext 30403    k.mikesch@klinikum-stuttgart.de Less <<
NCT02385955 Hematologic Malignancy Phase 2 Not yet recruiting April 2019 -
NCT00003311 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT03564704 Leukemia Leuk... More >>emia, Acute Adult Lymphoblastic Lymphoma Leukemia, Lymphoblastic Leukemia, T Cell Adult Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Lymphoblastic Leukemia Less << Phase 2 Phase 3 Recruiting May 30, 2021 China, Guangdong ... More >> Department of Hematology, Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou    +862062787349    zhs1@i.smu.edu.cn Less <<
NCT01161550 Leukemia, Myeloid, Acute Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02756962 Acute Myeloid Leukemia Phase 2 Recruiting July 31, 2024 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Meagan Jacoby, M.D., Ph.D.    314-454-8304    mjacoby@wustl.edu    Principal Investigator: Meagan Jacoby, M.D., Ph.D.          Sub-Investigator: Timothy Ley, M.D.          Sub-Investigator: David Spencer, M.D., Ph.D.          Sub-Investigator: Camille Abboud, M.D.          Sub-Investigator: John DiPersio, M.D., Ph.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: Armin Ghobadi, M.D.          Sub-Investigator: Brad Kahl, M.D.          Sub-Investigator: Iskra Pusic, M.D.          Sub-Investigator: Mark Schroeder, M.D.          Sub-Investigator: Keith Stockerl-Goldstein, M.D.          Sub-Investigator: Geoffrey Uy, M.D.          Sub-Investigator: Ravi Vij, M.D.          Sub-Investigator: Matthew Walter, M.D.          Sub-Investigator: Lukas Wartman, M.D.          Sub-Investigator: John Welch, M.D., Ph.D.          Sub-Investigator: Peter Westervelt, M.D., Ph.D.          Sub-Investigator: Amanda Cashen, M.D.          Sub-Investigator: Tanya Wildes, M.D.          Sub-Investigator: Terrence Wong, M.D. Less <<
NCT02323022 Acute Myeloid Leukemia Phase 3 Recruiting December 2020 China, Jiangsu ... More >> The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215006 Contact: Jia Chen, M.D.    +86 512 6778 1856    chenjiasuzhou@gmail.com Less <<
NCT01412879 Lymphoma Phase 2 Active, not recruiting August 2021 -
NCT02392429 Acute Myeloid Leukemia ... More >> Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting - United States, Alabama ... More >> University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States, 35233 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Mount Sinai Hospital New York, New York, United States, 10029 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States, 75390 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00037583 Acute Myeloid Leukemia Phase 2 Completed - -
NCT01412879 - Active, not recruiting - -
NCT03257241 Acute Myeloid Leukemia Phase 3 Recruiting December 31, 2020 Poland ... More >> Medical University of Bialystok Clinical Hospital Recruiting Białystok, Poland, 15-276 Contact: Jarosław Piszcz, Dr          Markiewicz Memorial Oncology Center Brzozow Recruiting Brzozów, Poland, 36-200 Contact: Andrzej Pluta, Dr          University Clinical Centre in Gdansk Recruiting Gdańsk, Poland, 80-210 Contact: Maria Bieniaszewska, Dr          Holycross Cancer Center Recruiting Kielce, Poland, 25-001 Contact: Marzena Wątek, Dr          Ludwik Rydygier Memorial Specialized Hospital Recruiting Kraków, Poland, 30-001 Contact: Małgorzata Raźny, Dr          Regional Specialised Hospital in Legnica Recruiting Legnica, Poland, 59-220 Contact: Jadwiga Hołojda          Independent Public University Hospital No. 1 in Lublin Recruiting Lublin, Poland, 20-001 Contact: Marek Hus, Prof.          Clinical Hospital at the Karol Marcinkowski Medical University in Poznan Recruiting Poznań, Poland, 60-355 Contact: MAciej Kaźmierczak, Dr          Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology Recruiting Łódź, Poland, 93-513 Contact: Agnieszka Wierzbowska, Prof.    +48426895191    agawierzbowska@wp.pl Less <<
NCT03214562 Other Diseases of Blood and Bl... More >>ood-forming Organs Acute Myeloid Leukemia Less << Phase 1 Phase 2 Recruiting September 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       cdinardo@mdanderson.org Less <<
NCT02766868 Lymphoblastic Leukemia, Acute,... More >> Adult Less << Phase 2 Recruiting July 2019 China ... More >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, China, 200025 Contact: Ling Wang    86-21-64370045 ext 601818    cclingjar@163.com Less <<
NCT01550185 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Terminated(Sponsor wanted stud... More >>y rewritten) Less << - United States, Georgia ... More >> Emory University, Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT00954941 Hematologic Diseases ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Chronic Myelogenous Leukemia Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00954941 - Completed - -
NCT01154439 Leukemia Phase 1 Active, not recruiting December 2018 Italy ... More >> Ematologia con trapianto- AOU Policlinico Consorziale di Bari Bari, Italy Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Università La Sapienza Roma, Italy, 00100 Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Azienda Ospedaliera Universitaria Policlinico Tor Vergata Rome, Italy, 00133 Less <<
NCT00073957 Lymphoma Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Vermont Fletcher Allen Health Care - Medical Center Campus Burlington, Vermont, United States, 05401 Less <<
NCT00915252 Acute Myeloid Leukemia Phase 2 Completed - Germany ... More >> RWTH Aachen, Medizinische Klinik IV Aachen, Germany, 52074 Sozialstiftung Bamberg, Klinikum am Bruderwald, Med. Klinik V Bamberg, Germany, 96049 Klinikum Bayreuth, Medizinische Klinik IV Bayreuth, Germany, 95445 Charite Campus Benjamin Franklin, Universitätsmedizin Berlin, Medizinische Klinik III Berlin, Germany Städt. Kliniken Bielefeld gem. GmbH, Klinikum Mitte, Klinik für Hämatologie, Onkologie, Palliativmedizin Bielefeld, Germany, 33604 Klinikum Chemnitz, Krankenhaus Küchenwald, Klinik für Innere Medizin III Chemnitz, Germany Universitätsklinikum Carl Gustav Carus, Medizinische Klinik und Poliklinik I Dresden, Germany Katholische Krankenhaus Duisburg Duisburg, Germany, 47166 Universitätsklinikum Erlangen, Medizinische Klinik 5 Erlangen, Germany Universitätsklinikum Essen, Klinik für Hämatologie Essen, Germany Klinikum Frankfurt (Oder) GmbH Frankfurt (Oder), Germany, 15236 Klinikum der Johann Wolfgang Goethe-Universität Frakfurt am Main Frankfurt am Main, Germany Asklepios Klinik St. Georg, Hämatologische Abteilung Hamburg, Germany St. Bernward Krankenhaus Hildesheim, Medizinische Klinik II Hildesheim, Germany Westpfalz-Klinikum GmbH, Med. Klinik I Kaiserslautern, Germany, 67655 Stiftungsklinikum Mittelrhein, Hämatologie/ Onkologie Koblenz, Germany, 56068 Johannes Gutenberg-Universität Mainz Klinikum, III. Medizinische Klinik und Poliklinik Mainz, Germany Phillips Universität Marburg, Fachbereich 20, ZIM Marburg, Germany Klinikum rechts der Isar, III. Medizinische Klinik Muenchen, Germany Universitätsklinikum Münster, Medizinische Klinik und Poliklinik A Münster, Germany, 48149 Klinikum Nürnberg, Medizinische Klinik 5 Nurnberg, Germany Klinikum Osnabrück, Klinik für Onkologie, Hämatologie, Immunologie Osnabruck, Germany Klinikum der Universität Regensburg, Klinik und Poliklinik für Innere Medizin I Regensburg, Germany Robert-Bosch-Krankenhaus, Zentrum für Innere Medizin Stuttgart, Germany Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I Trier, Germany, 2920 Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, 65199 Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II Wurzburg, Germany Less <<
NCT00039910 Non-Hodgkin Lymphoma ... More >> Hodgkin Disease Thrombocytopenia Less << Phase 3 Completed - -
NCT00071799 Myelodysplastic Syndromes Phase 3 Completed - -
NCT01035502 Acute Myeloid Leukemia Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 France CHU Lyon, Hospital Edouard Herriot Lyon, France, 69437 Institut Paoli-Calmettes Marseille, France, 13273 CHU Toulouse, Hospital Purpan Toulouse, France, 31059 Germany Charite University Hospital Benjamin Franklin Berlin, Germany, 12200 Universitätsklinikum Münster Münster, Germany Universitätsklinikum Ulm Ulm, Germany, D-89081 Norway Haukeland University Hospital Bergen, Norway Less <<
NCT00071799 - Completed - -
NCT00073957 - Completed - -
NCT00329030 - Completed - -
NCT00945724 Large B-cell Diffuse Lymphoma ... More >>of Testis Less << Phase 2 Recruiting December 2019 Italy ... More >> A.O. SS. Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, Italy Contact: Flavia Salvi, MD          Spedali Civili Recruiting Brescia, Italy Ematologia Ospedale Businco Recruiting Cagliari, Italy Contact: Giuseppina Cabras, MD          S. Martino Hospital Recruiting Genova, Italy European Institute of Oncology Recruiting Milan, Italy Principal Investigator: Giovanni Martinelli, MD          San Raffaele H Scientific Institute Recruiting Milan, Italy Contact: Andres Ferreri, MD       ferreri.andres@hsr.it    Principal Investigator: Andrés JM Ferreri, MD          Policlinico Recruiting Modena, Italy A.O. San Gerardo Recruiting Monza, Italy AOU Maggiore della Carità Recruiting Novara, Italy S. Matteo Recruiting Pavia, Italy Principal Investigator: Luca Arcaini, MD          Ospedale Civile Recruiting Piacenza, Italy U.O. Ematologia AUSL Ravenna Recruiting Ravenna, Italy Arcispedale Santa Maria Nuova Recruiting Reggio Emilia, Italy IFO Regina Elena Recruiting Roma, Italy Principal Investigator: Francesco Pisani, MD          Policlinico Universitario Campus Biomedico Recruiting Roma, Italy Contact: Giuseppe Avvisati, MD          Università La Sapienza Recruiting Rome, Italy Humanitas Recruiting Rozzano, Italy Contact: Monica Balzarotti          Azienda Ospedaliero-Universitaria Recruiting Sassari, Italy A.O. S. Maria Recruiting Terni, Italy A.O.U. San Giovanni Battista-Molinette, S.C. Ematologia 2 Recruiting Torino, Italy, 10134 Contact: Umberto Vitolo, M.D.       uvitolo@molinette.piemonte.it    Principal Investigator: Umberto Vitolo, M.D.          Ospedale di Circolo Fondazione Macchi Recruiting Varese, Italy Contact: Graziella Pinotti, MD          Switzerland IOSI Recruiting Bellinzona, Switzerland, 6500 Contact: Emanuele Zucca, MD    +41 91 8119040    ielsg@ticino.com    Principal Investigator: Emanuele Zucca, M.D. Less <<
NCT01074086 AML Phase 1 Completed - France ... More >> Sophie Park Paris, France, 75014 Less <<
NCT01478074 Acute Myeloid Leukemia Phase 1 Withdrawn(The treatment planne... More >>d was determined to be of low feasibility as no subject was found eligible and able to enroll after screening over 30 subjects) Less << - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01787474 Recurrent Adult Acute Myeloid ... More >>Leukemia Refractory Acute Myeloid Leukemia Less << Phase 1 Phase 2 Recruiting May 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Stefan O. Ciurea    713-792-8750       Principal Investigator: Stefan O. Ciurea Less <<
NCT00329030 Lymphoma, B-Cell ... More >> Lymphoma, Large-Cell, Immunoblastic Lymphoma, Non-Hodgkin Less << Phase 3 Completed - -
NCT00515788 Neoplastic Meningitis Phase 1 Terminated(Study terminated du... More >>e to slow accrual with no expansion to additional phase.) Less << - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00053131 Leukemia Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00801580 Lymphoid Leukemia Phase 2 Unknown September 2010 Italy ... More >> Institute of Hematology "L. & A. Seragnoli" Recruiting Bologna, Italy, 40138 Less <<
NCT03589729 Acute Myeloid Leukemia ... More >> Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Blasts 10 Percent or More of Bone Marrow Nucleated Cells High Risk Myelodysplastic Syndrome Myeloid Sarcoma Myeloproliferative Neoplasm Philadelphia Chromosome Positive Less << Phase 2 Recruiting December 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Maro Ohanian    713-792-2631       Principal Investigator: Maro Ohanian Less <<
NCT03661515 Acute Myeloid Leukemia Phase 1 Recruiting December 2019 Spain ... More >> Hospital Germans Tries i Pujol, Badalona Recruiting Badalona, Spain Contact: Susana Vives, Dr       svives@iconcologia.net    Hospital San Pedro de Alcántara, Recruiting Cáceres, Spain Contact: Juan Bergua, Dr       jmbergua@icloud.com    Hospital Universitario 12 de Octubre, Recruiting Madrid, Spain Contact: Pilar Martinez-Sanchez, Dr       mpmartinezsa@yahoo.es    Hospital la Fe Recruiting Valencia, Spain Contact: Pau Montesinos, Dr       montesinos_pau@gva.es Less <<
NCT01497002 Acute Myeloid Leukaemia Phase 3 Unknown December 2013 Germany ... More >> University of Leipzig, Hematology Recruiting Leipzig, Germany, 04103 Principal Investigator: Dietger Niederwieser Less <<
NCT02791919 CNS 2a CNS 2b... More >> CNS 2c CNS1 Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Less << Phase 1 Withdrawn(Other - Protocol mov... More >>ed to Disapproved) Less << May 31, 2019 -
NCT01484171 Acute Myeloid Leukemia Phase 3 Unknown December 2017 China, Beijing ... More >> The Affiliated Hospital of the Chinese Academy of Military Medical Science Recruiting Beijing, Beijing, China, 100071 Contact: huisheng ai, M.D.    86-01-66947126    huishengai@163.com    Contact: zheng dong, M.M    86-01-66947130    dongz1983@139.com Less <<
NCT01321346 Lymphoblastic Leukemia, Acute,... More >> Childhood Myelogenous Leukemia, Acute, Childhood Hodgkin's Disease Non-Hodgkin's Lymphoma Less << Phase 1 Completed - -
NCT00002766 Leukemia Lymp... More >>homa Less << Phase 3 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1678 Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States, 94305-5750 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 New York Medical College Valhalla, New York, United States, 10595 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00002766 - Completed - -
NCT02927938 Acute Myeloid Leukemia (AML) Phase 3 Active, not recruiting September 2022 United States, North Carolina ... More >> Levine Cancer Institute Charlotte, North Carolina, United States, 28204 Less <<
NCT01141712 - Completed - -
NCT02673060 Bone Metastasis Phase 1 Completed - -
NCT01141712 Lymphoma HIV Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010-3000 University of California San Diego Medical Center La Jolla, California, United States, 92093 UCLA Los Angeles, California, United States, 90035 University of CA, SF San Francisco, California, United States, 94143 United States, Florida University of Florida College of Medicine Gainesville, Florida, United States, 32610 H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 BMT Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Maryland University of Maryland Medical Systems, Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins Medical Institution Baltimore, Maryland, United States, 21231 United States, Missouri Washington University/Barnes Jewish Hospital Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medical College New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10174 University of Rochester Rochester, New York, United States, 14642 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Texas University of Texas/MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02056782 Acute Myeloid Leukemia Phase 1 Completed - United States, Georgia ... More >> Georgia Regents University Augusta - Div. of Hematology/Oncology - BMT Agusta, Georgia, United States, 30912 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Utah University of Utah Huntsman Cancer Institute - Div. of Hematology & Hematologic Malignncies Salt Lake City, Utah, United States, 84112 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00416819 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Less << Not Applicable Completed - -
NCT01389427 Mantle Cell Lymphoma Refractor... More >>y Less << Phase 1 Phase 2 Completed - France ... More >> CHU de Grenoble MICHALLON Grenoble Cedex 9, Hôpital Nord 217, France, 38043 Hôtel Dieu - Université de Nantes Nantes cedex, Place Alexis Ricordeau, France, 44093 Hôpital Henri Mondor Creteil, France, 94010 CHU de Dijon Dijon, France, 21000 Hôpital Saint-Eloi Montpellier, France, 34295 Hôpital Saint Louis Paris, France, 75475 Hôpital Necker Paris, France, 75743 Groupe hospitalier Sud Hôpital Haut-Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Benite, France, 69310 CHU Pontchaillou Rennes, France, 35003 CHU de Tours - Hôpital Bretonneau Tours, France, 37000 Less <<
NCT02905994 AML Phase 1 Withdrawn(Funding Withdrawn) - United States, Massachusetts ... More >> Massachusetts general Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Less <<
NCT00003619 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic Syndromes Thrombocytopenia Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Medical College of Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19129 Medical College of Pennsylvania Philadelphia, Pennsylvania, United States, 19129 Less <<
NCT00310128 AIDS-related Lymphoma ... More >> Adult Non-Hodgkin's Lymphoma Anaplastic Large Cell Lymphoma Less << Phase 2 Withdrawn(Drug supply unavaila... More >>ble) Less << - -
NCT01031498 Acute Myelogenous Leukemia ... More >> Chemotherapy-induced Nausea and Vomiting Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03356080 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Recruiting July 7, 2020 China ... More >> Beijing Friendship Hospital Not yet recruiting Beijing, China Fujian Medical University Union Hospital Not yet recruiting Fuzhou, China The People's Hospital of Guangxi Zhuang Autonomous Region Not yet recruiting Nanning, China Shanghai Tong Ren hospital Recruiting Shanghai, China Contact: Ligen Liu    18017337037    llg3532@shtrhospital.com    The center hospital of Shanghai Fengxian District Not yet recruiting Shanghai, China First Affiliated Hospital of Zhengzhou University. Not yet recruiting Zhengzhou, China Less <<
NCT02280525 Leukemia Phase 1 Active, not recruiting March 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00003407 Drug/Agent Toxicity by Tissue/... More >>Organ Leukemia Myelodysplastic Syndromes Neutropenia Less << Phase 2 Unknown - United States, Illinois ... More >> Cook County Hospital Chicago, Illinois, United States, 60612-9985 Rush Cancer Institute Chicago, Illinois, United States, 60612 Angelo P. Creticos, M.D. Cancer Center Chicago, Illinois, United States, 60657 Rush-Riverside Cancer Center Kankakee, Illinois, United States, 60901 Less <<
NCT00003729 Leukemia Phase 2 Terminated(low accrual) - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels (Bruxelles), Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels (Bruxelles), Belgium, 1090 Universitair Ziekenhuis Gent Ghent (Gent), Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege (Luik), Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHR de Grenoble - La Tronche Grenoble, France, 38043 Centre Hospitalier Regional de Lille Lille, France, 59037 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34295 CHR Hotel Dieu Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hopital Robert Debre Paris, France, 75019 Institut Curie - Section Medicale Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants (Purpan Enfants) Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Less <<
NCT01031498 - Completed - -
NCT01417767 Myelodysplastic Syndromes Phase 2 Phase 3 Unknown September 2013 China, Shanghai ... More >> Shanghai 6th People's Hospital Not yet recruiting Shanghai, Shanghai, China, 200233 Contact: Xiao Li       lixiao3326@yahoo.com.cn    Principal Investigator: Xiao Li Less <<
NCT00003190 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Untreated Adult Acute Myeloid Leukemia Less << Phase 3 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT03600558 - Recruiting May 2019 China, Tianjin ... More >> Tianjin Medical University General Hospital Recruiting Tianjin, Tianjin, China, 300000 Contact: Zonghong Shao, MD Less <<
NCT03135028 Hematologic Malignancy ... More >> Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting December 2018 Japan ... More >> University of Fukui Hospital Fukui, Japan, 910-1193 Kyushu University Hospital Fukuoka, Japan, 812-8582 Tokai University Hospital Kanagawa, Japan, 259-1193 Tohoku University Hospital Miyagi, Japan, 980-8574 NTT Medical Center Tokyo Tokyo, Japan, 141-8625 Kindai University Hospital Ōsaka, Japan, 589-8511 Less <<
NCT00080886 Lymphoma Phase 2 Completed - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7680 Less <<
NCT00025038 Juvenile Myelomonocytic Leukem... More >>ia Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01890746 Leukaemia, Acute Phase 2 Completed - -
NCT03558607 Secondary Acute Myelogenous Le... More >>ukemia Evolving From Myeloproliferative Disorder Less << Phase 1 Phase 2 Recruiting December 31, 2021 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of, 13620 Contact: Ryul Kim, Dr    +82 10 9412 6108    chrono0707@icloud.com    Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Ryul Kim, MD    +82 10 9412 6108    chrono0707@icloud.com    Principal Investigator: Youngil Koh, MD          Sub-Investigator: Sung soo Yoon, MD, PhD          Sub-Investigator: In ho Kim, MD          Sub-Investigator: Ryul Kim, MD Less <<
NCT01890746 - Completed - -
NCT01513603 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Burkitts Leukemia/Lymphoma Chronic Myelogenous Leukemia Less << Phase 2 Unknown January 2014 United States, New York ... More >> Westchester Medical Center/New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Karen Seiter, MD    914-493-7514    karen_seiter@nymc.edu    Principal Investigator: Karen Seiter, MD          Sub-Investigator: Delong Liu, MD, PhD          Sub-Investigator: Claudio Sandoval, MD Less <<
NCT00908180 Lymphoma Phase 2 Unknown - -
NCT00266136 Acute Myeloid Leukemia Phase 3 Completed - Germany ... More >> University of Muenster, Medical Center, Department of Medicine, Hematology and Oncology Muenster, Germany, 48129 Less <<
NCT02533115 - - - United States, California ... More >> UCLA Ronald Reagan Medical Center Los Angeles, California, United States, 90095 United States, Georgia Northside Hospital Atlanta, Georgia, United States, 30342 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Indiana Franciscan St. Francis Health Indianapolis, Indiana, United States, 46237 United States, Kansas The University of Kansas Hospital Kansas City, Kansas, United States, 66160 United States, New York Weill Cornell Medical College- NY Presbyterian Hospital New York, New York, United States, 10021 Less <<
NCT02781883 Acute Myeloid Leukemia (AML) Phase 2 Recruiting December 2018 United States, Kansas ... More >> University of Kansas Cancer Center Recruiting Fairway, Kansas, United States, 66205 Contact: Kerry Hepler, RN    913-945-7552    khepler@kumc.edu    Contact: Jecinta Scott, MS    913-945-7505    jscott11@kumc.edu    Principal Investigator: Tara Lin, MD          United States, New Jersey New Jersey Hematology Oncology Associates Recruiting Brick, New Jersey, United States, 08724 Contact: Apurv Agrawal, MD       agrawalmd@gmail.com    United States, New York Weill Cornell Medical College - New York - Presbyterian Hospital Recruiting New York, New York, United States, 10021 Contact: Gail J Roboz, MD    646-962-2700    gar2001@med.cornell.edu    Principal Investigator: Gail J Roboz, MD          United States, Texas University of Texas M.D. Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Maro Ohanian, DO    713-792-2631    mohanian@mdanderson.org    Principal Investigator: Maro Ohanian, MD          Baylor Scott & White Research Institute Recruiting Temple, Texas, United States, 76508 Contact: Niki Watson    254-724-2111    Niki.Watson@BSWHealth.org    Contact: Dedra Preece    254-724-2111    Dedra.Preece@BSWHealth.org    Principal Investigator: Kathleen Halka, MD          Sub-Investigator: Christian T Cable, MD          Sub-Investigator: Vinit G Karur, MD          Sub-Investigator: Mark Holguin, MD          Sub-Investigator: Rakesh Surapaneni, MD          United States, West Virginia West Virginia University/Mary Babb Randolph Cancer Center Recruiting Morgantown, West Virginia, United States, 26506 Contact: Michael Craig, MD    304-293-0609    craigm@wvumedicine.org Less <<
NCT02462265 Acute Myeloid Leukemia ... More >> Lymphoid Leukemia Less << Phase 2 Suspended December 2018 -
NCT00450801 Lymphoma Phase 2 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00209222 Lymphoma, Mantle-Cell Phase 3 Unknown December 2014 France ... More >> Groupe D´Etudes des Lymphomes De l´Adulte (GELA) Recruiting Paris, France, F-75743 Contact: Guylène Chartier    +33-1-42499811    Guylene.chartier@chu-stlouis.fr    Contact: Olivier Hermine, PhD    +33-1-44 49 52 83    hermine@necker.fr    Principal Investigator: Olivier Hermine, PhD          Germany German Low Grade Study Group (Glsg) Recruiting Munich, Germany, D-81377 Contact: Michael Unterhalt, Dr.    +49-89-7095 ext 4915    Michael.Unterhalt@med.uni-muenchen.de    Contact: Martin Dreyling, PhD    +49-89-7095 ext 2202    Martin.Dreyling@med.uni-muenchen.de    Principal Investigator: Wolfgang Hiddemann, PhD          Poland The Maria Sklodowska Memorial, Cancer Center - Inst. of Oncology Recruiting Warszawa, Poland, PL-02-781 Contact: Jan Walewski, MD    +48-22-546-2223    walewski@coi.waw.pl    Contact: Marek P Nowacki, MD    +48-22-546-2223       Principal Investigator: Jan Walewski, MD Less <<
NCT00019409 Leukemia Phase 3 Withdrawn - United States, Maryland ... More >> Pediatric Oncology Branch Bethesda, Maryland, United States, 20892 United States, Texas Texas Tech University Health Sciences Center School of Medicine Amarillo, Texas, United States, 79106 India Kidwai Memorial Institute of Oncology Bangalore, India, 560029 Cancer Institute (W.I.A.) Madras, India, 600020 Tata Memorial Centre Mumbai, India, 400012 All-India Institute of Medical Sciences New Delhi, India, 110029 Less <<
NCT02873338 Acute Myeloid Leukemia Phase 2 Recruiting November 2018 -
NCT02029950 Acute Myeloid Leukemia ... More >> Blasts 5-19 Percent of Peripheral Blood White Cells Blasts More Than 10 Percent of Bone Marrow Nucleated Cells Chronic Myelomonocytic Leukemia-2 High Risk Myelodysplastic Syndrome Myeloproliferative Neoplasm Previously Treated Myelodysplastic Syndrome Less << Phase 1 Active, not recruiting - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06520 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00878254 Mantle-Cell Lymphoma Phase 2 Recruiting December 2019 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33186 Contact: Izidore S. Lossos, MD    305-243-4785    ilossos@med.miami.edu    Principal Investigator: Izidore S Lossos, MD Less <<
NCT03765541 Relapsed or Refractory Acute M... More >>yeloid Leukemia Less << Phase 3 Not yet recruiting January 2024 France ... More >> CHU de Grenoble Not yet recruiting Grenoble, France Contact: Jean-Yves CAHN, PhD          CHU de Limoges Not yet recruiting Limoges, France Contact: Pascal TURLURE, MD          Institut Paoli Calmettes Not yet recruiting Marseille, France Contact: Norbert VEY, PhD          CHU de Montpellier Not yet recruiting Montpellier, France Contact: Hicheri Yosr, MD          CHU de Nantes Not yet recruiting Nantes, France Contact: Pierre PETERLIN, MD          CHU de Nîmes Not yet recruiting Nîmes, France Contact: Eric JOURDAN, MD          CHU de Bordeaux Not yet recruiting Pessac, France Contact: Arnaud PIGNEUX, PhD          CHU de Poitiers Not yet recruiting Poitiers, France Contact: Maria-Pilar GALLEGO-HERMANZ, MD Less <<
NCT02784561 Leukemia Phase 4 Not yet recruiting July 2020 -
NCT00428558 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> Service Hematologie Oncologie Nimes, France, 30029 Less <<
NCT03280030 Acute Myeloid Leukemia Phase 2 Recruiting June 20, 2022 Hong Kong ... More >> Novartis Investigative Site Recruiting Hong Kong, Hong Kong Japan Novartis Investigative Site Recruiting Nagoya-city, Aichi, Japan, 466-8650 Novartis Investigative Site Recruiting Toyoake city, Aichi, Japan, 470 1192 Novartis Investigative Site Recruiting Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Recruiting Matsuyama-city, Ehime, Japan, 790-8524 Novartis Investigative Site Recruiting Fukuoka city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Recruiting Fukuyama city, Hiroshima, Japan, 720-0001 Novartis Investigative Site Recruiting Isehara-city, Kanagawa, Japan, 259-1193 Novartis Investigative Site Recruiting Kochi city, Kochi, Japan, 781-8555 Novartis Investigative Site Recruiting Nagasaki-city, Nagasaki, Japan, 852-8501 Novartis Investigative Site Recruiting Sayama, Osaka, Japan, 589 8511 Novartis Investigative Site Recruiting Shimotsuke city, Tochigi, Japan, 329-0498 Novartis Investigative Site Recruiting Bunkyo-ku, Tokyo, Japan, 113-8677 Novartis Investigative Site Recruiting Shinagawa-ku, Tokyo, Japan, 141 8625 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03722 Taiwan Novartis Investigative Site Recruiting Putzu City, Chiayi Hsien, Taiwan, 61363 Novartis Investigative Site Recruiting Kaohsiung City, Taiwan, 83301 Novartis Investigative Site Recruiting Taipei, Taiwan, 10002 Novartis Investigative Site Recruiting Taoyuan, Taiwan, 33305 Less <<
NCT01350232 - Terminated(Poor accrual) - -
NCT01174888 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> The Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00450801 - Completed - -
NCT02255162 Acute Myeloid Leukemia (AML) ... More >> Acute Myelocytic Leukemia Acute Myelogenous Leukemia Acute Granulocytic Leukemia Acute Non-Lymphocytic Leukemia Less << Phase 1 Terminated(Slow Accrual) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01350232 Sickle Cell Anemia ... More >> Sickle Cell-hemoglobin C Disease Sickle Cell-β0-thalassemia Less << Not Applicable Terminated(Poor accrual) - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT02433483 Acute Myeloid Leukemia (AML) ... More >> Myelodysplastic Syndrome (MDS) Less << Phase 2 Terminated(The study was close... More >>d due to poor accrual and because of competing protocols.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00367497 Lymphoma, Non-Hodgkin Phase 2 Terminated(The stopping rule w... More >>as applied because of low response rates.) Less << - Japan ... More >> Keio University School of Medicine Tokyo, Japan, 160-8582 Less <<
NCT02433483 - Terminated(The study was close... More >>d due to poor accrual and because of competing protocols.) Less << - -
NCT01296178 Acute Myeloblastic Leukemia Not Applicable Recruiting December 2019 Spain ... More >> Hospital La Fe Recruiting Valencia, Spain Contact: Federico Moscardó, Dr       fedemoscardo@yahoo.es Less <<
NCT01880437 - Terminated - -
NCT01382147 Acute Myeloid Leukemia Phase 3 Completed - Germany ... More >> Vinzenz-Pallotti-Hospital, Innere Abteilung Bergisch-Gladbach, Germany, 51429 St. Hedwig Krankenhaus, Abteilung Innere Medizin Berlin, Germany, 10115 Vivantes Klinikum Neukoelln, Innere Medizin - Haematologie und Onkologie Berlin, Germany, 12351 HELIOS Klinikum Berlin-Buch, Klinik für Haematologie, Onkologie und Tumorimmunologie Berlin, Germany, 13125 Vivantes Klinikum Spandau, Klinik fuer Innere Medizin, Haematologie, Onkologie, Gastroenterologie und Palliativmedizin Berlin, Germany, 13585 Evangelisches Waldkrankenhaus Spandau Berlin, Germany, 13589 Evangelisches Krankenhaus Bielefeld gGmbH, Klinik fuer Innere Medizin, Haematologie, Onkologie und Palliativmedizin Bielefeld, Germany, 44791 Augusta-Krankenanstalt, Klinik fuer Haematologie, Onkologie und Palliativmedizin Bochum, Germany, 44791 Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Innere Medizin I Bonn, Germany, 53113 Knappschaftskrankenhaus Bottrop, Klinik fuer Innere Medizin Bottrop, Germany, 46242 St.-Johannes Hospital Dortmund, Klinik fuer Innere Medizin II Dortmund, Germany, 44137 St.-Antonius-Hospital Eschweiler, Klinik fuer Haematologie und internistische Onkologie Eschweiler, Germany, 52249 Klinikum Frankfurt / Oder GmbH, Medizinische Klinik I Frankfurt / Oder, Germany, 15236 St.-Josef-Hospital Gelsenkirchen-Horst, Klinik für Medizinische und Radiologische Onkologie, Hämatologie und Palliativmedizin Gelsenkirchen, Germany, 45899 Städtisches Klinikum Gütersloh, Medizinische Klinik II Gütersloh, Germany, 33332 Kath. Krankenhaus Hagen GmbH, Klinik fuer Haematologie und Onkologie Hagen, Germany, 58095 Klinikum Herford, Medizinische Klinik II Herford, Germany, 32049 Universitaetsklinikum Köln, Klinik I fuer Innere Medizin Köln, Germany, 50924 Klinikum Leverkusen gGmbH, Medizinische Klinik III Leverkusen, Germany, 51375 Klinikum der Stadt Ludwigshafen am Rhein gGmbH, Medizinische Klinik A Ludwigshafen, Germany, 67063 Universitätsklinikum Schleswig-Holstein, Medizinische Klinik I, Haematologie / Onkologie Luebbeck, Germany, 23538 Medizinische Fakultaet Mannheim der Universitaet Heidelberg, III. Medizinische Klinik Haematologie und Internistische Onkologie Mannheim, Germany, 68167 Carl-von-Basedow-Klinikum Saalekreis GmbH, Medizinische Klinik II Merseburg, Germany, 06217 Krankenhaus Maria Hilf GmbH, Krankenhaus St. Franziskus, Medizinische Klinik I Moenchengladbach, Germany, 41063 Klinikum der Universitaet Muenchen Medizinische Klinik und Polikklinik III Muenchen, Germany, 81377 Staedtisches Klinikum Harlaching, Klinik für Onkologie und Haematologie Muenchen, Germany, 81545 Klinikum Osnabrück, Klinik fuer Haematologie / Onkologie Osnabrück, Germany, 49076 Brüderkrankenhaus St. Josef Paderborn, Klinik fuer Haematologie / Onkologie Paderborn, Germany, 33098 Krankenhaus Barmherzige Brüder , Klinik fuer internistische Onkologie und Haematologie Regensburg, Germany, 93049 St.-Marien-Krankenhaus Siegen gem. GmbH, Medizinische Klinik III Siegen, Germany, 57072 Stiftung Deutsche Klinik für Diagnostik GmbH, Zentrum fuer Knochenmark- und Stammzelltransplantation Wiesbaden, Germany, 65191 Klinikum Idar-Oberstein GmbH, Innere Medizin I, Abteilung Haematologie / Onkologie Îdar-Oberstein, Germany, 55743 Less <<
NCT02936089 Acute Myeloid Leukemia ... More >> Risk Stratification Less << Not Applicable Not yet recruiting September 2020 -
NCT01325194 Primary Disease Phase 2 Active, not recruiting December 2017 Denmark ... More >> Department of Hematology, Århus University Hospital Århus, Denmark Finland Department of Oncology, Helsinki University Central Hospital Helsinki, Finland Norway Department of Oncology, Oslo University Hospital Oslo, Norway Sweden Department of Oncology, Lund University Hospital Lund, Sweden Less <<
NCT00553943 Lymphoma, Non-Hodgkin ... More >> Diffuse Large B-cell Lymphoma Less << Phase 2 Completed - Belgium ... More >> ZNA Stuivenberg Antwerpen, Belgium, 2060 Hôpital Saint Joseph Arlon, Belgium, Bruges A. Z. Sint-Jan Bruges, Belgium, 8000 UCL- Saint Luc Bruxelles, Belgium, 1200 CH Notre Dame Charleroi, Belgium, 6000 AZ VUB Jette, Belgium, 1090 CHR de la Citadelle Liège, Belgium, 4000 CHU Charleroi-Vésale Montigny-Le-Tilleul, Belgium, 6110 Clinique Saint Pierre Ottignies, Belgium, 1340 Heilig Hart Ziekenhuis Roeselare, Belgium, 8800 UCL - Mont-Godinne Yvoir, Belgium, 5530 France CH d'Annecy Annecy, France, F-74011 Centre Hospitalier d'Avignon Avignon, France, F-84902 Hôpital de Bayonne Bayonne, France, F-64100 Hôpital d'Avicenne Bobigny, France, F-93009 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, F-33300 CH de Brive Brive la Gaillarde, France, F-19190 CHU Clemenceau Caen, France, F-14033 Centre Francois Baclesse Caen, France, F-14076 CH de Chambery Chambery, France, F-73011 CH de Chartres Chartres, France, F-28018 Hôpital Gilles de Corbeil Corbeil-Essonnes, France, F-91108 Hôpital Henri Mondor Creteil, France, F-94010 CHU Le Bocage Dijon, France, F-21034 Centre Hospitalier de Dunkerque Dunkerque, France, F-59385 Hôpital Saint Louis La Rochelle, France, F-17019 Hôpital Andre Mignot Le Chesnay, France, F-78157 Hôpital Bicêtre Le Kremlin-Bicêtre, France, F-94270 CHU de Lens Lens, France, F-62307 Hopital Saint Vincent de Paul Lille, France, F-59020 CHU Claude Huriez Lille, France, F-59037 Hôpital Dupuytren Limoges, France, F-87000 Centre Leon Berard Lyon, France, F-69373 Hôpital des Chanaux Macon, France, F-71018 CH de Meaux Meaux, France, F-77100 Hôpital Bon Secours Metz, France, F-57038 Hôpital Emile Muller Mulhouse, France, F-68070 Centre Antoine Lacassagne Nice, France, F-06054 Hôpital Saint Louis Paris, France, F-75475 Hôpital Necker Paris, France, F-75743 Centre Hospitalier de Perpigan Perpignan, France, F-66046 Centre Hospitalier Lyon Sud Pierre Benite, France, F-69495 Centre Henri Becquerel Rouen, France, F-76038 CH de St Germain St Germain en Laye, France, F-78108 Hôpital Purpan Toulouse, France, F-31000 Hopital Brabois Vandoeuvre les Nancy, France Less <<
NCT01880437 Myelodysplastic Syndromes, Mye... More >>logenous Leukemia, Acute Less << Phase 2 Terminated - United States, California ... More >> Stanford, California, United States, 94305 United States, Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Kansas City, Missouri, United States, 64131 United States, New York New York, New York, United States, 10065 United States, Texas Houston, Texas, United States, 77030 Canada, Alberta Edmonton, Alberta, Canada, T6L5X8 Canada, Ontario Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Montreal, Quebec, Canada, H1T 2M4 Montreal, Quebec, Canada, H3T 1E2 Germany Braunschweig, Germany, 38114 Essen, Germany, 45122 Hamburg, Germany, 20246 Heidelberg, Germany, 69120 Münster, Germany, 48149 Less <<
NCT00290433 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02845232 - Completed - France ... More >> Hospices Civils de Lyon - Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet Pierre-benite, France, 69310 Less <<
NCT02587598 Solid Tumors Phase 1 Phase 2 Recruiting January 2020 -
NCT00002768 Leukemia Phase 2 Completed - United States, California ... More >> UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Maryland Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, New Jersey St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States, 07503 Less <<
NCT01363128 Leukemia Phase 2 Active, not recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02451774 Acute Lymphoblastic Leukemia Phase 2 Phase 3 Recruiting December 2020 Mexico ... More >> Hospital Civil de Guadalajara "Dr. Juan I. Menchaca" Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Ramon O Gonzalez Ramella, PhD    5213331719826    glezramella@hotmail.com    Contact: Fabiola P Medina Barajas, PhD    5213313461917    favyri@hotmail.com Less <<
NCT00002926 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Unknown - -
NCT03713580 Non-hodgkin Lymphoma Phase 1 Not yet recruiting December 31, 2020 -
NCT01297543 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia Myelodysplasia Less << Phase 1 Phase 2 Completed - United States, California ... More >> Moores UCSD Cancer Center La Jolla, California, United States, 92037 University of California San Francisco Medical Center San Francisco, California, United States, 94143 Stanford Hospital and Clinics Stanford, California, United States, 94305 United States, Illinois Loyola University Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States, 60153 United States, Indiana Indiana Blood and Marrow Transplantation, LLC Beech Grove, Indiana, United States, 46107 United States, Massachusetts University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States, 01655 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania The Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00487448 Myelodysplastic Syndrome ... More >> Acute Myeloblastic Leukemia Less << Phase 4 Completed - Spain ... More >> Hospital de la Ribera Alzira, Spain Hospital Germans Trias i Pujol Badalona, Spain Hospital del Mar Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital Puerta del Mar Cadiz, Spain Hospital del SAS Jerez de la Frontera, Spain Hospital de Leon Leon, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario La Paz Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Central de Asturias Oviedo, Spain Hospital Clínico de Salamanca Salamanca, Spain Hospital Arnau de Vilanova Valencia, Spain Hospital Dr. Pesset Valencia, Spain Hospital Universitario La Fe Valencia, Spain Less <<
NCT02668653 Acute Myeloid Leukemia ... More >> Leukemia Less << Phase 3 Recruiting November 2020 -
NCT01538472 Lymphoma Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02920008 Acute Myeloid Leukemia Phase 3 Active, not recruiting December 2019 -
NCT01538472 - Completed - -
NCT00594815 Lymphoma Not Applicable Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00594815 - Completed - -
NCT01564784 Acute Lymphoblastic Leukemia Phase 3 Completed - -
NCT03441048 Acute Myeloid Leukemia Phase 1 Recruiting April 1, 2020 United States, Wisconsin ... More >> Froedtert Hospital and the Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Cancer Center Clinical Trials Office    866-680-0505 ext 8900    cccto@mcw.edu    Principal Investigator: Sameem Abedin, MD Less <<
NCT02427620 Lymphoma Phase 2 Recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00038649 - Terminated(Sponsor discontinue... More >>d providing study drug.) Less << - -
NCT00820976 AML Phase 3 Completed - -
NCT01564784 - Completed - -
NCT03568994 Acute Myeloid Leukemia Early Phase 1 Recruiting January 2021 United States, Maryland ... More >> John Hopkins Medicine Not yet recruiting Baltimore, Maryland, United States, 21205 Contact: Cara Rabik, MD          United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Alexandra Stevens    832-824-4824       United States, Washington Seattle Children's Hospital Not yet recruiting Seattle, Washington, United States, 98101 Contact: Todd Cooper, MD Less <<
NCT03379727 Acute Myeloid Leukemia Phase 3 Recruiting December 30, 2021 -
NCT02084563 Acute Myeloid Leukemia ... More >> Myeloproliferative Neoplasms Myelodysplastic Syndromes Myeloproliferative/Myelodysplastic Neoplasm Less << Phase 2 Completed - Brazil ... More >> Hospital Israelita Albert Einstein Sao Paulo, SP, Brazil, 05651901 Less <<
NCT00038649 Myelogenous Leukemia, Chronic,... More >> Chronic Phase Less << Phase 2 Terminated(Sponsor discontinue... More >>d providing study drug.) Less << - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00501826 Leukemia Lymp... More >>hoblastic Lymphoma Leukemia, Lymphoblastic, Acute Less << Phase 2 Recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00594555 Chronic Myeloid Leukemia, Blas... More >>t Crisis Acute Myeloid Leukemia Less << Phase 2 Withdrawn(Principal Investigat... More >>or resigned position with the University of Cincinnati, closing study at this site will reopen study in new position) Less << November 2008 United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45267 Less <<
NCT02200978 Childhood Acute Promyelocytic ... More >>Leukemia Less << Phase 4 Recruiting September 2022 China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Xue-Qun Luo, professor       L-xuequn@126.com    Principal Investigator: Xue-Qun Luo, professor Less <<
NCT01723657 Leukemia, Myelocytic, Acute Phase 2 Completed - Spain ... More >> Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 ICO Hospital Universitari de Bellvitge L'Hospitalet del Llobregat, Barcelona, Spain, 08907 Hospital A Coruña A Coruña, Coruña, Spain, 15006 Hospital Universitari Son Espases Palma de Mallorca, Mallorca, Spain, 07198 Hospital Universitari Son Dureta Palma de Mallorca, Mallorca, Spain Hospital Verge de la Cinta Tortosa, Tarragona, Spain, 43517 Hospital del Mar Barcelona, Spain, 08003 Centro Medico Teknon Barcelona, Spain, 08022 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Vall d'Hebron Barcelona, Spain, 08035 Hospital Clínic de Barcelona Barcelona, Spain, 08036 Hopital Universitari de Girona Dr. Josep Trueta Girona, Spain, 17007 Hospital Universitari Arnau de Vilanova Lleida, Spain, 25006 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario Virgen de la Victoria Malaga, Spain, 29010 Hospital General Universitario de Murcia Murcia, Spain, 30008 Hospital Universitario Virgen del Rocio Sevilla, Spain, 41014 Hospital Universitari Joan XXIII Tarragona, Spain, 43007 Mutua de Terrassa Terrassa, Spain, 08225 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Hospital Universitario Rio Hortega Valladolid, Spain, 41010 Less <<
NCT01246752 Leukemia, Myeloid, Acute Phase 3 Unknown December 2017 Germany ... More >> Universitätsklinikum Aachen Recruiting Aachen, Germany Contact: Tim H Brümmendorf, Prof. Dr. med.          Principal Investigator: Tim H Brümmendorf, Prof. Dr. med.          Klinikum Augsburg Recruiting Augsburg, Germany Contact: Günter Schlimok, Prof. Dr. med.       schlimok@klinikum-augsburg.de    Principal Investigator: Günter Schlimok, Prof. Dr. med.          Bielefeld Klinikum Mitte Recruiting Bielefeld, Germany Contact: Martin Görner, PD Dr. med.       martin.goerner@klinikumbielefeld.de    Principal Investigator: Martin Görner, PD Dr. med.          Klinikum Chemnitz gGmbH Recruiting Chemnitz, Germany Contact: Mathias Hänel, PD Dr. med.       m.haenel@skc.de    Principal Investigator: Mathias Hänel, PD Dr. med.          University Hospital Carl Gustav Carus Recruiting Dresden, Germany, 01307 Contact: Martin Bornhäuser, Prof. Dr.       martin.bornhaeuser@uniklinikum-dresden.de    Principal Investigator: Martin Bornhäuser, Prof. Dr.          Universitätsklinikum Erlangen Recruiting Erlangen, Germany Contact: Wolf Rösler, Dr. med.       wolf.roesler@uk-erlangen.de    Principal Investigator: Wolf Rösler, Dr. med.          Universitätsklinikum Essen - Klinik für Knochenmarktransfusion Recruiting Essen, Germany Contact: Dietrich W Beelen, Prof. Dr. med.       dietrich.beelen@uk-essen.de    Principal Investigator: Dietrich W Beelen, Prof. Dr. med.          Universitätsklinikum Essen - Westdeutsches Tumorzentrum Recruiting Essen, Germany Contact: Richard Noppeney, Dr. med.       richard.noppeney@uk-essen.de    Principal Investigator: Richard Noppeney, Dr. med          Klinikum der Johann-Wolfgang-Goethe Universität Recruiting Frankfurt am Main, Germany Contact: Gesine Bug, PD Dr. med.       g.bug@em.uni-frankfurt.de    Principal Investigator: Gesine Bug, PD Dr. med.          Klinikum Frankfurt (Oder) GmbH Recruiting Frankfurt/Oder, Germany Contact: Michael Kiehl, Prof. Dr. med.       m.kiehl.km@klinikumffo.de    Principal Investigator: Michael Kiehl, Prof. Dr. med.          Ernst-Moritz-Arndt-Universitaet Greifswald Not yet recruiting Greifswald, Germany Contact: Gottfried Doelken, Prof. Dr. med.       doelken@uni-greifswald.de    Principal Investigator: Gottfried Doelken, Prof. Dr. med.          Universitätsklinikum Halle Recruiting Halle / Saale, Germany Contact: Lutz P. Müller, Dr. med.       lutz.mueller@uk-halle.de    Principal Investigator: Lutz P. Müller, Dr. med.          Asklepios Klinik St. Georg Recruiting Hamburg, Germany Contact: Norbert Schmitz, Prof. Dr. med.       n.schmitz@asklepios.com    Principal Investigator: Norbert Schmitz, Prof. Dr. med.          Universitätsklinikum Heidelberg Recruiting Heidelberg, Germany Contact: Tilmann Bochtler, Dr. med.          Principal Investigator: Tilmann Bochtler, Dr. med.          Universitaetsklinikum Leipzig - AöR Recruiting Leipzig, Germany Contact: Dietger Niederwieser, Prof. Dr. med.       dietger@medizin.uni-leipzig.de    Principal Investigator: Dietger Niederwieser, Prof. Dr. med.          Universitätsklinikum Magdeburg Recruiting Magdeburg, Germany Contact: Thomas Heinicke, Dr. med.       thomas.heinicke@med.ovgu.de    Principal Investigator: Thomas Heinicke, Dr. med.          Universitätsklinikum Mannheim Recruiting Mannheim, Germany Contact: Stefan Klein, PD Dr. med.       stefan.klein@umm.de    Principal Investigator: Stefan Klein, PD Dr. med.          Universitätsklinikum Gießen und Marburg GmbH Recruiting Marburg, Germany Contact: Andreas Neubauer, Prof. Dr. med.       neubauer@staff.uni-marburg.de    Principal Investigator: Andreas Neubauer, Prof. Dr. med.          Klinikum der LMU Universität - Campus Großhadern Recruiting München, Germany Contact: Johanna Tischer, Dr. med.       Johanna.Tischer@med.uni-muenchen.de    Principal Investigator: Johanna Tischer, Dr. med.          Universitätsklinikum Münster Recruiting Münster, Germany Contact: Matthias Stelljes, PD Dr. med.       stelljes@uni-muenster.de    Principal Investigator: Matthias Stelljes, Prof. Dr. med.          Städtisches Klinikum Nord Recruiting Nürnberg, Germany Contact: Kerstin Schäfer-Eckart, Dr.med.       schaefer@klinikum-nuernberg.de    Principal Investigator: Kerstin Schäfer-Eckart, Dr.med.          Ernst-von-Bergmann-Klinikum Potsdam Recruiting Potsdam, Germany Contact: Georg Maschmeyer, Prof. Dr.       gmaschmeyer@klinikumevb.de    Principal Investigator: Georg Maschmeyer, Prof. Dr.          Klinikum der Universität Regensburg Recruiting Regensburg, Germany Contact: Ernst Holler, Prof. Dr. med       ernst.holler@klinik.uni-regensburg.de    Principal Investigator: Ernst Holler, Prof. Dr. med          Robert-Bosch-Krankenhaus Recruiting Stuttgart, Germany Contact: Martin Kaufmann, Dr. med.       martin.kaufmann@rbk.de    Principal Investigator: Martin Kaufmann, Dr. med.          Klinikum Mutterhaus der Borromäerinnen gGmbH Recruiting Trier, Germany Contact: Michael R Clemens, Prof. Dr. med.       clemens@mutterhaus.de    Principal Investigator: Michael R Clemens, Prof. Dr. med.          Dt. Klinik für Diagnostik Recruiting Wiesbaden, Germany Contact: Gernot Stuhler, PD Dr. med.       gernot.stuhler@dkd-wiesbaden.de    Principal Investigator: Rainer Schwerdtfeger, PD Dr. med.          Universitätsklinikum Würzburg Recruiting Würzburg, Germany Contact: Stephan Mielke, PD Dr. med.       mielke_s@klinik-wuerzburg.de    Principal Investigator: Gernot Stuhler, PD Dr. med. Less <<
NCT02416908 Acute Myeloid Leukemia Phase 1 Phase 2 Active, not recruiting June 30, 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02105116 - Terminated(No patients were el... More >>igible to receive the experimental component of the protocol therapy.) Less << - -
NCT01177540 Pediatric Acute Myelogenous Le... More >>ukemia (AML) Less << Phase 2 Completed - -
NCT02278796 Lymphoma, Large B-Cell, Diffus... More >>e Lymphoma, Follicular Lymphoma, Mantle-Cell Less << Phase 2 Active, not recruiting December 2019 Austria ... More >> Krankenhaus der Elisabethinen Linz Linz, Austria, 4020 Hanusch Krankenhaus Wien Wien, Austria, 1140 Switzerland Department for Medical Oncology University Hospital/Inselspital Berne, Switzerland, 3010 Universitätsspital Zürich Zürich, Switzerland, 8091 Less <<
NCT03164057 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 2 Recruiting June 2027 United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Weili Sun, MD,PhD    800-826-4673    weilisun@coh.org    Principal Investigator: Weili Sun, MD,PhD          Children's Hospital of Central California Recruiting Madera, California, United States, 93636 Contact: Faisal Razzaqi, MD    866-353-5437    frazzaqi@valleychildrens.org    Principal Investigator: Faisal Razzaqi, MD          Children's Hospital of Orange County Recruiting Orange, California, United States, 92968 Contact: Jamie Frediani, MD    714-509-4348    jfrediani@choc.org    Principal Investigator: Jamie Frediani, MD          Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Norman J. Lacayo, MD          Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5983    dschiff@chsd.org    Principal Investigator: Deborah Schiff, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD    866-278-5833    tanja.gruber@stjude.org    Contact: Referral Office    866-278-5833    referralinfo@stjude.org    Principal Investigator: Tanja A. Gruber, MD, PhD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD    682-885-4007    kenneth.heym@cookchildrens.org    Principal Investigator: Kenneth M. Heym, MD Less <<
NCT03488225 Acute Lymphocytic Leukemia Phase 2 Recruiting March 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       ejabbour@mdanderson.org Less <<
NCT00136435 Acute Lymphoblastic Leukemia Phase 2 Active, not recruiting December 2018 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, New York University Of Columbia Medical Center New York, New York, United States Canada, Manitoba Manitoba Blood & Marrow Transplant Program CancerCare Manitoba Winnipeg, Manitoba, Canada Canada, Ontario McMaster University Medical Center Hamilton, Ontario, Canada Queen's University Kingston, Ontario, Canada London Health Sciences Centre London, Ontario, Canada Sunnybrook Health Sciences Centre Toronto, Ontario, Canada Canada, Quebec Hospital Maisonneuve-Rosemont Montreal, Quebec, Canada Royal Victoria Hospital Montreal, Quebec, Canada Canada, Saskatchewan Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada Canada Queen Elizabeth II Halifax, Canada Less <<
NCT01701323 Acute Leukemia of Ambiguous Li... More >>neage Acute Myeloid Leukemia Less << Phase 1 Terminated - United States, Georgia ... More >> Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03518112 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 2 Recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77339 Contact       ejabbour@mdanderson.org Less <<
NCT02877303 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 2 Recruiting November 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01794169 Acute Myeloid Leukemia Phase 2 Terminated(Poor recruitment) March 2018 Sweden ... More >> Karolinska University Hospital, Solna Stockholm, Sweden, 17176 Less <<
NCT02343939 Acute Myeloid Leukemia Phase 1 Phase 2 Active, not recruiting February 2020 United States, California ... More >> UCLA Los Angeles, California, United States United States, Illinois University of Chicago Chicago, Illinois, United States Loyola University Medical Center Maywood, Illinois, United States United States, Indiana Indiana University Indianapolis, Indiana, United States United States, Kansas University of Kansas Medical Center Research Institute, Inc Fairway, Kansas, United States United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States United States, Michigan Henry Ford Health System Detroit, Michigan, United States Karmanos Cancer Institute Detroit, Michigan, United States United States, New York Weill Cornell Medical College - New York - Presbyterian Hospital New York, New York, United States United States, North Carolina Duke Cancer Center Durham, North Carolina, United States United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States Ohio State University Columbus, Ohio, United States United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, South Carolina Saint Francis Cancer Center Greenville, South Carolina, United States Canada, Ontario Princess Margaret Toronto, Ontario, Canada Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada Germany Universitätsklinikum Frankfurt Medizinische Klinik II Frankfurt, Germany, 60590 Less <<
NCT02105116 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Not Applicable Terminated(No patients were el... More >>igible to receive the experimental component of the protocol therapy.) Less << - United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT02665143 Relapsed/Refractory Acute Myel... More >>oid Leukemia Less << Phase 1 Phase 2 Recruiting December 2019 United States, Connecticut ... More >> Yale University Recruiting New Haven, Connecticut, United States, 06520 Contact: Rebecca Lilian    203-737-8358    rebecca.lilian@yale.edu    United States, Tennessee Vanderbilt Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Channing V Dudley, RN, MSN    615-875-5503    channing.v.dudley@vanderbilt.edu    Principal Investigator: Stephen Strickland, MD Less <<
NCT00568815 Lymphoma Phase 2 Completed - China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT02660762 Leukaemia,Lymphoblastic Phase 2 Recruiting January 2019 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510060 Contact: yue lu, MD.    0086-02087342438    dr_luyue@sina.com Less <<
NCT02858804 Mantle Cell Lymphoma Phase 4 Recruiting June 2020 China ... More >> Shuhua Yi Recruiting Tianjin, China, 300020 Contact: Shuhua Yi, Doc    86-22-23909106    yishuhua@ihcams.ac.cn    Contact: Lugui Qiu, Doc    86-22-23909172    qiulg@ihcams.ac.cn Less <<
NCT03256071 Acute Myeloid Leukemia ... More >> Allogeneic Hematopoietic Stem Cell Transplantation Conditioning Less << Phase 2 Phase 3 Recruiting September 2021 China, Jiangsu ... More >> The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Xiaowen Tang, MD    +86-512-67781851    xwtang1020@163.com    Principal Investigator: Depei Wu, MD Less <<
NCT00578539 - Terminated - -
NCT00578539 Leukemia Hodg... More >>kin Lymphoma Non Hodgkin Lymphoma Myeloproliferative Disorders Less << Not Applicable Terminated - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02626338 Relapsed/Refractory Acute Myel... More >>oid Leukemia (AML) Less << Phase 1 Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas Little Rock, Arkansas, United States, 72205 United States, California City of Hope Medical Center Duarte, California, United States, 91010 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Houston Methodist Houston, Texas, United States, 77030 Less <<
NCT00004128 Leukemia Phase 3 Unknown - -
NCT02632708 Newly Diagnosed Acute Myeloid ... More >>Leukemia (AML) Untreated AML AML Arising From Myelodysplastic Syndrome (MDS) AML Arising From Antecedent Hematologic Disorder (AHD) AML Arising After Exposure to Genotoxic Injury Less << Phase 1 Active, not recruiting July 2020 United States, California ... More >> Duarte, California, United States, 91010 Los Angeles, California, United States, 90095 United States, Colorado Aurora, Colorado, United States, 80045 United States, Illinois Chicago, Illinois, United States, 60637 United States, Maryland Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston, Massachusetts, United States, 02215 United States, New Jersey Hackensack, New Jersey, United States, 07601 United States, New York New York, New York, United States, 10065 United States, Ohio Columbus, Ohio, United States, 43210 United States, Tennessee Nashville, Tennessee, United States, 37232 United States, Texas Dallas, Texas, United States, 75390 Houston, Texas, United States, 77030 Germany Ulm, Germany, 89081 Netherlands Amsterdam, Netherlands, 1081 HV Rotterdam, Netherlands, 3075 EA Less <<
NCT02326584 Acute Myeloid Leukemia ... More >> Acute Myelogenous Leukemia Less << Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California City of Hope National Medical Center Duarte, California, United States, 91010-3000 United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Illinois Cardinal Bernardin Cancer Center / Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States, 48201 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Ohio Cleveland Clinic, The Cleveland, Ohio, United States, 44195 James Cancer Hospital / Ohio State University Columbus, Ohio, United States, 43210 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 30384 United States, Texas Charles A. Sammons Cancer Center / Baylor University Medical Center Dallas, Texas, United States, 75246 MD Anderson Cancer Center / University of Texas Houston, Texas, United States, 77030-4095 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT01290120 Burkitt Lymphoma ... More >> B-ALL Less << Phase 2 Completed - Italy ... More >> Divisione di Ematologia e TMO, Ospedale San Maurizio Bolzano, (bz), Italy Ematologia e centro TMO - Ospedale Armando Businco Cagliari, (ca), Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, (cn), Italy Onco-Ematologia - Ospedale Civile Noale, (ve), Italy Dipartimento di Ematologia e Medicina Trasfusionale - Azienda Osp. Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy USC Ematologia Ospedali Riuniti di Bergamo Bergamo, BG, Italy Divisione Ematologia Spedali Civili Brescia, BS, Italy, 25123 Ematologia - AOU Careggi Firenze, FI, Italy Ematologia e TMO - Ospedale San Raffaele Milano, MI, Italy Ematologia - TMO - Ospedale San Gerardo Monza, MI, Italy Ematologia Ospedale San Bortolo Vicenza, VI, Italy, 36100 USC Ematologia Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Less <<
NCT01843179 Acute Myeloid Leukemia Phase 2 Withdrawn(Lack of Funding) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01390337 Leukemia, Myeloid, Acute Phase 1 Completed - United States, Florida ... More >> Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland Johns Hopkins Medical Institute Baltimore, Maryland, United States, 21231 United States, New York Memorial-Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01453205 - Completed - -
NCT00274807 Leukemia Phase 2 Completed - -
NCT00003405 Leukemia Phase 2 Unknown - United States, Illinois ... More >> Cook County Hospital Chicago, Illinois, United States, 60612-9985 Rush Cancer Institute Chicago, Illinois, United States, 60612 Angelo P. Creticos, M.D. Cancer Center Chicago, Illinois, United States, 60657 Rush-Riverside Cancer Center Kankakee, Illinois, United States, 60901 Less <<
NCT02886559 AML Relapse Phase 1 Phase 2 Recruiting June 2019 China ... More >> China PLA General Hospital Recruiting Beijing, China, 100039 Contact: Li Yu, M.D Ph.D    010-66937644    chunhuiliyu@yahoo.com    Principal Investigator: Li-Xin Yu Less <<
NCT03348033 Chronic Myeloid Leukemia Phase 1 Phase 2 Enrolling by invitation March 2020 -
NCT00002598 Leukemia Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00002481 Lymphoma Phase 2 Unknown - United States, Wisconsin ... More >> St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 Less <<
NCT03416179 Leukemia, Myeloid, Acute Phase 3 Recruiting July 22, 2025 -
NCT00591630 Diffuse Large Cell Lymphoma ... More >> Lymphoma Less << Phase 2 Active, not recruiting November 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01453205 Diffuse Large B-Cell Lymphoma Phase 2 Completed - -
NCT01830777 Acute Myelogenous Leukemia Phase 1 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00540956 Leukemia Not Applicable Completed - France ... More >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Less <<
NCT00002945 Leukemia Phase 3 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT01035463 Adult Nasal Type Extranodal NK... More >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 1 Phase 2 Active, not recruiting May 2018 United States, Kansas ... More >> University of Kansas Hospital - Westwood Cancer Center Westwood, Kansas, United States, 66205 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, Ohio Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT01476839 Recurrent Adult Hodgkin Lympho... More >>ma Less << Phase 1 Recruiting January 2021 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Eileen P. Smith    800-826-4673    esmith@coh.org    Principal Investigator: Eileen P. Smith Less <<
NCT02270788 Acute Myeloid Leukemia Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00549848 Acute Lymphoblastic Leukemia Phase 3 Active, not recruiting November 30, 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02724163 Acute Myeloid Leukaemia Phase 3 Recruiting December 2032 United Kingdom ... More >> Royal Aberdeen Children's Hospital Recruiting Aberdeen, United Kingdom, AB25 2ZG Aberdeen Royal Infirmary, NHS Grampian Recruiting Aberdeen, United Kingdom, AB25 2ZN Belfast City Hospital, Belfast Health and Social Care Trust Not yet recruiting Belfast, United Kingdom, BT9 7AB Birmingham Children's Hospital NHS Foundation Trust Recruiting Birmingham, United Kingdom, B4 6NH University Hospitals Bristol NHS Foundation Trust Recruiting Bristol, United Kingdom, BS1 3NU Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, United Kingdom, CB2 0QQ Cardiff and Vale University Health Board, Noah's Ark Children's Hospital for Wales Recruiting Cardiff, United Kingdom, CF14 4XW NHS Lothian, Royal Hospital for Sick Children Recruiting Edinburgh, United Kingdom, EH9 1LF NHS Greater Glasgow and Clyde, The Royal Hospital for Children Recruiting Glasgow, United Kingdom, G51 4TF Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom, LS9 7TF Alder Hey Children's NHS Foundation Trust Recruiting Liverpool, United Kingdom, L12 2AP University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom, NW1 2PG The Royal Marsden NHS Foundation Trust Recruiting London, United Kingdom, SW3 6JJ Great Ormond Street Hospital For Children NHS Trust Recruiting London, United Kingdom, WC1N 3JH Royal Manchester Childrens' Hospital , Central Manchester University Hospitals NHS Foundation Trust Recruiting Manchester, United Kingdom, M13 9WL The Christie NHS Foundation Not yet recruiting Manchester, United Kingdom, M20 4BX The Newcastle Upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle, United Kingdom, NE7 7DN Nottingham University Hospitals NHS Trust Recruiting Nottingham, United Kingdom, NG7 2UH John Radcliffe Hospital, Oxford Radcliffe Hospitals NHS Trust Recruiting Oxford, United Kingdom, OX3 9DU Sheffield Children's NHS Foundation Trust Recruiting Sheffield, United Kingdom, S10 2TH Southampton University Hospitals NHS Trust Recruiting Southampton, United Kingdom, SO16 6YD Less <<
NCT00003632 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00002571 Lymphoma Phase 2 Completed - -
NCT02577406 Leukemia, Myeloid ... More >> Isocitrate Dehydrogenase Less << Phase 3 Recruiting July 28, 2022 -
NCT00002674 Leukemia Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00363974 Leukemia, Myelomonocytic, Acut... More >>e Less << Phase 1 Phase 2 Completed - United States, California ... More >> Norris Cancer Center - University of Southern California Los Angeles, California, United States, 90033 UCLA Medical Center Los Angeles, California, United States, 90095 United States, Illinois Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 United States, Maryland Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 United States, Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030-4009 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hopital Maisonneuve-Rosemont Montreal, Quebec, Canada Less <<
NCT02342782 Mature T-Cell and NK-Cell Non-... More >>Hodgkin Lymphoma Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma Less << Phase 1 Recruiting August 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Jasmine Zain, MD    626-256-4673    jzain@coh.org    Principal Investigator: Jasmine Zain, MD Less <<
NCT01319864 Relapsed/Refractory AML ... More >> Relapsed/Refractory ALL Secondary AML/MDS Acute Leukemia of Ambiguous Lineage AML ALL Less << Phase 1 Completed - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85016 United States, Colorado The Children's Hospital of Denver Denver, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta/Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins Medical Center Baltimore, Maryland, United States, 21231 United States, Missouri The Children's Mercy Hospital and Clinics Kansas City, Missouri, United States, 64108 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Penn State Hershey Children's Hospital Hershey, Pennsylvania, United States, 17033 Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Less <<
NCT00646750 Non-Hodgkin's Lymphoma Phase 2 Completed - Spain ... More >> H.U. Central de Asturias, Oviedo Oviedo, Asturias, Spain H.Universitario de Canarias Santa Cruz de Tenerife, Canarias, Spain Clínica Universitaria de Navarra Pamplona, Navarra, Spain Hospital Universitario de Alicante Alicante, Spain H. de la Santa Creu i Sant Pau Barcelona, Spain Instituto Catalán de Oncología, Barcelona, Spain H. Reina Sofía Córdoba, Spain Clínica Puerta de Hierro, Madrid, Spain H.U. 12 de Octubre, Madrid, Spain H.U. Gregorio Marañón, Madrid, Spain H.U. La Paz Madrid, Spain H.U. La Princesa Madrid, Spain M.D. Anderson Internacional Madrid, Spain H. Morales Messeguer Murcia, Spain H.U. Virgen de la Arrixaca Murcia, Spain H. Clínico Universitario de Salamanca Salamanca, Spain H.U. Marqués de Valdecilla Santander, Spain H.U. La Fe Valencia, Spain Less <<
NCT00801216 B-Cell Lymphomas Phase 2 Unknown January 2012 Italy ... More >> San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Contact: Roberto Crocchiolo, MD       roberto.crocchiolo@hsr.it    Contact: Silvia Govi, MD       silvia.govi@hsr.it    Sub-Investigator: Andrea Assanelli, MD          San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Sub-Investigator: Roberto Crocchiolo, MD          Sub-Investigator: Silvia Govi, MD Less <<
NCT00335140 - Terminated(slow accrual) - -
NCT00369317 Childhood Acute Basophilic Leu... More >>kemia Childhood Acute Eosinophilic Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - -
NCT00002805 Leukemia Phase 2 Completed - -
NCT00335140 Lymphoma Phase 2 Terminated(slow accrual) - -
NCT02366663 Recurrent Diffuse Large B-Cell... More >> Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << Phase 3 Terminated(Withdrawal of spons... More >>or support) Less << - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00369317 - Completed - -
NCT02366663 - Terminated(Withdrawal of spons... More >>or support) Less << - -
NCT01943682 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Burkitt Lymphoma Diffuse Large Cell Lymphoma Gray Zone Lymphoma Lymphoblastic Lymphoma Anaplastic Large Cell Lymphoma Hodgkin Lymphoma Less << Phase 1 Active, not recruiting April 2019 United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT02834390 Acute Myeloid Leukemia Phase 1 Completed - Japan ... More >> Tokyo, Japan Less <<
NCT02518750 Acute Lymphoblastic Leukemia ... More >> Lymphoma, Non-Hodgkin's Leukemia, T-Cell Leukemia, B-Cell Less << Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00472056 Lymphoma Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00472056 - Completed - -
NCT00689169 Lymphoma, Large Cell, Diffuse Phase 2 Completed - France ... More >> service d'onco hématologie adultes, hôpital Saint Louis Paris, France, 75010 Less <<
NCT02400281 Acute Myeloid Leukemia Phase 1 Phase 2 Active, not recruiting April 2020 United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01690065 Chronic Myeloid Leukemia in My... More >>eloid Blast Crisis Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Recruiting December 2019 Korea, Republic of ... More >> Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Dong-Wook Kim, M.D., Ph.D.       dwkim@catholic.ac.kr    Principal Investigator: Dong-Wook Kim, M.D., Ph.D.          Ulsan University Hospital Recruiting Ulsan, Korea, Republic of, 682714 Principal Investigator: Hawk Kim, M.D., Ph.D.          Sub-Investigator: Jae-Hoo Park, M.D., Ph.D.          Sub-Investigator: Jae-Cheol Jo, M.D., Ph.D. Less <<
NCT02680951 Acute Myeloid Leukemia Phase 1 Withdrawn(Withdrawn due to lac... More >>k of participants.) Less << - -
NCT02896582 Mantle Cell Lymphoma Phase 2 Recruiting March 2025 France ... More >> CHU d'Amiens Recruiting Amiens, France, 80480 Principal Investigator: Jean-Pierre Marolleau, Dr          CHU d'Angers Recruiting Angers, France, 49000 Principal Investigator: Marie-Pierre Moles-Moreau, Dr          CH d'Avignon Recruiting Avignon, France, 84902 Principal Investigator: Hacene Zerazhi, Dr          CHU de Caen Recruiting Caen, France, 14033 Principal Investigator: Christophe Fruchart, Dr          CHU de Clermont Ferrand Recruiting Clermont Ferrand, France, 63000 Principal Investigator: Victoria Cacheux, Dr          Hopital Henri Mondor Recruiting Créteil, France, 94010 Principal Investigator: Corinne Haioun          CHU de Dijon - Hôpital le Bocage Recruiting Dijon, France, 21034 Principal Investigator: Olivier Casasnovas, Dr          CHU de Grenoble Recruiting Grenoble, France, 38700 Principal Investigator: Rémy Gressin, Dr          CHD Vendée Recruiting La Roche sur Yon, France, 85925 Principal Investigator: Nadine Morineau, Dr          Clinique Victor Hugo Recruiting Le Mans, France, 72000 Principal Investigator: Katell Le Du, Dr          CHRU Lille - Hôpital Claude Huriez Recruiting Lille, France, 59037 Principal Investigator: Franck MORSCHHAUSER, Pr          CHU Limoges Recruiting Limoges, France, 87042 Principal Investigator: Julie Abraham, Dr          CHU Montpellier Recruiting Montpellier, France, 34295 Principal Investigator: Guillaume Cartron, Dr          CHU Nantes Recruiting Nantes, France, 44093 Principal Investigator: Steven Le Gouill, Pr          Hôpital Saint Louis Recruiting Paris, France, 75475 Principal Investigator: Catherine THIEBLEMONT          APHP - Hopital Necker Recruiting Paris, France, 75743 Principal Investigator: Richard Delarue, Dr          CH Perpignan Recruiting Perpignan, France, 66046 Principal Investigator: Laurence Sanhes, Dr          CHU de Haut Leveque Recruiting Pessac, France, 33604 Principal Investigator: Kamal Bouabdallah, Dr          CHU Lyon Sud Recruiting Pierre Bénite, France, 69130 Principal Investigator: Gilles Salles          CHU de Poitiers Recruiting Poitiers, France, 86021 Principal Investigator: Vincent Delwail, Dr          Centre Hospitalier Annecy-Genevois Recruiting Pringy, France, 74374 Principal Investigator: Nicolas Daguindau, Dr          CHU Robert Debré Recruiting Reims, France, 51092 Principal Investigator: Alain Delmer, Pr          CHU Pontchaillou Recruiting Rennes, France, 35033 Principal Investigator: Thierry Lamy de la Chapelle, Pr          Centre Henri Becquerel Recruiting Rouen, France, 76038 Principal Investigator: Hervé Tilly, Dr          Institut de Cancérologie de Loire Recruiting Saint priest en Jarez, France, 42271 Principal Investigator: Jérome Cornillon, Dr          CHU de Strasbourg Recruiting Strasbourg, France, 67091 Principal Investigator: Luc-Matthieu Fornecker, Dr          I.U.C.T Oncopole Recruiting Toulouse, France, 31100 Principal Investigator: Lucie Oberic, Dr          CHRU Bretonneau Recruiting Tours, France, 37044 Principal Investigator: Caroline Dartigeas, Dr          CHU de Brabois Recruiting Vandoeuvre les Nancy, France Principal Investigator: Pierre Feugier, Dr          Gustave Roussy Cancer Campus Recruiting Villejuif, France, 94805 Principal Investigator: Vincent Ribrag, Dr Less <<
NCT01468311 - Active, not recruiting - -
NCT00244946 Lymphoma Phase 1 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00578461 Leukemia Canc... More >>er Lymphoma Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Less << Not Applicable Terminated - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00578461 - Terminated - -
NCT01468311 Hodgkin Disease ... More >> Hodgkin Lymphoma Less << Phase 1 Phase 2 Active, not recruiting September 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02776605 ALL Phase 2 Recruiting December 2020 Spain ... More >> Hospital Germans Trias i Pujol Recruiting Badalona, Spain Contact: Josep Mª Ribera, Dr       jribera@iconcologia.net    Hospital Clinic Recruiting Barcelona, Spain, 08036 Contact: Jordi Esteve, Dr       JESTEVE@clinic.ub.es    Hospital Universitario Vall d'Hebron Recruiting Barcelona, Spain Contact: Pere Barba, Dr       pebarba@vhebron.net    Hospital 12 de Octubre Recruiting Madrid, Spain Contact: Mª Pilar Martinez Sánchez, Dr       mpmartinezs.hdoc@salud.madrid.org    Hospital Virgen de la Victoria Recruiting Málaga, Spain Contact: Mª José Moreno, Dr       mjmorenorico@hotmail.com    Hospital Clinico Universitario de Salamanca Recruiting Salamanca, Spain Contact: Jesús Maria Hernández Rivas, Dr       jmhr@usal.es    Hospital Marques de Valdecilla Recruiting Santander, Spain Contact: Mª Aranzazu Bermudez, Dr       mbermudez@humv.es    C H Santiago de Compostela Recruiting Santiago de Compostela, Spain Contact: Natalia Alonso, Dr       natalia.alonso.vence@sergas.es    Hospital Virgen del Rocio Recruiting Sevilla, Spain Contact: Jose Gonzalez Campos, Dr       jose.gonzalez.sspa@juntadeandalucia.es    Hospital Clinico de Valencia Recruiting Valencia, Spain Contact: Mª del Mar Tormo, Dr       tormo_mar@gva.es    Hospital La Fe Recruiting Valencia, Spain Contact: Pau Montesinos, Dr       montesinos_pau@gva.es Less <<
NCT03263572 Malignant Neoplasms Stated as ... More >>Primary Lymphoid Haematopoietic Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting November 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       ejabbour@mdanderson.org Less <<
NCT01455025 Acute Myeloid Leukemia Phase 1 Terminated(no recruitment on t... More >>ime) Less << - France ... More >> Xavier THOMAS Lyon, France, 69437 Less <<
NCT00666588 Adult Acute Monoblastic Leukem... More >>ia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myelomonocytic Leukemia (M4) Childhood Acute Basophilic Leukemia Childhood Acute Eosinophilic Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Less << Phase 2 Completed - -
NCT00666588 - Completed - -
NCT00523939 - Terminated(Low accrual.) - -
NCT00523939 Neoplastic Meningitis ... More >> Lymphoma, B Cell Less << Phase 2 Terminated(Low accrual.) - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00534469 Leukemia Phase 2 Active, not recruiting January 2019 -
NCT00973752 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00973752 - Completed - -
NCT00096135 Leukemia Not Applicable Completed - -
NCT00096135 - Completed - -
NCT03736616 Diffuse Large B Cell Lymphoma Phase 2 Not yet recruiting September 2022 United States, Washington ... More >> Swedish Cancer Institute Not yet recruiting Seattle, Washington, United States, 98104 Contact: Neil Bailey          Principal Investigator: Krish Patel, MD Less <<
NCT03589326 Lymphoblastic Leukemia, Acute,... More >> Adult Acute Lymphoid Leukemia Leukemia, Acute Lymphoblastic Leukemia, Lymphoblastic Ph1 Chromosome Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Less << Phase 3 Recruiting July 4, 2026 United States, California ... More >> City of Hope - Duarte Recruiting Duarte, California, United States, 91010 United States, South Carolina Saint Francis Cancer Center Recruiting Greenville, South Carolina, United States, 29607 United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030-4000 Methodist Hospital Recruiting San Antonio, Texas, United States, 78229 Less <<
NCT02306291 Leukemia, Myeloid, Acute Phase 1 Phase 2 Active, not recruiting December 2018 United States, California ... More >> University of California, Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan, Ann Arbor Ann Arbor, Michigan, United States, 48109 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Washington University of Washington Seattle, Washington, United States, 98109 Australia Princess Alexandra Hospital Brisbane, Australia Ireland University Hospital Galway Galway, Ireland Less <<
NCT00002618 Lymphoma Phase 3 Completed - United States, Kansas ... More >> Via Christi Regional Medical Center-Saint Francis Campus Wichita, Kansas, United States, 67214 United States, Louisiana MBCCOP - LSU Medical Center New Orleans, Louisiana, United States, 70112 United States, North Carolina Memorial Mission Hospital Asheville, North Carolina, United States, 28801 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-0721 United States, Texas Medical City Dallas Hospital Dallas, Texas, United States, 75230 San Antonio Military Pediatric Cancer and Blood Disorders Center Lackland Air Force Base, Texas, United States, 78236-5300 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284 United States, Virginia Cancer Center, University of Virginia HSC Charlottesville, Virginia, United States, 22908 Puerto Rico University of Puerto Rico School of Medicine Medical Sciences Campus San Juan, Puerto Rico, 00936-5067 Switzerland Clinique de Pediatrie Geneva, Switzerland, 1211 Less <<
NCT00392834 - Completed - -
NCT00390793 Acute Lymphoblastic Leukemia ... More >> BCR-ABL1 Fusion Protein Expression Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia t(9;22) Less << Phase 2 Active, not recruiting August 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00392834 Lymphoma Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States, 90095-1793 UCSF Medical Center at Parnassus San Francisco, California, United States, 94143-0296 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Pennsylvania Oncology Hematology Associates, Incorporated - Philadelphia Philadelphia, Pennsylvania, United States, 19106 United States, Washington Floyd and Delores Jones Cancer Institute at Virginia Mason Medical Center Seattle, Washington, United States, 98101 United States, West Virginia West Virginia University Health Sciences Center - Charleston Charleston, West Virginia, United States, 25304 Less <<
NCT03019640 Mantle Cell Lymphoma ... More >> Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Indolent Adult Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Indolent Adult Non-Hodgkin Lymphoma Less << Phase 2 Recruiting March 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Yago L. Nieto    713-792-8750       Principal Investigator: Yago L. Nieto Less <<
NCT01004497 Acute Lymphoblastic Leukemia Phase 2 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chonju, Chonbuk, Korea, Republic of, 561-712 Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 National Cancer Center Goyang, Gyeonggi-do, Korea, Republic of, 410-769 Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of, 519-809 St. Vincent's Hospital, The Catholic University of Korea Suwon, Kyonggi-do, Korea, Republic of, 442-723 Yonsei University Severance Hospital Seoul, Korea, Republic of, 120-752 Catholic BMT Center, Seoul St. Mary's Hospital, The Catholic University of Korea Seoul, Korea, Republic of, 137-701 Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 Less <<
NCT00797810 Acute Lymphoblastic Leukemia ... More >> Non-Hodgkin's Lymphoma Less << Phase 4 Unknown - Italy ... More >> Institute of Haematology "L. e A. Seragnoli" Recruiting Bologna, Italy Contact: Giovanni Martinelli, MD Less <<
NCT03760445 Leukemia, Myeloid, Acute Phase 1 Phase 2 Not yet recruiting October 13, 2022 -
NCT02393157 Non-Hodgkin Lymphoma ... More >> Burkitt Lymphoma Diffuse Large B-Cell Lymphoma Primary Mediastinal B-cell Lymphoma CD20+ Lymphoblastic Lymphoma Follicular Lymphoma, Grade III Less << Phase 2 Recruiting June 2019 United States, New York ... More >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Jessica Hochberg, MD    914-594-2150    jessica_hochberg@nymc.edu    Contact: Mitchell Cairo, MD    914-594-2150    mitchell_cairo@nymc.edu Less <<
NCT01700946 Recurrent B-Cell Childhood Acu... More >>te Lymphoblastic Leukemia Recurrent Childhood B-Lymphoblastic Lymphoma Less << Phase 2 Recruiting October 2021 United States, California ... More >> Rady Children's Hospital and Health Center Completed San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Sima Jeha, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Sima Jeha, MD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD    682-885-4007       Principal Investigator: Kenneth M. Heym, MD Less <<
NCT01621477 Acute Lymphoblastic Leukemia ... More >> Acute Myelocytic Leukemia Chronic Myelocytic Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Hodgkin or Non-Hodgkin Lymphoma Sarcoma, Myeloid Less << Phase 2 Terminated(Study was terminate... More >>d in August 2016 due to replacement by a new study.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00124644 Leukemia Phase 1 Terminated(Withdrawn due to "t... More >>oxicity" problems) Less << - United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210-1240 Less <<
NCT02570542 Diffuse Large B-cell Lymphoma ... More >>(DLBCL) Relapsed Diffuse Large B-cell Lymphoma (DLBCL) Refractory Diffuse Large B-cell Lymphoma (DLBCL) Less << Phase 2 Recruiting October 2019 United States, Nebraska ... More >> University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198-7680 Contact: Matthew Lunning, D.O.          Principal Investigator: Matthew Lunning, D.O.          United States, New Jersey Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States Contact: Craig Sauter, MD    212-639-3460       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Craig Sauter, MD    212-639-3460       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Craig Sauter, MD    212-639-3460       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Craig Sauter, MD    212-639-3460       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Craig Sauter, MD    212-639-3460       Northwell Health Recruiting Manhasset, New York, United States, 11030 Contact: Ruthee-lu Bayer, MD    516-734-8973       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Craig Sauter, MD    212-639-3460       Contact: Sergio Giralt, MD    212-639-6009       Principal Investigator: Craig Sauter, MD          Columbia University Recruiting New York, New York, United States Contact: Markus Mapara, MD    212-305-5098       University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Michael Becker, MD    585-275-5823       Principal Investigator: Michael Becker, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States Contact: Craig Sauter, MD    212-639-3460       United States, Ohio University Hospitals Seidman Cancer Center Not yet recruiting Cleveland, Ohio, United States Contact: Paolo Caimi, MD    216-844-3951       United States, Tennessee Tennessee Oncology Recruiting Nashville, Tennessee, United States, 37203 Contact: Carlos Bachier, MD    615-342-7440       United States, Texas Texas Transplant Institute Recruiting San Antonio, Texas, United States, 78229 Contact: Paul Shaughnessy, MD    210-575-3817       Principal Investigator: Paul Shaughnessy, MD          United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Nirav Shah, MD    414-955-8296 Less <<
NCT00416598 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia With Myelodysplasia-Related Changes Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting - -
NCT00866307 - Completed - -
NCT00866307 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, Arizona ... More >> Phoenix Childrens Hospital Phoenix, Arizona, United States, 85016 United States, California Miller Children's Hospital Long Beach, California, United States, 90806 Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Rady Children's Hospital - San Diego San Diego, California, United States, 92123 University of California San Francisco Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Florida Nemours Children's Clinic-Jacksonville South Jacksonville, Florida, United States, 32207 United States, Georgia Children's Healthcare of Atlanta - Egleston Atlanta, Georgia, United States, 30322 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 Kosair Children's Hospital Louisville, Kentucky, United States, 40202 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, New York The Steven and Alexandra Cohen Children's Medical Center of New York New Hyde Park, New York, United States, 11040 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Legacy Emanuel Children's Hospital Portland, Oregon, United States, 97227 Legacy Emanuel Hospital and Health Center Portland, Oregon, United States, 97227 United States, Pennsylvania Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Methodist Children's Hospital of South Texas San Antonio, Texas, United States, 78229 Australia, Western Australia Princess Margaret Hospital for Children Perth, Western Australia, Australia, 6008 Canada, Ontario Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT00416598 - Active, not recruiting - -
NCT01356290 Medulloblastoma Phase 2 Recruiting April 2023 United States, Illinois ... More >> Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611-2605 Contact: Emily Golbeck       egolbeck@luriechildrens.org    Contact: Kevin Ritt       kritt@luriechildrens.org    Principal Investigator: Stewart Goldman, MD          Sub-Investigator: Rishi Lulla, MD          United States, Massachusetts Dana-Farber Cancer Institute and Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Joanne Kennedy, RN, BA    617-632-5324    Joanne_Kennedy1@dfci.harvard.edu    Principal Investigator: Susan Chi, MD          Austria Medical University of Graz Recruiting Graz, Austria, 8036 Contact: Elisabeth Hulla-Gumbsch    +43 316 385 ext 82686    elisabeth.hulla-gumbsch@klinikum-graz.at    Principal Investigator: Martin Benesch, MD          Medical University of Innsbruck Recruiting Innsbruck, Austria, 6020 Contact: Yvonne Ennemoser, MSc    +43 512 504 ext 23605    yvonne.ennemoser@tirol-kliniken.at    Principal Investigator: Roman Crazzolara, MD          Kepler Universitätsklinikum Med Campus IV Recruiting Linz, Austria, 4020 Contact: Martina Winkler    +43 5 7680 84 ext 24302    martina.winkler@gespag.at    Principal Investigator: Georg Ebetsberger, MD          Salzburger Universitätsklinikum Recruiting Salzburg, Austria, 5020 Contact: Agnes Gamper, MD    +43 662 448257 ext 759    a.gamper@salk.at    Principal Investigator: Agnes Gamper, MD          Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Andreas Peyrl, MD    +43 1 40400 ext 32320    andreas.peyrl@meduniwien.ac.at    Contact: Irene Slavc, MD    +43 1 40400 ext 32320    irene.slavc@meduniwien.ac.at    Principal Investigator: Andreas Peyrl, MD          Sub-Investigator: Irene Slavc, MD          Czechia University Hospital Brno Recruiting Brno, Czechia, 61300 Contact: Alexandra Martincekova, MD    +420532234755    Martincekova.Alexandra@fnbrno.cz    Principal Investigator: Jaroslav Sterba, MD          Sub-Investigator: Zdenek Pavelka, MD          Motol University Hospital Prague Recruiting Prague, Czechia, 15006 Contact: Klara Hruba    +42 0224436401    klara.hruba@fnmotol.cz    Principal Investigator: David Sumerauer, MD          Denmark University hospital Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Karsten Nysom, MD    +45 3545 0809    karsten.nysom@regionh.dk    Principal Investigator: Karsten Nysom, MD          France Centre Oscar Lambret Terminated Lille, France, 59037 Sweden Sahlgrenska Universitetssjukhuset Recruiting Göteborg, Sweden, 416 85 Contact: Karin Fritzson    +46 31 343 58 65    karin.fritzson@vgregion.se    Contact: Anna Schröder- Håkansson    +46 31 343 58 65    anna.schroder_hakansson@vgregion.se    Principal Investigator: Magnus Sabel, MD          Sub-Investigator: Birgitta Lannering, Prof          Universitetssjukhuset Linköping Recruiting Linköping, Sweden, 581 85 Contact: Birgitta Hellström    +46 10 103 13 54    birgitta.hellstrom@regionostergotland.se    Contact: Pernilla Augustsson    +46 10-103 13 50    pernilla.augustsson@regionostergotland.se    Principal Investigator: Irene Devenney, MD          Skånes universitetssjukhus Recruiting Lund, Sweden, 221 85 Contact: Yvonne Håkansson    +46 46-17 80 64    Yvonne.Hakansson@skane.se    Contact: Simon Johansson    +46 46-17 80 64    simon.johansson@skane.se    Principal Investigator: Helena Mörse, MD          Karolinska University Hospital Recruiting Stockholm, Sweden, SE-171 76 Contact: Carina Rinaldo    +46 8 517 701 51    carina.rinaldo@karolinska.se    Contact: Yvonne Copeland    +46 8 517 724 84    yvonne.copeland-wahlo@karolinska.se    Principal Investigator: Stefan Holm, MD          Norrlands Universitetssjukhus Recruiting Umeå, Sweden, 901 85 Contact: Marita Wikström-Larsson    +46 90-785 02 44    Marita.Vikstrom.Larsson@vll.se    Principal Investigator: Mattias Mattsson          Akademiska sjukhuset Recruiting Uppsala, Sweden, 751 85 Contact: Katarina Vallin    +46 18 611 34 94    katarina.vallin@akademiska.se    Principal Investigator: Anders Öberg, MD Less <<
NCT03147612 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia With BCR-ABL1 Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting February 8, 2024 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-4764       Principal Investigator: Elias Jabbour Less <<
NCT02280993 Hodgkin Lymphoma ... More >> Refractory Relapse Less << Phase 1 Active, not recruiting May 2020 Denmark ... More >> Rigshospitalet Copenhagen, Denmark France Centre Hospitalier Universitaire Lille, France Hospices Civils de Lyon Lyon, France Centre Hospitalier et Universitaire Nantes, France Hôpital Saint Louis Paris, France Institut Gustave Roussy Paris, France Netherlands Academic Medical Center Amsterdam, Netherlands, 1105 AZ Free University Medical Center Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands Erasmus Medical Center Rotterdam, Netherlands United Kingdom Cambridge University Hospitals NHS Foundation Trust | Addenbrooke's Hospital Cambridge, United Kingdom King's College Hospital NHS Foundation Trust London, United Kingdom Christie Hospital, Manchester Manchester, United Kingdom Less <<
NCT00002833 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01236144 Acute Myeloid Leukaemia ... More >> High Risk Myelodysplastic Syndrome Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> Aberdeen Royal Infirmary Aberdeen, United Kingdom Belfast City Hospital Belfast, United Kingdom Birmingham Heartlands Hospital Birmingham, United Kingdom Addenbrooke's Hospital Cambridge, United Kingdom University Hospital of Wales Cardiff, United Kingdom Castle Hill Hospital Hull, United Kingdom St James's University Hospital Leeds, United Kingdom Royal Liverpool University Hospital Liverpool, United Kingdom St Bartholomew's Hospital London, United Kingdom Christie Hospital Manchester, United Kingdom Manchester Royal Infirmary Manchester, United Kingdom Freeman Hospital Newcastle, United Kingdom Nottingham University Hospital Nottingham, United Kingdom Less <<
NCT00126191 - Terminated(closed due to slow ... More >>accrual) Less << - -
NCT00126191 Burkitt Lymphoma ... More >> Non-Hodgkins Lymphoma Atypical Burkitt Lymphoma Less << Phase 2 Terminated(closed due to slow ... More >>accrual) Less << - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00964743 - Terminated(Low Accrual) - -
NCT00671658 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01621477 - Terminated(Study was terminate... More >>d in August 2016 due to replacement by a new study.) Less << - -
NCT00964743 Neoplastic Meningitis Not Applicable Terminated(Low Accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00732498 Lymphoma Phase 2 Active, not recruiting December 31, 2019 United States, Arizona ... More >> The University of Arizona Cancer Center Tucson, Arizona, United States, 85724 Less <<
NCT02848183 Pediatric Acute Myeloid Leukem... More >>ia Less << Phase 2 Recruiting - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Recruiting Chonnam, Korea, Republic of Contact: Hoon Kook, MD, PhD       hoonkook@chonnam.ac.kr    Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Keon Hee, MD, PhD    82-2-3410-3532    hema2170@skku.edu    St. Mary Hospital Recruiting Seoul, Korea, Republic of Contact: Bin Cho, MD, PhD       chobinkr@catholic.ac.kr Less <<
NCT00372593 Leukemia Phase 3 Completed - -
NCT00360750 Retinoblastoma Not Applicable Unknown - United Kingdom ... More >> Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT02553460 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Recruiting October 2031 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Paul Gaynon, MD    323-361-4110    pgaynon@chla.usc.edu    Principal Investigator: Paul Gaynon, MD          Children's Hospital of Orange County Recruiting Orange, California, United States, 92868 Contact: Ivan Kirov, MD    714-997-3000    ikirov@choc.org    Principal Investigator: Ivan Kirov, MD          Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Norman J. Lacayo, MD          Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5983    dschiff@chsd.org    Principal Investigator: Deborah Schiff, MD          United States, Minnesota Children's Hospital and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55102 Contact: Michael Richards, MD    612-813-5193    Michael.richards@childrensmn.org    Principal Investigator: Michael Richards, MD          United States, North Carolina St. Jude Affiliate-Charlotte Recruiting Charlotte, North Carolina, United States, 28204 Contact: Christine Bolen, MD    704-384-1900    cybolen@novanthealth.org    Principal Investigator: Christine Bolen, MD          United States, Ohio Cincinnati Children's Hospital Recruiting Cincinnati, Ohio, United States, 45229 Contact: Erin Breese, MD, PhD    513-636-2799    erin.breese@cchmc.org    Principal Investigator: Erin Breese, MD, PhD          Rainbow Babies & Children's Hospital Recruiting Cleveland, Ohio, United States, 44106 Contact: Yousif Matloub, MD    216-844-5437    yousif.matloub@uhhospitals.org    Principal Investigator: Yousif Matloub, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Bill Chang, MD    503-494-1080    changb@ohsu.edu    Principal Investigator: Bill Chang, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD    866-278-5833    tanja.gruber@stjude.org    Contact: Referral Office    866-278-5833    referralinfo@stjude.org    Principal Investigator: Tanja A. Gruber, MD, PhD          United States, Virginia Children's Hospital of the King's Daughters (CHKD) Recruiting Norfolk, Virginia, United States, 23507 Contact: Eric Lowe, MD    757-668-7243    eric.lowe@chkd.org    Principal Investigator: Eric Lowe, MD          Canada, Alberta Alberta Children's Hospital Recruiting Calgary, Alberta, Canada, T3A 6A8 Contact: Victor A. Lewis, MD    403-220-6898    victor.lewis@ahs.ca    Principal Investigator: Victor A. Lewis, MD          Stollery Children's Hospital Recruiting Edmonton, Alberta, Canada, T6G 2B7 Contact: Sunil Desai, M.B.Ch.B., FRCP(c)    780-248-5415    sunil.desai@ahs.ca    Principal Investigator: Sunil Desai, M.B.Ch.B., FRCP(c)          Canada, British Columbia Children's & Women's Health Centre of British Columbia Recruiting Vancouver, British Columbia, Canada, V6H 3V4 Contact: Kirk R. Schultz, MD    604-875-2345 ext 6477    kschultz@mail.ubc.ca    Principal Investigator: Kirk R. Schultz, MD          Canada, Ontario McMaster Children's Hospital at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L85 4J9 Contact: Uma Athale, MD    905-521-2100 ext 73376    athaleu@mcmaster.ca    Principal Investigator: Uma Athale, MD          Canada, Quebec The Montreal Children's Hospital (MUHC-McGill) Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Catherine Vezina, MD    514-412-4445    catherine.vezina@muhc.mcgill.ca    Principal Investigator: Catherine Vezina, MD          Centre Hospitalier Universitaire Sainte-Justine Recruiting Montreal, Quebec, Canada, HcT 1C5 Contact: Henrique Bittencourt, MD    514-345-4931    henrique.bittencourt.hsj@ssss.gouv.qc.ca    Contact: Yvan Samson       yvan.samson@umontreal.ca    Principal Investigator: Henrique Bittencourt, MD          Centre Hospitalier Universitaire de Quebec Recruiting Québec, Quebec, Canada, G1V 4G2 Contact: Bruno Michon, MD    418-525-4444    bruno.michon@mail.chuq.qc.ca    Principal Investigator: Bruno Michon, MD Less <<
NCT02521493 Blasts 5 Percent or More of Bo... More >>ne Marrow Nucleated Cells Childhood Acute Myeloid Leukemia Childhood Myelodysplastic Syndrome Cytopenia Down Syndrome Myeloid Leukemia Associated With Down Syndrome Myeloproliferative Neoplasm Trisomy 21 Trisomy 21 Mosaicism Less << Phase 3 Recruiting - -
NCT01496547 Acute Leukemia Phase 2 Unknown June 2018 China ... More >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, China, 200025 Contact: Jiong HU, M.D.          Principal Investigator: Ling Wang, M.D. Less <<
NCT00388193 Acute Lymphoblastic Leukemia ... More >> Burkitt's Lymphoma Less << Phase 2 Completed - Spain ... More >> Hospital General de Alicante Alicante, Spain Hospital "Santa Creu i Sant Pau" Barcelona, Spain Hospital Clínico y Provincial de Barcelona Barcelona, Spain Complejo Hospitalario de Cáceres Cáceres, Spain Hospital general de Jerez de la Frontera Jerez de la Frontera, Spain Hospital Juan Canalejo La Coruña, Spain Hospital Clínico San Carlos de Madrid Madrid, Spain Hospital Doce de Octubre Madrid, Spain Hospital Universitario Morales Meseguer, Murcia Murcia, Spain Hospital Carlos Haya Málaga, Spain Hospital Son Dureta Palma de Mallorca, Spain Hospital Clínico Universitario de Salamanca Salamanca, Spain Hospital Universitario Virgen del Rocío Sevilla, Spain Hospital La Fe Valencia, Spain Hospital Txagorritxu Vitoria, Spain Less <<
NCT00372593 - Completed - -
NCT00669877 - Completed - -
NCT02059239 Hodgkin's Lymphoma ... More >> Non-Hodgkin's Lymphoma Less << Not Applicable Recruiting June 2021 United States, New York ... More >> Weill Cornell Medical College Recruiting New York, New York, United States, 10065 Contact: Ashlee Torres, RN    212-746-7117    ant9105@med.cornell.edu    Contact: June Greenberg, RN    212-746-2651    jdg2002@med.cornell.edu    Principal Investigator: Tsiporah Shore, MD Less <<
NCT02756572 Blasts 10 Percent or More of B... More >>one Marrow Nucleated Cells Chronic Myelomonocytic Leukemia-2 High Grade Malignant Neoplasm Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts-2 Myeloid Neoplasm Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mary-Elizabeth M. Percival    206-606-1320    mperciva@seattlecca.org    Principal Investigator: Mary-Elizabeth M. Percival Less <<
NCT00276601 Leukemia Phase 2 Completed - United States, Alabama ... More >> Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Florida University of Florida Shands Cancer Center Gainesville, Florida, United States, 32610-0232 United States, Georgia Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Nebraska UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01278602 Diffuse Large B-cell Lymphoma Phase 2 Unknown February 2014 China ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Ye Guo, MD       pattrick_guo@msn.com    Principal Investigator: Ye Guo, MD Less <<
NCT03113162 Multiple Sclerosis Phase 1 Recruiting May 29, 2022 Philippines ... More >> Makati Medical Center Recruiting Makati, Philippines, 1229 Contact: Marviel T Berboso, RN    8888999 ext 3613    Inquiry.CTC@makatimed.net.ph Less <<
NCT00002609 Leukemia Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00669877 Burkitt's Lymphoma ... More >> Burkitt'S-like Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01074047 Acute Myeloid Leukemia Phase 3 Completed - -
NCT02828358 Acute Leukemia of Ambiguous Li... More >>neage Childhood B Acute Lymphoblastic Leukemia KMT2A Gene Rearrangement Mixed Phenotype Acute Leukemia Less << Phase 2 Suspended(Met accural pending ... More >>evaluation of enrolled pats.) Less << September 30, 2019 -
NCT00844298 Leukemia Phase 2 Completed - Korea, Republic of ... More >> Daegu Fatima Hospital Daegu, Korea, Republic of, 701-600 Kyungpook National University Hospital Daegu, Korea, Republic of, 702-701 Yeungnam University Medical Center Daegu, Korea, Republic of, 712-749 Daegu Catholic University Hospital Daegu, Korea, Republic of National Cancer Center - Korea Goyang, Korea, Republic of, 410-769 Chonnam National University Hwasun Hospital Jeollanam-do, Korea, Republic of, 519-809 Gyeongsang National University Hospital Jinju, Korea, Republic of, 660-701 Pusan National University Hospital Pusan, Korea, Republic of, 602-739 Inje University Seoul Paik Hospital Seoul, Korea, Republic of, 100-032 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Kyung Hee University Hospital Seoul, Korea, Republic of, 130-702 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Konkuk University Medical Center Seoul, Korea, Republic of, 143-729 Ajou University Hospital Suwon, Korea, Republic of, 441-749 Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT00844298 - Completed - -
NCT02272478 Acute Myeloid Leukaemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Phase 3 Recruiting October 2020 United Kingdom ... More >> UHW Recruiting Cardiff, United Kingdom, CF14 4XN Principal Investigator: Steve Knapper          Nottingham University Hospital Recruiting Nottingham, United Kingdom Contact: Nigel Russell, MD Less <<
NCT03629873 Lymphoma, Large B-Cell, Diffus... More >>e Mantle Cell Lymphoma Peripheral T Cell Lymphoma Double-hit Lymphoma Less << Phase 2 Recruiting August 1, 2020 China, Jiangsu ... More >> Hematological Department, People's Hospital of Jiangsu Province Recruiting Nanjing, Jiangsu, China, 210029 Contact: Wei Xu, Ph.D.    +86-2568302182    xuwei10000@hotmail.com Less <<
NCT01074047 - Completed - -
NCT01451515 Lymphoblastic Lymphoma Phase 2 Active, not recruiting June 30, 2021 United States, California ... More >> Rady Children's Hospital San Diego San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01858922 Hodgkin Disease Phase 2 Active, not recruiting March 2021 United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00020943 Lymphoma Phase 2 Completed - -
NCT01670084 B-cell Adult Acute Lymphoblast... More >>ic Leukemia Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Withdrawn(No Accrual) September 2017 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00199147 Acute Myeloid Leukemia Phase 4 Unknown - Germany ... More >> University Hospital, Medical Department II Recruiting Frankfurt, Germany, 60590 Contact: Oliver G Ottmann, MD    ++49-69-6301-4802    ottmann@em.uni-frankfurt.de    Contact: Gesine Bug, MD    ++49-69-6301-4802    g.bug@em.uni-frankfurt.de    Principal Investigator: Oliver G Ottmann, MD          Sub-Investigator: Gesine Bug, MD Less <<
NCT00003593 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - -
NCT00536978 - Completed - -
NCT03553238 Leukemia, Acute ... More >> Leukemia, T Cell Leukemia, Lymphoblastic Less << Phase 2 Phase 3 Recruiting August 30, 2020 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou, MD, PhD    +862062787349    zhs1@i.smu.edu.cn Less <<
NCT00536978 Lymphoma Leuk... More >>emia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00165178 Acute Lymphoblastic Leukemia Phase 3 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00577629 Lymphoma, B-Cell Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00577629 - Completed - -
NCT00875667 Mantle Cell Lymphoma ... More >> Lymphoma, Mantle-Cell Less << Phase 2 Active, not recruiting July 5, 2019 -
NCT01702961 Lymphoma Hodg... More >>kin's Disease Less << Not Applicable Active, not recruiting August 2018 United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT02602587 Acute Myeloid Leukemia Not Applicable Active, not recruiting March 2019 France ... More >> Chu Toulouse Toulouse, France Less <<
NCT00038610 Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01319981 Leukemia Phase 2 Active, not recruiting December 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00038610 - Completed - -
NCT01702961 - Active, not recruiting - -
NCT00184041 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90032 Less <<
NCT00079482 Acute Myeloid Leukemia Phase 2 Completed - -
NCT00270881 Acute Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Less << Phase 1 Phase 2 Completed - Japan ... More >> Keio University School of Medicine Tokyo, Japan, 160-8582 Less <<
NCT01805557 Diffuse Large B-cell Lymphoma ... More >>Refractory Diffuse Large B-cell Lymphoma Recurrent Less << Phase 2 Phase 3 Unknown February 2018 Italy ... More >> AOU Careggi Terminated Firenze, FI, Italy, 50134 A.O. Niguarda Recruiting Milano, MI, Italy, 20162 Contact: Chiara Rusconi, MD    +39 02 - 64442668    chiara.rusconi@ospedaleniguarda.it    Principal Investigator: Chiara Rusconi, MD          Osp. San Gerardo Not yet recruiting Monza, MI, Italy, 20052 Contact: Enrico Pogliani, MD    039-2339435    enrico.pogliani@unimib.it; marziaborsetto@yahoo.it    Principal Investigator: Enrico Pogliani, MD          Ospedale Civile Guglielmo da Saliceto Recruiting Piacenza, PC, Italy, 29121 Contact: Daniele Vallisa, MD    +39 0523-303701/719    d.vallisa@auslpc.it    Principal Investigator: Daniele Vallisa, MD          CRO Aviano Recruiting Aviano, Pordenone, Italy, 33081 Contact: Mariagrazia Michieli, M.D.       mmichieli@cro.it    Principal Investigator: Mariagrazia Michieli, M.D.          Osp. Umberto I Recruiting Nocera Inferiore, SA, Italy, 84014 Contact: Alfonso M. D'Arco, MD    +39 081-9213370    medint.nocera@libero.it    Principal Investigator: Alfonso M. D'Arco, MD          Medicina Interna 2 ad indirizzo Ematologico AOU San Luigi Gonzaga Not yet recruiting Orbassano, Torino, Italy, 10043 Contact: Giuseppe Saglio, Prof.    00390119026721    giuseppe.saglio@unito.it    Principal Investigator: Giuseppe Saglio, Prof.          AOU San Giovanni Battista-Ematologia 1 Recruiting Torino, TO, Italy, 10126 Contact: Marco Ladetto, MD    +39 011-6334264    marco.ladetto@unito.it;antonella.fiorillo@yahoo.it    Principal Investigator: Marco Ladetto, MD          Azienda Ospedaliero - Universitaria di Udine Recruiting Udine, UD, Italy, 33100 Contact: Francesco Zaja, MD    +39 0432-559662    zaja.francesco@aoud.sanita.fvg.it;d'odorico.cristina@aoud.sanita.fvg.it    Principal Investigator: Francesco Zaja, MD          Osp. S. Antonio Abate Gallarate Recruiting Gallarate, Varese, Italy Principal Investigator: Fabrizio Ciambelli, MD          Ospedale di Circolo e Fondazione Macchi - Ematologia Not yet recruiting Varese, VA, Italy, 21100 Contact: Francesco Passamonti    +39 0332-393648    francesco.passamonti@ospedale.varese.it    Principal Investigator: Francesco Passamonti, MD          A.O. SS. Antonio e Biagio e C. Arrigo Recruiting Alessandria, Italy, 15121 Contact: Flavia Salvi, MD    +39 0131206294    segreteria@filinf.it    Principal Investigator: Flavia Salvi, MD          Clinica di ematologia AOU Umberto I Ospedali Riuniti Recruiting Ancona, Italy, 60100 Contact: Guido Gini, M.D    00390713580384    g.gini@ospedaliriuniti.marche.it    Principal Investigator: Guido Gini, M.D.          Divisione di Ematologia Spedali Civili Recruiting Brescia, Italy Principal Investigator: Alessandra Tucci, MD          Presidio Ospedaliero A.Perrino - Divisione di Ematologia Terminated Brindisi, Italy Divisione di Ematologia Osp. Businco Recruiting Cagliari, Italy Principal Investigator: Giuseppina Cabras, MD          Ospedale Roberto Binaghi Not yet recruiting Cagliari, Italy Principal Investigator: Giorgio La Nasa, DM          Università Cattolica Campobasso Terminated Campobasso, Italy A.O. Universitaria Ospedali Riuniti di Foggia Not yet recruiting Foggia, Italy Principal Investigator: Silvana Capalbo, MD          Ematologia 1 Ospedale S. Martino Not yet recruiting Genova, Italy, 16132 Principal Investigator: Angelo Michele Carella, PROF          Azienda Universitaria San Martino Not yet recruiting Genova, Italy Principal Investigator: Marco Gobbi, MD          Ospedale Santa Maria Goretti Not yet recruiting Latina, Italy Principal Investigator: Angelo De Blasio, MD          Ospedale Vito Fazzi Not yet recruiting Lecce, Italy Principal Investigator: Nicola Di Renzo, MD          SC Ematologia ‐ Trapianto di midollo osseo Fond. IRCCS Istituto Nazionale Tumori Recruiting Milano, Italy, 20133 Contact: Paolo Corradini, Prof.    00390223902950    paolo.corradini@unimi.it    Principal Investigator: Paolo Corradini, Prof.          Ospedale Maggiore IRCCS-Dipartimento di Ematologia Not yet recruiting Milano, Italy Principal Investigator: Luca Baldini, MD          AORN Cardarelli U.O.Ematologia Not yet recruiting Napoli, Italy Principal Investigator: Vincenzo Mettivier, MD          SCDU Ematologia ‐ Università del Piemonte Orientale Recruiting Novara, Italy, 28100 Contact: Gianluca Gaidano, Prof.    00390321660663       Principal Investigator: Gianluca Gaidano, Prof.          Ematologia e Immunologia Clinica, Dipartimento di Medicina Università di Padova Recruiting Padova, Italy, 35100 Contact: Giampiero Semenzato, Prof.    00390498212298    g.semenzato@unipd.it    Principal Investigator: Giampiero Semenzato, Prof.          Ospedale S. Antonio Not yet recruiting Padova, Italy Principal Investigator: Dario Marino, MD          Oncoematologia Dipartimento oncologico La Maddalena Not yet recruiting Palermo, Italy, 90146 Contact: Maurizio Musso, M.D.    00390916806801    mamusso@libero.it    Principal Investigator: Maurizio Musso, M.D.          U.O. Complessa di Ematologia Ospedale di Parma Recruiting Parma, Italy, 43100 Contact: Franco Aversa, Prof.    00390521903263    franco.aversa@unipr.it    Principal Investigator: Franco Aversa, Prof.          Fond. Maugeri - Centro medico Not yet recruiting Pavia, Italy Principal Investigator: Vittorio Fregoni, MD          Osp. S. Maria delle Croci Recruiting Ravenna, Italy Principal Investigator: Alfonso Zaccaria, MD          AO Bianchi Melacrino Morelli UO Ematologia Recruiting Reggio Calabria, Italy Principal Investigator: Caterina Stelitano, MD          AO Arcispedale S.Maria Nuova Ematologia Recruiting Reggio Emilia, Italy Principal Investigator: Francesco Merli, MD          Osp. degli Infermi Divisione di Oncologia Not yet recruiting Rimini, Italy Principal Investigator: Annalisa Molinari, MD          Ospedale Oncologico regionale CROB Not yet recruiting Rionero in Vulture (PZ), Italy Principal Investigator: Pellegrino Musto, MD          Ematologia Ospedale S.Camillo Forlanini Not yet recruiting Roma, Italy, 00149 Contact: Roberta Battistini, M.D.       rbattistini@scamilloforlanini.rm.it    Principal Investigator: Roberta Battistini, M.D.          A.O. Universitaria S. Andrea Recruiting Roma, Italy Principal Investigator: Maria Cristina, Cox          Osp.Sant'Eugenio Divisione di Ematologia Not yet recruiting Roma, Italy Principal Investigator: Elisabetta Abruzzese, MD          Policlinico Universitario Tor Vergata Not yet recruiting Roma, Italy Principal Investigator: Maria Cantonetti, MD          Universita' La Sapienza Not yet recruiting Roma, Italy Principal Investigator: Maurizio Martelli, MD          Clinica Humanitas Recruiting Rozzano (MI), Italy Sub-Investigator: Balzarotti Monica, MD          Policlinico Le Scotte Clinica Ematologica Not yet recruiting Siena, Italy Principal Investigator: Alberto Fabbri, MD          SC Oncoematologia con autotrapianto AO Santa Maria Recruiting Terni, Italy, 05100 Contact: Anna Marina Liberati, Prof    0744/205971    marinal@unipg.it    Principal Investigator: Anna Marina Liberati, M.D.          Osp. San Giovanni Battista_Molinette Ematologia 2 Recruiting Torino, Italy Principal Investigator: Umberto Vitolo, MD          Divisione di Ematologia Ospedale S. Nicola Not yet recruiting Trani, Italy Principal Investigator: Gaetano De Santis, MD Less <<
NCT01366898 Acute Lymphoblastic Leukemia Phase 4 Recruiting December 2019 Spain ... More >> Hospital Germans Trias i Pujol and all Hospital Pethema Recruiting Badalona, Barcelona, Spain Contact: José Mª Ribera, Dr       jribera@iconcologia.net Less <<
NCT00955916 Leukemia Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT03072771 Diffuse Large B Cell Lymphoma Phase 1 Recruiting September 30, 2021 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Armin Ghobadi, M.D.    314-747-2743    arminghobadi@wustl.edu    Principal Investigator: Armin Ghobadi, M.D. Less <<
NCT00968760 Lymphoma B-ce... More >>ll Lymphoma Less << Phase 1 Active, not recruiting June 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03182244 Acute Myeloid Leukemia With FM... More >>S-like Tyrosine Kinase (FLT3) Mutation Less << Phase 3 Recruiting June 2020 -
NCT01828489 Pediatric Acute Myeloblastic L... More >>eukemia Less << Phase 3 Recruiting March 2023 Belgium ... More >> HUDERF, L'Hôpital des Enfants Hématologie / Oncologie Recruiting Brussel, Belgium, 1020 Contact: Laurence Dedeken, MD, PhD    +32 2 4773311    laurence.dedeken@huderf.be    UZ Brussel, Pediatrische Hemato-Oncologie F930 Recruiting Brussel, Belgium, 1090 Contact: Jutte Van der Werff ten Bosch, MD, PhD    +32 2 4774111    JVDWerff@uzbrussel.be    UCL, Cliniques Universitaires Saint-Luc Recruiting Brussel, Belgium, 1200 Contact: Sophie Dupont, MD, PhD    +32 2 7641111    sophie.dupont@uclouvain.be    Ghent University Hospital, Children´s Hospital, Princess Elisabeth, Department of Pediatric Hematology-Oncology Recruiting Ghent, Belgium, 9000 Contact: Barbara de Moerloose, MD, PhD       barbara.demoerloose@uzgent.be    UZ Leuven, Kinder Hemato-Oncologie Recruiting Leuven, Belgium, 3000 Contact: Anne Uyttebroeck, MD, PhD    +32 16 33 22 11    anne.uyttebroeck@uzleuven.be    CHR Citadelle Recruiting Liège, Belgium Contact: Marie-Françoise Dresse, MD, PhD    +32 42238980    marie.francoise.dresse@chrcitadelle.be    CHC Espérance Recruiting Montegnée, Belgium Contact: Pierre Philippet, MD, PhD    +32 42249111    pierre.philippet@chc.be    Denmark Department of Pediatrics, Aarhus University Hospital Skejby Recruiting Aarhus, Denmark, 8200 Contact: Henrik Hasle, MD, PhD       hasle@dadlnet.dk    Dept of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen Recruiting Copenhagen, Denmark Contact: Birgitte Lausen, MD, PhD       birgitte.lausen@rh.regionh.dk    Estonia Tallinn Children's Hospital, Dep. Hematology oncology Not yet recruiting Tallinn, Estonia, 13419 Contact: Kadri Saks, MD, PhD       kadri.saks@lastehaigla.ee    Finland Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, Helsinki University Central Hospital Recruiting Helsinki, Finland, 00029 Contact: Kirsi Jahnukainen, MD, PhD       kirsi.jahnukainen@ki.se    Department of Pediatrics, Kuopio University Hospital Recruiting Kuopio, Finland, 70211 Contact: Pekka Riikonen    +358 447172392    pekka.riikonen@kuh.fi    Principal Investigator: Pekka Riikonen          Department of Pediatrics, Oulu University Hospital Recruiting Oulu, Finland, 90029 Contact: Merja Möttönen    +358 83155251    merja.mottonen@ppshp.fi    Principal Investigator: Merja Möttönen          Department of Pediatrics, Tampere University Central Hospital Recruiting Tampere, Finland, 33521 Contact: Mikko Arola    +358 3 31164386    mikko.arola@pshp.fi    Principal Investigator: Mikko Arola          Department of Pediatrics, Turku University Central Hospital Recruiting Turku, Finland, 20520 Contact: Minna Koskenvuo, MD, PhD    +358 50 3624430    minna.koskenvuo@utu.fi    Principal Investigator: Minna Koskenvuo          Hong Kong Dept of Paediatrics & Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Shau-Yin Ha, MD, PhD       syha@hku.hk    Iceland Children´s Hospital, Landspitali University Hospital Not yet recruiting Reykjavik, Iceland Contact: Olafur Jonsson, MD, PhD       olafurgi@landspitali.is    Netherlands VU University Medical Center Department of Pediatric Oncology/Hematology Recruiting Amsterdam, Netherlands, 1007 Contact: Gertjan Kaspers, MD, PhD       GJL.Kaspers@vumc.nl    Emma Children's Hospital/ Amsterdam Medical Center Department of Pediatric Oncology Recruiting Amsterdam, Netherlands, 1100 DD Contact: Huib Caron, MD, PhD       h.n.caron@amc.uva.nl    Department of Pediatric Oncology/Hematology Beatrix childrens hospital / University Medical Center Groningen Recruiting Groningen, Netherlands, 9700 RB Contact: Eveline de Bont, MD, PhD       e.de.bont@bkk.umcg.nl    University Medical Center Nijmegen Department of Pediatric Oncology/Hematolog Recruiting Nijmegen, Netherlands, 6500 HB Contact: Dunja te Loo, MD, PhD       m.teloo@cukz.umcn.nl    Erasmus MC - Sophia Childrens Hospital University Medical Center Rotterdam Recruiting Rotterdam, Netherlands, 3000 CB Contact: Marry van den Heuvel-Eibrink, MD, PhD       m.vandenheuvel@erasmusmc.nl    Norway Department of Pediatrics, Haukeland University Hospital, Bergen Recruiting Bergen, Norway, 5021 Contact: Dorota , Wojcik    +47 55 97 50 00    dorota.malgorzata.wojcik@helse-bergen.no    Principal Investigator: Dorota Wojcik          Pediatric Dept, Women and Children's Division, Oslo University Hospital Rikshospitalet Recruiting Oslo, Norway, N-0424 Contact: Bernward Zeller, MD, PhD       bernward.zeller@ous-hf.no    Department of Pediatrics, University Hospital of North Norway, Tromsoe Recruiting Tromsoe, Norway, N-9038 Contact: Trond Flaegstad    +47 91507766    Trond.Flaegstad@unn.no    Principal Investigator: Trond Flaegstad          Department of Cancer and Haemathology, St Olavs Hospital, Trondheim University Hospital Recruiting Trondheim, Norway, N-7006 Contact: Svein Kolmannskog    +47 815 55 850    svein.kolmannskog@ntnu.no    Principal Investigator: Svein Kolmannskog          Sweden Queen Silvias Childrens and Adolescents Hospital Recruiting Gothenburg, Sweden, 41685 Contact: Jonas Abrahamsson, MD, PhD       jonas.abrahamsson@vgregion.se    Principal Investigator: Jonas Abrahamsson          Dept of Pediatrics, Linköpings University Hospital Recruiting Linköping, Sweden, 58185 Contact: Mikael Behrendtz, MD, PhD          Principal Investigator: Mikael Behrendtz          Dept of Pediatrics, Skåne University Hospital Recruiting Lund, Sweden, 22241 Contact: Cornelis Pronk, MD, PhD       kees-jan.pronk@med.lu.se    Astrid Lindgrens Barnsjukhus, Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Karin Belander-Strålin, MD       karin.belander-stralin@karolinska.se    Dept of Pediatrics, Norrlands University Hospital Recruiting Umeå, Sweden, 90185 Contact: Ulrika Norén-Nyström, MD, PhD       Ulrika.norennystrom@pediatri.umu.se    Dept of Pediatrics, Akademiska barnsjukhuset Recruiting Uppsala, Sweden, 751 85 Contact: Josefine Palle, MD, PhD       josefine.palle@akademiska.se Less <<
NCT02722135 Leukemia, Myeloid, Acute Phase 1 Withdrawn September 2018 Belgium ... More >> Boehringer Ingelheim Investigational Site Gent, Belgium Less <<
NCT03259516 Myelodysplastic Syndromes Phase 1 Phase 2 Recruiting December 25, 2021 Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Ivan S. Moiseev, MD, PhD    +79217961951    moisiv@mail.ru    Contact: Elena V Morozova, MD, PhD    +79119278229    dr_morozova@mail.ru    Principal Investigator: Boris V Afanasyev, MD, Prof          Sub-Investigator: Elena V Morozova, MD, PhD          Sub-Investigator: Yulia V Rudnizkaya, MD, PhD          Sub-Investigator: Ivan S Moiseev, MD, PhD          Sub-Investigator: Nikolai Yu Tcvetkov, MD Less <<
NCT00822094 Acute Myeloid Leukemia Phase 2 Completed - -
NCT00151242 Acute Myeloid Leukemia Phase 2 Phase 3 Completed - Austria ... More >> Department of Hematology/Oncology, University Hospital Innsbruck Innsbruck, Austria, 6020 Department of Internal Medicine I, Krankenhaus der Barmherzigen Schwestern Linz, Austria, 4010 Medical Department III, St. Johann-Hospital Salzburg, Austria, 5020 Center of Hematology and Oncology, Hanusch-Hospital Wien, Austria, 1140 Germany Department of General Internal Medicine, University Hospital of Bonn Bonn, Germany, 53127 Medical Department I, Hospital Bremen-Mitte Bremen, Germany, 28177 Clinical Center of Hematology and Oncology, University Hospital of Düsseldorf Düsseldorf, Germany, 40225 Department of Hematology and Oncology, Hospital Essen Süd, Ev. Hospital of Essen-Werden Essen, Germany, 45239 Medical Department III, Hematology/Oncology, University of Frankfurt Frankfurt, Germany, 60590 Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst Frankfurt, Germany, 65929 Internal Medicine I, University of Freiburg Freiburg, Germany, 79106 Medical Department IV, University Hospital of Giessen Giessen, Germany, 35392 Department of Internal Medicine, Wilhelm-Anton-Hospital gGmbH Goch, Germany, 47574 Centre of Internal Medicine, University Hospital Göttingen Göttingen, Germany, 37075 Department of Oncology and Hematology, University Hospital Eppendorf Hamburg, Germany, 20246 Medical Department II, Hematology and Oncology, General Hospital Altona Hamburg, Germany, 22763 Medical Department III, Clinical Center Hanau Hanau, Germany, 63450 Medical Department III, Hospital Hannover-Siloah Hannover, Germany, 30449 Department of Hematology, Hematology and Oncology, Medizinische Hochschule Hannover Hannover, Germany, 30625 Department of Internal Medicine I, University Hospital of Saarland Homburg, Germany, 66421 Medical Department II, City Hospital Karlsruhe gGmbH Karlsruhe, Germany, 76133 Medical Department II, University Hospital of Kiel Kiel, Germany, 24116 Department of Internal Medicine/Hematology and Oncology, Cartias Hospital Lebach Lebach, Germany, 66822 Department of Hematology and Oncology, Hospital of Lüdenscheid Lüdenscheid, Germany, 58505 Department of Hematology and Internal Oncology, University Hospital of Mainz Mainz, Germany, 55101 Medical Department III, Clinical Center Rechts der Isar München, Germany, 81675 Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH Oldenburg, Germany, 26133 Department of Hematology and Oncology, Caritas Hospital St. Theresia Saarbrücken, Germany, 66113 Department of Oncology, Clinical Center of Stuttgart Stuttgart, Germany, 70174 Medical Department II, Diakonie Hospital Stuttgart, Germany, 70176 Medical Department I, Hospital of Barmherzige Brüder Trier, Germany, 54292 Department of Internal Medicine II, University Hospital of Tübingen Tübingen, Germany, 72076 Medical Clinic II-Hematology/Oncology, Hospital Villingen-Schwenningen Villingen-Schwenningen, Germany, 78050 Medical Department I, Helios Hospital Wuppertal Wuppertal, Germany, 42283 Less <<
NCT00955916 - Completed - -
NCT03165851 - Completed - China, Tianjin ... More >> InstituteHBDH Tianjin, Tianjin, China, 300020 Less <<
NCT01534949 Diffuse Large B-Cell Lymphoma Phase 1 Terminated - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00180128 Leukemia, Promyelocytic, Acute Phase 4 Unknown November 2012 Germany ... More >> Department of Medicine I, University Hospital Carl Gustav Carus Recruiting Dresden, Germany, 01307 Contact: Markus Schaich, MD    +49-351-458 ext -4251    markus.schaich@uniklinikum-dresden.de    Contact: Silke Soucek    +49-351-458 ext -4251    silke.soucek@uniklinikum-dresden.de Less <<
NCT00199108 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 2 Phase 3 Unknown June 2008 Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00925873 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> GOELAMS Tours, France, 37000 Less <<
NCT01990807 Childhood Acute Lymphoblastic ... More >>Leukemia Philadelphia Chromosome, Ph^1^, Absent B-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 4 Unknown October 2014 China, Tianjin ... More >> Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Scienses Recruiting Tianjin, Tianjin, China, 300020 Contact: Xiaofan Zhu, MD    +86-22-23909001    xfzhu1981@126.com    Principal Investigator: Xiaofan Zhu, MD Less <<
NCT00822094 - Completed - -
NCT00187161 Non-Hodgkin Lymphoma ... More >> Acute Lymphoblastic Leukemia, Mature B-Cell Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02420717 Leukemia Phase 2 Recruiting July 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00866749 Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03555955 Hematologic Malignancy ... More >> Acute Myeloid Leukemia Acute Lymphocytic Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Less << Phase 1 Not yet recruiting March 2021 -
NCT00783653 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - Germany ... More >> Prof. Dr. med. Walter Fiedler Hamburg, Germany, 20246 PD Dr. med. Jürgen Krauter Hannover, Germany, 30625 Dr. Katharina Götze München, Germany, 81675 Prof. Dr. Helmut R. Salih Tübingen, Germany, 72076 Dr. Richard Schlenk Ulm, Germany, 89081 Less <<
NCT03462095 Precursor Cell Lymphoblastic L... More >>eukemia-Lymphoma Less << Not Applicable Recruiting December 1, 2022 Russian Federation ... More >> National Research Center for Hematology Recruiting Moscow, Russian Federation, 125167 Contact: Elena N Parovichnikova, MD PhD    +7(495)6124313    elenap@blood.ru Less <<
NCT00474006 ACUTE MYELOGENOUS LEUKEMIA Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138-736 Less <<
NCT00186966 Acute Myeloid Leukemia Phase 3 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02504359 Plasma Cell Leukemia ... More >> Recurrent Plasma Cell Myeloma Less << Phase 1 Recruiting July 1, 2021 United States, North Carolina ... More >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Cristina Gasparetto    919-668-1017    cristina.gasparetto@duke.edu    Principal Investigator: Cristina Gasparetto          United States, Oregon OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Emma C. Scott    503-494-2398    scottem@ohsu.edu    Principal Investigator: Emma C. Scott Less <<
NCT02416206 Multiple Myeloma Phase 2 Recruiting May 2020 United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Recruiting Atlanta, Georgia, United States, 30342 Contact: Scott R. Solomon, MD    404-255-1930 Less <<
NCT00968253 Leukemia Acut... More >>e Lymphocytic Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01966497 - Recruiting November 2019 France ... More >> Avicenne Recruiting Bobigny, Ile De France, France, 93 Contact: Claude Gardin, MD       claude.gardin@avc.aphp.fr Less <<
NCT00968253 - Completed - -
NCT03446638 Myelodysplastic Syndromes Not Applicable Not yet recruiting September 2022 United States, Florida ... More >> University of Florida Not yet recruiting Gainesville, Florida, United States, 32608 Less <<
NCT02421939 Leukemia, Acute Myeloid (AML) Phase 3 Active, not recruiting December 2020 -
NCT01516580 B-cell Non Hodgkin Lymphoma ... More >> Mature B-cell Leukemia Burkitt-type Less << Phase 3 Active, not recruiting December 2021 Belgium ... More >> University Hospitals Leuven Leuven, Belgium, 3000 Canada Children Oncology Group Operations centres Monrovia, Canada China The University of Hong Kong (Clinical Trials Centre) Hong-Kong, China France Institut de Cancérologie Gustave roussy Villejuif, France, 94805 Hungary 2nd Dept. of Pediatrics Semmelweis Univ. Budapest, Hungary, 1094 Italy Associazione Italiana di Ematologia ed Oncologia Pediatrica Padova, Italy, 35128 Netherlands Emma Children's Hospital Amsterdam, Netherlands, 1105 AZ Poland Rectorat of Medical University Wroclaw, Poland Spain Sociedad Española de Hematología y Oncología Pediátricas Valencia, Spain, 46010 United Kingdom University of Birmingham Birmingham, United Kingdom Less <<
NCT00002970 Recurrent Childhood Acute Lymp... More >>hoblastic Leukemia Recurrent Childhood Lymphoblastic Lymphoma T-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00969891 - Completed - Denmark ... More >> Rigshospitalet, Hematology clinic Copenhagen, Denmark, 2100 Herlev Hospital, Hematology Clinic Herlev, Denmark, 2730 Less <<
NCT02419755 Mixed Lineage Acute Leukemia ... More >> Acute Myeloid Leukemia Acute Lymphoid Leukemia Less << Phase 2 Terminated(Accrual goals were ... More >>no longer feasible based on restrictions imposed by the DSMB.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02419755 - Terminated(Accrual goals were ... More >>no longer feasible based on restrictions imposed by the DSMB.) Less << - -
NCT02676856 Acute Myeloid Leukemia Not Applicable Unknown August 2018 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Fen Huang    +86-020-62787883    13826204917@163.com Less <<
NCT00098774 Lymphoma Phase 2 Completed - -
NCT00691015 - Completed - -
NCT01873495 Acute Myelogenous Leukemia (AM... More >>L) Less << Phase 2 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00691015 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT02535806 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 2 Terminated(Funding source disc... More >>ontinued) Less << - United States, Missouri ... More >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less <<
NCT00098774 - Completed - -
NCT01225874 Leukemia Not Applicable Completed - -
NCT00345865 Lymphoma Phase 2 Active, not recruiting January 2019 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00006747 Graft Versus Host Disease ... More >> Lymphoma Less << Phase 2 Completed - -
NCT00274248 Acute Myelogenous Leukemia Phase 1 Completed - United States, Massachusetts ... More >> The Dana Farber Cancer Institute Boston, Massachusetts, United States, 02134 Less <<
NCT02314273 Pancytopenia Due to Chemothera... More >>py Less << Phase 4 Completed - China, Beijing ... More >> Beijing Children's Hospital Beijing, Beijing, China China, Jiangsu Nanjing Children's Hospital Nanjing, Jiangsu, China Soochow University Affiliated Children's Hospital Soochow, Jiangsu, China China, Shanghai Shanghai Children's Medical Center Shanghai, Shanghai, China, 200127 Children's Hospital of Fudan University Shanghai, Shanghai, China Less <<
NCT00002502 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00464217 Acute Myeloblastic Leukaemia Phase 4 Completed - Spain ... More >> Hospital General de Albacete Albacete, Spain Hospital Universitario Alicante, Spain Hospital Ntra. Sra. del Rossell Cartagena, Spain Hospital General Castellón, Spain Hospital Puerta del Mar Cádiz, Spain Hospital de Galdacano Galdacano, Spain Hospital Ciudad de Jaén Jaen, Spain Hospital Insular de las Palmas Las Palmas de Gran Canaria, Spain Hospital Xeral Lugo, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Universitario de Alcalá de Henares Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Virgen de la Arrixaca Murcia, Spain Hospital Virgen de la Victoria Málaga, Spain Hospital Central de Asturias Oviedo, Spain Clínica Universitaria de Pamplona Pamplona, Spain Hospital Montecelo Pontevedra, Spain Hospital Clínico Universitario Salamanca, Spain Hospital Arnau de Vilanova Valencia, Spain Hospital Clínico Valencia, Spain Hospital Dr. Pesset Valencia, Spain Hospital Clínico Valladolid, Spain Hospital Virgen de la Concha Zamora, Spain Less <<
NCT00002565 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Brazil Faculdade de Medicina do ABC Sao Paulo, Brazil, 01224--010 Chile Clinica Alemana Santiago, Chile, 5951 Less <<
NCT01182415 Non-Hodgkin's Lymphoma ... More >> CNS Lymphoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02130869 Neuroblastoma ... More >> Lymphoma High-risk Tumor Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00196768 Relapsed Acute Promyelocytic L... More >>eukemia Refractory Acute Promyelocytic Leukemia Less << Phase 4 Unknown - Germany ... More >> Eva Lengfelder, MD, PhD Recruiting Mannheim, Germany, 68305 Principal Investigator: Eva Lengfelder, MD, PhD Less <<
NCT00885508 Myelodysplastic Syndrome ... More >> Chronic Myelomonocytic Leukemia Acute Myeloid Leukemia Less << Phase 2 Unknown December 2015 France ... More >> CH Angers Angers, France, 49 000 hopital Victor Dupouy Argenteuil, France, 95107 Centre Hospitalier de La Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93 000 CHU Haut-Lévèque Bordeaux, France, 33604 Centre hospitalier de Chambéry Chambéry, France, 73011 CHU de Clermont-Ferrand Clermont-Ferrand, France, 63058 Centre henri Mondor Creteil, France, 94010 Centre Hospitalier du Mans Le Mans cedex, France, 72037 Centre Hospitalier de Lens Lens, France, 32307 centre hospitalier de Lens Lens, France, 62307 Hôpital Limoges Limoges, France, 87046 Centre Hospitalier Lyon Sud Lyon, France, 69495 Institut Paoli Calmettes Marseille, France, 13009 CHU Brabois Nancy, France, 54511 CHU de nantes Nantes, France, 44093 Hôpital Archet1 Nice, France, 06202 Hoiptal St Louis Paris, France, 75475 Hopital Cochin-Hematology Paris, France, 75679 Centre Hospitalier Joffre Perpignan, France, 66046 Centre Henri Becquerel Rouen, France, 76038 Hôpital Hautepierre Strasbourg, France, 67098 Hopital Purpan Service d'Hématologie Clinique Toulouse, France, 31059 CH de Valence Valence, France, 26953 Institut gustave Roussy Villejuif, France, 94805 Less <<
NCT01324180 Acute Lymphoblastic Leukemia Phase 1 Completed - United States, Florida ... More >> Holtz Children's Hospital University of Miami Miller School of Medicine Miami, Florida, United States, 33136 Arnold Palmer Hospital for Children Orlando, Florida, United States, 32806 All Children's Hospital Saint Petersburg, Florida, United States, 33701 United States, New York Montefiore Medical Center, The Children's Hospital at Montefiore The Bronx, New York, United States, 10467 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT03173612 Acute Myeloid Leukemia Not Applicable Recruiting December 2022 China, Tianjin ... More >> InstituteHBDH Recruiting Tianjin, Tianjin, China, 300020 Contact: Zhu Xiaofan    86-21-23909001    xfzhu@ihcams.ac.cn    Principal Investigator: Guo Ye          Principal Investigator: Yang Wenyu          Principal Investigator: Chen Xiaojuan          Principal Investigator: Chen Yumei          Principal Investigator: Ruan Min Less <<
NCT01182415 - Completed - -
NCT00392990 Lymphoma Phase 2 Active, not recruiting October 2019 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 John H. Stroger Cook County Hospital Chicago, Illinois, United States, 60612 Rush University Medical Center Chicago, Illinois, United States, 60612 Loyola University Medical Center Maywood, Illinois, United States, 60153 Advocate Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068-1174 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New Jersey The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Less <<
NCT02844218 - Completed - France ... More >> Hospices Civils de Lyon - Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet Pierre-benite, France, 69310 Less <<
NCT02461121 Acute Myeloid Leukemia Phase 3 Completed - China, Beijing ... More >> Affiliated Hospital of Academy of Military Medical Sciences , Beijing, Beijing, China, 100071 Less <<
NCT00002812 Leukemia Phase 3 Completed - -
NCT00577993 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00176462 - Completed - -
NCT00039130 - Completed - -
NCT01358253 Acute Lymphoblastic Leukemia Phase 4 Completed - China, Shanghai ... More >> Ruijin Hospital Shanghai, Shanghai, China, 200025 Less <<
NCT00176462 Acute Lymphocytic Leukemia Phase 2 Completed - United States, New Jersey ... More >> Jersey Shore University Medical Center Neptune, New Jersey, United States, 07754 Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT03410407 - Not yet recruiting July 2019 Italy ... More >> Dipartimento di Biotecnologie Cellulari ed Ematologia, "Sapienza", Università di Roma Not yet recruiting Roma, Italy Contact: Alessandro Pulsoni          Principal Investigator: Alessandro Pulsoni Less <<
NCT03101579 Leptomeningeal Metastases Phase 1 Completed - China, Jilin ... More >> The First Hospital of Jilin University Changchun, Jilin, China, 130021 Less <<
NCT03418038 High Grade B-Cell Lymphoma Wit... More >>h MYC and BCL2 or BCL6 Rearrangements Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma Recurrent Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Lymphoma Less << Phase 2 Recruiting March 15, 2024 United States, Arizona ... More >> Mayo Clinic in Arizona Not yet recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Craig B. Reeder          United States, Florida Mayo Clinic in Florida Not yet recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Taimur Sher          United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Umar Farooq       umar-farooq@uiowa.edu    Principal Investigator: Umar Farooq          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Thomas E. Witzig Less <<
NCT00084838 Central Nervous System Tumor, ... More >>Pediatric Less << Phase 2 Completed - United States, California ... More >> Stanford Cancer Center Stanford, California, United States, 94305-5826 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520-8028 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus Atlanta, Georgia, United States, 30342 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States, 55404 United States, Nevada Sunrise Hospital and Medical Center Las Vegas, Nevada, United States, 89109 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less <<
NCT02741388 B-cell Lymphoma Phase 1 Recruiting June 2020 Belgium ... More >> Institut Jules Bordet Recruiting Bruxelles, Belgium Contact: Marie MAEREVOET, MD    +32 25 41 32 12       Principal Investigator: Marie MAEREVOET, MD          France CHU Dijon Recruiting Dijon, France Contact: Olivier CASASNOVAS, MD    +33380295041       Principal Investigator: Olivier CASASNOVAS, MD          CHRU de Lille - Hôpital Claude Huriez Recruiting Lille, France Contact: Franck MORSCHHAUSER, MD    +33320445713       Principal Investigator: Franck MORSCHHAUSER, MD          CHU Montpellier - Hôpital Saint Eloi Recruiting Montpellier, France Contact: Guillaume CARTRON, MD    +33467338079       Principal Investigator: Guillaume CARTRON, MD          CHU Nancy - Hôpital de Brabois Recruiting Nancy, France Contact: Pierre FEUGIER, MD    +33383153282       Principal Investigator: Pierre FEUGIER, MD          Hôpital Saint-Louis Recruiting Paris, France Contact: Catherine THIEBLEMONT, MD    +33142499236       Principal Investigator: Catherine THIEBLEMONT, MD          CHU Bordeaux - Centre François Magendie Recruiting Pessac, France Contact: Kamal BOUABDALLAH    +33557656511       Principal Investigator: Kamal BOUABDALLAH, MD          Centre Henri Becquerel Recruiting Rouen, France Contact: Hervé TILLY, MD    +33232082202       Principal Investigator: Hervé TILLY, MD Less <<
NCT00039130 Leukemia Lymp... More >>homa Less << Phase 2 Completed - -
NCT03384654 Precursor Cell Lymphoblastic L... More >>eukemia-Lymphoma Less << Phase 2 Recruiting August 10, 2021 -
NCT02340936 Diffuse Large B-cell Lymphoma Phase 1 Phase 2 Active, not recruiting September 2019 Spain ... More >> ICO- Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 ICO- Hospital Duran i Reynals L´Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital del Mar Barcelona, Spain, 08003 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Regional Universitario de Málaga Málaga, Spain, 29010 Alejandro Martín Salamanca, Spain, 37007 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Hospital Universitario La Fe Valencia, Spain, 46026 Less <<
NCT00084838 - Completed - -
NCT00109837 Leukemia Phase 2 Completed - -
NCT02662647 AML Phase 2 Recruiting December 2019 China, Beijing ... More >> Navy General Hospital Recruiting Beijing, Beijing, China, 100048 Contact: Li-Xin Wang, M.D Ph.D    86-010-66958509    wanglixin1991@sohu.com    Principal Investigator: Li-Xin Wang, M.D. Ph.D. Less <<
NCT00109837 - Completed - -
NCT02483000 Burkitt Lymphoma ... More >> CD20-Positive Neoplastic Cells Present Diffuse Large B-Cell Lymphoma Indolent Non-Hodgkin Lymphoma Mantle Cell Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Refractory Mature B-Cell Non-Hodgkin Lymphoma Less << Phase 1 Recruiting March 1, 2025 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal    206-288-2037    agopal@u.washington.edu    Principal Investigator: Ajay K. Gopal Less <<
NCT02954653 Acute Myeloid Leukemia Phase 1 Terminated - United States, Arizona ... More >> The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States, 85719 Banner-University Medical Center Tucson Tucson, Arizona, United States, 85724 United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, North Carolina Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00354107 Anaplastic Large Cell Lymphoma... More >> Recurrent Childhood Anaplastic Large Cell Lymphoma Less << Phase 1 Phase 2 Terminated - United States, Pennsylvania ... More >> Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00286845 - Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center and DiaTech Oncology Nashville, Tennessee, United States, 37212 Less <<
NCT00505921 Lymphoma Phase 2 Terminated(Slow Accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00354107 - Terminated - -
NCT02633137 Mantle Cell Lymphoma ... More >> Untreated Less << Phase 2 Active, not recruiting December 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States, 07920 Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 Memorial Sloan Kettering Bergen Montvale, New Jersey, United States, 07645 United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Rockville Centre Rockville Centre, New York, United States, 11570 Less <<
NCT00992446 - Completed - -
NCT03234985 - Recruiting February 2019 France ... More >> Service d'hématologie - Centre Hospitalier Lyon Sud - Hospices Civils de LYON Recruiting Pierre-Bénite, France, 69495 Contact: Xavier THOMAS, MD    04 78 86 22 40 ext +33    xavier.thomas@chu-lyon.fr    Contact: Christelle MACHON, PharmD    04 72 66 64 00 ext +33    christelle.machon@chu-lyon.fr    Principal Investigator: Xavier THOMAS, MD Less <<
NCT02303821 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 1 Recruiting October 18, 2019 -
NCT00002704 Leukemia Phase 2 Completed - -
NCT00992446 Adult Diffuse Large B-Cell Lym... More >>phoma B-Cell Non-Hodgkin Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Non-Hodgkin Lymphoma T-Cell Non-Hodgkin Lymphoma Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00931645 Chronic Lymphocytic Leukemia Phase 3 Completed - France ... More >> DBIM Hopital Saint Louis Paris, France, 75000 Less <<
NCT02638428 Relapsed Pediatric Solid Tumor... More >> Refractory Pediatric Solid Tumor Relapsed Pediatric AML Refractory Pediatric AML Less << Phase 2 Recruiting December 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT02481310 Adult Burkitt Lymphoma ... More >> B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma Diffuse Large B-Cell Lymphoma MYC Gene Mutation Plasmablastic Lymphoma Less << Phase 1 Phase 2 Recruiting July 2020 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Barbara Pro, MD    312-695-6180       Principal Investigator: Barbara Pro, MD          United States, Massachusetts Tufts University Recruiting Medford, Massachusetts, United States, 02155 Contact: Andreas Klein, MD    617-636-2694       Principal Investigator: Andreas Klein, MD          United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Andrew Evens, DO, MSc          Principal Investigator: Andrew Evens, DO, MSc          United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Deepa Jagadeesh, MD    216-445-6503       Principal Investigator: Deepa Jagadeesh, MD          United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Mehdi Hamadani, MD    414-805-0505       Principal Investigator: Mehdi Hamadani, MD Less <<
NCT00695409 Lymphoma Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT00695409 - Completed - -
NCT00505921 - Terminated(Slow Accrual.) - -
NCT00863460 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Active, not recruiting May 2026 France ... More >> Cancérologie Hôpital Sud Amiens, France, 80054 Chu D'Angers Angers, France CHR Argenteuil Argenteuil, France, 95100 CHU de Besancon Besançon, France Institut Bergonié Bordeaux, France, 33076 CHU Hôtel Dieu Clermont-Ferrand, France CHU Michalon Grenoble, France, 38043 Centre Hospitalier Lens Lens, France CHU de Limoges Limoges, France, 87042 CHU de la Timone Marseille, France, 13009 Hôtel Dieu Nantes Nantes, France Centre Antoine Lacassagne Nice, France CHU de Nimes Nîmes, France GH Pitié-Salpétrière Paris, France, 75013 CHG Saint Jean Perpignan, France, 66046 CHU Hôpital Bernard Poitiers, France, 86021 Chu Reims Reims, France Hôpital Pontchaillou Rennes, France, 35033 Centre René Huguenin Saint Cloud, France, 92210 Institut de Cancérologie Saint-Priest en Jarez, France CH de Saint-Quentin Saint-Quentin, France Hôpital Bretonneau Tours, France CHU Nancy - Hôpital Neurologique Vandoeuvre les Nancy, France, 54500 Less <<
NCT00193973 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Completed - Australia, Australian Capital ... More >>Territory The Canberra Hospital Garran, Australian Capital Territory, Australia, 2605 Australia, New South Wales Calvary Mater Newcastle Newcastle, New South Wales, Australia, 2298 Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Westmead Hospital Wentworthville, New South Wales, Australia, 2145 Illawarra Cancer Care Centre Wollongong, New South Wales, Australia Australia, Queensland Royal Brisbane Hospital Herston, Queensland, Australia, 4029 Mater QRI South Brisbane, Queensland, Australia, 4101 Premion - Tugun Tugun, Queensland, Australia, 4224 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria Andrew Love Cancer Centre, Geelong Hospital Geelong, Victoria, Australia, 3220 Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 8006 Australia, Western Australia Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia, 6009 New Zealand Auckland Hospital Auckland, New Zealand, 1001 Christchurch Hospital Christchurch, New Zealand, 4710 Less <<
NCT03485950 Other Infectious Diseases Phase 2 Recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       iraad@mdanderson.org Less <<
NCT02688140 Acute Promyelocytic Leukemia Phase 3 Recruiting January 2022 France ... More >> French-Belgian-Swiss APL study group Not yet recruiting Multiple Locations, France Contact: Pierre Fenaux, Prof. Dr.       pierre.fenaux@avc.ap-hop-paris.fr    Contact: Lionel Ades, Dr.       lionel.ades@sls.aphp.fr    Germany AML-CG study group Recruiting Multiple Locations, Germany Contact: Eva Lengfelder, Prof. Dr.       Eva.Lengfelder@umm.de    AML-SG study group Recruiting Multiple Locations, Germany Contact: Richard F. Schlenk, Prof. Dr.       Richard.Schlenk@uniklinik-ulm.de    OSHO study group Recruiting Multiple Locations, Germany Contact: Dietger Niederwieser, Prof. Dr.       Dietger.Niederwieser@medizin.uni-leipzig.de    SAL study group Recruiting Multiple Locations, Germany Contact: Uwe Platzbecker, Prof. Dr.    +49 351 458 ext 3192    uwe.platzbecker@uniklinikum-dresden.de    Contact: Michaela Sauer    +49 351 458 ext 3192    michaela.sauer@uniklinikum-dresden.de    Italy GIMEMA study group Not yet recruiting Multiple Locations, Italy Contact: Francesco Lo-Coco, Prof. Dr.       Francesco.lo.coco@uniroma2.it    Contact: Fabio Efficace, Dr.       f.efficace@gimema.it    Netherlands HOVON study group Not yet recruiting Multiple Locations, Netherlands Contact: Edo Vellenga, Prof. Dr.       e.vellenga@umcg.nl    Spain PETHEMA study group Not yet recruiting Multiple Locations, Spain Contact: Miguel A. Sanz, Prof. Dr.       sanz_mig@gva.es    Contact: Pau Montesinos, Prof. Dr.       montesinos_pau@gva.es Less <<
NCT01921387 Recurrent B-Cell Non-Hodgkin L... More >>ymphoma Recurrent Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent T-Cell Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Hodgkin Lymphoma Refractory Mantle Cell Lymphoma Refractory T-Cell Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Active, not recruiting July 26, 2021 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01438138 - Completed - -
NCT01230983 Cardiac Toxicity ... More >> Leukemia Lymphoma Less << Phase 3 Completed - -
NCT00070187 Lymphoma Phase 2 Phase 3 Completed - -
NCT03579927 CD19 Positive ... More >> Mantle Cell Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Less << Phase 1 Phase 2 Not yet recruiting January 1, 2020 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact       krezvani@mdanderson.org Less <<
NCT00734773 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Neurotoxicity Less << Early Phase 1 Withdrawn(Lack of funding) - -
NCT02099292 Relapsed Non-Hodgkin-Lymphoma Phase 2 Completed - -
NCT02419469 - Terminated(Slow Accrual) - -
NCT03286634 Down Syndrome ... More >> Acute Lymphoblastic Leukemia Childhood Cancer Less << Phase 2 Recruiting March 31, 2033 Hong Kong ... More >> Prince of Wales Hospital Recruiting Shatin, New Territories, Hong Kong Contact: Chi Kong Li, MBBS       ckli@cuhk.edu.hk    Japan Kagoshima University Hospital Recruiting Kagoshima, Japan, 890-8544 Contact: Yasuhiro Okamoto       okamoto@m2.kufm.kagoshima-u.ac.jp    Malaysia University of Malaya Medical Centre Not yet recruiting Kuala Lumpur, Malaysia, 59100 Contact: Hany Arrifin, MBBS       hany@ummc.edu.my    Subang Jaya Medical Centre Not yet recruiting Subang Jaya, Malaysia, 47500 Contact: Hai Peng Lin, MBBS       flslhp@gmail.com    Sub-Investigator: Lee Lee Chan, MBBS          Singapore National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Allen Yeoh, MBBS       allen_yeoh@nuhs.edu.sg    KK Women's and Children's Hospital Not yet recruiting Singapore, Singapore, 229899 Contact: Ah Moy Tan, MBBS       tan.ah.moy01@singhealth.com.sg    Taiwan National Taiwan University Children's Hospital Not yet recruiting Taipei, Taiwan, 100 Contact: Tsamn Lin Dong, MD       dtlin@ntuh.gov.tw    Mackay Memorial Hospital Not yet recruiting Taipei, Taiwan, 10449 Contact: Hsi-Che Liu, MD       hsiche@mmh.org.tw    Chang Gung Memorial Hopsital, Linkou Not yet recruiting Taoyuan, Taiwan, 333 Contact: Shih-Hsiang Chen, MD       samechen@cgmh.org.tw Less <<
NCT02419469 Leukemia Prec... More >>ursor-B Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Lymphoma Less << Phase 2 Terminated(Slow Accrual) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01979536 Anaplastic Large Cell Lymphoma... More >>, ALK-Positive Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma CD30-Positive Neoplastic Cells Present Less << Phase 2 Recruiting December 31, 2021 -
NCT02797470 HIV Infection ... More >> Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Plasmablastic Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Recurrent Burkitt Lymphoma Recurrent Follicular Lymphoma Stage III Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage IV Follicular Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 1 Phase 2 Recruiting June 2034 United States, California ... More >> UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Stephanie Pirucki    858-657-7705    spirucki@ucsd.edu    Principal Investigator: Matthew Wieduwilt, MD, PhD          University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Mehrdad Abedi    916-734-3772    Mehrdad.abedi@ucdmc.ucdavis.edu    Principal Investigator: Mehrdad Abedi          UCSF Medical Center-Mount Zion Not yet recruiting San Francisco, California, United States, 94115 Contact: Mehrdad Abedi    916-734-3772    Mehrdad.abedi@ucdmc.ucdavis.edu    Principal Investigator: Mehrdad Abedi          United States, New York Memorial Sloan-Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 Contact: Ariela Noy    212-639-7423    noya@mskcc.org    Principal Investigator: Ariela Noy Less <<
NCT02293109 Contiguous Stage II Adult Lymp... More >>hoblastic Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage IV Adult Lymphoblastic Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting December 2018 United States, California ... More >> University of California Davis Recruiting Sacramento, California, United States, 95817 Contact: Mehrdad Abedi    916-734-3771    mabedi@ucdavis.edu    Principal Investigator: Mehrdad Abedi Less <<
NCT00195871 Lymphoblastic Lymphoma Phase 2 Unknown December 2015 Belgium ... More >> Chr de La Citadelle Liege, Belgium, 4000 Cliniques Universitaires U C L de Mont Godinne Yvoir, Belgium, 5530 France C H U D'Angers Angers, France, 49033 Centre Hospitalier de La Region Annecienne Annecy, France, 74011 Chu de Grenoble Grenoble, France, 38043 Centre Hospitalier de Lens Lens, France, 62300 Edouard Herriot Hospital Lyon, France, 69437 Pierre Benite Hospital Lyon, France, 69495 Institut Paoli Calmettes Marseilles, France, 13273 Saint-Louis Hospital Paris, France, 75000 La Pitie Salpetriere Hospital Paris, France, 75013 Cochin Hospital Paris, France, 75014 Marechal Joffre Hospital Perpignan, France, 66046 Centre Hospitalier de Poitiers Poitiers, France, 86000 Chu de Reims Robert Debre Hospital Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancerologie de La Loire Saint Priest En Jarez, France, 42271 Bretonneau Hospital Tours, France, 37044 Chu de Brabois Vandoeuvre Les Nancy, France, 54511 Less <<
NCT01921387 - Active, not recruiting - -
NCT01769911 Adult Nasal Type Extranodal NK... More >>/T-cell Lymphoma AIDS-related Diffuse Large Cell Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma AIDS-related Diffuse Small Cleaved Cell Lymphoma AIDS-related Immunoblastic Large Cell Lymphoma AIDS-related Lymphoblastic Lymphoma AIDS-related Peripheral/Systemic Lymphoma AIDS-related Small Noncleaved Cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma HIV-associated Hodgkin Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Hairy Cell Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage I AIDS-related Lymphoma Stage II AIDS-related Lymphoma Stage III AIDS-related Lymphoma Stage IV AIDS-related Lymphoma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Not Applicable Withdrawn - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02405676 Mature B-cell Non-Hodgkin Lymp... More >>homa Less << Phase 2 Phase 3 Recruiting December 2024 China, Sichuan ... More >> West China Second University Hospital of Sichuan University Recruiting Chengdu, Sichuan, China Contact: Yi-Ping Zhu, MD       zhuyiping@918.com    Contact: Xia Guo, MD       guoxkl@163.com Less <<
NCT00180102 Leukemia, Nonlymphocytic, Acut... More >>e Less << Phase 4 Completed - Germany ... More >> Medical Department I, University Hospital Carl Gustav Carus Dresden, Germany, 01307 Less <<
NCT00098839 Recurrent Childhood Acute Lymp... More >>hoblastic Leukemia Less << Phase 1 Phase 2 Completed - -
NCT00074165 Brain and Central Nervous Syst... More >>em Tumors Drug/Agent Toxicity by Tissue/Organ Lymphoma Thrombocytopenia Less << Phase 2 Terminated(Lack of accrual) - United States, Ohio ... More >> Good Samaritan Hospital Cancer Treatment Center, Hatton Institute Cincinnati, Ohio, United States, 45220 United States, Oregon Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 Less <<
NCT02907359 Myelodysplastic Syndromes ... More >> Leukemia, Myelomonocytic, Chronic Less << Phase 3 Recruiting December 2019 -
NCT00074165 - Terminated(Lack of accrual) - -
NCT01147939 Acute Myeloid Leukemia (AML) Phase 3 Completed - -
NCT02205762 Langerhans Cell Histiocytosis Phase 2 Phase 3 Recruiting July 2023 United States, Arizona ... More >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85006 Contact: Michael Henry, MD       mhenry@phoenixchildrens.com    Principal Investigator: Michael Henry, MD          United States, Arkansas Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Kimo Stine, MD       stinekimoc@uams.edu    Principal Investigator: Kimo Stine, MD          United States, California Children's Hospital of Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Rima Jubran, MD       rjubran@chla.usc.edu    Principal Investigator: Rima Jubran, MD          Valley Children's Healthcare Not yet recruiting Madera, California, United States, 93636 Contact: David Samuel, MD       DSamuel@valleychildrens.org    Contact: Faisal Razzaqi, MD       FRazzaqi@valleychildrens.org    Principal Investigator: David Samuel, MD          United States, Connecticut Connecticut Children's Medical Center Not yet recruiting Hartford, Connecticut, United States, 06106 Contact: Andrea Orsey, MD       aorsey@connecticutchildrens.org    Principal Investigator: Andrea Orsey, MD          United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Stephan Ladisch, MD       sladisch@childrensnational.org    Contact: Jay Greenberg, MD       jagreenb@childrensnational.org    United States, Maryland Johns Hopkins University Not yet recruiting Baltimore, Maryland, United States, 21287 Contact: Elias Zambidis, MD       EZambid1@jhmi.edu    Contact: Christine Pratilas, MD       Cpratil1@jhmi.edu    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Mary Huang, MD    617-726-2737    mshuang@partners.org    Principal Investigator: Mary Huang, MD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Barbara Degar, MD    617-632-6801    bdegar@partners.org    Principal Investigator: Barbara Degar, MD          United States, Minnesota Children's Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Michael Richards, MD       Michael.richards@childrensmn.org    Contact: Nathan Gossai, MD       nathan.gossai@childrensmn.org    United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Steven Diamond, MD       Steven.Diamond@hackensackmeridian.org    Contact: Burton Appel, MD       Burton.appel@hackensackmeridian.org    United States, New York Cohen Children's Medical Center Recruiting New Hyde Park, New York, United States, 11040 Contact: Carolyn Fein Levy, MD       clevy4@northwell.edu    Contact: Jeffery Lipton, MD       jlipton@northwell.edu    Columbia University / Herbert Irving Cancer Center Recruiting New York, New York, United States, 10032 Contact: Maria Luis Sulis, MD       mls95@cumc.columbia.edu    Contact: Julia Glade Bender, MD       jg589@cumc.columbia.edu    Staten Island University Hospital Recruiting Staten Island, New York, United States, 10305 Contact: Sarah Vaiselbuh, MD    718-226-6435    svaiselbuh@nshs.edu    Principal Investigator: Sarah Vaiselbuh`, MD          SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Melanie Comito, MD       comitom@upstate.edu    Contact: Andrea Dvorak, MD       dvoraka@upstate.edu    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Michael Jordan, MD    513-636-1773    Michael.jordan@cchmc.org    Contact: Ashish Kumar, MD    513-803-1631    ashish.kumar@cchmc.org    United States, South Carolina Medical Universtiy of South Carolina/Hollings Cancer Center Not yet recruiting Charleston, South Carolina, United States, 29425 Contact: Jacqueline Kraveka, DO    843-792-2957    kravekjm@musc.edu    Principal Investigator: Jacqueline Kraveka, DO          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Patrick Campbell, MD       patrick.campbell@stjude.org    Principal Investigator: Patrick Campbell, MD          United States, Washington Providence Sacred Heart Children's Hospital Recruiting Spokane, Washington, United States, 99204 Contact: Stefanos Intzes, MD       stefanos.intzes@providence.org    Contact: Judy Felgenhauer, MD       judy.felgenhauer@providence.org Less <<
NCT00098839 - Completed - -
NCT00187005 Acute Lymphoblastic Leukemia Phase 3 Terminated(Toxicity) - United States, Tennessee ... More >> St.Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02844361 Waldenstr?m Macroglobulinemia Phase 4 Recruiting May 2020 China ... More >> Shuhua Yi Recruiting Tianjin, China, 300020 Contact: Shuhua Yi, Doc    86-22-23909106    yishuhua@ihcams.ac.cn    Contact: Lugui Qiu, Doc    86-22-23909172    qiulg@ihcams.ac.cn Less <<
NCT02072811 Acute Myeloid Leukemia Phase 3 Unknown February 2018 Poland ... More >> Copernicus Memorial Hospital Recruiting Lodz, Poland, 93-510 Principal Investigator: Agnieszka Wierzbowska, Dr hab. n. med. Less <<
NCT02779283 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Less << Phase 1 Recruiting June 1, 2019 United States, Oregon ... More >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Stephen E. Spurgeon    503-494-8950    spurgeos@ohsu.edu    Principal Investigator: Stephen E. Spurgeon Less <<
NCT00002869 Leukemia Phase 3 Unknown - United Kingdom ... More >> Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT01500161 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia Hodgkins Disease Non-Hodgkins Lymphoma Aplastic Anemia Multiple Myeloma Myelodysplastic Syndrome Less << Phase 2 Terminated(Insufficient accrua... More >>ls) Less << - United States, Texas ... More >> Texas Oncology Amarillo, Texas, United States, 79106 Less <<
NCT03591510 FLT3-mutated Acute Myeloid Leu... More >>kemia Less << Phase 2 Not yet recruiting April 21, 2025 Korea, Republic of ... More >> Novartis Investigative Site Seoul, Korea, Republic of, 03080 Less <<
NCT01540812 - Recruiting December 2019 Spain ... More >> Hospital Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain Contact: Jose Mª Ribera, Dr       jmribera@iconcologia.com Less <<
NCT00025402 Leukemia Phase 3 Unknown - -
NCT02088541 Acute Myeloid Leukemia (AML) Phase 2 Completed - -
NCT02348489 Leukemia, Myeloid, Acute Phase 3 Completed - -
NCT00906945 - Completed - -
NCT02228772 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma B-cell Adult Acute Lymphoblastic Leukemia T-cell Adult Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting July 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Philip Amrein, MD    617-726-8748    Amrein.Philip@mgh.harvard.edu    Principal Investigator: Philip Amrein, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Malgotzata McMasters, MD    617-667-9920    mmcmaste@bidmc.harvard.edu    Principal Investigator: Malgorzata McMasters, MD          Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel DeAngelo, MD, Ph.D    617-632-2645    DDEANGELO@PARTNERS.ORG    Principal Investigator: Daniel DeAngelo, MD, Ph.D Less <<
NCT00137995 Lymphoma, Large-Cell, Diffuse Phase 3 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Australia Australian leukemia and lymphoma group Sydney, Australia Belgium Groupe d'atude des lymphome de l'adulte Yvoir, Belgium Czech Republic Czech Lymphoma study group Praha, Czech Republic Finland Hospital district of south west Finland Turku, Finland Germany German high grade non hodgkin's lymphoma group Hamburg, Germany Israel Israel Society of Hematology Tel-Hashomer, Israel Sweden Nordic center Uppsala, Sweden Switzerland Schweirische Arbeitsgruppe fur klinische Krebsforschung Lausanne, Switzerland United Kingdom National cancer research institute London, United Kingdom Less <<
NCT01146977 Acute Myeloid Leukemia Phase 2 Unknown December 2015 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Asanbyeongwon-gil, songpa-gu, Korea, Republic of, 138-736 Contact: Yae Eun Jang, nurse    82-2-3010-6378    redpin75@paran.com Less <<
NCT01477606 Acute Myeloid Leukemia Phase 2 Active, not recruiting June 2020 -
NCT00906945 Leukemia, Myeloid, Acute Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01050036 Leukemia, Myeloid Not Applicable Recruiting December 2018 Korea, Republic of ... More >> Wonkwang University Hospital Recruiting Iksan, Chollabuk-do, Korea, Republic of, 570749 Contact: Yeonghui Park, RN    82-63-859-2640    bej02@naver.com    Principal Investigator: Hyeok Shim, M.D. & PhD.          Gyeongsang National University Hospital Recruiting Jinju, Gyeongsangnam-do, Korea, Republic of, 660702 Contact: Hyeok Choi, RN    82-55-750-9454    hyeau79@yahoo.co.kr    Principal Investigator: Gyeong Won Lee, M.D. & PhD.          Hallym University Sacred Heart Hospital Recruiting Anyang, Kyeongki-do, Korea, Republic of, 431796 Contact: Hyo Jung Kim, M.D. & PhD.    82-31-380-3704    hemonc@hallym.or.kr    Principal Investigator: Dae Young Zang, M.D. & PhD.          Sub-Investigator: Hyo Jung Kim, M.D. & PhD.          Kosin University, Gospel Hospital Recruiting Busan, Korea, Republic of, 602702 Contact: Aeran Lee, RN    82-51-990-5820    chewon88@paran.com    Principal Investigator: Yang Soo Kim, M.D. & PhD.          Sub-Investigator: Seong-Hoon Shin, M.D. & PhD.          Sub-Investigator: Ho-Sup Lee, M.D. & PhD.          Busan Paik Hospital, Inje University College of Medicine Recruiting Busan, Korea, Republic of, 614735 Contact: Hyejung Eum, RN    82-51-890-6987    cake78@nate.com    Principal Investigator: Young-Don Joo, M.D. & PhD.          Sub-Investigator: Won-Sik Lee, M.D. & PhD.          Daegu Fatima Hospital Recruiting Daegu, Korea, Republic of, 701600 Contact: Jung-eun Lee, RN    82-53-940-7687    chachaje@fatima.or.kr    Principal Investigator: Jung-lim Lee, M.D. & PhD.          Sub-Investigator: Sun-ah Lee, M.D. & PhD.          Yeongnam University Hospital Recruiting Daegu, Korea, Republic of, 705717 Contact: Young Mi Chun, RN    82-53-620-3069    jerry1032@hanmail.net    Principal Investigator: Myung Soo Hyun, M.D. & PhD.          Sub-Investigator: Min Kyoung Kim, M.D. & PhD.          Daegu Catholic University Medical Center Recruiting Daegu, Korea, Republic of, 705718 Contact: Hun Mo Ryoo, M.D. & PhD    82-53-650-4034    rhmrhm@cu.ac.kr    Contact: Sung Hwa Bae, M.D. & PhD    82-53-650-4388    sunghwa@cu.ac.kr    Principal Investigator: Hun Mo Ryoo, M.D. & PhD          Sub-Investigator: Sung Hwa Bae, M.D. & PhD          Gachon University Gil Hospital Recruiting Inchon, Korea, Republic of, 405-760 Contact: Jin Hee Park, M.D. & PhD.          Principal Investigator: Jin Hee Park, M.D. & PhD.          Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Mi Ryang Jang, RN    82-2-3010-7084    mrzzang82@naver.com    Contact: Mijin Jeon, RN    82-2-3010-6689    mjjeon1982@gmail.com    Sub-Investigator: Kyoo-Hyung Lee, M.D. & PhD          Sub-Investigator: Je-Hwan Lee, M.D. & PhD          Sub-Investigator: Jung-Hee Lee, M.D. & PhD.          Principal Investigator: Dae-Young Kim, M.D.          Ulsan University Hospital, University of Ulsan College of Medicine Recruiting Ulsan, Korea, Republic of, 682714 Contact: Mi-young Kim, RN    82-52-250-8537    miyoung3798@yahoo.co.kr    Contact: Eun-hee Lee, RN, CNS    82-52-250-8516    gival2@uuh.ulsan.kr    Principal Investigator: Jae-Hoo Park, M.D. & PhD.          Sub-Investigator: Young Joo Min, M.D. & PhD.          Sub-Investigator: Hawk Kim, M.D. & PhD. Less <<
NCT01005914 Leukemia Phase 2 Terminated(Increased rate of b... More >>acterial infections) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT00890656 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00186875 - Completed - -
NCT00890656 - Completed - -
NCT00133991 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Pennsylvania Drexel University College of Medicine - Center City Hahnemann Campus Philadelphia, Pennsylvania, United States, 19102 Less <<
NCT01005914 - Terminated(Increased rate of b... More >>acterial infections) Less << - -
NCT01908777 T Cell Non-Hodgkin Lymphoma Phase 2 Recruiting July 2020 United States, Florida ... More >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Farhad Khimani, MD          Contact    1-888-663-3488       Principal Investigator: Farhad Khimani, MD          United States, New Jersey Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: Steven Horwitz, MD    212-639-3045       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Steve Horwitz, MD    212-639-3045       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Steven Horwitz, MD    212-639-3045       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Steven Horwitz, MD    212-639-3045       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 11065 Contact: Steven Horwitz, MD    212-639-3045       Contact: Parastoo Dahi, MD    212-639-5846       Principal Investigator: Steven Horwitz, MD          Weill Cornell Medical Center Recruiting New York, New York, United States Contact: Jia Ruan, MD          Principal Investigator: Jia Ruan, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Steven Horwitz, MD          United States, Washington University of Washington School of Medicine Recruiting Seattle, Washington, United States, 98109 Contact: Andrei Shustov, MD          Principal Investigator: Andrei Shustov, MD Less <<
NCT01516593 HIV Burkitt's... More >> Lymphoma Less << Phase 2 Unknown August 2015 Italy ... More >> Oncologia Medica A - Centro di Riferimento Oncologico Not yet recruiting Aviano (PN), Italy Contact: Michele Spina, MD    +300434659 ext 284    mspina@cro.it    Principal Investigator: Michele Spina, MD          Ematologia - A.O. Spedali Civili Not yet recruiting Brescia, Italy Contact: Alessandro Re, MD    +39030399 ext 5438    sandrore@aruba.it    Principal Investigator: Alessandro Re, MD          Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte Tabor Recruiting Milano, Italy Contact: Andrés JM Ferreri, MD    +39022643 ext 7649    ferreri.andres@hsr.it    Contact: Marta Bruno Ventre, MD       brunoventre.marta@hsr.it    Principal Investigator: Andrés JM Ferreri, MD          S.C. Oncologia Medica - Ospedale San Paolo Not yet recruiting Milano, Italy Contact: Niccolò Frungillo, MD       niccolo.frungillo@ao.sanpaolo.it    Principal Investigator: Niccolò Frungillo, MD          S.C. Oncologia Medica 3 - IRCCS Istituto Nazionale Tumori (INT) Not yet recruiting Milano, Italy Contact: Massimo Di Nicola, MD    +39022390 ext 2360    massimo.dinicola@istitutotumori.mi.it    Principal Investigator: Massimo Di Nicola, MD          U.O.C. Immunodeficienze virali - I.N.M.I. L. Spallanzani Not yet recruiting Roma, Italy Contact: Andrea Antinori, MD    +390655170 ext 348    andrea.antinori@inmi.it    Principal Investigator: Andrea Antinori, MD          S.C. Oncoematologia - A.O. Santa Maria Not yet recruiting Terni, Italy Contact: Anna Marina Liberati, MD    +390744205 ext 971    marinal@unipg.it    Principal Investigator: Anna Marina Liberati, MD          U.O. Ematologia 2 - Ospedale San Giovanni Battista Not yet recruiting Torino, Italy Contact: Dino Allione, MD    +39011633 ext 6685    ballione@molinette.piemonte.it    Principal Investigator: Dino Allione, MD Less <<
NCT00002816 Leukemia Phase 3 Completed - -
NCT01769209 - Completed - -
NCT00186875 Acute Lymphoblastic Leukemia ... More >> Lymphoma, Lymphoblastic Less << Phase 2 Completed - United States, California ... More >> Rady Children's Hospital and Health Center San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01769209 B-cell Adult Acute Lymphoblast... More >>ic Leukemia (ALL) Ph-positive Adult Acute Lymphoblastic Leukemia (ALL) Recurrent Adult Acute Lymphoblastic Leukemia (ALL) T-cell Adult Acute Lymphoblastic Leukemia (ALL) Less << Phase 2 Completed - United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less <<
NCT00133991 - Completed - -
NCT00004114 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Phase 1 Withdrawn(Study never opened) - -
NCT03558412 T-lymphoblastic Lymphoma Phase 4 Recruiting June 1, 2020 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com    Contact: Mingzhi Zhang, Pro,Drc    13838565629    mingzhi_zhang@126.com Less <<
NCT00006363 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Erythroid Leukemia (M6) Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Childhood Acute Basophilic Leukemia Childhood Acute Eosinophilic Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00647049 Primary Non Hodgkin Lymphoma o... More >>f the Central Nervous System Less << Phase 2 Unknown August 2013 Germany ... More >> University Hospital Freiburg Recruiting Freiburg, Germany, 79106 Contact: Gerald Illerhaus, Dr.    00497612703785    Gerald.Illerhaus@uniklinik-freiburg.de    Contact: Andreas Zähringer    00497612707378    andreas.zaehringer@uniklinik-freiburg.de Less <<
NCT00875693 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 1 Completed - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT02845882 Lymphoblastic Lymphoma Phase 2 Phase 3 Recruiting December 2025 China ... More >> West China Second University Hospital Recruiting Chengdu, China Contact: Xia Guo, M.D.       guoxkl@163.com    Shanghai Children's Medical Center Recruiting Shanghai, China, 200127 Contact: Yi-Jin Gao, M.D.    86-21-38626161 ext 82064    gaoyijin@scmc.com.cn    Contact: Jing-yan Gao, M.D. Less <<
NCT00103285 B-cell Childhood Acute Lymphob... More >>lastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - -
NCT00151255 Acute Myeloid Leukemia Phase 3 Completed - Austria ... More >> Department of Hematology/Oncology, University Hospital of Innsbruck Innsbruck, Austria, 6020 Department of Internal Medicine I, Krankenhaus der Barmherzigen Schwestern Linz, Austria, 4010 Medical Department III, St. Johann Hospital Salzburg, Austria, 5020 Center of hematology and oncology, Hanusch Hospital Wien, Austria, 1140 Germany Department of Internal Medicine I, Central Hospital of Augsburg Augsburg, Germany, 86856 Department of General Internal Medicine, University Hospital of Bonn Bonn, Germany, 53127 Medical Department I, Hospital of Bremen-Mitte Bremen, Germany, 28177 Department of Hematology and Oncology, Hospital Essen-Süd, Ev. Hospital of Essen-Werden Essen, Germany, 45239 Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst Frankfurt, Germany, 65929 Medical Department IV, University Hospital of Giessen Giessen, Germany, 35392 Department of Internal Medicine, Wilhelm-Anton Hospital gGmbH Goch, Germany, 47574 Centre of Internal Medicine, University Hospital of Göttingen Göttingen, Germany, 37075 Department of Oncology and Hematology, University Hospital Eppendorf Hamburg, Germany, 20246 Medical Department II, General Hospital Altona Hamburg, Germany, 22763 Medical Department III, Hospital of Hanau Hanau, Germany, 63450 Medical Department III, Hospital of Hannover-Siloah Hannover, Germany, 30449 Department of Internal Medicine I, University Hospital of Saarland Homburg, Germany, 66421 Medical Department II, City Hospital Karlsruhe gGmbH Karlsruhe, Germany, 76133 Medical Department II, University Hospital of Kiel Kiel, Germany, 24116 Department of Internal Medicine/Hematology and Oncology, Caritas Hospital Lebach Lebach, Germany, 66822 Department of Hematology/Oncology, Clinical Center of Lüdenscheid Lüdenscheid, Germany, 58515 Medical Department III, Clinical Center Rechts der Isar München, Germany, 81675 Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH Oldenburg, Germany, 26133 Department of Hematology and Oncology/Caritas Hospital St. Theresa Saarbrücken, Germany, 66113 Department of Oncology, Clinical Center of Stuttgart Stuttgart, Germany, 70174 Medical Department II, Diakonie Hospital Stuttgart, Germany, 70176 I. Medical Department, Hospital of Barmerzigen Brüder Trier, Germany, 54292 Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen Villingen - Schwenningen, Germany, 78050 Medical Department I, Helios Hospital Wuppertal Wuppertal, Germany, 42283 Less <<
NCT01887587 Relapsed or Refractory Acute L... More >>ymphoblastic Leukemia Relapsed or Refractory Lymphoblastic Lymphoma Mixed Phenotype Acute Leukemia Less << Phase 1 Terminated(SAE- risk of overal... More >>l protocol treatment outweighs benefits) Less << August 2018 United States, Wisconsin ... More >> Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01371981 Acute Myeloid Leukemia ... More >> Leukemia Cutis Myeloid Neoplasm Myeloid Sarcoma Untreated Adult Acute Myeloid Leukemia Untreated Childhood Myeloid Neoplasm Less << Phase 3 Active, not recruiting - -
NCT03579082 Diffuse Large B Cell Lymphoma Phase 4 Recruiting December 1, 2019 China, Henan ... More >> Oncology Department of The First Affilliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com    Contact: Mingzhi Zhang, Pro,Drc    13838565629    mingzhi_zhang@126.com Less <<
NCT03013998 Previously Untreated Acute Mye... More >>loid Leukemia Less << Phase 1 Phase 2 Recruiting December 2021 United States, Arizona ... More >> Mayo Clinic Arizona Recruiting Phoenix, Arizona, United States, 85054 Principal Investigator: Lisa Sproat, MD          United States, California UCLA Ronald Reagan Medical Center Recruiting Los Angeles, California, United States, 90095 Principal Investigator: Gary Schiller, MD          University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Principal Investigator: Gabriel Mannis, MD          United States, Colorado University of Colorado Recruiting Denver, Colorado, United States, 80203 Principal Investigator: Dan Pollyea, MD          United States, Florida Mayo Clinic Florida Recruiting Jacksonville, Florida, United States, 32224 Principal Investigator: James Foran, MD          United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30308 Principal Investigator: William Blum, MD          United States, Illinois University of Chicago Recruiting Chicago, Illinois, United States, 60637 Principal Investigator: Wendy Stock, MD          United States, Maryland University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201 Principal Investigator: Maria Baer, MD          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Principal Investigator: Eytan M Stein, MD          United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43210 Principal Investigator: John C Byrd, MD          Principal Investigator: Alice Mims, MD          Principal Investigator: Alison R Walker, MD, MPH          United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Principal Investigator: Uma Borate, MD          United States, Texas University of Texas Southwestern Recruiting Dallas, Texas, United States, 75390 Principal Investigator: Prapti Patel, MD          United States, Utah Huntsman Cancer Institute, University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Principal Investigator: Michael Deininger, MD, PhD Less <<
NCT00013533 Hodgkin Lymphoma ... More >> Lymphocytic Leukemia Mixed Cell Leukemia Myelodysplastic Syndrome Non Hodgkin's Lymphoma CML ALL AML Lymphoma Less << Early Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03642236 FLT3-ITD Mutation ... More >> Acute Myeloid Leukemia Brutons Tyrosine Kinase Less << Phase 2 Phase 3 Enrolling by invitation September 2023 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510515 Less <<
NCT00429416 Hematologic Malignancies Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University` Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01889407 - Unknown July 2016 China, Guangdong ... More >> Bing Xu Recruiting GuangZhou, Guangdong, China, 510515 Contact: Bing Xu, M.D    13189096353    xubingzhangjian@126.com    Contact: Xutao Guo, M.D    13802426709    gxt827@126.com    Principal Investigator: Bing Xu, M.D Less <<
NCT00429416 - Completed - -
NCT01947322 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - France ... More >> Service d'Hématologie Clinique du Pr. Leblond- Hôpital Pitié salpêtrière Paris, France, 75013 Service d'Hématologie adultes du Pr. Hermine - Hôpital Necker Enfants Malades Paris, France, 75015 Service d'Hématologie oncologie du Pr. Mohty -Hôpital Saint Antoine Paris, France, 75571 Service d'Hématologie Clinique du Pr. Cordonnier-Hôpital Henri Mondor Paris, France, 94010 Less <<
NCT01724879 Philadelphia Positive Acute Ly... More >>mphoblastic Leukemia Less << Phase 2 Completed - Germany ... More >> Robert Bosch Krankenhaus Stuttgart, Baden-Württemberg, Germany, 70376 Klinikum der Universität Regensburg Regensburg, Bayern, Germany, 93042 University Hospital of Frankfurt, Medical Dept. II Frankfurt, Hessen, Germany, 60590 Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 Universitätsklinikum Essen Essen, NRW, Germany, 45147 Universitätsklinik Münster Münster, NRW, Germany, 48149 Universitätsklinik Dresden Dresden, Sachsen, Germany, 01307 Uniklinik Aachen Aachen, Germany, 52074 Charité Universitätsmedizin Berlin Berlin, Germany, 13353 University Hospital Düsseldorf Düsseldorf, Germany, 40225 Universitätsklinikum Göttingen Göttingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, 20099 Universitätsklinik Köln Köln, Germany, 50937 Universität Leipzig, José-Carreras-Haus Leipzig, Germany, 04103 Universitätskliniken Mainz Mainz, Germany, 55101 Klinikum Mannheim Mannheim, Germany, 68167 Universitätsklinikum Großhadern München, Germany, 81377 Klinikum Nürnberg Nord Nürnberg, Germany, 90419 Klinikum Oldenburg Oldenburg, Germany, 26133 Universität Rostock Rostock, Germany, 18055 Medizinische Universitätsklinik Ulm Ulm, Germany, 89070 Medizinische Poliklinik der Universität Würzburg Würzburg, Germany, 97070 Less <<
NCT03392714 PCNSL Phase 2 Active, not recruiting January 20, 2019 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun-gun, Jeollanam-do, Korea, Republic of, 519-809 Less <<
NCT02996617 Lymphoma,Non-Hodgkin Phase 4 Unknown December 2018 China, Shandong ... More >> Department of Hematology, Provincial Hospital Affiliated to Shandong University Recruiting Jin'an, Shandong, China, 250012 Contact: Xin Wang, MD, PHD    86-531-68778331    xinw007@126.com    Contact: changqing zhen, MD    86-531-68778331    zcq1521@163.com Less <<
NCT01528085 Philadelphia Chromsome Positiv... More >>e Acute Lymphoblastic Leukemia Less << Phase 2 Unknown November 2018 -
NCT00146120 Acute Myeloid Leukemia Phase 3 Completed - Austria ... More >> Department of Hematology / Oncology, University Hospital of Innsbruck Innsbruck, Austria, 6020 III Medical Department, Hematology and Oncology Center, Hanuschhospital Wien Wien, Austria, 1140 Germany Department of General Internal Medicine, University Hospital of Bonn Bonn, Germany, 53127 Department of Internal Medicine Hematology, Heinrich-Heine University Düsseldorf, Germany, 40225 Department of Interial Medicine III, City Hospital Frankfurt Am Main - Höchst Frankfurt, Germany, 65927 Medical Department IV, University of Gießen Gießen, Germany, 35392 Department of Interial Medicine, Wilhelm-Anton-Hospital Goch Goch, Germany, 47574 Centre of Interial Medicine, University of Göttingen Göttingen, Germany, 37075 Medical Department III of Hematology and Oncology, General Hospital Altona Hamburg, Germany, 22763 Department of Interial Medicine V, University of Heidelberg Heidelberg, Germany, 69120 Department of Interial Medicine I, University Hospital of Saarland Homburg, Germany, 66421 Medical Department II, City Hospital Karlsruhe gGmbH Karlsruhe, Germany, 76133 Medical Department II, University Hospital of Kiel Kiel, Germany, 24116 Department of Interial Medicine /Hematology and Oncology, Caritas Hospital Lebach Lebach, Germany, 66822 I. Medical Department, City Hospital München-Schwabing München, Germany, 80804 Medical Department III, Clinical Center rechts der Isar München, Germany, 81675 Department of Hematology and Oncology, City Hospital Neunkirchen gGmbH Neunkirchen, Germany, 66538 Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH Oldenburg, Germany, 26133 Department of Hematologie and Oncology, Caritas Hospital St. Theresa Saarbrücken Saarbrücken, Germany, 66113 Clinikal Cetner of Stuttgart, Center of Oncology Stuttgart, Germany, 70174 Medical Department I, Clinical Center of Stuttgart Stuttgart, Germany, 70191 Hospital of Barmherzige Brüder, I Medical Department Trier, Germany, 54292 Less <<
NCT00893399 Acute Myeloid Leukemia Phase 3 Active, not recruiting July 2020 -
NCT03123887 - Completed - China, Heilongjiang ... More >> Institute of Harbin Hematology Oncology Harbin, Heilongjiang, China, 150000 Less <<
NCT00103285 - Completed - -
NCT00075725 Leukemia Phase 3 Completed - -
NCT03616470 Acute Myeloid Leukemia Phase 3 Recruiting December 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel J DeAngelo, MD, PhD    617-632-2645    Daniel_Deangelo@dfci.harvard.edu    Principal Investigator: Daniel DeAngelo, MD, PhD          United States, New York University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Brandon DeLorme    585-275-5295    Brandon_Delorme@URMC.Rochester.edu    Principal Investigator: Jane Liesveld, MD          United States, Ohio The Ohio State University Wexner Medical Center and James Cancer Hospital Recruiting Columbus, Ohio, United States, 43210 Contact: Jennifer Dienno    614-293-0752    Jennifer.Dienno@osumc.edu    Principal Investigator: Alice Mims, MD          United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Naval Daver, MD    713-794-4392    NDaver@mdanderson.org    Principal Investigator: Naval Daver, MD          United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Niall Curley    206-606-1231    Ncurley8@seattlecca.org    Principal Investigator: Pamela Becker, MD, PhD Less <<
NCT00003143 Lymphoma Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT01679860 Lymphoma, T-Cell, Peripheral Phase 2 Completed - Italy ... More >> Azienda Ospedaliera S. Luigi Orbassano, Torino, Italy, 10043 Ospedale SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy, 15100 University of Ancona - Division of Hematology Ancona, Italy, 62020 Ospedale Riuniti, Bergamo - Division of Hematology Bergamo, Italy, 24128 Ospedale Generale Regionale Bolzano Bolzano, Italy, 39100 Spedali Civili di Brescia Brescia, Italy, 25123 Azienda Ospedale Vittorio Emanuele Ferrarorro S. Bambino- Università di Catania Catania, Italy, 94124 Ospedale S. Croce - Division of Hematology Cuneo, Italy, 12100 IRCCS Ospedale Maggiore Policlinico di Milano Milano, Italy, 20122 Ospedale San Raffaele, Milano - Division of Hematology Milan, Italy, 20100 Division of Hematology - Fondazione IRCCS Istituto Nazionale Tumori Milan, Italy, 20133 Ospedale Cervello - Bone Marrow Transplantation Unit Palermo, Italy Ospedale San Carlo Potenza, Italy, 85100 Azienda OspedalieraSan Giovanni Battista Torino, Italy, 10126 Università di Torino- Azienda Ospedaliera S. Giovanni Battista Torino, Italy, 10126 Policlinico Universitario Udine Udine, Italy Azienda Ospedaliera Policlinico di Verona Verona, Italy, 37134 Less <<
NCT00005596 Leukemia Phase 3 Completed - -
NCT00943553 Acute Myelogenous Leukemia (AM... More >>L) Less << Phase 2 Withdrawn(Terminated by Sponso... More >>r) Less << - India ... More >> New Delhi, India, 110085 Less <<
NCT00882206 Leukemia Lymp... More >>homa Less << Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> University of Minnesota Amplatz Children's Hospital Minneapolis, Minnesota, United States, 55455 Less <<
NCT03117751 Acute Lymphoblastic Leukemia ... More >> Acute Lymphoblastic Lymphoma Less << Phase 2 Phase 3 Recruiting March 31, 2028 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Hiroto Inaba, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Hiroto Inaba, MD, PhD Less <<
NCT00882206 - Terminated(Slow accrual) - -
NCT01148173 Lymphoma, Non-Hodgkin Phase 2 Unknown October 2012 Germany ... More >> Charité Universitätsmedizin Recruiting Berlin, Germany, 12200 Contact: Lars Fischer, MD    +49308445 ext 4096    lars.fischer@charite.de    Contact: Agnieszka Korfel, MD    +49308445 ext 4096    agnieszka.korfel@charite.de Less <<
NCT00075725 - Completed - -
NCT00580372 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00366275 Follicular Lymphoma Phase 2 Completed - Italy ... More >> Division of Hematology, IRCCS Policlinico S. Matteo, University of Pavia Pavia, Italy, 27100 Less <<
NCT00580372 - Completed - -
NCT00366275 - Completed - -
NCT00774332 Acute Lymphoblastic Leukemia Phase 2 Unknown December 2009 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Jung-Hee Lee, Doctor    82-2-3010-5794    jhleecr@amc.seoul.kr Less <<
NCT03603795 Acute Myeloid Leukemia Phase 2 Recruiting September 2024 France ... More >> CHU ANGERS - Maladies du sang Not yet recruiting Angers, France, 49933 Contact: Mathilde HUNAULT, Dr    02 41 35 45 82    mahunault@chu-angers.fr    CH de la Côte Basque - Hématologie Not yet recruiting Bayonne, France, 64109 Contact: Anne BANOS, Dr    +33 5 59 44 38 32    abanos@ch-cotebasque.fr    CHU Estaing Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Aurélie RAVINET, Dr    04 73 75 00 65    aravinet@chu-clermontferrand.fr    CHU Grenoble - Hématologie Clinique Recruiting Grenoble, France, 38043 Contact: Claude-Eric BULABOIS, Dr    04 76 76 57 55    cebulabois@chu-grenoble.fr    Institut Paoli-Calmettes - Hématologie 2 Not yet recruiting Marseille, France, 13000 Contact: Norbert VEY, Pr    +33 4 91 22 36 95    veyn@ipc.unicancer.fr    Hôpital Saint-Eloi - Hématologie Clinique Not yet recruiting Montpellier, France, 34295 Contact: Yosr HICHERI, Dr    +33 4 67 33 24 18    y-hicheri@chu-montpellier.fr    HOPITAL E. MULLER - Hématologie Not yet recruiting Mulhouse, France, 68070 Contact: Mario OJEDA-URIBE, Dr    +33(0)3 89 64 77 55    ojeda-uribem@ghrmsa.fr    CHU HOTEL DIEU - Hématologie Clinique Not yet recruiting Nantes, France, 44093 Contact: Pierre PETERLIN, Dr    +33(0)2 40 08 32 71    pierre.peterlin@chu-nantes.fr    CHU Caremeau Not yet recruiting Nîmes, France, 30029 Contact: Eric JOURDAN, Dr    04 66 68 32 31    eric.jourdan@chu-nimes.fr    CHU La Milétrie - Hématologie Clinique Not yet recruiting Poitiers, France, 86000 Contact: Maria-Pilar GALLEGO-HERNANZ, Dr    +33(0)5 49 44 44 44    maria-pilar.gallego-hernanz@chu-poitiers.fr    CHU Pontchaillou Not yet recruiting Rennes, France, 35033 Contact: Marc BERNARD, Dr    02 40 08 32 71    marc.bernard@chu-rennes.fr    CHU Hautepierre - Hématologie Not yet recruiting Strasbourg, France, 67098 Contact: Bruno LIOURE, Dr    +33(0)3 88 12 76 76    bruno.lioure@chru-strasbourg.fr    Institut Universitaire du Cancer de Toulouse Oncopole - Service d'Hématologie Recruiting Toulouse, France, 31059 Contact: Christian RECHER, Pr    +33 5 31 15 63 55    recher.christian@iuct-oncopole.fr    Sponsor FILO Not yet recruiting Tours, France, 37044 Contact: Mélanie COTTOT, Mrs    +33247478899    m.dupin@chu-tours.fr    CHU de Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54500 Contact: Caroline BONMATI, Dr    03 83 15 52 49    c.bonmati@chu-nancy.fr Less <<
NCT01614197 Lymphoblastic Leukemia, Acute,... More >> Childhood Lymphoblastic Lymphoma Peripheral T-cell Lymphoma Less << Phase 1 Recruiting December 2019 -
NCT00004228 Lymphoma Phase 3 Unknown - -
NCT01025505 Treatment Ste... More >>m Cell Transplantation Less << Phase 2 Active, not recruiting December 2018 Italy ... More >> Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy Dipartimento Area Medica P.O. Ascoli Piceno, Italy, 63100 UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari Bari, Italy Ospedali Riuniti Bergamo, Italy Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy Sezione di Ematologia e Trapianti Spedali Civili Brescia, Italy, 21125 Osp. Reg. A. Di Summa Brindisi, Italy Servizio di Ematologia - CTMO - ASL 8 P.O. Binaghi Cagliari, Italy Ospedale Ferrarotto Catania, Italy, 95124 Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Clinica Ematologica - Università degli Studi Genova, Italy Ospedale Niguarda "Ca' Granda" Milano, Italy, 20122 Sez. di medicina Interna Oncologia ed Ematologia Modena, Italy Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Ospedale di Rilievo Nazionale "A. Cardarelli" Napoli, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Ospedale S. Luigi Gonzaga Orbassano, Italy, 10043 Università degli Studi di Padova - Ematologia ed Immunologia Clinica Padova, Italy Ospedali Riuniti 'Villa Sofia-Cervello' Palermo, Italy Div. di Ematologia IRCCS Policlinico S. Matteo Pavia, Italy, 27100 Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore Pesaro, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy, 65100 Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Piacenza, Italy Ospedale S.Maria delle Croci Ravenna, Italy, 48100 Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Rimini Ospedale "Infermi" Rimini, Italy Complesso Ospedaliero S. Giovanni Addolorata Roma, Italy, 00184 Università degli Studi - Policlinico di Tor Vergata Roma, Italy, 21100 U.O.C. Ematologia - Ospedale S.Eugenio Roma, Italy Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SCDO Ematologia 2 AOU S.Giovanni Battista Torino, Italy Policlinico Universitario - Clinica Ematologia Udine, Italy, 33100 Policlinico G.B. Rossi Verona, Italy, 37134 Less <<
NCT03435848 Acute Myeloid Leukemia Phase 2 Recruiting April 1, 2021 United States, Illinois ... More >> Northwestern Memorial Hospital Not yet recruiting Chicago, Illinois, United States, 60611 Principal Investigator: Olga Frankfurt          United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Not yet recruiting Columbus, Ohio, United States, 43210 Principal Investigator: Alice Mims, Mims          United States, Pennsylvania Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Principal Investigator: Salina Luger          United States, Texas Baylor Scott & White Research Institute Dallas Texas Recruiting Dallas, Texas, United States, 75246 Principal Investigator: Micah Burch          United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506-9162 Principal Investigator: Michael Craig          Israel Soroka University Medical Center Recruiting Be'er Sheva, Israel, PO Box 151 Principal Investigator: Itai Levi          Rambam medical center hematology department Recruiting Haifa, Israel, 4655202 Contact: Tsila Zuckerman, MD       'Tsila Zuckerman'    Principal Investigator: Tsila Zuckerman, prof          Shaare Zedek Medical Center Recruiting Jerusalem, Israel, P.O.B 3235 Principal Investigator: Chezi Ganzel          Rabin Medical Center Recruiting Petach Tikva, Israel, 49100 Principal Investigator: Ofir Wolach          Tel Aviv Sourasky Medical Center Recruiting Tel Aviv, Israel, 6423906 Principal Investigator: Moshe Yakir Less <<
NCT00153530 Central Nervous System Lymphom... More >>a Less << Phase 4 Completed - Germany ... More >> Charite Campus Benjamin Franklin Berlin, Germany, 12200 Less <<
NCT03020030 Acute Lymphoblastic Leukemia, ... More >>Pediatric Less << Phase 3 Recruiting December 2026 United States, Massachusetts ... More >> Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Lewis Silverman, MD    617-632-6191    lewis_silverman@dfci.harvard.edu    Principal Investigator: Lewis Silverman, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis Silverman, MD    617-632-6191    lewis_silverman@dfci.harvard.edu    Principal Investigator: Lewis Silverman, MD          United States, New York Montefiore Medical Center Recruiting Bronx, New York, United States, 104617 Contact: Lisa Gennarini, MD       lfigueir@montefiore.org    Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Kara Kelly, MD       Kara.Kelly@RoswellPark.org    Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian Recruiting New York, New York, United States, 10032 Contact: Justine Kahn, MD       jk2034@cumc.columbia.edu    Principal Investigator: Justine Kahn, MD          United States, Rhode Island Hasbro Children's Hospital / Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Jennifer Welch, MD       jwelch@lifespan.org    Canada, Quebec Hospital Sainte Justine, University of Montreal Recruiting Montreal, Quebec, Canada Contact: Jean-Marie LeClerc, MD       jean-marie.leclerc@umontreal.ca    Principal Investigator: Jean-Marie LeClerc, MD          Centre Hospitalier U. de Quebec Recruiting Quebec City, Quebec, Canada Contact: Bruno Michon, MD       bruno.michon@mail.chuq.qc.ca    Principal Investigator: Bruno Michon, MD Less <<
NCT03523429 Philadelphia Chromosome-negati... More >>ve or BCR-ABL-negative, CD19-positive ALL Less << Phase 2 Recruiting January 2025 Spain ... More >> Hospital Germans Trias i Pujol and all Hospital Pethema Recruiting Badalona, Barcelona, Spain Contact: Jose Mª Ribera, Dr    93 465 12 00    jribera@iconcologia.net    Hospital Clinico Universitario de Salamanca Recruiting Salamanca, Spain Contact: Jesús Maria Hernández Rivas, Dr    923 29 11 00    jmhr@usal.es Less <<
NCT00002798 Childhood Acute Erythroleukemi... More >>a (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Ringed Sideroblasts Secondary Myelodysplastic Syndromes Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT03080766 Acute Myeloid Leukemia ... More >> Complex Karyotype Less << Phase 2 Recruiting February 28, 2021 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Chunxiao Zhang, SC    852-22554361    chunxiao@hku.hk Less <<
NCT00047268 Leukemia Myel... More >>odysplastic/Myeloproliferative Neoplasms Less << Phase 3 Unknown - Germany ... More >> Universitaetskinderklinik - Universitaetsklinikum Freiburg Freiburg, Germany, D-79106 Less <<
NCT02995655 Myelodysplastic Syndromes ... More >> Acute Myeloid Leukemia AML MDS Less << Phase 1 Active, not recruiting November 30, 2023 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00700544 AML Elderly P... More >>atients Less << Phase 3 Completed - France ... More >> Arnaud PIGNEUX Pessac, France, 33604 Less <<
NCT01106144 - Unknown - Korea, Republic of ... More >> Samsung Medical Center IRB Recruiting Seoul, South Korea, Korea, Republic of, 135-710 Contact: Dong Hwan Kim, M.D., Ph.D.    82-2-3410-1768    drkiim@medimail.co.kr Less <<
NCT01334086 Acute Myeloid Leukemia Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01665001 Precursor Lymphoid Neoplasms Phase 2 Unknown August 2018 Poland ... More >> Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch Not yet recruiting Gliwice, Poland, 44-101 Contact: Sebastian Giebel, MD    0048322788523    sgiebel@io.gliwice.pl Less <<
NCT03609060 Acute Myeloid Leukemia Phase 2 Recruiting December 31, 2025 France ... More >> CHU ANGERS - Maladies du sang Recruiting Angers, France, 49933 Contact: Mathilde HUNAULT, Dr    02 41 35 45 82    mahunault@chu-angers.fr    Ch Avignon Not yet recruiting Avignon, France, 84000 Contact: Safia CHEBREK, Dr    +33 4 32 75 93 00    chebrek.safia@ch-avignon.fr    CH de la Côte Basque - Hématologie Not yet recruiting Bayonne, France, 64109 Contact: Anne BANOS, Dr    +33 5 59 44 38 32    abanos@ch-cotebasque.fr    CHRU JEAN MINJOZ - Hématologie Not yet recruiting Besançon, France, 25030 Contact: Yohan DESBROSSES, Dr    +33 3 81 66 82 32    ydesbrosses@chu-besancon.fr    CHU Brest - Hôpital Morvan - Hématologie Clinique Not yet recruiting Brest, France, 29609 Contact: Gaëlle GUILLERM, Dr    +33 2 98 22 35 04    gaelle.guillerm@chu-brest.fr    CH de Béziers - Hématologie Not yet recruiting Béziers, France, 34500 Contact: Alain SAAD, Dr    +33 4 67 35 70 63    alain.saad@ch-beziers.fr    Clinique du Parc - Hématologie Not yet recruiting Castelnau-le-Lez, France, 34170 Contact: Carole EXBRAYAT, Dr    +33 4 67 33 15 12    carole.exbrayat@groupeclinipole.fr    CHU Estaing - Hématologie Clinique Adulte Not yet recruiting Clermont-Ferrand, France, 63000 Contact: Romain GUIEZE, Dr    +33 4 73 75 00 65    rguieze@chu-clermontferrand.fr    CHU Grenoble - Hématologie Clinique Not yet recruiting Grenoble, France, 38043 Contact: Martin CARRE, Dr    +33 4 76 76 57 55    mcarre1@chu-grenoble.fr    Institut Paoli-Calmettes - Hématologie 2 Not yet recruiting Marseille, France, 13000 Contact: Norbert VEY, Pr    +33 4 91 22 36 95    veyn@ipc.unicancer.fr    CHR de Mercy - Hématologie Not yet recruiting Metz, France, 57085 Contact: Véronique DORVAUX, Dr    +33 3 87 55 33 04    v.dorvaux@chr-metz-thionville.fr    Hôpital Saint-Eloi - Hématologie Clinique Not yet recruiting Montpellier, France, 34295 Contact: Yosr HICHERI, Dr    +33 4 67 33 24 18    y-hicheri@chu-montpellier.fr    HOPITAL E. MULLER - Hématologie Not yet recruiting Mulhouse, France, 68070 Contact: Mario OJEDA-URIBE, Dr    +33(0)3 89 64 77 55    ojeda-uribem@ghrmsa.fr    CHU HOTEL DIEU - Hématologie Clinique Not yet recruiting Nantes, France, 44093 Contact: Pierre PETERLIN², Dr    +33(0)2 40 08 32 71    pierre.peterlin@chu-nantes.fr    CHR ORLEANS - Hématologie Recruiting Orléans, France, 44100 Contact: Omar BENBRAHIM, Dr    +33(0)2 38 22 99 27    omar.benbrahim@chr-orleans.fr    HOPITAL COCHIN - Hématologie Not yet recruiting Paris, France, 75014 Contact: Lise WILLEMS, Dr    +33(0)1 58 41 26 70    lise.willems@aphp.fr    CENTRE HOSPITALIER SAINTJEAN - Hématologie Clinique Not yet recruiting Perpignan, France, 66000 Contact: Laurence SANHES, Dr    +33(0)4 68 61 89 02    laurence.sanhes@ch-perpignan.fr    Hôpital Haut Levêque- CFM -Hématologie Clinique Et Thérapie Cellulaire Not yet recruiting Pessac, France, 33604 Contact: Arnaud PIGNEUX, Pr    +33 5 57 65 65 11    arnaud.pigneux@chu-bordeaux.fr    CHU La Milétrie - Hématologie Clinique Not yet recruiting Poitiers, France, 86000 Contact: Maria-Pilar GALLEGO-HERNANZ, Dr    +33(0)5 49 44 44 44    maria-pilar.gallego-hernanz@chu-poitiers.fr    CHU Reims - Hôpital Robert Debré - Hématologie Clinique Not yet recruiting Reims, France, 51100 Contact: Chantal HIMBERLIN, Dr    +33(0)3 26 78 36 44    chimberlin@chu-reims.fr    CHU Pontchaillou - Hématologie Not yet recruiting Rennes, France, 35033 Contact: Marc BERNARD, Dr    +33(0)2 99 28 99 86    marc.bernard@chu-rennes.fr    CHU Hautepierre - Hématologie Not yet recruiting Strasbourg, France, 67098 Contact: Bruno LIOURE, Dr    +33(0)3 88 12 76 76    bruno.lioure@chru-strasbourg.fr    Institut Universitaire du Cancer de Toulouse Oncopole - Service d'Hématologie Recruiting Toulouse, France, 31059 Contact: Christian RECHER, Pr    +33 5 31 15 63 55    recher.christian@iuct-oncopole.fr    CHU Bretonneau - Centre Henri Kaplan - Hématologie et Thérapie Cellulaire Not yet recruiting Tours, France, 37044 Contact: Emmanuel GYAN, Pr    +33(0)2 47 47 37 12    emmanuel.gyan@univ-tours.fr    CHU Nancy - Hopitaux Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54500 Contact: Gabrielle ROTH-GUEPIN, Dr    +33(0)3 83 15 76 86    g.roth-guepin@chru-nancy.fr Less <<
NCT00083551 Multiple Myeloma Phase 3 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00873093 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Lymphoblastic Lymphoma T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - -
NCT00004228 - Unknown - -
NCT02028650 - Completed - China, Beijing ... More >> Affiliated Hospital of Academy of Military Medical Sciences Beijing, Beijing, China, 100071 Less <<
NCT00083551 - Completed - -
NCT00574509 Lymphoma Phase 1 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7680 Less <<
NCT03507244 Leptomeningeal Metastasis Phase 1 Phase 2 Recruiting December 31, 2019 China, Jilin ... More >> The First Hospital of Jilin University Recruiting Changchun, Jilin, China, 130021 Contact: Zhenyu Pan, Professor    +8615804302753    dr-zypan@163.com    Contact: Guozi Yang, Professor    +8615804302755    guoziyang_1982@163.com Less <<
NCT01484093 Mantle Cell Lymphoma Phase 1 Phase 2 Active, not recruiting November 2019 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT00006367 Chronic Myeloproliferative Dis... More >>orders Less << Phase 2 Completed - United States, Alaska ... More >> Katmai Oncology Group Anchorage, Alaska, United States, 99508-4627 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 United States, Illinois University of Illinois College of Medicine Chicago, Illinois, United States, 60612 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Missouri Washington University Siteman Cancer Center Saint Louis, Missouri, United States, 63110 United States, New York New York Presbyterian Hospital - Cornell Campus New York, New York, United States, 10021 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 France Hopital Saint-Louis Paris, France, 75475 United Kingdom Addenbrooke's NHS Trust Cambridge, England, United Kingdom, CB2 2QQ Less <<
NCT01453504 Hodgkin Lymphoma Phase 1 Phase 2 Recruiting December 2018 Germany ... More >> 1st Dept. of Medicine, Cologne University Hospital Recruiting Cologne, Germany Contact: Michael Fuchs       ghsg@uk-koeln.de Less <<
NCT00723658 Lymphoma Phase 2 Withdrawn(lack of accrual) - United States, Connecticut ... More >> Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States, 06105 United States, Indiana St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove, Indiana, United States, 46107 Reid Hospital & Health Care Services Richmond, Indiana, United States, 47374 United States, Kansas Lawrence Memorial Hospital Lawrence, Kansas, United States, 66044 Wesley Medical Center Wichita, Kansas, United States, 67214 United States, Michigan Saint Joseph Mercy Cancer Center Ann Arbor, Michigan, United States, 48106-0995 CCOP - Michigan Cancer Research Consortium Ann Arbor, Michigan, United States, 48106 Oakwood Cancer Center at Oakwood Hospital and Medical Center Dearborn, Michigan, United States, 48123-2500 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Genesys Hurley Cancer Institute Flint, Michigan, United States, 48503 Hurley Medical Center Flint, Michigan, United States, 48503 Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods, Michigan, United States, 48236 Foote Memorial Hospital Jackson, Michigan, United States, 49201 Sparrow Regional Cancer Center Lansing, Michigan, United States, 48912-1811 St. Mary Mercy Hospital Livonia, Michigan, United States, 48154 St. Joseph Mercy Oakland Pontiac, Michigan, United States, 48341-2985 Mercy Regional Cancer Center at Mercy Hospital Port Huron, Michigan, United States, 48060 Seton Cancer Institute at Saint Mary's - Saginaw Saginaw, Michigan, United States, 48601 St. John Macomb Hospital Warren, Michigan, United States, 48093 United States, Ohio Grandview Hospital Dayton, Ohio, United States, 45405 Good Samaritan Hospital Dayton, Ohio, United States, 45406 David L. Rike Cancer Center at Miami Valley Hospital Dayton, Ohio, United States, 45409 CCOP - Dayton Dayton, Ohio, United States, 45420 Blanchard Valley Medical Associates Findlay, Ohio, United States, 45840 Middletown Regional Hospital Franklin, Ohio, United States, 45005-1066 Charles F. Kettering Memorial Hospital Kettering, Ohio, United States, 45429 UVMC Cancer Care Center at Upper Valley Medical Center Troy, Ohio, United States, 45373-1300 Clinton Memorial Hospital Wilmington, Ohio, United States, 45177 Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia, Ohio, United States, 45385 Less <<
NCT01295307 Acute Myeloid Leukemia Phase 2 Completed - Germany ... More >> HELIOS Klinikum Bad Saarow Bad Saarow, Germany Klinikum Chemnitz gGmbH Chemnitz, Germany University Hospital Carl Gustav Carus Dresden, Germany, 01307 Universitätsklinikum Erlangen Erlangen, Germany Klinikum der J. W. Goethe-Universität Frankfurt am Main, Germany Klinikum Mannheim GmbH Mannheim, Germany Universitätsklinikum Münster Münster, Germany Klinikum Nürnberg Nord Nürnberg, Germany Universitätsklinikum Tübingen Tübingen, Germany Universitätsklinikum Würzburg Würzburg, Germany Less <<
NCT00939653 Relapsed Acute Myelogenous Leu... More >>kemia Less << Phase 2 Terminated(Study lost funding ... More >>and it was decided that it could not meet it's accrual goals.) Less << - United States, California ... More >> Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Illinois Children's Memorial Chicago, Illinois, United States United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 United States, New York New York University Medical Center New York, New York, United States, 10016 United States, North Carolina Levine Children's Hospital at Carolinas Medical Center Charlotte, North Carolina, United States, 28203 United States, Tennessee Vanderbilt Children's Hospital Nashville, Tennessee, United States Less <<
NCT03710772 CD20 Positive ... More >> Mantle Cell Lymphoma Less << Phase 2 Not yet recruiting May 18, 2023 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Luhua (Michael) Wang    713-792-2860       Principal Investigator: Luhua (Michael) Wang Less <<
NCT00873093 - Completed - -
NCT00005977 Leukemia Lymp... More >>homa Less << Phase 3 Completed - -
NCT03686345 Core Binding Factor Acute Myel... More >>oid Leukemia (CBF-AML) Less << Phase 2 Active, not recruiting December 31, 2025 Italy ... More >> Ospedale Cà Granda - Niguarda S.C: Ematologia Milano, Italy, 20162 Less <<
NCT00459524 - Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00003602 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Unknown - United Kingdom ... More >> Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Less <<
NCT00187070 Lymphoma, Large Cell ... More >> Lymphoma, Non-Hodgkin Less << Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Reaearch Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00006045 Leukemia Phase 3 Unknown - -
NCT02657785 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Phase 3 Enrolling by invitation December 2024 China, Beijing ... More >> Navy General Hospital Beijing, Beijing, China, 100048 Less <<
NCT00005585 Leukemia Phase 3 Completed - -
NCT00423826 - - - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00363025 Acute Myeloid Leukemia Phase 3 Terminated - France ... More >> Hopital Avicenne Bobigny, France Hopital Percy Clamart, France Hopital Henri Mondor Creteil, France CHU Lille, France CHU Limoges, France Hopital Edouard Herriot Lyon, France Hopital Pitie-Salpetriere Paris, France Hopital Saint-Louis Paris, France CHU Rouen, France CNLCC Rouen, France CNLCC Saint-Cloud, France CH Versailles, France IGR Villejuif, France Less <<
NCT00373529 - Completed - -
NCT03319901 Leukemia Phase 1 Recruiting April 30, 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Daniel DeAngelo, MD, PhD    617-632-2645    Daniel_DeAngelo@DFCI.Harvard.Edu    Principal Investigator: Daniel DeAngelo, MD, PhD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Nitin Jain, MD    713-745-6080    njain@mdanderson.org    Principal Investigator: Nitin Jain, MD Less <<
NCT01953770 Childhood Acute Lymphoblastic ... More >>Leukemia Less << Not Applicable Active, not recruiting June 2018 -
NCT02836158 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Phase 3 Recruiting December 2030 China, Beijing ... More >> Navy General Hospital Recruiting Beijing, Beijing, China, 100048 Contact: Liren Qian, M.D.    +861066957676    qlr2007@126.com Less <<
NCT00373529 Acute Myelogenous Leukemia ... More >> Acute Myeloid Leukemia Less << Phase 2 Completed - -
NCT00574080 Multiple Myeloma Phase 3 Terminated(low accrual) - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT03125642 Non-Hodgkin Lymphoma ... More >> Hodgkin Lymphoma Less << Phase 2 Recruiting April 30, 2026 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Veronika Bachanova, MD Less <<
NCT00101101 - Active, not recruiting - -
NCT01358201 Acute Lymphoblastic Leukemia Phase 4 Recruiting December 2020 -
NCT01046825 Mature B-Cell Lymphoma Phase 2 Phase 3 Recruiting October 31, 2022 United States, California ... More >> Rady Children's Hospital San Diego Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5811    dschiff@rchsd.org    Principal Investigator: Deborah Schiff, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: John T Sandlund, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: John T Sandlund, MD          Egypt Children's Cancer Hospital Recruiting Cairo, Egypt, 11787 Contact: Hany Abdel Rahman, MD          Principal Investigator: Hany Abdel Rahman, MD          Singapore National University Health System Recruiting Singapore, Singapore, 119228 Contact: Allen Yeoh, MD       allen_yeoh@nuhs.edu.sg    Principal Investigator: Allen Yeoh, MD Less <<
NCT00101101 Lymphoma Phase 2 Active, not recruiting March 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT00930605 Peripheral T-cell Lymphoma Phase 2 Completed - Thailand ... More >> King Chulalongkorn Memorial Hospital Bangkok, Thailand Less <<
NCT00054327 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00054327 - Completed - -
NCT00028899 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Completed - -
NCT00002578 Lymphoma Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033-0800 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00574080 - Terminated(low accrual) - -
NCT00049517 Leukemia Phase 3 Active, not recruiting January 2019 -
NCT00049517 - Active, not recruiting - -
NCT00378365 Leukemia, Promyelocytic, Acute Phase 3 Unknown September 2016 France ... More >> Chu Avicenne Recruiting Bobigny, France, 93000 Contact: Lionel ADES, MD,PhD    +33(0)- 148 95 70 55    Lionel.ades@avc.aphp.fr    Principal Investigator: Lionel ADES, MD Less <<
NCT03258931 Newly Diagnosed FLT3 Mutated A... More >>ML Less << Phase 3 Recruiting November 2024 United States, California ... More >> US Davis Health Recruiting Sacramento, California, United States, 95817 Contact: Brian Jonas, MD    800-282-3284    bajonas@ucdavis.edu    United States, Florida Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Kendra Sweet, MD    813-745-6841    Kendra.Sweet@moffitt.org    United States, Kansas University of Kansas Recruiting Kansas City, Kansas, United States, 66160 Contact: Sunil Abhyankar, MD    913-588-9281    sabhyankar@kumc.edu    United States, Massachusetts Dana-Farber Cancer Insitute Recruiting Boston, Massachusetts, United States, 02215 Contact: Richard M Stone, MD    617-632-2214    Richard_Stone@dfci.harvard.edu    United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Jay Yang, MD    800-527-6266    yangj@karmanos.org    Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Yue Guo, MD    800-436-7936    YGUO1@hfhs.org    United States, New York Roswell PArk Recruiting Buffalo, New York, United States, 14263 Contact: Eunice S Wang, MD    716-845-3544    eunice.wang@roswellpark.org Less <<
NCT02443077 Diffuse Large B-Cell Lymphoma ... More >>Activated B-Cell Type Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High Grade B-Cell Lymphoma, Not Otherwise Specified Recurrent Burkitt Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << Phase 3 Recruiting - -
NCT00002835 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00636922 Acute Myeloid Leukemia Phase 1 Unknown January 2014 Australia, Victoria ... More >> BaysideHealth, The Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT00015873 Leukemia Phase 3 Completed - -
NCT03097588 Hematopoietic Cell Transplanta... More >>tion Recipient Malignant Neoplasm Less << Phase 2 Recruiting May 2019 United States, Oregon ... More >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Joseph Bubalo    503-494-8007    bubaloj@ohsu.edu    Principal Investigator: Joseph Bubalo Less <<
NCT00058292 Lymphoma Phase 1 Completed - United States, Illinois ... More >> Hematology-Oncology Associates of Illinois Chicago, Illinois, United States, 60611-2998 Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00002657 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 2 Completed - -
NCT00058461 B-cell Childhood Acute Lymphob... More >>lastic Leukemia Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma L3 Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Less << Phase 2 Terminated - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT03572764 Myelodysplastic Syndromes Phase 1 Not yet recruiting November 30, 2025 United States, Florida ... More >> Moffitt Cancer Center Not yet recruiting Tampa, Florida, United States, 33612 Contact: David Sallman, M.D.    888-663-3488       Principal Investigator: David Sallman, M.D.          United States, Missouri Washington University School of Medicine Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Meagan Jacoby, M.D., Ph.D.    314-747-7949    mjacoby@wustl.edu    Principal Investigator: Meagan Jacoby, M.D., Ph.D.          Sub-Investigator: Geoffrey Uy, M.D.          Sub-Investigator: Kathryn Trinkaus, Ph.D.          United States, Washington Fred Hutchinson Cancer Research Center Not yet recruiting Seattle, Washington, United States, 98109 Contact: Bart Scott, M.D.    206-667-1990    bscott@fredhutch.org    Principal Investigator: Bart Scott, M.D. Less <<
NCT00556127 Diffuse Large B-Cell Lymphoma ... More >> POOR PROGNOSIS Less << Phase 2 Completed - Italy ... More >> Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Ospedale Regionale, Divisione di Oncologia, Aosta, Italy Azienda Ospedaliera Ospedale Policlinico Consorziale Bari, Italy Osp. degli Infermi Biella, Italy Spedali Civili Brescia, Italy Centro Trapianti Midollo Osseo, P.O. Businco Cagliari, Italy Ospedale S. Gerardo Monza, Italy Osp. maggiore della Carità Novara, Italy Università degli Studi Policlinico Monteluce Perugia, Italy Divisione di Medicina, Ospedale Generale E. Agnelli, Pinerolo Torino, Italy Istituto per la Ricerca e la Cura del Cancro, Candiolo Torino, Italy Osp. S. Giovanni Battista "Molinette" Torino, Italy Ospedale di Chivasso e Ivrea Torino, Italy Stabilimento Ospedaliero Ciriè - Torino, Italy Less <<
NCT00388531 Lymphoblastic Leukemia ... More >> Lymphoma Less << Phase 2 Completed - Spain ... More >> Hospital "Santa Creu i Sant Pau" Barcelona, Spain Hospital Clínico y Provincial de Barcelona Barcelona, Spain Hospital Germans Trias i Pujol Barcelona, Spain Hospital Clínico San Carlos de Madrid Madrid, Spain Hospital Doce de Octubre Madrid, Spain . Hospital Clínico Universitario Virgen de la Victoria Málaga, Spain Hospital Clínico Universitario de Salamanca Salamanca, Spain Hospital Universitario Virgen del Rocío Sevilla, Spain Hospital La Fe Valencia, Spain Less <<
NCT00187057 Ataxia-Telangiectasia Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02611492 Philadelphia Chromosome Positi... More >>ve Adult Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting December 2025 France ... More >> Hopital Saint Louis Recruiting Paris, France, 75010 Contact: Hervé Dombret, MDPhD    +33 (0)1 57 27 68 47    herve.dombret@aphp.fr Less <<
NCT00898456 - Active, not recruiting - United States, Indiana ... More >> Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States, 46845 Less <<
NCT00526175 Acute Lymphoblastic Leukemia Phase 4 Completed - Spain ... More >> Complejo Hospitalario Universitario de Albacete Albacete, Spain Hospital General de Alicante Alicante, Spain Hospital de Badalona Germans Trias i Pujol Badalona, Spain Hospital de Sant Pau Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Valle Hebrón-Materno Infantil Barcelona, Spain Basurtuko Ospitalea Basurto, Spain Complejo Hospitalario Reina Sofía Córdoba, Spain Hospital General de Guadalajara Guadalajara, Spain Complejo Hospitalario León Leon, Spain Hospital Clínico San Carlos de Madrid Madrid, Spain . Hospital Clínico Universitario Virgen de la Victoria Málaga, Spain Complejo Asistencial Son Dureta Palma de Mallorca, Spain Hospital Clinico Universitario Salamanca, Spain Hospital Clínico Universitario de Salamanca Salamanca, Spain Complejo Hospitalario Universitario de Santiago Santiago de Compostela, Spain Hospital General de Segovia Segovia, Spain H.U. Virgen del Rocio Sevilla, Spain Hospital Joan XXIII Tarragona, Spain Hospital Arnau de Vilanova Valencia, Spain Hospital Clínic Valencia, Spain Hospital La Fe Valencia, Spain Hospital Universitario Dr. Peset Valencia, Spain Hospital Clínico de Valladolid Valladolid, Spain Hospital Clínico Lozano Blesa Zaragoza, Spain Less <<
NCT00355199 Diffuse Large B-Cell Lymphoma Phase 3 Completed - Italy ... More >> Clinica di Ematologia - Nuovo Ospedale Torrette Ancona, Italy U.O. Ematologia - Ospedali Riuniti di Bergamo Bergamo, Italy Divisione di Ematologia - Ospedale Centrale di Bolzano Bolzano, Italy CTMO - Ematologia - Ospedale "R. Binaghi" Cagliari, Italy Divisione di Ematologia - Ospedale Ferrarotto Catania, Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Divisione Ematologia - Istituto S. Raffaele Milano, Italy Oncologia Medica - Istituto Nazionale dei Tumori Milano, Italy U.O. Ematologia - Istituto Nazionale dei Tumori Milano, Italy Divisione di Ematologia - Azienda Ospedaliera Padova, Italy Ematologia - Azienda Ospedaliera V. Cervello Palermo, Italy Ematologia Clinica - Ospedale Civile di Pescara Pescara, Italy Ematologia e TMO - Ospedale S. Camillo Roma, Italy Divisione Universitaria di Ematologia - Azienda Ospedaliera S. Giovanni Battista (Molinette) Torino, Italy Dipartimento di Medicina Clinica e Sperimentale - Università di Verona Verona, Italy Divisione di Ematologia - Presidio Ospedaliero S. Bortolo Vicenza, Italy Less <<
NCT00355199 - Completed - -
NCT00002638 Leukemia Phase 2 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 Less <<
NCT00869284 Lymphoma Phase 2 Completed - France ... More >> Emmanuel Gyan Tours, France, 37000 Less <<
NCT00007852 Lymphoma Phase 2 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 Less <<
NCT00096772 - Completed - -
NCT00863512 Lung Cancer Phase 3 Terminated - -
NCT00005962 Leukemia Phase 2 Completed - -
NCT00863512 - Terminated - -
NCT00005945 Leukemia Phase 3 Completed - -
NCT00003783 Leukemia Phase 2 Completed - -
NCT00107354 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00549835 Mucositis Pai... More >>n Leukemia Less << Not Applicable Withdrawn(Inadequate funding) - United States, Maryland ... More >> Johns Hopkins Medical Institutions Baltimore, Maryland, United States Less <<
NCT01840566 Non-Hodgkin's Lymphoma Phase 1 Active, not recruiting April 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00004086 Leukemia Lymp... More >>homa Less << Phase 1 Unknown - United States, New Jersey ... More >> Garden State Cancer Center Belleville, New Jersey, United States, 07103 Less <<
NCT00520130 Myelodysplastic Syndrome ... More >> Hodgkin's Lymphoma Non-Hodgkin's Disease Acute Leukemia Multiple Myeloma Less << Phase 1 Phase 2 Active, not recruiting December 2018 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00003217 Leukemia Lymp... More >>homa Less << Phase 1 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, California Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States, 94304 United States, Illinois Children's Memorial Hospital, Chicago Chicago, Illinois, United States, 60614 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 University of Rochester Cancer Center Rochester, New York, United States, 14642 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Oklahoma Oklahoma Memorial Hospital Oklahoma City, Oklahoma, United States, 73126-0307 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-0721 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 Cook Children's Medical Center - Fort Worth Fort Worth, Texas, United States, 76104 United States, Wisconsin Midwest Children's Cancer Center Milwaukee, Wisconsin, United States, 53226 Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T2T 5C7 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT03662087 Minimal Residual Disease,Acute... More >> Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation Less << Phase 2 Phase 3 Recruiting October 2022 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hua Jin    +86-020-61641613    499509173@qq.com Less <<
NCT00520130 - Active, not recruiting - -
NCT00928200 Relapsed Acute Lymphoblastic L... More >>eukemia Allergy to PEG e.Coli Asparaginase Allergy to Native e.Coli Asparaginase Less << Phase 1 Terminated(Study was terminate... More >>d due to lack of accrual.) Less << - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States United States, California City of Hope Duarte, California, United States, 91010 Miller Children's Hospital Long Beach, California, United States Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Oakland Children's Hospital Oakland, California, United States Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Illinois Children's Memorial Chicago, Illinois, United States United States, Maryland Johns Hopkins University Baltimore, Maryland, United States United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 University of Minnesota Children's Hospital Minneapolis, Minnesota, United States United States, New York New York University Medical Center New York, New York, United States, 10016 Children's Hospital New York-Presbyterian New York, New York, United States, 10032 United States, Ohio Nationwide Childrens Hospital Columbus, Ohio, United States United States, Oregon Oregon Health and Science University Portland, Oregon, United States United States, Tennessee Vanderbilt Children's Hospital Nashville, Tennessee, United States United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Kids Toronto, Ontario, Canada Less <<
NCT00003671 Leukemia Phase 2 Completed - -
NCT02203526 Primary Central Nervious Syste... More >>m Lymphoma Less << Phase 1 Recruiting June 15, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00002590 Lymphoma Phase 2 Completed - -
NCT00946374 Mantle-Cell Lymphoma Phase 2 Unknown June 2011 Germany ... More >> University Hospital Recruiting Heidelberg, Germany, 69120 Contact: Markus Munder, MD Less <<
NCT02519712 - Terminated(Lack of accrual) - -
NCT00002524 Lymphoma Phase 2 Completed - United States, Florida ... More >> MD Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02039726 AML Phase 3 Active, not recruiting July 2019 -
NCT02519712 Acute Myeloid Leukemia (AML) Not Applicable Terminated(Lack of accrual) - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00025259 - Completed - -
NCT00025259 Childhood Lymphocyte-Depleted ... More >>Classical Hodgkin Lymphoma Childhood Mixed Cellularity Classical Hodgkin Lymphoma Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma Childhood Nodular Sclerosis Classical Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Stage III Childhood Hodgkin Lymphoma Stage IV Childhood Hodgkin Lymphoma Less << Phase 3 Completed - -
NCT00073736 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - United States, California ... More >> University of California at Irvine Orange, California, United States, 92868 Hong Kong Prince of Wales Hospital - Comprehensive Cancer Trial Unit Shatin, New Territories, Hong Kong Taiwan Tri-Services General Hospital Taipei, Nei Hu District, Taiwan, 114 Chang-Gung Memorial Hospital Taipei, Taoyuan County, Taiwan, 333 Less <<
NCT00600353 Myeloma, Plasma-Cell ... More >> Lymphoma, Malignant Less << Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT01258816 Relapsed/Refractory AML Phase 1 Completed - Spain ... More >> ICO - Hospital Duran i Reynals Barcelona, Catalunya, Spain, 08907 Hospital General de la Vall d' Hebron Barcelona, Spain, 08035 Hospital San Pedro Alcantara Cáceres, Spain, 10003 United Kingdom Brighton & Sussex University Hospitals NHS Trust Brighton, United Kingdom, BN2 5BE University Hospital of Wales, Cardiff Cardiff, United Kingdom, CF14 4XW St Bartholomew's Hospital London, United Kingdom, EC1A 7BE Less <<
NCT00405743 Hematologic Malignancies ... More >> AML Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Mew York Medical College, Division of Oncology Valhalla, New York, United States, 10595 United States, North Carolina Duke University Medical Center (DUMC) Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Institute for Drug Development (IDD), Cancer Therapy and Research Center, 7979 Wurzbach Rd. San Antonio, Texas, United States, 78229 France Hematology Service, Hôpital Beaujon and Hôpital Avicenne Bobigny, Paris, France, 93009 Centre Hospitalier Universitaire, CHU de Lyon, Service d'Hematologie Clinique Lyon, France, 69437 Institut Paoli-Calmettes Marseille, France, 13273 Centre Hospitalier Universitaire CHU de Toulouse, Hopital Purpan Toulouse, France, 40031-31059 Germany University Hospital Benjamin Franklin Med.Clinic III Berlin, Germany, 12200 Department of Internal Medicine Klinikum der Johann Wolfgang Goethe-Universität Medizinische Klinik II Frankfurt am Main, Germany, 60590 Westfälische Wilhelms-Universität Münster Medizinische Klinik und Polikinik Innere Medizin A Münster, Germany, 48129 Italy Institute of Hematology & Medical Oncology L and A Serágnoli University of Bologna Bologna, Italy, 40138 Universitá degli Studi di Roma Ematologia- Policlinico Tor Vergata Rome, Italy, 00133 Norway Department of Hematology, Ullevål University Hospital, University of Oslo Oslo, Norway, 0407 United Kingdom Christie Hospital Manchester, United Kingdom, M20 4BX Less <<
NCT00600353 - Completed - -
NCT00498407 Advanced Colorectal Cancer ... More >> Colorectal Cancer Less << Phase 2 Completed - United Kingdom ... More >> Aberdeen Royal Infirmary, Foresterhill, Aberdeen, United Kingdom, AB25 2ZN The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN Medical Oncology Dept. of Cancer Studies and Molecular Medicine, Leicester Royal Infirmary Leicester, United Kingdom, LEI 5WW Macmillan Lead Clinician in Gastro-intestinal Cancer Mount Vernon Cancer Centre Northwood, United Kingdom, HA6 2RN Less <<
NCT00689845 Lymphoma Not Applicable Unknown - United Kingdom ... More >> Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Contact Person    44-113-206-6400       St. George's Hospital Recruiting London, England, United Kingdom, SW17 0QT Contact: Contact Person    44-208-725-2425    rpetteng@sghms.ac.uk    Christie Hospital Recruiting Manchester, England, United Kingdom, M20 4BX Contact: Contact Person    44-845-226-3000       Mount Vernon Cancer Centre at Mount Vernon Hospital Recruiting Northwood, England, United Kingdom, HA6 2RN Contact: Contact Person    44-1923-826-111       Cancer Research Centre at Weston Park Hospital Recruiting Sheffield, England, United Kingdom, S1O 2SJ Contact: Contact Person    44-114-226-5007    b.w.hancock@sheffield.ac.uk    Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person    44-238-079-6186    johnsonp@soton.ac.uk    Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Contact Person    44-208-661-3279    david.cunningham@rmh.nhs.uk    Saint Bartholomew's Hospital Recruiting London, United Kingdom Contact: Contact Person    44-207-796-3979    silvia.montoto@cancer.org.uk Less <<
NCT00831636 Ovarian Cancer Phase 1 Phase 2 Completed - Belgium ... More >> U.Z. Gasthuisberg, Gynecologic Oncology, Herestraat 49 Leuven, Belgium, B-3000 Italy Medical Oncology C, National Cancer Institute, Centro di Riferimento Oncologico Aviano (PN), Italy Medical Oncology B, National Cancer Institute, Via Mariano Semmola Naples, Italy, IT-80131 Department of Oncology, Catholic University of the Sacred Heart Rome, Italy, 00168 Medical Oncology, Fatebenefratelli Hospital, Isola Tiberina Rome, Italy Less <<
NCT01626664 Adult T-cell Leukemia-Lymphoma Phase 2 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Florida University of Miami / Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Memorial Sloan Kettering New York, New York, United States, 10021 Columbia Presbyterian New York, New York, United States, 10032 Weill Cornell Medical College New York, New York, United States, 10065 Belgium Cliniques Universitaires Saint-Luc Bruxelles, Belgium, 1200 Brazil Hospital Universitario Professor Edgard Santos- UFBA Salvador, Bahia, Brazil, 40110-060 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Sao Paulo- SP, Brazil, CEP 05403-000 France CHU de Fort de France Fort De France Cedex, France, BP 632 97261 Hospital Necker Paris, France, 75743 Peru Hospital Nacional Edgardo Rebagliati Martins Lima, Peru, Lima11 Instituto Oncologico Miraflores Lima, Peru, Lima18 United Kingdom Guy's Hospital London, United Kingdom, SE1 9RT Imperial College London, United Kingdom, W2 1PG Sandwell General Hospital West Midlands, United Kingdom, B71 4HJ Less <<
NCT01457040 Acute Lymphoblastic Leukemia ... More >> Stem Cell Transplantation, Hematopoietic Less << Phase 2 Phase 3 Completed - China, Guangdong ... More >> Department of Hematology, Nanfang Hospital Guangzhou, Guangdong, China, 510515 Less <<
NCT03624270 Acute Promyelocytic Leukemia Phase 2 Recruiting December 31, 2023 Hong Kong ... More >> Department of Medicine, the University of Hong Kong, Queen Mary Hospital Recruiting Hong Kong, N/A = Not Applicable, Hong Kong Contact: Harinder Singh Harry Gill    +852 22554542    gillhsh@hku.hk Less <<
NCT01783964 Not Applicable as This is a Ma... More >>ss Balance/Pharmacokinetic Study Performed in Healthy Subjects Less << Phase 1 Completed - United Kingdom ... More >> Quotient Clinical Ruddington, Nottngham, United Kingdom, NG11 6JS Less <<
NCT01626664 - Completed - -
NCT03187210 Lymphoma Phase 1 Phase 2 Recruiting June 2022 Switzerland ... More >> Department for Medical Oncology University Hospital/Inselspital Recruiting Berne, Switzerland, 3010 Principal Investigator: Thomas Pabst, Prof Dr med Less <<
NCT00002744 Leukemia Phase 3 Completed - -
NCT00613457 Leukemia Phase 3 Completed - -
NCT00004056 Leukemia Phase 1 Completed - -
NCT00314743 Nausea Vomiti... More >>ng Less << Early Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01511562 Lymphoma Phase 2 Active, not recruiting - -
NCT01219816 B ALL CD22+ E... More >>xpression Refractory B-ALL Less << Phase 2 Completed - France ... More >> Angers University Hospital Angers, France, 49933 University Hospital Caen, France, 14000 HEnri Mondor Hospital Creteil, France, 94010 Edouard Herriot Hospital Lyon, France, 69437 Institut Paoli Calmette Marseille, France, 13373 Nantes University Hospital Nantes, France, 44000 Saint Louis Hospital Paris, France, 75010 St Antoine Paris, France, 75015 Haut-Leveque Hospital Pessac, France, 33604 CHU de Poitiers Poitiers, France, 86021 Purpan Hospital Toulouse, France, 37509 Less <<
NCT02881086 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 3 Recruiting June 2025 Germany ... More >> University Hospital of Frankfurt (Main) Recruiting Frankfurt (Main), Germany, 60590 Less <<
NCT00187122 Lymphoblastic Lymphoma Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00000689 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 1 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 90033 Less <<
NCT01842672 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Lymphoblastic Lymphoma Diffuse Large B-cell Lymphoma Burkitt Lymphoma/Leukemia Less << Phase 1 Phase 2 Recruiting December 2018 United States, New York ... More >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell Cairo, MD    914-594-3650    mitchell_cairo@nymc.edu    Contact: Lauren Harrison, MSN    617-285-7844    lauren_harrison@nymc.edu    United States, North Carolina Levine Children's Hospital Recruiting Charlotte, North Carolina, United States, 28204 Contact: Javier Oesterheld, MD    704-381-9900    Javier.Oesterheld@carolinashealthcare.org Less <<
NCT03236857 Malignancies ... More >>Acute Lymphoblastic Leukemia (ALL) Acute Myeloid Leukemia (AML) Non-Hodgkin's Lymphoma Neuroblastoma Less << Phase 1 Recruiting April 7, 2022 -
NCT02374424 Diffuse, Large B-Cell, Lymphom... More >>a Less << Phase 2 Terminated(interim analysis pl... More >>anned as per protocol didn't provide positive outcome) Less << - Italy ... More >> Azienda Ospedaliera S. Gerardo Di Monza Monza, Monza Brianza, Italy, 20900 Onco-Ematologia I.R.C.C. Candiolo, TO, Italy Ospedale Mauriziano Torino, TO, Italy, 10128 Ospedale San Bortolo Vicenza, VI, Italy, 36100 Ospedale "C. e G. Mazzoni", UOC Ematologia Ascoli Piceno, Italy, 63100 Ospedale di Bolzano, Reparto di Ematologia & CTMO Bolzano, Italy, 39100 A.O. Universitaria Careggi Di Firenze Firenze, Italy, 50139 USL 6 Livorno Centro Aziendale Ematologia Livorno, Italy, 57124 SC Ematologia AO Riuniti Papardo Piemonte Messina, Italy Ospedale dell'Angelo, U.O. Ematologia Mestre, Italy, 30174 A.O. Universitaria Policlinico Di Modena Modena, Italy, 41124 AUO Padova-Ematologia e Immunologia Clinica Padova, Italy, 35121 A.O. Ospedali Riuniti Villa Sofia-Cervello, U.O. Ematologia I Palermo, Italy, 90146 Ematologia Policlinico San Matteo Pavia, Italy, 27100 AO di Perugia S. Maria della misericordia Perugia, Italy, 06132 A.O. Universitaria Pisana Pisa, Italy, 56126 Ematologia Ospedale S.Camillo Forlanini Roma, Italy, 00149 Ematologia e Trapianto Istituto Regina Elena IFO Roma, Italy Policlinico Universitario Campus biomedico Roma, Italy Less <<
NCT01235793 B-Cell Lymphoma Originating in... More >> the CNS Less << Phase 2 Terminated(The clinical trial ... More >>was terminated due to poor enrollment) Less << - United States, California ... More >> Cedars Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT00957320 Acute Lymphoblastic Leukemia Phase 1 Withdrawn(no patients enrolled... More >>, decided not to pursue study) Less << - United States, Georgia ... More >> Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Less <<
NCT00000703 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Los Angeles County - USC Med Ctr Los Angeles, California, United States, 90033 UCLA CARE Ctr Los Angeles, California, United States, 90095 San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States, 941102859 United States, District of Columbia George Washington Univ Med Ctr Washington, District of Columbia, United States, 20037 United States, Louisiana Charity Hosp / Tulane Univ Med School New Orleans, Louisiana, United States, 70112 Louisiana State Univ Med Ctr / Tulane Med School New Orleans, Louisiana, United States, 70112 Tulane Univ School of Medicine New Orleans, Louisiana, United States, 70112 United States, Massachusetts Univ of Massachusetts Med Ctr Worcester, Massachusetts, United States, 01655 United States, New York Bellevue Hosp / New York Univ Med Ctr New York, New York, United States, 10016 Saint Luke's - Roosevelt Hosp Ctr New York, New York, United States, 10025 Mount Sinai Med Ctr New York, New York, United States, 10029 Univ of Rochester Medical Center Rochester, New York, United States, 14642 United States, Pennsylvania Milton S Hershey Med Ctr Hershey, Pennsylvania, United States, 170330850 United States, South Carolina Julio Arroyo West Columbia, South Carolina, United States, 29169 Less <<
NCT02850822 - Recruiting June 2020 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-61641613    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT01235793 - Terminated(The clinical trial ... More >>was terminated due to poor enrollment) Less << - -
NCT00791947 Peripheral T-Cell Lymphoma Phase 2 Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Copenhagen Hospital Copenhagen, Denmark Vejle Hospital Vejle, Denmark Finland OULO University Hospital Oulu, Oulo, Finland Kuopio University Hospital Kuopio, Finland, 70211 Norway Oslo University Hospital Oslo, Norway, 0310 Ullevaal University Hospital Oslo, Norway, 0407 Rogaland Hospital Rogaland, Norway St.Olavs Hospital Trondheim, Norway, 7006 Less <<
NCT00672165 Leukemia Myel... More >>odysplastic Syndrome Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01180322 Acute Myeloid Leukemia (AML) Phase 2 Unknown October 2016 Austria ... More >> Universitätsklinikum Innsbruck Innsbruck, Austria, 6020 Krankenhaus der Barmherzigen Schwestern Linz, Austria, 4010 Elisabethinen Krankenhaus Linz Linz, Austria, 4020 Landeskliniken Salzburg Salzburg, Austria, 5020 Hanuschkrankenhaus Wien, Austria, 1140 Germany Universitätsklinikum Charité Berlin Berlin, Germany, 13353 Knappschaftskrankenhaus Bochum-Langendreer Bochum, Germany, 44892 Universitätsklinikum Bonn Bonn, Germany, 53111 Städtisches Klinikum Braunschweig Braunschweig, Germany, 38114 Klinikum Bremen-Mitte Bremen, Germany, 28177 Klinikum Darmstadt Darmstadt, Germany, 64283 Universitätsklinikum Düsseldorf Düsseldorf, Germany, 40225 Kliniken Essen Süd, Evangelischs Krankenhaus Essen, Germany, 45239 Klinikum Esslingen Esslingen, Germany, 73730 Klinikum Frankfurt-Höchst Frankfurt, Germany, 65929 Medizinisches Versorgungszentrum Fulda Fulda, Germany, 36043 Universitätsklinikum Gießen Gießen, Germany, 35392 Wilhelm-Anton-Hospital Goch Goch, Germany, 47574 Universitätsklinikum Göttingen Göttingen, Germany, 37075 Sklepios Klinik Hamburg-Altona Hamburg, Germany, 22763 Evangelisches Krankenhaus Hamm Hamm, Germany, 59063 Klinikum Hanau Hanau, Germany, 63450 KRH Klinikum Hannover-Siloah Hannover, Germany, 30449 Medizinische Hochschule Hannover Hannover, Germany, 30625 SLK-Kliniken Heilbronn Heilbronn, Germany, 74078 Städtisches Klinikum Karlsruhe Karlsruhe, Germany, 76133 Universitätsklinikum Schleswig-Holstein Kiel, Germany, 24116 Caritas-Krankenhaus Lebach Lebach, Germany, 66822 Klinikum Lippe Lemgo, Germany, 32657 Klinikum Lüdenscheid Lüdenscheid, Germany, 58515 Klinikum der Johannes-Guttenberg-Universität Mainz, Germany, 55131 Johannes Wesling Klinikum Minden Minden, Germany, 32429 Stauferklinikum Schwäbisch-Gmünd Mutlangen, Germany, 73557 Klinikum rechts der Isar München, Germany, 81675 Klinikum Passau Passau, Germany, 94032 Krankenhaus der Barmherzigen Brüder Regensburg, Germany, 93049 Caritas-Klinik St. Theresia Saarbrücken, Germany, 66113 Klinikum Stuttgart Stuttgart, Germany, 70174 Diakonie-Klinikum Stuttgart Stuttgart, Germany, 70176 Krankenhaus der Barmherzigen Brüder Trier, Germany, 54292 Universitätsklinikum Tübingen Tübingen, Germany, 72076 Universitätsklinikum Ulm Ulm, Germany, 89081 Schwarzwald-Baar-Klinikum Villingen-Schwenningen, Germany, 78050 Helios Klinikum Wuppertal, Germany, 42283 Less <<
NCT00586755 Mantle Cell Lymphoma Phase 2 Completed - -
NCT01130194 Follicular Lymphoma Phase 2 Completed - United States, Missouri ... More >> Saint Louis University Cancer Center Saint Louis, Missouri, United States, 63110 Less <<
NCT02371161 Non Hodgkin Lymphoma Phase 2 Recruiting February 2023 Italy ... More >> A.O. SS.Antonio e Biagio e C. Arrigo Recruiting Alessandria, AL, Italy, 15121 Contact: Flavia Salvi, MD    0131-206066    fsalvi@ospedale.al.it    Principal Investigator: Flavia Salvi, MD          Ospedali Riuniti Recruiting Ancona, AN, Italy, 60126 Contact: Attilio Olivieri, MD    071-5964226    a.olivieri@univpm.it    Principal Investigator: Attilio Olivieri, MD          Ospedale Perrino Active, not recruiting Brindisi, BR, Italy, 72100 Spedali Civili Recruiting Brescia, BS, Italy, 25123 Contact: Alessandra Tucci, MD    030-3995438    alessandra.tucci@spedalicivili.brescia.it    Principal Investigator: Alessandra Tucci, MD          Policlinico Vittorio Emanuele Active, not recruiting Catania, CT, Italy, 95123 Casa Sollievo della Sofferenza Active, not recruiting San Giovanni Rotondo, FG, Italy, 71013 IRST Meldola Recruiting Meldola, Forlì-Cesena, Italy, 47014 Contact: Gerardo Musuraca    0543-739291    g.musuraca@irst.emr.it    Principal Investigator: Gerardo Musuraca, MD          IRCCS San Martino - IST Active, not recruiting Genova, GE, Italy, 16132 ASUR Marche, Area Vasta 3 Active, not recruiting Civitanova Marche, MC, Italy, 62012 AO Riuniti Papardo Piemonte Recruiting Messina, ME, Italy, 98158 Contact: Donato Mannina, MD    090-3992239    donamanni@gmail.com    Principal Investigator: Donato Mannina, MD          IRCCS Humanitas Recruiting Rozzano, Milano, Italy, 20089 Contact: Luca Castagna, MD    02-82244580    luca.castagna@humanitas.it    Principal Investigator: Luca Castagna, MD          AO Niguarda Ca' Granda Recruiting Milano, MI, Italy, 20162 Contact: Chiara Rusconi, MD    02-64442668    chiara.rusconi@ospedaleniguarda.it    Principal Investigator: Chiara Rusconi, MD          Ospedale Civile "Guglielmo da Saliceto" Recruiting Piacenza, PC, Italy, 29100 Contact: Daniele Vallisa, MD    0523-303719    d.vallisa@ausl.pc.it    Principal Investigator: Danilele Vallisa, MD          Centro di Riferimento Oncologico Recruiting Aviano, PN, Italy, 33081 Contact: Mariagrazia Michieli, MD    0434-659601    mmichieli@cro.it    Principal Investigator: Mariagrazia Michieli, MD          Azienda Ospaliero Universitaria di Parma Recruiting Parma, PR, Italy, 43126 Contact: Francesca Re, MD    0521-033306    fre@ao.pr.it    Principal Investigator: Francesca Re, Prof.          Ospedale San Carlo Active, not recruiting Potenza, PZ, Italy, 85100 AUSL di Ravenna Recruiting Ravenna, RA, Italy, 48100 Contact: Monica Tani, MD    0544-286223    monica.tani@ausl.ra.it    Principal Investigator: Monica Tani, MD          A.O. Bianchi - Melacrino - Morelli Active, not recruiting Reggio Calabria, RC, Italy, 89125 Asmn-Irccs Recruiting Reggio Emilia, RE, Italy, 43123 Contact: Francesco Merli, MD    0522-296618    merli.francesco@asmn.re.it    Principal Investigator: Francesco Merli, MD          Policlinico Sant'Andrea Recruiting Roma, RM, Italy, 00189 Contact: Maria Christina Cox, MD    338-2268017    chrisscox@gmail.com    Principal Investigator: Maria Christina Cox, MD          Ospedale Nocera- Pagani Active, not recruiting Nocera Inferiore, SA, Italy, 84014 AOU San Giovanni e Ruggi Active, not recruiting Salerno, SA, Italy, 84131 AOU Città della Salute e della Scienza Recruiting Torino, TO, Italy, 10126 Contact: Federica Cavallo, MD    011-6334301    f.cavallo@unito.it    Principal Investigator: Federica Cavallo, MD          Ospedale Mauriziano Active, not recruiting Torino, TO, Italy, 10128 AO Santa Maria Active, not recruiting Terni, TR, Italy, 05100 Ospedale S.Andrea Active, not recruiting Vercelli, VC, Italy, 13100 Ospedale degli Infermi Recruiting Rimini, Italy, 47923 Contact: Anna Lia Molinari    0541-705423    annalia.molinari@auslromagna.it    Principal Investigator: Anna Lia Molinari, MD Less <<
NCT00281879 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Unusual Cancers of Childhood Less << Phase 2 Terminated - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00281879 - Terminated - -
NCT01920737 Leukemia Phase 2 Recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Jae Park, MD    212-639-4048       Contact: Martin Tallman, MD          Principal Investigator: Jae Park, MD          Weill Cornell Medical Center Recruiting New York, New York, United States Contact: Ellen Ritchie, MD          Principal Investigator: Ellen Ritchie, MD          United States, North Carolina Duke University Medical Center Active, not recruiting Durham, North Carolina, United States, 27701 United States, Pennsylvania Lehigh Valley Health Network Recruiting Allentown, Pennsylvania, United States, 18103 Contact: Brian Patson, MD    610-402-7880 Less <<
NCT01184885 Lymphoid Malignancies (New or ... More >>Relapsed) Acute Lymphoblastic Leukemia Burkitt Lymphoma Lymphoblastic Lymphoma Mantle Cell Lymphoma Adult T-cell Leukemia/Lymphoma Less << Early Phase 1 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT03643276 Acute Lymphoblastic Leukemia, ... More >>Pediatric Less << Phase 3 Recruiting July 14, 2028 -
NCT03560908 Relapsed AML ... More >>T(8;21) C-KIT Mutation Less << Phase 1 Recruiting December 31, 2020 China, Tianjin ... More >> HBDH Recruiting Tianjin, Tianjin, China, 300020 Contact: Hui Wei Less <<
NCT02396043 Lymphoma, Lymphoblastic Phase 2 Recruiting March 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510060 Contact: Zhongjun Xia, MD.    0086-02087342438    zhongjunxia_64@sina.com Less <<
NCT03150004 Acute Myeloid Leukemia Phase 2 Recruiting June 1, 2020 United States, Wisconsin ... More >> Froedtert & the Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Medical College of Wisconsin Clinical Cancer Center    414-805-8900    cccto@mcw.edu Less <<
NCT00052299 Leukemia Phase 3 Completed - -
NCT01606579 Acute Myeloid Leukemia ... More >> Chronic Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Georgia ... More >> Emory University / Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Massachusetts University of Massachusetts Medical Center Worcester, Massachusetts, United States, 01655 United States, New Mexico New Mexico Cancer Care Alliance Albuquerque, New Mexico, United States, 87106 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210-1267 United States, Texas University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00275015 Chronic Lymphocytic Leukemia Phase 2 Completed - -
NCT00006122 Leukemia Phase 2 Completed - Austria ... More >> Innsbruck Universitaetsklinik Innsbruck, Austria, A-6020 Belgium A.Z. St. Jan Brugge, Belgium, 8000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 CHU Sart-Tilman Liege, Belgium, B-4000 Croatia University Hospital Rebro Zagreb, Croatia, 41000 France Hopital Edouard Herriot Lyon, France, 69437 Hotel Dieu de Paris Paris, France, 75181 Hopital Necker Paris, France, 75743 Germany Medizinische Klinik und Poliklinik Heidelberg, Germany, D-69115 Eberhard Karls Universitaet Tuebingen, Germany, D-72076 Italy Ospedale Generale Regionale Bolzano, Italy, 39100 Ospedali Riuniti Reggio Calabria, Italy, 89100 Ospedale San Eugenio Rome, Italy, 00144 Azienda Policlinico Umberto Primo Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 Netherlands Groot Ziekengasthuis 's-Hertogenbosch 's-Hertogenbosch, Netherlands, 5211 NL Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Less <<
NCT01184885 - Completed - -
NCT02055924 B-cell Lymphoma Phase 1 Terminated(ANSM decision due t... More >>o veino occlusive disease (security alert)) Less << - Belgium ... More >> Universite Catholique de Louvain Saint Luc Bruxelles, Belgium CHU de Liège Liège, Belgium, 04000 CHU UCL Namur asbl Yvoir, Belgium, 5530 France Centre François Baclesse Caen, France, 14076 Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon - Hôpital le Bocage Dijon, France, 21034 CHRU de Lille - Hôpital Claude Huriez Lille, France, 59037 Centre Léon Bérard Lyon, France, 69373 CHU Montpellier Montpellier, France, 34295 CHU de Nantes Nantes, France, 44093 Hôpital Saint Louis Paris, France, 75475 Centre François Magendie - Hôpital du Haut Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Bénite, France, 69495 CHU Pontchaillou Rennes, France, 35003 Centre Henri Becquerel Rouen, France, 76038 Less <<
NCT03068819 Acute Myeloid Leukemia in Chil... More >>dren Less << Phase 1 Recruiting November 30, 2024 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Amanda Cashen, M.D.    314-454-8323    acashen@wustl.edu    Principal Investigator: Amanda Cashen, M.D.          Sub-Investigator: Jeffrey Bednarski, M.D., Ph.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: Shalini Shenoy, M.D.          Sub-Investigator: Robert Hayashi, M.D.          Sub-Investigator: Andrew Cluster, M.D.          Sub-Investigator: John DiPersio, M.D., Ph.D.          Sub-Investigator: Peter Westervelt, M.D., Ph.D.          Sub-Investigator: Geoffrey Uy, M.D.          Sub-Investigator: Ravi Vij, M.D.          Sub-Investigator: Camille Abboud, M.D.          Sub-Investigator: Rizwan Romee, M.D.          Sub-Investigator: Meagan Jacoby, M.D., Ph.D.          Sub-Investigator: Iskra Pusic, M.D.          Sub-Investigator: Armin Ghobadi, M.D.          Sub-Investigator: Mark Schroeder, M.D.          Sub-Investigator: Keith Stockerl-Goldstein, M.D. Less <<
NCT02013167 - Terminated - -
NCT01830361 Acute Myeloid Leukemia Phase 2 Active, not recruiting September 2020 Germany ... More >> Klinikum Chemnitz gGmbH, Klinik für Innere Medizin III Chemnitz, Germany Universitätsklinikum Dresden Medizinische Klinik und Poliklinik I Dresden, Germany Marien Hospital Düsseldorf, Germany Universitätsklinikum Erlangen, Medizinische Klinik 5 Erlangen, Germany Klinikum der Johann-Wolfgang-Goethe Universität Frankfurt Main, Germany Universitätsklinikum Heidelberg Heidelberg, Germany Universitätsklinikum Jena, Klinik für Innere Medizin II Jena, Germany Universitätsklinikum Gießen und Marburg GmbH Marburg, Germany Universitätsklinikum Münster Münster, Germany Städtisches Klinikum Nord Nürnberg, Germany Klinikum der Universität Regensburg Regensburg, Germany Less <<
NCT02643589 Hematopoietic Stem Cell Transp... More >>lantation Less << Not Applicable Unknown December 2016 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Ren Lin    +86-020-62787883    lansinglinren@hotmail.com Less <<
NCT02013167 Relapsed/Refractory B-precurso... More >>r Acute Lymphoblastic Leukemia Less << Phase 3 Terminated - -
NCT03582254 Primary Central Nervous System... More >> Lymphoma Less << Not Applicable Recruiting May 12, 2020 France ... More >> Pitié Salpêtrière Hospital Recruiting Paris, France, 75013 Contact: Aurélie KAS, Dr Less <<
NCT02172872 Acute Myeloid Leukemia (AML) Phase 3 Recruiting December 2019 -
NCT01690507 MDS AML Phase 1 Phase 2 Completed - China, Beijing ... More >> Navy General Hospital Beijing, Beijing, China, 100048 China Chinese PLA General Hospital Beijing, China, 100853 Less <<
NCT01186328 Lymphoblastic Leukemia, Acute ... More >> Lymphoblastic Leukemia, Acute, Childhood Leukemia, Lymphoblastic, Acute, T Cell Leukemia, Lymphoblastic, Acute Less << Phase 1 Terminated(The company (Enzon ... More >>Pharmaceuticals)providing the drug EZN-3042 decided to end its development of EZN-3042.) Less << - -
NCT03376958 Relapsed /Refractory Diffuse L... More >>arge B Cell Lymphoma Less << Phase 4 Recruiting February 1, 2019 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com Less <<
NCT01883180 Hematopoietic Stem Cell Transp... More >>lantation Antithymocyte Globulin Viral Infection Less << Phase 4 Completed - China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510515 Less <<
NCT00408005 T Acute Lymphoblastic Leukemia... More >> T Lymphoblastic Lymphoma Less << Phase 3 Completed - -
NCT01665014 Multiple Myeloma Phase 2 Unknown August 2016 Poland ... More >> Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch Not yet recruiting Gliwice, Poland, 44-101 Contact: Sebastian Giebel, MD    0048322788523    sgiebel@io.gliwice.pl    Principal Investigator: Sebastian Giebel, MD Less <<
NCT02682732 Leukemia, Myeloid, Acute Not Applicable Recruiting December 2020 Canada, Ontario ... More >> Juravinski Hospital and Cancer Center Recruiting Hamilton, Ontario, Canada Contact: Mohammed Almakadi, MBBS       almakams@mcmaster.ca    Principal Investigator: Mohammed Almakadi, MBBS Less <<
NCT00002547 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00744081 AML Phase 2 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany Less <<
NCT02067143 Untreated Philadelphia Positiv... More >>e Acute Lymphoblastic Leukemia De Novo Secondary Low-dose Corticosteroids Pretreatment Less << Phase 2 Active, not recruiting October 2018 -
NCT01014208 - Completed - -
NCT01865110 Mantle Cell Lymphoma Phase 3 Recruiting March 2024 -
NCT01014208 Lymphoma, Large-Cell, Diffuse Phase 3 Completed - -
NCT00853008 Acute Lymphoblastic Leukemia Phase 4 Active, not recruiting January 2019 Spain ... More >> Hospital General Alicante, Spain Hospital Germans Trias i Pujol Badalona, Spain Clínica Teknon Barcelona, Spain Hospital Clínic i Provincial Barcelona, Spain Hospital de Sant Pau Barcelona, Spain Hospital Duran y Reynals Barcelona, Spain Hospital Vall d'Hebrón Barcelona, Spain Hospital General Castellón, Spain Hospital San Pedro de Alcántara Cáceres, Spain Hospital Puerta del Mar Cádiz, Spain Hospital Josep Trueta Girona, Spain Hospital Universitario Guadalajara, Spain Hospital Juan Canalejo La Coruña, Spain Hospital Xeral Lugo, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico Universitario Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Carlos Haya Málaga, Spain Hospital Virgen de la Victoria Málaga, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Llàtzer Palma de Mallorca, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital Clínico Universitario Salamanca, Spain Hospital Marqués de Valdecilla Santander, Spain Hospital Xeral Santiago, Spain Hospital Virgen del Rocio Sevilla, Spain Hospital Joan XXIII Tarragona, Spain Hospital Mútua de Terrassa Terrassa, Spain Hospital Clínico Universitario Valencia, Spain Hospital Dr Pesset Valencia, Spain Hospital General Valencia, Spain Hospital La Fe Valencia, Spain Hospital Clínico Valladolid, Spain Hospital Virgen de la Concha Zamora, Spain Hospital Lozano Blesa Zaragoza, Spain Less <<
NCT00000801 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 2 Completed - United States, California ... More >> San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States, 941102859 San Francisco Gen Hosp San Francisco, California, United States, 941102859 United States, Colorado Univ of Colorado Health Sciences Ctr Denver, Colorado, United States, 80262 United States, Massachusetts Beth Israel Deaconess - West Campus Boston, Massachusetts, United States, 02215 ECOG Data Management Office Brookline, Massachusetts, United States, 02146 United States, New York Mount Sinai Med Ctr New York, New York, United States, 10029 United States, South Carolina Julio Arroyo West Columbia, South Carolina, United States, 29169 Less <<
NCT02354313 MANTLE CELL LYMPHOMA Phase 3 Active, not recruiting January 2019 -
NCT03564470 Leukemia Leuk... More >>emia, Acute Leukemia, Lymphoblastic Leukemia, B-cell Less << Phase 2 Phase 3 Recruiting August 30, 2020 China, Guangdong ... More >> Department of Hematology, Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou, PhD, MD    86-20-62787349    zhs1@i.smu.edu.cn Less <<
NCT00002471 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, New York Kaplan Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00002532 Leukemia Phase 2 Unknown - Germany ... More >> Medizinische Hochschule Hannover Hannover, Germany, D-30625 Less <<
NCT00003578 Lymphoma Phase 3 Unknown - -
NCT00002658 Leukemia Neut... More >>ropenia Less << Phase 3 Unknown - United Kingdom ... More >> University of Wales College of Medicine Cardiff, Wales, United Kingdom, CF14 4XN Less <<
NCT00550992 Leukemia Not Applicable Unknown - United States, Massachusetts ... More >> Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis B. Silverman, MD    617-632-5285       United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Clinical Trials Office - St. Jude Children's Research Hospital    901-595-4644       United States, Texas M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U    713-792-3245       United States, Washington Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle, Washington, United States, 98105 Contact: Blythe Thomson, MD    206-987-2106       Austria St. Anna Children's Hospital Recruiting Vienna, Austria, A-1090 Contact: Georg Mann, MD    43-1-4017-1250       Belgium Hopital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Alice Ferster, MD    32-2-477-2678    aferster@ulb.ac.be    Czech Republic University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD    420-2-2443-6401    jan.stary@lfmotol.cuni.cz    France CHR Hotel Dieu Recruiting Nantes, France, 44093 Contact: Francoise Mechinaud, MD    33-1-4249-9046       Germany University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub    49-404-2803-2580       Medizinische Hochschule Hannover Recruiting Hannover, Germany, D-30625 Contact: Martin Schrappe, MD, PhD    49-511-532-6713       Italy Nuovo Ospedale San Gerardo at University of Milano-Bicocca Recruiting Monza, Italy, 20052 Contact: Andrea Biondi, MD    39-039-233-3661    biondi@galactica.it    Netherlands Erasmus MC - Sophia Children's Hospital Recruiting Rotterdam, Netherlands, 3015 GJ Contact: Rob Pieters, MD, MSC, PhD    31-10-463-6691    rob.pieters@erasmusmc.nl    United Kingdom Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Phil Ancliff, MD    44-20-7829-8831 Less <<
NCT00002534 Leukemia Phase 3 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00040690 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT00002531 Leukemia Phase 2 Unknown - Germany ... More >> Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Less <<
NCT00002665 Leukemia Neut... More >>ropenia Thrombocytopenia Less << Phase 2 Completed - -
NCT00002701 Leukemia Phase 3 Unknown - -
NCT00920153 Lymphoma Phase 3 Terminated(Other new drugs) - France ... More >> FILO French Innovative Leukemia Organization Tours Cedex, France, 37044 Less <<
NCT00003388 Lymphoma Phase 2 Completed - United States, California ... More >> Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States, 94304 Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, New Jersey Raritan Bay Medical Center Perth Amboy, New Jersey, United States, 08861 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 MBCCOP-Our Lady of Mercy Cancer Center Bronx, New York, United States, 10466 Less <<
NCT00137111 Lymphoblastic Leukemia, Acute Phase 3 Active, not recruiting November 2020 United States, Tennessee ... More >> St Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 Less <<
NCT00002549 Leukemia Phase 3 Unknown - -
NCT00006455 Lymphoma Phase 3 Unknown - Austria ... More >> St. Anna Children's Hospital Vienna, Austria, A-1090 Belgium U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Gustave Roussy Villejuif, France, F-94805 Germany Kinderklinik Giessen, Germany, D-35385 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Netherlands Dutch Childhood Leukemia Study Group Den Haag, Netherlands, 2504 AM Spain Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Sweden Karolinska University Hospital - Huddinge Stockholm, Sweden, S-171 76 Switzerland University Children's Hospital Zurich, Switzerland, CH-8032 United Kingdom Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Less <<
NCT00137111 - Active, not recruiting - -
NCT00018954 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Egypt National Cancer Institute of Egypt Cairo, Egypt India Kidwai Memorial Institute of Oncology Bangalore, India, 560029 Cancer Institute (W.I.A.) Madras, India, 600020 Tata Memorial Centre Mumbai, India, 400012 Less <<
NCT00275106 Lymphoma Phase 3 Terminated(Withdrawn due to an... More >> excess of toxic deaths) Less << - Germany ... More >> Kinderklinik Giessen, Germany, D-35385 Ireland Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00494897 Acute Lymphoblastic Leukemia Phase 4 Completed - -
NCT02523976 Acute,Leukemia, Lymphoid Phase 2 Enrolling by invitation August 2019 China, Tianjin ... More >> Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin, China, 300020 Less <<
NCT02894645 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 4 Unknown - Malaysia ... More >> University of Malaya Medical Centre Recruiting Kuala Lumpur, Malaysia, 59100 Contact: Hany Arrifin, MBBS    +603 7949 6785    hany@ummc.edu.my    Subang Jaya Medical Centre Recruiting Subang Jaya, Malaysia, 47500 Contact: Hai Peng Lin, MBBS       flslhp@gmail.com    Contact: Lee Lee Chan, MBBS       drchanleelee@gmail.com    Singapore National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Allen Yeoh, MBBS    (+65) 6772 4406    allen_yeoh@nuhs.edu.sg    KK Women's and Children's Hospital Recruiting Singapore, Singapore, 229899 Contact: Ah Moy Tan, MBBS    (+65) 63941039    tan.ah.moy01@singhealth.com.sg Less <<
NCT00003436 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - United Kingdom ... More >> Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT00400946 Drug/Agent Toxicity by Tissue/... More >>Organ Leukemia Less << Phase 3 Active, not recruiting June 2019 United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Rhode Island Hasbro Children's Hospital Providence, Rhode Island, United States, 02903 United States, Virginia INOVA Fairfax Hospital Fairfax, Virginia, United States, 22031 Canada, Ontario McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Hopital Sainte Justine Montreal, Quebec, Canada, H3T 1C5 Centre de Recherche du Centre Hospitalier de l'Universite Laval Sainte Foy, Quebec, Canada, GIV 4G2 Puerto Rico San Jorge Children's Hospital Santurce, Puerto Rico, 00912 Less <<
NCT00430118 Leukemia Phase 3 Completed - -
NCT00476190 Acute Lymphoblastic Leukemia Phase 2 Active, not recruiting December 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Children's Hospital of Boston Boston, Massachusetts, United States, 02115 Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Utah LDS Hospital Salt Lake City, Utah, United States, 84143 Canada, British Columbia Vancouver Cancer Center Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada Canada, Nova Scotia QEII, Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Quebec Hopital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 Hopital Maisonneuve Rosemont Montreal, Quebec, Canada, H1T 2M4 Hopital Notre-Dame Montreal, Quebec, Canada McGill University Department of Oncology Montreal, Quebec, Canada Less <<
NCT00002499 Leukemia Phase 2 Phase 3 Unknown - Argentina ... More >> Grupo Argentino de Tratamiento de la Leucemia Aguda Buenos Aires, Argentina, 1425 Less <<
NCT00720109 - Completed - -
NCT00974792 Lymphoma Phase 2 Unknown - United Kingdom ... More >> Nottingham City Hospital Recruiting Nottingham, England, United Kingdom, NG5 1PB Contact: A. McMillan    44-115-969-1169 Less <<
NCT00002494 Leukemia Lymp... More >>homa Less << Phase 2 Completed - -
NCT01085617 Leukemia Muco... More >>sitis Oral Complications Less << Phase 3 Recruiting July 2023 United Kingdom ... More >> UCL Cancer Institute Recruiting London, England, United Kingdom, WC1E 6DD Contact: Contact Person    44-207-830-2833 Less <<
NCT00513188 Lymphoma Not Applicable Withdrawn - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00002757 Leukemia Lymp... More >>homa Less << Phase 3 Completed - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 United Kingdom Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Less <<
NCT02723994 Leukemia Phase 2 Recruiting May 2024 -
NCT00764907 Leukemia Phase 3 Unknown - Czech Republic ... More >> University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD    420-2-2443-6401    jan.stary@lfmotol.cuni.cz Less <<
NCT00669812 Lymphoma Smal... More >>l Intestine Cancer Less << Phase 2 Unknown - United Kingdom ... More >> Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Anne Lennard    44-191-282-4743    a.l.lennard@ncl.ac.uk Less <<
NCT01117441 Leukemia Phase 3 Active, not recruiting December 2021 -
NCT00049569 L1 Childhood Acute Lymphoblast... More >>ic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Non-T, Non-B Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00558519 Leukemia Phase 2 Active, not recruiting - -
NCT00400946 - Active, not recruiting - -
NCT00002517 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHR de Grenoble - La Tronche Grenoble, France, 38043 Centre Hospitalier Regional de Lille Lille, France, 59037 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34295 CHR Hotel Dieu Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hopital Robert Debre Paris, France, 75019 Institut Curie - Section Medicale Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants (Purpan Enfants) Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Less <<
NCT00005823 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2RR University College Hospital London, England, United Kingdom, WC1E 6AU University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XN Less <<
NCT01005758 Leukemia Phase 2 Unknown - -
NCT03571321 Acute Lymphoblastic Leukemia ... More >> ALL, Childhood ALL Less << Phase 1 Not yet recruiting September 5, 2024 United States, Illinois ... More >> University of Chicago Medical Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Howie Weiner    773-702-2084    hweiner@medicine.bsd.uchicago.edu    Contact: Peggy Green, RN    (773) 702-0267    mgreen@medicine.bsd.uchicago.edu    Principal Investigator: Emily Currant, MD Less <<
NCT00343369 Leukemia Not Applicable Unknown - Germany ... More >> Evangelisches Krankenhauus Bielfeld Recruiting Biefeld, Germany, 33617 Contact: N. Jorch, MD    49-52-177-278-050       Klinikum Bremen-Mitte Recruiting Bremen, Germany, D-28205 Contact: Arnulf Pekrun, MD, PhD    49-421-497-3656    arnulf.pekrun@klinikum-bremen-mitte.de    Universitaetsklinikum Duesseldorf Recruiting Duesseldorf, Germany, D-40225 Contact: Contact Person    49-211-311-7990       Universitats - Kinderklinik Recruiting Greiswald, Germany, 17487 Contact: James F. Beck, MD    49-383-486-6325    beck@uni-greifswald.de    University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub    49-404-2803-2580       Kreskrankenhaus Kinderabteilung Recruiting Heide, Germany, 25746 Contact: Streitberger    49-481-785-911       Clinic for Bone Marrow Transplantation and Hematology and Oncology Recruiting Idar-Oberstein, Germany, D-55743 Contact: Wenzel Nuernberger, MD, PhD    49-6781-66-1582    wnuernberger@bmt-center-io.com    Klinikum Krefeld GmbH Recruiting Krefeld, Germany, D-47805 Contact: P. Thomas    49-2151-322-375       Universitaets - Kinderklinik Recruiting Leipzig, Germany, D-04317 Contact: Dieter Koerholz, MD    49-341-9726-246    koerd@medizin.uni-leipzig.de    Johannes Gutenberg University Recruiting Mainz, Germany, D-55101 Contact: P. Gutjahr, MD    49-6131-17-2112       Krankenhaus Neuwerk Klinik fuer Kinder und Jugendmedizin Recruiting Moenchengladbach, Germany, D-41066 Contact: Wolfgang Mueller, MD    49-2161-668-2481       Dr. von Haunersches Kinderspital der Universitaet Muenchen Recruiting Munich, Germany, D-80337 Contact: Arndt Borkhardt    49-89-5160-4498       Staedtisches Krankenhaus Muenchen - Harlaching Recruiting Munich, Germany, D-81545 Contact: Papucek    49-89-6210-2710       Klinik St. Hedwig-Kinderklinik Recruiting Regensburg, Germany, 93049 Contact: Ove Peters    49-941-369-5404       Dr. Horst-Schmidt-Kliniken Recruiting Wiesbaden, Germany, D-65199 Contact: Gerhard Beron, MD    49-611-43-2564       Helios Kliniken Wuppertal University Hospital Recruiting Wuppertal, Germany, D-42283 Contact: B. Dohrn, MD    49-202-896-3823    bdohrn@wuppertal.helios-klinikum.de Less <<
NCT00005589 Lymphoma Phase 3 Completed - -
NCT00618501 Leukemia Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00004903 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Unknown - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 Less <<
NCT03206671 Mature B-cell Non-Hodgkin Lymp... More >>homa Less << Phase 3 Recruiting August 2024 -
NCT00004905 Leukemia Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT03150693 B Acute Lymphoblastic Leukemia Phase 3 Recruiting August 2024 -
NCT00002982 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00005998 Lymphoma Phase 2 Withdrawn(Withdrawn because st... More >>udy never enrolled patients) Less << - -
NCT00004878 Graft Versus Host Disease ... More >> Leukemia Less << Phase 2 Withdrawn(study never opened) - -
NCT00002719 Leukemia Neut... More >>ropenia Less << Phase 3 Completed - Italy ... More >> Azienda Policlinico Umberto Primo Rome, Italy, 00161 Less <<
NCT00222612 Acute Lymphoblastic Leukemia Phase 4 Unknown August 2013 United Kingdom ... More >> Sheffield Children's Hospital Recruiting Sheffield, United Kingdom, S10 2TH Contact: Ajay Vora       ajay.vora@sch.nhs.uk Less <<
NCT00002771 Leukemia Phase 3 Unknown - Germany ... More >> III Medizinische Klinik Mannheim Mannheim, Germany, D-68135 Less <<
NCT00572013 Lymphoma Phase 1 Phase 2 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center, Section of Oncology/Hematology Omaha, Nebraska, United States, 68198 Less <<
NCT02431403 Lymphoma, Non-Hodgkin Phase 1 Phase 2 Recruiting - Korea, Republic of ... More >> Dong-A University Hospital Recruiting Busan, Korea, Republic of Contact: Ji Sook Park       dongahicrc5@naver.com    Inje University Busan Paik Hospital Recruiting Busan, Korea, Republic of Contact: Jin Hwa Kong    +82-51-890-6987    velika-jh@nate.com    Kosin University Gospel Hospital Recruiting Busan, Korea, Republic of Contact: Saet Byeol Park       siou7777@naver.com    Pusan National University Hospital Recruiting Busan, Korea, Republic of Contact: Younghee Kim    +82-51-240-7899    shinyspring@naver.com    Ulsan University Hospital Recruiting Ulsan, Korea, Republic of Contact: Mi Sun Jeon       uuh3103@naver.com Less <<
NCT00005803 Prolymphocytic Leukemia ... More >> Recurrent Adult Hodgkin Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Refractory Small Lymphocytic Lymphoma T-Cell Chronic Lymphocytic Leukemia T-Cell Prolymphocytic Leukemia Less << Phase 1 Phase 2 Active, not recruiting September 1, 2018 United States, Utah ... More >> Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Less <<
NCT00005803 - Active, not recruiting - -
NCT00521014 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00004192 Lymphoma Neut... More >>ropenia Less << Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00439556 CD20 Positive ... More >> Hematopoietic and Lymphoid Cell Neoplasm Lymphocytic Neoplasm Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00006695 Lymphoma Phase 2 Completed - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT00696735 Follicular Lymphoma Phase 3 Completed - France ... More >> Emmanuel GYAN Tours, France, 37000 Philippe COLOMBAT Tours, France, 37000 Less <<
NCT01156883 Leukemia Not Applicable Completed - Italy ... More >> Complesso Ospedaliero S. Giovanni Addolorata Roma, (rm), Italy, 00184 Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy USL 8 - Ospedale S.Donato Arezzo, Italy Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli, Italy Az.Ospedaliera S.G.Moscati Avellino, Italy UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari Bari, Italy Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Divisione di Ematologia Ospedale A. Perrino Brindisi, Italy Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia Catanzaro, Italy Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna Ferrara, Italy Divisione Ematologia 1 - Azienda Ospedaliera Universitaria "San Martino" Genova, Italy ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Lecce, Italy Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy Ospedale Niguarda " Ca Granda" Milano, Italy Centro Oncologico Modenese - Dipartimento di Oncoematologia Modena, Italy Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" Napoli, Italy UOSC di Ematologia Oncologica - Istituto Nazionale Tumori "Fondazione Senatore Giovanni Pascale" Napoli, Italy zienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Inferiore U.O. Medicina Interna Ematologia ed Oncologia P.O. Umberto I Nocera Inferiore, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Divisione di Ematologia con trapianto di midollo - A.U. Policlinico "Paolo Giaccone" Palermo, Italy Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy Cattedra di Ematologia CTMO Università degli Studi di Parma Parma, Italy S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo Pavia, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Università di Pisa - Azienda Ospedaliera Pisana - Dipartimento di Oncologia, dei Trapianti e delle nuove Tecnologie in Medicina - Divisione di Ematologia Pisa, Italy Dipartimento Oncologico - Ospedale S.Maria delle Croci Ravenna, Italy Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova Reggio Emilia, Italy Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia Roma, Italy Divisione di Ematologia - Ospedale S. Camillo Divisione di Ematologia - Ospedale S. Camillo Roma, Italy Divisione Ematologia - Università Campus Bio-Medico Roma, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy U.O.C. Ematologia - Ospedale S.Eugenio Roma, Italy Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy Universita Degli Studi "La Sapeinza" Rome, Italy, 00161 Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza S. G. Rotondo, Italy Serv. di Ematologia Ist. di Ematologia ed Endocrinologia Sassari, Italy Struttura Complessa Ematologia - Azienda Sanitaria Locale BAT1- Presidio Ospedaliero Bisceglie-Trani Trani, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Verona, Italy Less <<
NCT01770444 Chest Pain Not Applicable Completed - Korea, Republic of ... More >> Seoul national university Bundang hospital Seongnam-si, Korea, Republic of, 463-707 Asan Medical Center Seoul, Korea, Republic of, 138-736 Seoul national university Boramae medical center Seoul, Korea, Republic of, 156-707 Less <<
NCT00003957 Lymphoma Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00005863 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - United Kingdom ... More >> Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS Less <<
NCT00720447 Lymphoma Phase 2 Unknown - -
NCT03736382 Obstructive Sleep Apnea Not Applicable Recruiting October 2020 United States, Michigan ... More >> John D Dingell VA Medical Center Recruiting Detroit, Michigan, United States, 48201 Contact: Jason H Mateika, Ph.D.    313-576-4481    am1819@wayne.edu    Contact: Raichel M Alex, Ph.D.    313-576-4454    gm9041@wayne.edu    Principal Investigator: Jason H Mateika, Ph.D.          Wayne State University Recruiting Detroit, Michigan, United States, 48201 Contact: Jason H Mateika, Ph.D.    313-576-4481    am1819@wayne.edu    Contact: Raichel M Alex, Ph.D.    313-576-4454    gm9041@wayne.edu    Principal Investigator: Jason H Mateika, Ph.D. Less <<
NCT01256398 Acute Lymphoblastic Leukemia ... More >> Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting - -
NCT01008462 B-Cell Prolymphocytic Leukemia... More >> Hypodiploidy Loss of Chromosome 17p Plasma Cell Leukemia Progression of Multiple Myeloma or Plasma Cell Leukemia Recurrent Adult Hodgkin Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Non-Hodgkin Lymphoma Refractory Plasma Cell Myeloma Refractory Small Lymphocytic Lymphoma t(14;16) t(4;14) T-Cell Prolymphocytic Leukemia Waldenstrom Macroglobulinemia Less << Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mohamed L. Sorror    206-667-6298    msorror@fhcrc.org    Principal Investigator: Mohamed L. Sorror          United States, Wisconsin Froedtert and the Medical College of Wisconsin Completed Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00720109 Adult B Acute Lymphoblastic Le... More >>ukemia With t(9;22)(q34;q11.2); BCR-ABL1 Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Phase 3 Completed - -
NCT00521014 - Completed - -
NCT00557193 - Completed - -
NCT00792948 Acute Lymphoblastic Leukemia ... More >> Adult Acute Lymphoblastic Leukemia in Remission Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Adult L1 Acute Lymphoblastic Leukemia Adult L2 Acute Lymphoblastic Leukemia Adult T Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting September 24, 2019 -
NCT00557193 Acute Lymphoblastic Leukemia ... More >> Acute Undifferentiated Leukemia Childhood T Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - -
NCT00792948 - Active, not recruiting - -
NCT01371630 Acute Lymphoblastic Leukemia ... More >> B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Recruiting August 31, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-7026       Principal Investigator: Elias Jabbour Less <<
NCT03479918 Lymphoma, High-Grade Phase 3 Recruiting March 15, 2024 Russian Federation ... More >> National Research Center for Hematology Recruiting Moscow, Russian Federation, 125167 Contact: Elena Parovichnikova, MD, PhD       director@blood.ru    Sub-Investigator: Sergey Kravchenko, MD, PhD          Sub-Investigator: Anna Misyurina, MD, PhD          Sub-Investigator: Aminat Magomedova, MD, PhD          Sub-Investigator: Sergey Kulikov, PhD          Sub-Investigator: Alla Kovrigina, PhD          Sub-Investigator: Tatiana Obukhova, PhD Less <<
NCT02844530 CD22+ Relapsed/Refractory B-AL... More >>L Less << Phase 2 Withdrawn - France ... More >> CHU de Clermont-Ferrand Clermont-Ferrand, France, 63000 Less <<
NCT02101853 B Acute Lymphoblastic Leukemia Phase 3 Recruiting - -
NCT01190930 Acute Lymphoblastic Leukemia ... More >> Adult B Lymphoblastic Lymphoma Ann Arbor Stage I B Lymphoblastic Lymphoma Ann Arbor Stage II B Lymphoblastic Lymphoma Childhood B Acute Lymphoblastic Leukemia Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Childhood B Lymphoblastic Lymphoma Down Syndrome Hypodiploid B Acute Lymphoblastic Leukemia Intrachromosomal Amplification of Chromosome 21 Philadelphia Chromosome Positive Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Active, not recruiting - -
NCT02112916 Adult T Acute Lymphoblastic Le... More >>ukemia Ann Arbor Stage II Adult Lymphoblastic Lymphoma Ann Arbor Stage II Childhood Lymphoblastic Lymphoma Ann Arbor Stage III Adult Lymphoblastic Lymphoma Ann Arbor Stage III Childhood Lymphoblastic Lymphoma Ann Arbor Stage IV Adult Lymphoblastic Lymphoma Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma Childhood T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Suspended(Other - Temporary cl... More >>osure) Less << - -
NCT02003222 Acute Lymphoblastic Leukemia ... More >> B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative BCR/ABL1 Fusion Protein Negative Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting - -
NCT02883049 B Acute Lymphoblastic Leukemia... More >> Central Nervous System Leukemia Ph-Like Acute Lymphoblastic Leukemia Testicular Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting - -
NCT03250338 Relapsed/Refractory Acute Myel... More >>oid Leukemia With FLT3 Activating Mutations Less << Phase 3 Recruiting October 2021 United States, California ... More >> UC Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Brian Jonas, MD    916-734-5959       United States, Kansas Kansas University Recruiting Kansas City, Kansas, United States, 666160 Contact: Sunil Abhyankar, MD          Principal Investigator: Sunil Abhyankar, MD          United States, Michigan Karmanos Cancer Center Recruiting Detroit, Michigan, United States, 48201 Contact: Jay Yang, MD       yangj@karmanos.org    Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Yue Guo, MD          Principal Investigator: Yue Guo, MD          United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Eunice Wang, MD          Principal Investigator: Eunice Wang, MD Less <<
NCT01827605 Relapsed Follicular Lymphoma Phase 3 Recruiting April 2019 -
NCT02339740 Acute Promyelocytic Leukemia W... More >>ith PML-RARA Less << Phase 3 Recruiting - -
NCT03393611 Myelodysplastic Syndromes ... More >> Leukemia, Myeloid, Acute Leukemia, Relapsed Adult Acute Myeloid Myelodysplastic Syndromes, Previously Treated Less << Phase 1 Recruiting November 30, 2021 United States, New York ... More >> Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Jennifer Bourke, RN    212-746-2844    jeb9097@med.cornell.edi    Contact: Usama Gergis, MD    646-962-7950    usg2001@med.cornell.edu    Principal Investigator: Usama Gergis, MD          Sub-Investigator: Koen van Besien, MD          Sub-Investigator: Tsiporah Shore, MD          Sub-Investigator: Sebastian Mayer, MD Less <<
NCT00039377 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Less << Phase 2 Completed - -
NCT03007147 B Acute Lymphoblastic Leukemia... More >> BCR-ABL1 Fusion Protein Expression Minimal Residual Disease Philadelphia Chromosome Positive T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting June 30, 2026 -
NCT02665065 Acute Myeloid Leukemia ... More >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Less << Phase 3 Recruiting June 2020 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Less <<
NCT02042391 Posttransplant Lymphoprolifera... More >>tive Disorder Less << Phase 2 Recruiting December 2022 Germany ... More >> Uniklinik RWTH Aaachen Klinik für Onkologie, Hämatologie und Stammzell-transplantation Med. Klinik IV Recruiting Aachen, Germany, 52074 Charite Universitätsmedizin Berlin Campus Mitte, Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie Recruiting Berlin, Germany, 10117 Charité - Universitätsmedizin Berlin CCM Medizinische Klinik m. S. Nephrologie Recruiting Berlin, Germany, 10117 Universitätsklinikum Bonn Med. Klinik III/ZIM Hämatologie/Onkologie Recruiting Bonn, Germany, 53105 DIAKO Bremen gGmbH, Klinik für Hämatologie und Onkologie Recruiting Bremen, Germany, 28239 Universitätsklinikum Erlangen Med. Klinik 5 Hämatologie und Intern. Onkologie Recruiting Erlangen, Germany, 91054 Universitätsklinikum Essen Klinik für Hämatologie Recruiting Essen, Germany, 45147 Malteser Krankenhaus St. Franziskus-Hospital Med. Klinik 1 Recruiting Flensburg, Germany, 24939 Universitätsklinikum Frankfurt Med. Klinik III, Nephrologie Recruiting Frankfurt/Main, Germany, 60590 Universitätsklinikum Gießen Med. Klinik IV Recruiting Gießen, Germany, 35385 Universitätsmedizin Göttingen, Klinik für Hämatologie und medizinische Onkologie Not yet recruiting Göttingen, Germany, 37075 Nephrologisches Zenrtum Niedersachsen Not yet recruiting Hann-Münden, Germany, 34346 Medizinische Hochschule Hannover Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation Recruiting Hannover, Germany, 30625 Medizinische Universitätsklinik Heidelberg Abteilung Innere Medizin V Recruiting Heidelberg, Germany, 69120 II. Medizinische Klinik, Universitätsklinikum Schleswig-Holstein Campus Kiel Recruiting Kiel, Germany, 24105 Universitätsmedizin der Johannes-Gutenberg-Universität III. Medizinische Klinik Recruiting Mainz, Germany, 55101 Klinikum der Universität München-Großhadern Med. Klinik III Recruiting München, Germany, 81377 Klinikum Oldenburg gGmbH Klinik für Innere Medizin II Recruiting Oldenburg, Germany, 26133 Klinikum Passau II. Med. Klinik Recruiting Passau, Germany, 94032 Universitätsmedizin Rostock Klinik für Innere Medizin III Hämatologie, Onkologie, Palliativmedizin Not yet recruiting Rostock, Germany, 18057 Klinikum Stuttgart Klinik für Hämatologie und int. Onkologie Recruiting Stuttgart, Germany, 70174 Less <<
NCT00016302 T-cell Childhood Acute Lymphob... More >>lastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00002925 Leukemia Phase 1 Phase 2 Completed - -
NCT00022737 Childhood Acute Lymphoblastic ... More >>Leukemia in Remission Recurrent Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00199186 Philadelphia Positive Acute Ly... More >>mphoblastic Leukemia Lymphoid Blastic Phase of Chronic Myeloid Leukemia Less << Phase 2 Unknown - Germany ... More >> Medizinische Klinik II, Johann Wolfgang Goethe Universität Recruiting Frankfurt/Main, Germany, 60590 Contact: Oliver G Ottmann, M.D.    ++49-69-6301-0 ext 6221    ottmann@em.uni-frankfurt.de Less <<
NCT00381680 B-cell Childhood Acute Lymphob... More >>lastic Leukemia L1 Childhood Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - -
NCT01773187 Primary Myelofibrosis ... More >> Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis Less << Phase 3 Terminated - -
NCT00039377 - Completed - -
NCT00057811 - Completed - -
NCT00302003 - Unknown - -
NCT00671034 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - -
NCT00381680 - Completed - -
NCT00302003 Childhood Favorable Prognosis ... More >>Hodgkin Lymphoma Childhood Lymphocyte Depletion Hodgkin Lymphoma Childhood Mixed Cellularity Hodgkin Lymphoma Childhood Nodular Sclerosis Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Less << Phase 3 Unknown - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00866918 Childhood Acute Promyelocytic ... More >>Leukemia (M3) Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - -
NCT00057811 Childhood Burkitt Lymphoma ... More >> Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00866918 - Completed - -
NCT00499018 Diffuse Large B-Cell Lymphoma ... More >> IPI≥2 Less << Phase 3 Unknown September 2013 -
NCT00671034 - Completed - -
NCT01424982 Acute Lymphoblastic Leukemia ... More >> Adult Acute Lymphoblastic Leukemia in Complete Remission B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Philadelphia Chromosome Positive Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting October 31, 2021 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-7026       Principal Investigator: Elias Jabbour Less <<
NCT00131027 Lymphoblastic Leukemia, Acute Phase 3 Unknown September 2011 Japan ... More >> Department of Hematology, Nagoya University Graduate School of Medicine Recruiting Nagoya, Japan, 466-8550 Contact: Fumihiko Hayakawa, MD       bun-hy@med.nagoya-u.ac.jp    Principal Investigator: Fumihiko Hayakawa, MD Less <<
NCT00599937 Leukemia, Promyelocytic, Acute Phase 3 Completed - -
NCT02316613 - Completed - France ... More >> Neuilly-sur-seine, France, 92521 Less <<
NCT02356159 Myelodysplastic Syndrome ... More >> Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Acute Leukemia Multiple Myeloma Less << Phase 1 Phase 2 Recruiting January 1, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT00377169 - Completed - -
NCT03390387 Childhood Acute Lymphoblastic ... More >>Leukemia Less << Not Applicable Recruiting November 2025 -
NCT00592111 Pediatric Hod... More >>gkin's Disease Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00558220 Diffuse Large B-Cell Lymphoma.... More >> Primary Mediastinal B-Cell Lymphoma Follicular Lymphoma Grade III Less << Phase 2 Completed - Czech Republic ... More >> University Hospital Brno-Bohunice Brno, Czech Republic, 625 00 Hospital Chomutov Chomutov, Czech Republic, 430 12 University Hospital Hradec Králové Hradec Králové, Czech Republic, 500 05 University Hospital Královské Vinohrady Prague, Czech Republic, 100 34 General University Hospital Prague, Czech Republic, 128 08 University Hospital Motol Prague, Czech Republic, 150 00 Hospital Ústí nad Labem Usti nad Labem, Czech Republic, 401 13 Hospital České Budějovice České Budějovice, Czech Republic Less <<
NCT01364363 Severe Aplastic Anemia ... More >> Paroxysmal Nocturnal Hemoglobinuria Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Myeloproliferative Syndromes Chronic Myelogenous Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Multiple Myeloma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Large Granulocytic Leukemia Less << Not Applicable Recruiting January 2023 United States, California ... More >> Scripps Green Hospital Recruiting La Jolla, California, United States, 92037 Contact: Carol Burian    858-554-2845    Burian.Carol@scrippshealth.org    Principal Investigator: Jeffrey W. Andrey, MD Less <<
NCT01429610 Precursor Cell Lymphoblastic L... More >>eukemia-Lymphoma Less << Phase 2 Active, not recruiting January 1, 2019 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun, Chollanamdo, Korea, Republic of Hematologic Oncology Clinic, National Cancer Center Ilsan, Kongki, Korea, Republic of Division of Hematology-Oncology, Dong-A University College of Medicine Busan, Korea, Republic of Dong-A University College of Medicine Busan, Korea, Republic of Inje University Busan Paik Hospital Busan, Korea, Republic of Inje University Haeundae-Paik Hospital Busan, Korea, Republic of Kosin University College of Medicine, Kosin University Gospel Hospital Busan, Korea, Republic of Catholic University of Daegu School of Medicine Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Kyungpook National Unviersity Hospital Daegu, Korea, Republic of Yeungnam University College of Medicine Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of Chung-Ang University Hospital Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Soonchunhyang University Hospital Seoul, Korea, Republic of Ulsan University Hospital, University of Ulsan College of Medicine Ulsan, Korea, Republic of Less <<
NCT02316613 - Completed - -
NCT02036489 Acute Lymphobkastic Leukemia Phase 4 Recruiting December 2019 Spain ... More >> Hospital Germans Trias i Pujol Recruiting Barcelona, Spain Contact: Josep Mª Ribera, Dr       jribera@iconcologia.net Less <<
NCT01045889 HIV-related Lymphoma ... More >> HIV Infections Less << Phase 2 Completed - Italy ... More >> AO Spedali Civili di Brescia Brescia, Italy, 25123 Less <<
NCT03515200 Acute Lymphoblastic Leukemia, ... More >>in Relapse Acute Lymphoblastic Leukemia With Failed Remission Less << Phase 1 Recruiting September 2022 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Tanja A. Gruber, MD, PhD Less <<
NCT00554164 Lymphoma, High-grade Phase 3 Completed - Germany ... More >> Department of Hematology, University Hospital Essen Essen, Germany, 45122 Less <<
NCT00586547 Leukemia Canc... More >>er Less << Phase 1 Completed - United States, Texas ... More >> Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00466258 HIV Infections ... More >> Diffuse Large B Cell Lymphoma Less << Phase 4 Completed - Spain ... More >> H. Son Llatzer Palma de Mallorca, Baleares, Spain Germans Trias i Pujol Badalona, Barcelona, Spain Consorci Sanitari de Mataró Mataro, Barcelona, Spain H. Parc Taulí Sabadell, Barcelona, Spain Consorci Sanitari de Terrassa Terrassa, Barcelona, Spain Hospital de Navarra Pamplona, Navarra, Spain H. Clínic i Provincial, Barcelona Barcelona, Spain H. Vall d'Hebron, Barcelona Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Sant Pau, Barcelona Barcelona, Spain ICO - Duran i Reynals, Hospitalet de Llobregat Barcelona, Spain ICO - Josep Trueta Girona, Spain H. Gregorio Marañón Madrid, Spain H. Joan XXIII Tarragona, Spain Hospital Universitario Dr. Peset Valencia, Spain Less <<
NCT00572221 Underperforming Nursing Homes Not Applicable Completed - United States, Massachusetts ... More >> Institute for Aging Research, Hebrew Senior Life Roslindale, Massachusetts, United States, 02131 Less <<
NCT00604916 Pneumonia Early Phase 1 Completed - -
NCT02842931 Diffuse Large B-Cell Lymphoma Phase 3 Recruiting February 2023 Russian Federation ... More >> National Research Center for Hematology Recruiting Moscow, Russian Federation, 125167 Contact: Aminat U Magomedova, MD, PhD    495-613-2446 ext 007    maminat@mail.ru    Contact: Sergay K Kravchenko, MD, PhD    495-613-2446 ext 007    krav-hsc-ramn@mail.ru    Principal Investigator: Aminat U Magomedova, MD, PhD          Sub-Investigator: Sergey K Kravchenko, MD, PhD          Sub-Investigator: Anna E Misurina, MD, PhD Less <<
NCT03572075 Endometriosis Not Applicable Recruiting April 2019 Italy ... More >> Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi Hospital Recruiting Bologna, BO, Italy, 40138 Contact: Simona Del Forno    00393288948806    simona.delforno2@unibo.it    Principal Investigator: Mohamed Mabrouk          Principal Investigator: Renato Seracchioli          Principal Investigator: Simona Del Forno          Sub-Investigator: Diego Raimondo          Sub-Investigator: Alessandro Arena Less <<
NCT01498601 Pneumonia Not Applicable Completed - Canada, British Columbia ... More >> Royal Columbian Hospital New Westminster, British Columbia, Canada, V3L 3W7 Less <<
NCT01498601 - Completed - -
NCT02425904 Langerhans Cell Histiocytosis Phase 2 Recruiting September 2022 United States, Arizona ... More >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85016 Contact: Michael Henry, MD    602-933-0920    MHenry@phoenixchildrens.com    United States, Arkansas Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Kimo Stine, MD    501-364-1494    StineKimoC@uams.edu    United States, California Children's Hospital of Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Rima Jubran, MD    323-361-5639    rjubran@chla.usc.edu    University of California San Francisco Medical Center Recruiting San Francisco, California, United States, 94143 Contact: Michelle Hermiston, MD    415-476-3831    HermistonM@peds.ucsf.edu    United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Stephen Ladisch, MD       sladisch@childrensnational.org    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: David Ebb, MD    617-726-2737    DEBB@mgh.harvard.edu    Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Barbara Degar, MD    617-632-5186    Barbara_Degar@dfci.harvard.edu    Principal Investigator: Barbara Degar, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Barbara Degar, MD    617-632-5186    barbara_degar@dfci.harvard.edu    Principal Investigator: Barbara Degar, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Eric Jacobsen, MD    617-632-6633    EdJacobsen@partners.org    United States, New York Mount Sinai Medical Center Recruiting New York, New York, United States, 10029 Contact: Birte Wistinghausen, MD    212-241-7022    Birte.wistinghausen@mssm.edu    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Ashish Kumar, MD    513-803-1631    Ashish.Kumar@cchmc.org    United States, Pennsylvania The Children's Hospital of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Michael Hogarty, MD    215-590-2821    hogartym@email.chop.edu    United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Patrick Campbell, MD       patrick.campbell@stjude.org    Principal Investigator: Patrick Campbell, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carl Allen, MD    832-822-4890    ceallen@txch.org Less <<
NCT00057005 Leukemia Phase 1 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT01941680 - Active, not recruiting March 2021 Guadeloupe ... More >> CHU Pinteà Pitre/Abymes Pointe à Pitre, Guadeloupe Martinique CHU de Martinique Fort de France, Martinique Less <<
NCT00498836 Malignant Melanoma Phase 2 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Cancer Therapy and Research Center, Institute for Drug Development San Antonio, Texas, United States, 78229 Norway The Norwegian Radium Hospital Oslo, Norway, NO-0310 Sweden Lund University Hospital Lund, Sweden, SE-221 85 Umeå University Hospital Umeå, Sweden Uppsala University Hospital Uppsala, Sweden, SE-751 85 Less <<
NCT00526305 Acute Lymphoblastic Leukemia Phase 4 Completed - -
NCT02055781 Primary Myelofibrosis ... More >> Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis Less << Phase 3 Terminated - -
NCT00526409 Acute Lymphoblastic Leukemia Phase 4 Completed - Spain ... More >> Hospital materno Infantil vall d'Hebrón Barcelona, Spain Hospital Niño Jesús Madrid, Spain Hospital Virgen de la Arrixaca Murcia, Spain Hospital Infantil Carlos Haya Málaga, Spain Less <<
NCT00131053 Lymphoblastic Leukemia, Acute Phase 2 Unknown September 2011 Japan ... More >> Department of Hematology, Nagoya University Graduate School of Medicine Recruiting Nagoya, Japan, 466-8550 Contact: Fumihiko Hayakawa, MD       bun-hy@med.nagoya-u.ac.jp    Principal Investigator: Fumihiko Hayakawa, MD Less <<
NCT00016887 Lymphoma Phase 3 Unknown - Belgium ... More >> AZ Sint-Jan Brugge, Belgium, 8000 Italy Ospedale Civile Alessandria Alessandria, Italy, I-15100 Less <<
NCT00025636 Lymphoma Phase 3 Unknown - -
NCT00000658 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 3 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 900331079 UCLA CARE Center CRS Los Angeles, California, United States, 90095 Ucsf Aids Crs San Francisco, California, United States, 941102859 United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80262 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States, 60612 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 462025250 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States United States, Massachusetts Beth Israel Deaconess Med. Ctr., ACTG CRS Boston, Massachusetts, United States, 02118 Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States, 02215 Bmc Actg Crs Boston, Massachusetts, United States United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 Beth Israel Med. Ctr. (Mt. Sinai) New York, New York, United States, 02215 NY Univ. HIV/AIDS CRS New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Ctr. New York, New York, United States, 10021 Univ. of Rochester ACTG CRS Rochester, New York, United States, 14642 United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States, 275997215 United States, Ohio Case CRS Cleveland, Ohio, United States The Ohio State Univ. AIDS CRS Columbus, Ohio, United States, 432101228 United States, Pennsylvania Hosp. of the Univ. of Pennsylvania CRS Philadelphia, Pennsylvania, United States, 19104 Pitt CRS Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00198991 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)69 6301 5194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)69 6301 6365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT00199056 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00199004 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital of Frankfurt, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00199017 Lymphoma, Lymphoblastic Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00012051 Lymphoma Phase 3 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Netherlands HagaZiekenhuis - Locatie Leyenburg 's-Gravenhage, Netherlands, 2545 CH Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands, 5211 NL Meander Medisch Centrum Amersfoort, Netherlands, 3816 CP Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 BE Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1081HV Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7500 KA University Medical Center Groningen Groningen, Netherlands, 9713 EZ Medisch Centrum Leeuwarden - Zuid Leeuwarden, Netherlands, 8934 AD Leiden University Medical Center Leiden, Netherlands, 2300 CA Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Isala Klinieken - locatie Sophia Zwolle, Netherlands, 8000 GK Less <<
NCT00061945 Acute Undifferentiated Leukemi... More >>a B-cell Adult Acute Lymphoblastic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia L1 Adult Acute Lymphoblastic Leukemia L1 Childhood Acute Lymphoblastic Leukemia L2 Adult Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00199069 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany Less <<
NCT00276809 Chronic Lymphocytic Leukemia Phase 2 Completed - Germany ... More >> Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany, D-12200 Universitaetsklinikum Essen Essen, Germany, D-45122 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Medizinische Hochschule Hannover Hannover, Germany, D-30625 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69120 Staedtisches Klinikum Karlsruhe gGmbH Karlsruhe, Germany, 76133 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24105 Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany, D-39120 Universitatsklinik Mainz Mainz, Germany, 55101 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 Less <<
NCT00130195 Acute Lymphoblastic Leukemia Phase 2 Completed - Japan ... More >> Department of Hematology, Nagoya University Graduate School of Medicine Nagoya, Japan, 466-8550 Less <<
NCT00002761 Leukemia Phase 1 Phase 2 Withdrawn(PI left institution) - -
NCT03753581 Electric Stimulation Therapy Not Applicable Enrolling by invitation March 30, 2020 Spain ... More >> Juan Avendaño-Coy Toledo, Spain, 45071 Less <<
NCT00003631 - Completed - -
NCT00002552 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00002785 Leukemia Phase 2 Completed - -
NCT00439296 Recurrent Pediatric ALL ... More >> Relapsed Pediatric ALL Acute Lymphoblastic Leukemia Refractory Pediatric ALL Less << Phase 1 Terminated(The study was stopp... More >>ed due to poor accrual and lack of funding.) Less << - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 United States, New York New York University Medical Center New York, New York, United States, 10016 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00317408 Lymphoma Not Applicable Unknown - -
NCT00061945 - Completed - -
NCT00003631 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00080925 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00002868 Leukemia Phase 3 Completed - United States, New Jersey ... More >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States, 07701 United Kingdom Royal Infirmary Glasgow, Scotland, United Kingdom, G4 0SF Less <<
NCT00440726 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 United States, New York New York University Medical Center New York, New York, United States, 10016 Children's Hospital New York-Presbyterian New York, New York, United States, 10032 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00002514 Leukemia Phase 3 Completed - -
NCT00022126 Leukemia Phase 2 Completed - -
NCT00004231 Lymphoma Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00003187 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Phase 2 Phase 3 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Kentucky Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States, 40536-0084 United States, Minnesota University of Minnesota Medical School Minneapolis, Minnesota, United States, 55455 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 United States, Ohio Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, South Carolina University of South Carolina School of Medicine Columbia, South Carolina, United States, 29203 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84132 United States, Virginia Massey Cancer Center Richmond, Virginia, United States, 23298-0037 United States, Wisconsin Midwest Children's Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00002691 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00454480 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Phase 3 Completed - -
NCT00005985 Lymphoma Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00002718 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00002756 Leukemia Phase 2 Completed - -
NCT00198978 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)6963015194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)6963016365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT00199082 Burkitt's Lymphoma ... More >> Burkitt's Leukemia Mediastinal Neoplasms Lymphoblastic Lymphoma Large Cell Anaplastic Lymphoma Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00003215 Lymphoma Phase 3 Completed - Austria ... More >> Allgemeines Krankenhaus der Stadt Wien Vienna, Austria, A-1090 Germany Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, D-65199 Greece Saint Savvas Cancer Hospital of Athens Athens, Greece, 11522 Italy European Institute of Oncology Milano, Italy, 20141 Switzerland Universitatsspital-Basel Basel, Switzerland, CH-4031 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital, Bern Bern, Switzerland, CH-3010 Ratisches Kantons und Regionalspital Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Collonge-Bellerive, Switzerland, CH-1245 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, 1011 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Klinik Hirslanden Zurich, Switzerland, CH-8008 Less <<
NCT00070174 Leukemia Phase 2 Completed - -
NCT00003815 Lymphoma Phase 3 Unknown - United Kingdom ... More >> Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Less <<
NCT00003650 Lymphoma Phase 3 Unknown - France ... More >> Centre Leon Berard Lyon, France, 69373 Less <<
NCT00238368 Lymphoma Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00005802 Leukemia Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00005603 Leukemia Phase 3 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States, 94304 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0128 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Illinois Saint Jude Midwest Affiliate Peoria, Illinois, United States, 61637 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216-4505 United States, New York Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio Children's Hospital Medical Center - Cincinnati Cincinnati, Ohio, United States, 45229-3039 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97201-3098 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555-0361 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00002700 Leukemia Lymp... More >>homa Less << Phase 3 Completed - -
NCT00199095 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00002865 Leukemia Phase 2 Completed - United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 Less <<
NCT00003437 Leukemia Phase 3 Unknown - United Kingdom ... More >> Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Less <<
NCT00003728 Leukemia Lymp... More >>homa Less << Phase 3 Unknown - Belgium ... More >> Ziekenhuis Netwerk Antwerpen Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Ghent University Ghent, Belgium, B-9000 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34059 CHR Hotel Dieu Nantes, France, 44035 Hopital de l'Archet CHU de Nice Nice, France, F-06202 CHU - Hopital Robert Debre Paris, France, 75019 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Instituto Portugues de Oncologia Centro do Porto, SA Porto, Portugal, 4200 Less <<
NCT00027547 Leukemia Phase 1 Phase 2 Completed - United States, Oregon ... More >> Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Less <<
NCT00003423 Lymphoma Phase 3 Unknown - United Kingdom ... More >> Hospital for Sick Children NHS Trust London, England, United Kingdom, WC1N 3JH Less <<
NCT00002676 Lymphoma Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Colorado CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States, 80209-5031 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Columbus Columbus, Ohio, United States, 43206 CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.58mL

0.72mL

0.36mL

17.88mL

3.58mL

1.79mL

35.76mL

7.15mL

3.58mL
Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

[1]Iwasaki H, Huang P, et al. Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells. Blood. 1997 Jul 1;90(1):270-8.

[2]Johnson SA, et al. Nucleoside analogues in the treatment of haematological malignancies. Expert Opin Pharmacother. 2001 Jun;2(6):929-43.

[3]Wills P, Hickey R, et al. A novel in vitro model system for studying the action of ara-C. Cancer Chemother Pharmacol. 1996;38(4):366-72.

[4]Wang Z, Wang S, et al. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21CIP1 in leukemic cell (U937) differentiation induced by low concentrations of 1-beta-D-arabinofuranosylcytosine. Differentiation. 2000 Aug;66(1):1-13.

[5]Wang X, Chen Z, et al. Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition. Haematologica. 2018 Mar;103(3):466-476.

[6]Schwieger J, Esser KH, et al. Establishment of a long-term spiral ganglion neuron culture with reduced glial cell number:

 

Historical Records

Categories

Inhibitors/Agonists
Cell Cycle
Nucleoside Antimetabolite/Analog
Inhibitors/Agonists
DNA Damage
Nucleoside Antimetabolite/Analog

Tags: Cytarabine | Cytosine β-D-arabinofuranoside | Cytosine Arabinoside | Ara-C | Cytosine Arabinoside hydrochloride | Ara-C hydrochloride | Cytosine β-D-arabinofuranoside hydrochloride | DNA Synthesis | Nucleoside Antimetabolite | Nucleoside Analog | nucleoside analog | DNA synthesis inhibitor | acute myeloid leukemia | chronic myelogenous leukemia | chemotherapy | apoptosis | 69-74-9